cell_line_id,drug_id,response
B-CPAP,135421197,1.178862358485884
SF268,71751553,4.591733155494545
SNU-1214,135984461,4.331180195663339
GOS-3,54618771,2.751038853336045
A-673,2742550,4.033526638201744
RT-4,9911463,3.5197462916355073
MV4-11,sirolimus-bortezomib (250-1 mol-mol),-0.4533727146594301
JHUEM-7,9915743,2.288162918918336
SNU-899,selumetinib-GDC-0941 (4-1 mol-mol),0.9114020833269496
HCC1438,selumetinib-GDC-0941 (4-1 mol-mol),1.8999757097381424
GCT,65628,3.937581767993038
JHH-6,9926054,3.460826847853425
Caki-1,54618771,1.6306245872023055
CAL-33,135659046,3.957573500074978
RPMI-8226,100016,4.270983790022636
OCI-Ly3,9926054,1.7075624586647575
HCC-56,6918638,0.2361722846831457
COLO 699,9884685,-1.6553137427056115
Capan-1,54618771,1.2966911040963736
Ri-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1783875799681585
TALL-1 [Human adult T-ALL],9915743,0.282075897468642
NCI-H1915,6918638,-0.1155536778195901
JHUEM-1,71751553,4.152599364438323
PE/CA-PJ15,135659046,3.5653102065107176
647V,49836020,-1.4541135312501283
BICR 6,9911463,4.323874314228029
HCC4006,6918638,1.1355769823914148
NCI-H2106,2742550,3.343740248931034
Mel Ho,65628,4.368881393126495
BICR 56,136227924,3.153782585129781
SK-N-AS,selumetinib-GDC-0941 (4-1 mol-mol),-0.6593922451468693
JJN-3,9915743,0.8433303744027496
SK-MEL-2,3854666,3.3106573281169664
RL,9926054,1.8760180722442283
8-MG-BA,54618771,3.7934452714384954
Hs 683,10322450,2.9588176453624766
SF539,9926054,1.722417855539817
KP-2,54618771,1.1956106328766414
IGR-39,selumetinib-GDC-0941 (4-1 mol-mol),2.3690668734503415
SW948,4705,1.720002028261835
BT 232,1566236,2.96800449677677
YH-13,6918638,0.7209706519949683
NCI-H2405,9868037,0.0658407711920554
TOV-112D,9911463,4.387944714861712
SW1990,11152667,-1.371942963553871
Panc 02.03,9911463,4.953148943637795
MHH-ES-1,3854666,0.6560806360047275
NCI-H522,9911463,3.273817127322074
K-562,135421197,2.032823128578147
A-549,3465537,3.857188765779011
BT 340,9911463,3.653234979635605
A3/Kawakami,54618771,0.7801439877237109
TE-14,1566236,3.7463982876900177
COV362,sirolimus-bortezomib (250-1 mol-mol),0.7278420573421237
SW948,1566236,2.0550116218076235
HT-1376,selumetinib-GDC-0941 (4-1 mol-mol),5.083732024121345
HT-1080,9911463,3.8798634306890105
LOX-IMVI,54618771,-0.8031507578309087
G-402,selumetinib-GDC-0941 (4-1 mol-mol),1.3603902664341745
FTC-238,135984461,5.145147478477925
BT 187,9911463,2.9501767294250607
Hs 940.T,9868037,4.608468279286332
SK-N-MC,71751553,4.671564506916946
NCI-H2106,9915743,2.062061101089789
U266B1,9911463,4.2942847065196394
Kasumi-2,3854666,0.5999676074569762
MDA-MB-361,3465537,1.4227411882949614
MDA-MB-453,9935249,2.561550169446695
UACC-257,10322450,5.085942175181601
NCI-H520,65628,4.358434508292663
SUIT-2,11152667,1.417612600480328
A-204,selumetinib-GDC-0941 (4-1 mol-mol),0.2553877558733737
HSC-2,71751553,4.4976955122650155
BT-12,6918638,1.843242029093903
RD,11152667,0.3513258141441123
JHUEM-2,11152667,-0.7431230896020583
BT 422,sirolimus-bortezomib (250-1 mol-mol),0.5835017840972496
MeWo,4705,3.307515593807436
TT2609-C02,9884685,3.4868790724366425
FTC-238,71751553,4.356328665274234
647V,3854666,1.0737576185285356
AML-193,2746,2.0410312997302698
AsPC-1,11152667,-0.9426796832875202
HOP-62,2742550,5.0895590073246595
Hs 888.T,9884685,1.2229455399044955
KMS-12-BM,2746,1.2802142564618226
COV644,11152667,0.0100466059649179
COLO 792,sirolimus-bortezomib (250-1 mol-mol),0.2253153763681567
RL,100016,6.4335673885856135
TE-11,11494412,-0.2865529339214188
TE-14,136227924,3.1216716097465365
KLE,9935249,5.162792026951856
HCC1143,100016,7.122041956726765
MOTN-1,9911463,3.133435605539891
KMS-11,135984461,2.862381632910091
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
SNU-761,54618771,-1.251470969575028
HCC44,11152667,-1.1903603696824805
NCI-H841,11494412,-0.8697727818940187
5637,tanespimycin-bortezomib (250-1 mol-mol),-0.6809849161541731
WSU-DLCL2,sirolimus-bortezomib (250-1 mol-mol),-6.394861252001346
697,71751553,3.5236027453781404
BT 245,9926054,2.9422912383021393
SK-BR-3,100016,6.79119351825136
PaTu 8988s,selumetinib-GDC-0941 (4-1 mol-mol),-0.6255434999404949
ChaGo-K-1,2742550,3.263905661793297
JHH-5,100016,5.964491744827364
HCC1428,9926054,2.453077305759455
HCC827,3854666,0.8630947489226746
SK-MEL-24,11152667,1.2067542330034051
TE-10,65628,4.400493664627162
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
Rh18,3854666,3.614341837202171
NCI-H1581,9884685,0.1991439741532774
P12-Ichikawa,selumetinib-GDC-0941 (4-1 mol-mol),1.616010765024319
SUP-B15,6918638,-0.8049733622393979
SNU-398,54639665,-0.6353401826184709
OAW42,135421197,2.0874020814941643
CFPAC-1,9911463,4.23074803596426
SNU-761,136227924,3.0890701215325085
RCC10RGB,9911463,4.415558893727306
HSC-3,9935249,4.975494741872852
JHH-5,9911463,2.4505780103780563
SNU-685,65628,4.307858928134081
MOLP-8,9935249,-5.983061984872936
SUP-T1,9911463,3.1631435618556827
L-428,4705,3.188037531722373
EoL-1,54639665,4.29545945108559
OAW42,sirolimus-bortezomib (250-1 mol-mol),1.527275498618008
BHT-101,9926054,1.1931762912946844
TALL-1 [Human adult T-ALL],selumetinib-GDC-0941 (4-1 mol-mol),0.2604149322081276
AN3-CA,71751553,3.9967289000483097
CAL-62,100016,6.567555445612565
MOLP-2,2746,2.18726921703514
JeKo-1,9915743,1.243422351043917
OCI-Ly10,65628,4.9673691925811685
MKN74,54618771,1.3558742291917982
NCI-H2405,136227924,3.1304062683146747
U-251MG,9935249,3.268808759101635
HT-144,sirolimus-bortezomib (250-1 mol-mol),0.2937138425316054
OV7,11152667,1.2259129508261295
SK-N-SH,sirolimus-bortezomib (250-1 mol-mol),0.20777860601932
MEC-1,54618771,0.2642234138424628
FTC-133,65628,4.302527639906617
GOS-3,100016,7.242262816552233
MOLP-2,3465537,2.360381635863911
SH-4,71751553,3.2437962454136016
KYSE-140,9935249,3.7147808884364473
PL-21,136227924,2.3397761554923413
SUIT-2,9935249,5.647291906272881
BT 271,9884685,0.6655753843685114
RVH-421,tanespimycin-bortezomib (250-1 mol-mol),-0.2539281679768233
KALS-1,136227924,3.4972882997363257
HDQ-P1,54618771,4.6079698372057605
SW48,9915743,2.691515978939234
UM-UC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0032411460887714
AU565,9926054,0.9817648939808896
697,135421197,-0.0099062080038934
COLO 680N,54618771,3.898900204814355
NCI-H929,100016,3.8135603062591
SNU-626,tanespimycin-bortezomib (250-1 mol-mol),0.974779826853052
L-540,9911463,3.3305533835855528
U-251MG,tanespimycin-bortezomib (250-1 mol-mol),-1.2552870435525063
NCI-H1341,9915743,0.2650285979263042
KE-39,3854666,4.449857131704124
HSC-3,54618771,0.6642536113718133
SNG-M,24779724,4.480201208969766
SK-N-AS,2742550,3.823682171563052
NCI-H838,1566236,2.1277007205357275
GSU,selumetinib-GDC-0941 (4-1 mol-mol),-0.0301350261262937
ONCO-DG-1,9884685,0.4243352102423045
HEC-1-A,71751553,4.403700885127046
MOLP-2,1566236,1.5712857054768314
Kuramochi,54618771,2.421317406339968
HSC-3,tanespimycin-bortezomib (250-1 mol-mol),-0.9764630835173828
VM-CUB-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2001367648558769
HMCB,136227924,3.0347930044007643
MDA-MB-415,9884685,-0.7698340401064314
NCI-H226,54618771,1.8675416009470285
BT-12,135421197,1.7013160656627575
MSTO-211H,9884685,-1.5007126123703023
SUP-M2,135984461,3.87048061577109
MDA-MB-468,71751553,4.192901853519086
NCI-H1915,54618771,0.2887330377515757
LS123,1566236,1.625300036443469
DB,11494412,-1.392713123619272
SUP-M2,9915743,1.8223517486811256
OVCAR-5,4705,3.2119011926923378
WM793,tanespimycin-bortezomib (250-1 mol-mol),-1.2734227949577797
HCC1806,135421197,3.3559114199150697
2004,2742550,3.45905626352143
MOLT-16,11152667,-3.3929002826964085
KNS-60,136227924,2.463930704521007
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
SNU-423,9884685,0.0513758273382596
NCI-H1299,136227924,3.5346618762414392
NCI-H211,9868037,1.83710145053469
PSN1,sirolimus-bortezomib (250-1 mol-mol),0.321817101338521
AsPC-1,135421197,1.8824248695595285
MES-SA,3465537,3.3813308976048706
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028
HEC-1-A,9868037,3.1210515206348246
ESS-1,3854666,1.0692309253016814
CW-2,2746,2.3288495510322087
TE-5,6918638,0.0730063512653744
TUHR10TKB,9926054,2.161946529406516
NCI-H2171,9915743,0.832341910278816
COLO 205,9935249,3.504893004849407
RL,135659046,3.5403288851191927
Caov-3,135984461,4.111460769399049
JIMT-1,9926054,3.6367846725262543
8-MG-BA,11494412,3.720947721009423
BT 286,selumetinib-GDC-0941 (4-1 mol-mol),-1.4527059239825568
NCI-H1385,11152667,0.7857053918396109
RPMI-8226,9935249,2.1777849990691025
FTC-238,100016,6.441740826290021
SNU-449,11494412,2.814472666417892
NCI-H661,1566236,3.2299922345410006
EoL-1,6918638,-2.889280053807362
SNU-685,100016,6.855109756647912
VMRC-RCW,135984461,3.0066717091132182
HDLM-2,9868037,2.9118865294279943
Hs 578T,3854666,0.9314111663705392
DEL,tanespimycin-bortezomib (250-1 mol-mol),-1.3033090305095067
BHY,49836020,5.6544174202433855
OVCAR-5,9915743,0.3174164391419692
SNU-61,tanespimycin-bortezomib (250-1 mol-mol),-0.3977146693406259
OCI-Ly19,9884685,-0.3928365240686269
JHOS-2,2746,4.554227628602608
SNU-1,135659046,4.075705949169052
Lu-99,135421197,1.2736591779946078
NCI-H446,9884685,-0.3047801458707657
Panc 08.13,9935249,3.22505822571949
DMS 114,3854666,0.9964134582157976
Caov-3,9915743,1.9155459693646115
EHEB,65628,3.796785261187004
MOLM-6,11152667,-3.090915690268157
COR-L105,1566236,2.352597865521479
NU-DHL-1,9935249,0.0276338554577939
L-1236,54618771,1.349542879439561
KYM-1,100016,6.934049900113359
JHUEM-7,9911463,3.659236793496393
NCI-H1563,9868037,3.932153442928962
HCC1806,136227924,2.6306602850580387
BT 498,6918638,3.833356013639187
MKN74,2746,3.2220393473660973
NCI-H460,3854666,3.1385110084048065
GaMG,135659046,4.983259743883316
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
HT-1197,9911463,2.9411019344315217
NCI-H1623,136227924,2.959018127447204
U-118MG,9911463,4.435757923179886
MOLP-2,136227924,2.531478892468582
OV-90,11494412,2.6360991056690053
U-251MG,135984461,4.456560738711495
BT 224,sirolimus-bortezomib (250-1 mol-mol),0.3912560811158826
NCI-H520,9911463,3.6961325383043007
Pfeiffer,100016,6.236222400968574
HEY A8,9926054,2.010020919181283
GDM-1,3854666,0.7201378614035356
8505C,135421197,0.9629586989681284
U-BLC1,9915743,-4.280634530876826
ZR-75-30,54618771,0.9428020193636316
BICR 6,11494412,-0.0780471229924908
TYK-nu,9884685,1.973055967006664
TE-6,9868037,2.429153883082853
SNU-387,sirolimus-bortezomib (250-1 mol-mol),0.5952265743447468
P12-Ichikawa,54618771,-0.5432908489240523
ZR-75-1,2746,4.074441390340067
HCC1438,tanespimycin-bortezomib (250-1 mol-mol),-1.8197339175047005
SYO-1,3854666,0.8909773661164561
DK-MG,1566236,1.8656983972525785
MEC-1,3854666,0.5961187704066611
RCH-ACV,sirolimus-bortezomib (250-1 mol-mol),0.6092850769346084
Aska-SS,tanespimycin-bortezomib (250-1 mol-mol),-0.5241440221117086
KMH-2,tanespimycin-bortezomib (250-1 mol-mol),-0.7573218655291942
BT-474,9868037,4.006182036110513
Sq-1,sirolimus-bortezomib (250-1 mol-mol),0.8750306611034651
EFE-184,73707386,3.690171940356052
JJN-3,tanespimycin-bortezomib (250-1 mol-mol),-0.8037062174146113
SW1417,135659046,3.701977348188013
JJN-3,65628,4.557976519589219
OVCAR-4,2746,3.8556050114326506
HEC-265,9935249,3.718501307594467
Hs 578T,2746,2.072712678704015
DU145,71751553,4.612532696139562
HD-MY-Z,65628,4.144650294210182
GDM-1,135398744,6.258827934702185
SNU-478,65628,4.317035065954759
BICR 16,9915743,1.7576705506596324
RPMI-8226,3854666,0.1565872953150206
ALL-SIL,54618771,-0.3818526805852408
NU-DUL-1,2742550,3.078844862941076
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
SK-N-BE(2),6918638,-0.1264166594674796
Ki-JK,136227924,2.2053195341815424
NCI-H2122,136227924,3.797810316623325
BT 232,sirolimus-bortezomib (250-1 mol-mol),1.5892274515835794
P12-Ichikawa,9915743,0.5856133039095079
NCI-H2172,54618771,2.767787208774524
PaTu 8988t,3854666,2.839522644305469
ONCO-DG-1,9935249,3.554031601583604
BT 245,71751553,4.246004451264995
Ci-1,11152667,-1.2211092701119557
H-STS,100016,5.985929376611731
HuT 78,2746,0.9832751477780014
AGS,136227924,3.766909782373439
NCI-H1793,49836020,4.8036601506688275
YD-10B,3854666,0.8759037420312452
SNU-886,10322450,3.968731934637612
SF268,100016,6.377468220379779
COLO 792,9911463,3.3724671090253793
EC-GI-10,9915743,-1.6990033620090657
KYSE-180,3854666,2.7659153089015898
Panc 05.04,2746,3.125163927586484
KNS-42,3854666,2.658975673692566
NCI-H446,selumetinib-GDC-0941 (4-1 mol-mol),2.0638797586373263
SNU-668,3854666,3.728623982687201
LS180,9911463,3.681535048080384
JJN-3,44487872,5.329764604860554
EJM,54618771,0.5366367501744294
BT 231,3854666,-0.8969243562437486
HuNS1,3854666,0.1228986912397878
HT-144,135984461,4.033555973965414
ESS-1,2746,2.6118901158900423
LOX-IMVI,135398744,6.429324407359154
Hs 822.T,54618771,1.097463284906687
KMS-11,9911463,3.370246429208364
TC-71,10322450,2.6904194400167207
Mono-Mac-1,650361,3.717997934004441
ES-2,54618771,2.1434167327207954
Mono-Mac-1,11152667,-4.583124026355614
TE-9,136227924,3.0742454984310825
SNU-423,1566236,1.8226515664509473
HT-29,sirolimus-bortezomib (250-1 mol-mol),1.8819281446300895
FTC-238,11494412,0.3673314774517735
MFE-296,71751553,4.455327794268508
Caov-3,selumetinib-GDC-0941 (4-1 mol-mol),3.787884726335324
RPMI-8402,9911463,3.009293370203492
NCI-H810,9915743,0.7242422490458518
HD-MY-Z,1566236,1.7825991347956482
PaTu 8988s,tanespimycin-bortezomib (250-1 mol-mol),-2.9825646134003825
647V,11494412,0.9980508040818752
TT2609-C02,9911463,4.397605537094769
SF539,11494412,-0.7610024681264586
RKO,9935249,5.020114551473781
SUP-HD1,135421197,1.0608859931865553
NCI-H838,11152667,-0.3515468004130501
GB-1,3854666,2.326131738518675
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305
NCI-H508,tanespimycin-bortezomib (250-1 mol-mol),-0.2037245877334007
T24,3854666,1.9739653742964731
KYSE-30,2746,4.052809859815596
BC-3C,9926054,1.793966289929591
ZR-75-30,2742550,4.106554973592453
SNU-878,9911463,2.819735999013875
KP-2,3854666,3.6631158292147226
BT 330,9926054,2.1336209959126253
KE-39,9935249,3.082096285966509
Raji,11152667,-1.6469558196734089
BT 428,100016,4.306836909333982
VMRC-RCZ,tanespimycin-bortezomib (250-1 mol-mol),0.3038563935305308
MHH-CALL-3,9911463,4.211712369373876
MDST8,3854666,1.4298592595361392
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
SK-N-SH,3854666,-0.6483541731368345
Karpas-422,65628,4.69981691134154
SNU-1033,2746,3.071869125008986
IGR-37,136227924,2.9944260233382667
RPMI-7951,tanespimycin-bortezomib (250-1 mol-mol),-3.2107041108384524
JMSU-1,49836020,6.465700185404903
Caov-3,2746,3.7712035722232304
TE-15,6918638,-0.5881050446638335
NCI-H1563,71751553,4.037519551970505
BT-16,71751553,4.230204942204508
SK-N-SH,135421197,1.303640254483224
COLO 792,135421197,2.064004994537627
Mino,3465537,1.332066458036503
NCI-H69,9926054,1.6669613133383836
KP-2,4705,3.822790950107379
LOX-IMVI,2746,2.55877549764083
NH-6,135659046,3.541103193914359
SR,3854666,0.7752570600014472
COR-L105,100016,7.1590039780101895
OAW42,3465537,3.409740302129575
JVM-2,9926054,1.9901106639385144
TE-4,4705,1.41757349828419
RS4;11,4705,2.710513990501979
Mono-Mac-6,9884685,-0.179940591951051
NUGC-4,11152667,-1.113957335382959
253J-BV,9915743,1.703363927754684
HeLa,2746,3.522514487554161
OV7,3854666,3.3865666364071223
Daudi,9926054,1.7776420054693636
HMC-1-8,136227924,3.367197210687835
DND-41,135984461,3.0712550622908643
HuCC-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.370448841464423
U-118MG,9926054,1.9994289810495935
MKN74,9884685,2.0469611247981625
MEC-1,9926054,1.8123305243841612
NCI-H838,4705,3.3276720699815563
NCI-H226,selumetinib-GDC-0941 (4-1 mol-mol),3.612309653965627
TE-14,11494412,0.7185329040944464
NCI-H1651,9868037,4.401411250995596
OV-90,135984461,4.4198301628710475
LUDLU-1,135659046,3.627701709010381
NCI-H2196,3854666,0.3982979522037077
NCI-H211,54618771,-0.4464011185148343
KYM-1,135421197,2.2292481943308906
Hs 294T,sirolimus-bortezomib (250-1 mol-mol),0.1024720435012197
Caov-3,49836020,-0.0609342715049496
WM115,3465537,1.2344570371137795
BT-549,1566236,1.7296376770428397
CAL-54,9926054,1.984720179187459
Hs 688(A).T,3465537,3.232721194822597
IMR-32,100016,6.43791059275997
U266B1,11494412,-0.8114470542074865
TTC-709,1566236,1.4753512072750776
NUGC-4,9868037,2.67095726720747
TUHR14TKB,6918638,1.3183057311971391
MOLP-8,100016,7.090961588333011
SK-N-FI,11152667,-1.0361820542951687
A101D,1566236,2.4335097410517914
OVTOKO,sirolimus-bortezomib (250-1 mol-mol),1.6633585904908004
Caki-1,11152667,0.81941066368069
NCI-H1666,selumetinib-GDC-0941 (4-1 mol-mol),-1.4234011879049815
TALL-1 [Human adult T-ALL],100016,4.020437007073488
SNU-503,2746,2.787173124084262
HCC1500,135421197,1.2704457907642457
HEL,9911463,3.4775133545177774
OVCAR-8,11152667,-1.64737502837339
NCI-H2122,3854666,2.0598225653016424
TE-14,9911463,3.9221721376636816
HCC1588,9911463,3.721403474338108
BT 172,3854666,1.4651755366799823
RPMI-8226,9915743,0.7773898345283005
SUP-HD1,1566236,0.9887534979431616
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
BT 271,3465537,1.4031174390930885
NCI-H841,54618771,1.7073628985349325
OC 314,9911463,3.7977277680710393
SNU-475,9926054,2.638013601993947
HGC-27,3465537,1.8864187021975392
TE-15,sirolimus-bortezomib (250-1 mol-mol),0.9127775689721958
SHP-77,54618771,1.054053584588012
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
SCaBER,11494412,0.3138504125122266
SNU-1,1566236,1.7318278950694468
ACHN,2746,3.5458826569709587
M059K,71751553,4.748260141833626
COLO 201,selumetinib-GDC-0941 (4-1 mol-mol),0.0601925657233566
NCI-H1341,9935249,-1.1000276739958554
AU565,3465537,1.0667310492419344
ECC12,sirolimus-bortezomib (250-1 mol-mol),1.6381290256709142
NCI-H1944,100016,8.062523558454052
JHUEM-1,sirolimus-bortezomib (250-1 mol-mol),0.1143622651277921
PaTu 8902,3854666,4.137852419807088
F-36P,6918638,-0.9703997893287856
BT 228,4705,2.9776742374727436
SUP-M2,54618771,0.2858718534698647
Calu-3,100016,7.471917827082483
TCCSUP,135421197,2.510598154952076
786-O,135421197,1.9891121265690648
KMS-11,135421197,1.6070380180755417
NCI-H508,3854666,3.6716452946739313
NCI-H1105,4705,1.2739510490449024
HT-29,135421197,2.624845390114819
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
Jurkat,54618771,-0.5483098658584711
NCI-H1563,9884685,1.788333404380603
SNB-75,9911463,3.761177145867038
EB1,136227924,2.1314721571590876
BICR 31,4705,2.7587837218207194
ZR-75-30,9915743,-8.763917050030939
OVCAR-8,sirolimus-bortezomib (250-1 mol-mol),1.6177185023966834
TYK-nu,135659046,3.766078033019111
VMRC-LCD,54618771,1.8324078419915515
P12-Ichikawa,9868037,1.7340437958552062
SBC-5,135398744,6.447254342428179
IMR-32,136227924,2.2103917598606326
SNU-C5,2742550,4.034700516109946
NCI-H716,11152667,-0.7087449737081221
F-36P,9868037,2.720274888315988
GaMG,4705,3.2307282924763845
SNU-16,9935249,0.7935481401053108
U266B1,135421197,2.0671733343036247
SNU-201,54618771,1.5381558224082674
DK-MG,2746,3.5429718490608924
BL-70,4705,3.4398242170879723
COLO 792,4705,2.7626450241642355
NCI-H716,9911463,3.7061520966996033
CAL-51,10322450,3.881825194853649
NCI-H2052,136227924,3.050038230910341
NCI-H1568,65628,3.926137474064237
LK-2,9935249,3.1585878787064803
BT 333,selumetinib-GDC-0941 (4-1 mol-mol),3.256611594261358
JURL-MK1,65628,4.134392418722166
Ci-1,2746,3.190931407467591
COLO 829,71751553,4.323103675248641
SUP-HD1,9911463,3.4202590539145836
CAL-62,tanespimycin-bortezomib (250-1 mol-mol),1.0619884321927937
MHH-CALL-4,49836020,-0.2445846673370129
OAW28,11494412,4.413959214794941
G-361,100016,5.501390716782531
KATO III,9915743,3.5253109145888013
OUMS-23,49836020,3.7624735721332736
Ki-JK,selumetinib-GDC-0941 (4-1 mol-mol),1.348149232454661
BT 440,4705,3.213211271406504
Daoy,11152667,0.0005739166010448
CAL-27,135984461,4.281831870560516
Hs 611.T,54618771,-1.6189149218844685
COLO 678,2742550,4.164672443152451
NCI-H1563,9926054,1.9605295654487136
SW48,54618771,0.2213541125267267
SK-MEL-1,54618771,1.3594910944295866
Calu-3,2742550,3.0539698835079863
NCI-H2081,65628,3.78371199726488
Aska-SS,100016,5.454856815374324
VCaP,9884685,-1.1282350078658885
HCC1954,73707386,2.4821792049497824
SW1116,9915743,-1.8123899004443464
KMH-2,9915743,0.5597932998699471
TE 441.T,24779724,4.334447186977638
SF268,9915743,0.6317459379603247
AN3-CA,135421197,1.808403236431818
NCI-H2122,11152667,-1.4729705548083307
BT 482,9926054,2.2206643781764184
SF268,sirolimus-bortezomib (250-1 mol-mol),0.3840315084108963
SW48,11152667,-1.5089069748808788
VM-CUB-1,9926054,1.9231906197166304
JHUEM-3,9884685,0.8743192311633359
OCI-Ly3,3854666,0.4334929140420765
NCI-H841,9926054,1.733938420008062
NOMO-1,9911463,3.1879476164010243
BHY,selumetinib-GDC-0941 (4-1 mol-mol),0.2537821037586068
CAL-33,54618771,-0.7874087703723603
Hs 683,3854666,0.633440254190545
HOP-92,24779724,4.387185953628773
KM12,1566236,3.3530659738635333
Capan-1,1566236,1.8786990481071677
RT-4,135984461,3.767018649492271
TE 441.T,sirolimus-bortezomib (250-1 mol-mol),0.170107693301359
CW-2,136227924,3.283467391951437
TE-10,54618771,1.2495537185307453
BC-3C,54618771,1.3234339265863326
SK-N-AS,71751553,4.378274889288709
JURL-MK1,10322450,3.220647204131025
BICR 18,11494412,1.6811938858482085
IST-Mes1,11152667,-0.1137559634255308
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
BT 416,135659046,3.716005987498819
TE 617.T,11494412,-0.0865540584067903
J82,4705,3.746320789135998
Panc 10.05,9911463,3.4870522809555653
Li-7,65628,4.354303680077222
CML-T1,11152667,-2.6898641024331584
OE19,11494412,2.655503410227205
SU-DHL-1,49836020,5.336381428124731
GP2d,2746,2.2157786787544023
OCI-Ly10,2746,1.6714722565073843
BV-173,1566236,1.4234045213430984
TE 441.T,selumetinib-GDC-0941 (4-1 mol-mol),1.683399232345051
OPM-2,11152667,-1.3080541002664456
8305C,54618771,0.5083809192665402
BT 159,9915743,2.235896124208317
MOLT-3,135659046,2.7195018879588995
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
MeWo,3854666,0.739672925768373
MeWo,tanespimycin-bortezomib (250-1 mol-mol),1.6748762379833977
JeKo-1,6918638,-1.1344735337684004
BxPC-3,2742550,6.208235416241253
NCO2,9915743,0.6795436219303662
NCI-H2030,selumetinib-GDC-0941 (4-1 mol-mol),1.942385025880709
Caki-2,11152667,1.5240540155219149
MCAS,1566236,2.0523817086491296
NCI-H2452,11152667,-1.2581393219211725
SK-MEL-28,73707386,4.4832416514767335
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
SaOS-2,3854666,0.6354016080385003
NCI-H196,9911463,4.433350594042992
HDLM-2,9915743,-1.1010684043189596
HSC-2,1566236,1.667339069930402
8-MG-BA,135421197,2.5937417683499526
MFE-319,1566236,3.6446257988507
KMS-34,9915743,0.841267495899617
SJSA-1,11152667,-1.6734619502857082
COV434,sirolimus-bortezomib (250-1 mol-mol),-0.3799222121291876
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
IGR-39,9911463,4.324644624489837
COV362,11494412,2.0789814812325855
JeKo-1,136227924,2.4041415853814687
HuG1-N,54618771,1.617121666996059
BT 328,135398744,6.520469371663204
LS1034,sirolimus-bortezomib (250-1 mol-mol),1.3157999694585985
WM793,11152667,-0.0685864179324616
CAL-51,135659046,3.6035863494873137
DLD-1,selumetinib-GDC-0941 (4-1 mol-mol),3.851473421315054
SYO-1,65628,3.525115275598551
Ci-1,136227924,2.861978373437932
OVCAR-4,135984461,4.697392944988172
Rh30,73707386,2.7421591744749745
SNU-387,135659046,3.67285635575436
SNU-407,135984461,4.363892494969776
BT 340,9868037,4.513244290019421
NCI-H1623,9911463,3.95788841498078
Peer,135421197,0.5765613346520675
SNU-61,selumetinib-GDC-0941 (4-1 mol-mol),0.6805559460270842
CHP-126,9868037,2.7962624557740385
Panc 05.04,tanespimycin-bortezomib (250-1 mol-mol),-3.230060411523549
BT 444,9911463,3.786370986996904
SNU-387,71751553,5.286582011756761
SNU-308,3854666,3.849126427296356
8505C,54618771,0.8247832120162748
PaTu 8988s,9926054,1.8956430403525124
SW620,9915743,1.1918924065742125
KP-2,9884685,3.910318291012164
BT 416,11494412,-1.7443510359170835
KATO III,71751553,3.9676851594161304
SK-N-MC,135984461,4.087273122460901
MHH-NB-11,9911463,3.881225823923783
NCI-H2405,11152667,-1.3641856896039837
OCI-Ly3,2746,1.9886775425138576
BICR 6,2746,3.4354439873980143
SET-2,135984461,1.767736462015104
LOX-IMVI,11494412,1.902525347361519
MDA-MB-361,9911463,4.323497130466389
NCI-H2452,9911463,3.657985193851277
SUP-M2,3854666,-1.0118736970987623
KNS-62,4705,4.3663723212199885
HCT 116,11152667,1.3675862061051176
NCO2,135984461,1.9525292456009808
MDA-MB-157,3854666,0.668628762558335
BT 333,sirolimus-bortezomib (250-1 mol-mol),0.4281916150518835
YAPC,135984461,4.395865755985396
MDA-MB-231,9911463,3.910290396938666
NCI-H1184,65628,3.2450245277105867
BT-474,11152667,2.684788398514369
LS513,11152667,-0.1030849983220042
MOLM-13,65628,2.9573007313246924
SW1116,4705,0.6661703449380979
SU-DHL-4,9868037,3.0850955865320695
NCI-H358,9915743,-2.527498846949541
Hs 895.T,11152667,0.141102349832315
RERF-LC-Ad2,tanespimycin-bortezomib (250-1 mol-mol),0.3910876035437155
IGROV-1,9926054,1.8111808945519428
HH [Human lymphoma],2742550,2.063067793366252
SNU-398,9915743,1.0980624705271882
Aska-SS,1566236,2.835493117782545
PL-21,135398744,6.318867550173511
22Rv1,9884685,-1.1677338946675415
ECC10,10322450,3.1238725703849988
PE/CA-PJ41 (clone D2),9884685,0.9202237029017308
YH-13,1566236,1.6600939078751014
NCI-H650,73707386,3.7981145791895705
UACC-257,136227924,2.920939130155667
Hs 683,54618771,0.8006472003548896
NCI-H2126,selumetinib-GDC-0941 (4-1 mol-mol),2.896687453534691
MPP 89,selumetinib-GDC-0941 (4-1 mol-mol),2.3167615576876734
T24,3465537,3.175784055433204
HT-144,3854666,2.3799435938580076
NCI-H358,135984461,4.245060558791378
NCI-H2228,9884685,1.6616453832187148
TYK-nu,sirolimus-bortezomib (250-1 mol-mol),0.7718318576607361
EFO-21,71751553,5.137367529423648
TE 617.T,4705,0.0619159999462867
RD,135984461,3.5201159395246293
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
COLO 668,11494412,0.7802380816103417
FTC-133,4705,5.547028107549284
HCC1195,11152667,0.1400980443335025
JURL-MK1,136227924,2.4264924164691135
KNS-81,4705,2.5413050318058596
PE/CA-PJ49,9926054,1.8069972619127008
SUP-T11,73707386,1.4307849373586292
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
Panc 04.03,54618771,1.7180394725494992
NU-DHL-1,9868037,1.5827566273106026
Fu97,sirolimus-bortezomib (250-1 mol-mol),-0.4373916466224739
WM1799,sirolimus-bortezomib (250-1 mol-mol),0.8718810301114039
NALM-6,tanespimycin-bortezomib (250-1 mol-mol),0.0910863571713514
Kelly,9915743,1.2517863913865832
MM1.S,135421197,1.5136201913497214
LMSU,1566236,2.090789851327695
NCI-H1105,11494412,1.05624549663504
SUP-M2,6918638,-1.8081420223018785
HDQ-P1,selumetinib-GDC-0941 (4-1 mol-mol),1.336429644847675
NCI-H2110,9915743,1.734073577383887
RVH-421,sirolimus-bortezomib (250-1 mol-mol),0.2798149280233217
SK-LMS-1,sirolimus-bortezomib (250-1 mol-mol),0.2757332914045335
SNU-1076,100016,6.986031941643801
NCI-H322,9884685,1.1030205864116356
AML-193,65628,3.6139480198766822
CAS-1,54618771,0.3007933924780016
U-937,135421197,1.66797552132573
SNU-620,9935249,-0.059115681236359
SF539,3854666,0.2673517991428248
NCI-H2452,54618771,2.226699645078912
OC 314,11152667,0.476340993676233
SNU-387,54618771,3.696671727532153
U-251MG,9926054,2.2647834350690483
OVSAHO,9911463,3.940240147394606
RD,54618771,0.0144347314731342
HT-1376,sirolimus-bortezomib (250-1 mol-mol),1.0351777976040455
KYSE-520,11494412,3.6154468143610825
KMS-11,3465537,1.1905372585392755
COV434,4705,5.401407376455341
GDM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.4015630537734989
MHH-ES-1,9868037,2.631225103410452
HEC-1-A,2742550,3.858745606484426
Panc 10.05,11152667,0.4061024027057239
IGROV-1,49836020,5.658436828096057
KYO-1,9926054,1.8377950360183533
NCI-H810,54618771,0.890127008742605
KP-2,10322450,5.99994747446592
YAPC,sirolimus-bortezomib (250-1 mol-mol),1.6566311249890242
NCI-H2029,71751553,4.3547337585188615
KNS-81,sirolimus-bortezomib (250-1 mol-mol),0.8491294280424774
MPP 89,9884685,1.0647805860804536
SEM,11494412,-0.8044371012013913
OAW42,65628,4.461928912240859
GB-1,11152667,0.7961300588467334
A-172,tanespimycin-bortezomib (250-1 mol-mol),0.1851985294738919
BT 112,6918638,0.7933014260092189
G-402,9935249,2.789116740198665
Hep-G2,3854666,3.2360339128212554
TUHR4TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.368524394039708
8505C,sirolimus-bortezomib (250-1 mol-mol),0.1276397939018833
GB-1,9868037,4.836422813626047
KYSE-510,11152667,1.4867272406888024
HOS,135421197,1.1481730372475163
NUGC-3,65628,4.4498634773511725
NCI-H727,sirolimus-bortezomib (250-1 mol-mol),1.838886799564678
SNU-387,11152667,-0.6652185187285166
NCI-H841,sirolimus-bortezomib (250-1 mol-mol),0.0818724348323602
COLO 829,135421197,3.0893974148285466
BV-173,4705,2.8039060927559505
UM-UC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.321826526721954
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
IGR-37,9911463,4.34930148495989
A-673,54618771,0.7910545462175201
NCI-H1623,4705,0.0935418442786881
PSN1,54618771,1.0833304445253575
NCI-H292,54618771,0.019803014891406
COV362,6918638,2.636273495865165
Detroit 562,65628,4.413660609351981
WM266-4,9915743,5.517914495108045
Hs 852.T,54618771,3.3539274587451935
ECC10,9911463,2.6804416943678917
KU-19-19,9935249,4.318045076797651
RMG-I,sirolimus-bortezomib (250-1 mol-mol),1.380025279026371
BT 139,135421197,2.718205377140928
BT 340,11152667,1.694199353559282
OV7,selumetinib-GDC-0941 (4-1 mol-mol),2.168494345054348
ME-1 [Human leukemia],9915743,0.9546590301314803
NCI-H1915,tanespimycin-bortezomib (250-1 mol-mol),-3.029490834381303
ZR-75-30,9935249,3.534829888991848
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
HEL 92.1.7,9915743,0.818697547230163
OV7,1566236,2.0738454479215087
SNU-46,11152667,0.3589036654746563
NCI-H841,135659046,3.31199371059189
BT 482,54618771,0.8626033669866102
Hs 766T,54618771,0.4813536193297115
KP-3,135984461,4.664901942241971
A-375,9911463,4.039687099931349
SNU-8,9926054,2.0095672828148636
HEC-6,136227924,2.983713037764577
NCI-H2171,135421197,2.0026019926205185
Li-7,2742550,3.2014821761988244
NU-DUL-1,10322450,3.4880509453639763
NCI-H522,10322450,3.5945001970925787
A-204,24779724,4.583598164298229
PL-21,135984461,4.312224560924431
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
SK-N-MC,1566236,1.1445008025862364
RPMI-6666,3854666,0.6368398839729822
HT-1080,tanespimycin-bortezomib (250-1 mol-mol),0.0826003622808549
SNU-216,71751553,4.1520368918370965
WSU-DLCL2,9926054,0.3298976492900614
KE-39,71751553,4.448067406832394
Peer,tanespimycin-bortezomib (250-1 mol-mol),-0.7923610578586646
LK-2,135421197,2.2865264373163487
NCI-H2087,9926054,1.8666936138192145
BxPC-3,9868037,2.7194108471732243
G-402,3854666,1.4392948064524391
PE/CA-PJ15,9884685,0.3729589706560922
NCI-N87,9926054,1.7069639615174013
HEY A8,135421197,2.419965019315952
KMS-18,65628,5.193689022316172
HT-144,4705,3.2699315895586127
JHH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.7984148033328824
RD,71751553,4.447029966270882
A-253,650361,3.561835185419963
BT 147,6918638,2.7935207721855764
Ishikawa (Heraklio) 02 ER-,135984461,4.462174661404989
Namalwa,4705,3.621778373883038
HeLa,9926054,1.7615972318293558
TE-15,selumetinib-GDC-0941 (4-1 mol-mol),1.395228567811366
SW1088,135659046,4.039700337753171
MPP 89,71751553,5.281111904460767
NCI-H520,9911463,3.6961325383043007
BT 231,9935249,0.8788796020104754
DMS 53,9915743,0.9976254394471727
MOLM-13,2742550,3.0943449980031845
CAL-78,tanespimycin-bortezomib (250-1 mol-mol),-2.747028808134876
NCI-H322,4705,1.051415284541447
TCC-Pan2,selumetinib-GDC-0941 (4-1 mol-mol),0.1470991216405226
NCI-H1395,11494412,4.0372714005300026
IGROV-1,11152667,-1.4116509977729443
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
SCC-4,54618771,3.088112117698249
KMS-27,9884685,-0.4174100202309531
LOX-IMVI,136227924,2.635687863612288
MIA PaCa-2,54618771,1.4864580952045414
LS411N,49836020,4.501659667614969
BT 245,9868037,3.6125967873896543
COLO 320,9868037,3.042611566071044
SW579,136227924,2.120211379000796
NCI-H2126,9915743,3.640256854727969
PaTu 8988t,1566236,2.792784501487116
P31/FUJ,54618771,-0.1557090961755644
SNU-C4,9915743,0.291849772396667
WM983B,135421197,2.3980917008752725
MIA PaCa-2,71751553,4.303479284138883
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
ONS-76,3854666,0.984876663182433
DU145,9884685,1.2239638281476493
SK-N-BE(2),54618771,0.9594673871894048
P3HR-1,9915743,1.4210240305197754
DMS 114,135421197,1.272483451000873
COLO 205,9911463,3.950435193023514
NCO2,54618771,-0.1705151191723565
NH-6,9915743,0.850347452828082
SNU-738,sirolimus-bortezomib (250-1 mol-mol),1.9846643128257275
SW1710,3854666,1.210332525594085
ECC12,9926054,2.4969836568853507
SHP-77,9911463,3.880568712678563
NCI-H2081,9911463,2.5760332235225016
HuT 78,9915743,-0.3205464670121912
HPAC,54618771,1.6074763393424083
U266B1,100016,6.458228016262307
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
GSS,9935249,2.9109339589908374
SCC-9,100016,6.423023301160456
NCI-H2106,9911463,3.3350071984194356
NCI-H1623,71751553,5.091527890142487
Capan-1,71751553,4.749042559112668
A-253,1566236,1.9034646060389304
KNS-60,10322450,5.014085797692543
U-251MG,1566236,3.4645251762745506
SNU-398,3465537,3.876042527546671
KYO-1,4705,2.8597279175992925
Panc 08.13,6918638,1.0573629526558566
NCI-H28,selumetinib-GDC-0941 (4-1 mol-mol),0.00452428337889
NUGC-3,100016,7.160996607387645
G-401,1566236,1.5621622205700352
Jurkat,65628,3.880362964919709
HCC1438,9911463,4.347213742956148
SIG-M5,11494412,0.6608906203269307
BL-70,9911463,2.445001964287348
YD-10B,9911463,3.649905942597577
A-204,11152667,-2.7777919264690505
Rh18,2742550,3.0219531402353565
Lu-99,9911463,4.284576210673527
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823
KNS-42,9935249,5.700998341787269
Mono-Mac-1,2746,1.2768381662660928
CAL-27,9911463,3.9808339840731537
SW948,3854666,3.050289300885683
CAL-54,135984461,1.524237172079529
SNU-C2A,2742550,4.524601558141107
SK-MEL-30,3854666,4.201898778622083
BT 187,2746,4.1078549912417355
SNU-1272,54618771,3.136436186338116
UM-UC-1,135659046,3.598030387266929
YKG-1,10322450,5.46076367923885
T-47D,6918638,0.9017402025049926
SW982,11494412,0.9362353205677216
SK-LMS-1,71751553,5.37247176250955
G-402,11494412,0.8196805103807205
G-361,9911463,3.257776789856645
TE 617.T,54639665,4.38998607843506
IA-LM,11494412,5.732457488131999
SK-N-BE(2),11152667,0.2196247397695578
SNU-C1,100016,6.347812039507436
HCC827,73707386,5.245993299227604
JMSU-1,sirolimus-bortezomib (250-1 mol-mol),0.8204079064012788
HCC1954,11152667,-1.3224396298390433
HGC-27,11152667,-1.849804730861495
RERF-LC-MS,4705,3.292681011259135
PE/CA-PJ49,6918638,-0.873109094603626
SUP-B15,4705,3.3539496545861542
ONS-76,tanespimycin-bortezomib (250-1 mol-mol),1.246384835528882
ST486,11152667,-1.2094487766375612
CHP-212,9935249,1.3663209076830405
WM115,135421197,2.9135607351561883
LXF 289,selumetinib-GDC-0941 (4-1 mol-mol),2.154352876327122
Detroit 562,54618771,-0.8917291521267056
BT 164,6918638,0.5981127471787415
KYSE-510,10322450,3.90855044095945
WM1799,135421197,2.490323876838408
Karpas-620,73707386,2.2664961291067995
G-292 clone A141B1,9915743,4.37083604289579
SW1417,2746,3.073421161812704
NCI-H526,9935249,3.1967186299160466
NCI-H1623,9915743,-1.6977137550638366
YD-38,sirolimus-bortezomib (250-1 mol-mol),1.3505427312079858
RVH-421,9926054,1.6904251361057423
WM793,2746,3.494212158504219
NCI-H650,sirolimus-bortezomib (250-1 mol-mol),1.8480757652183293
WM1799,65628,6.439328359215507
NCI-H322,9926054,1.834077312686318
HCC4006,11152667,-0.7682912604310446
SNU-C4,135421197,3.0670219235957914
BFTC-909,650361,3.8112149600795706
BV-173,100016,4.070459829867503
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
PE/CA-PJ49,11494412,-0.4920931569097222
SK-N-MC,9915743,0.8828684389930763
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
NCI-H2087,9915743,0.7035169318123878
B-CPAP,9935249,3.6331972825505474
RPMI-8226,9926054,1.537898782638624
WM983B,4705,3.3375940959152244
NCI-H1792,135421197,1.9377775784144329
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392
KO52,9926054,1.7676529122170044
BT 145,9935249,1.8068162159792407
NCI-H1092,135421197,1.379439810077043
NCI-H522,9884685,0.1045560296672991
CML-T1,sirolimus-bortezomib (250-1 mol-mol),-2.349010287951753
BFTC-905,9915743,1.39772044573247
NCI-H2228,135659046,3.319323346147118
AML-193,9868037,1.69446413413849
SNU-81,44494148,1.061827805146114
BT 328,135659046,3.8583019402961343
BEN,9915743,3.139870035792778
HEC-6,9911463,4.040117768715498
Panc 04.03,9911463,4.4327726522455855
SET-2,54618771,0.9858111819135928
TOV-21G,2746,4.617945270091336
SK-MEL-2,selumetinib-GDC-0941 (4-1 mol-mol),1.2441784901384163
786-O,3854666,2.4233058508969414
M-07e,9868037,1.7477051770285184
RERF-LC-A1,9926054,2.5963235420247965
SK-MES-1,6918638,0.2897648687563215
SNU-449,3854666,3.254678167809475
HCC95,sirolimus-bortezomib (250-1 mol-mol),1.734022258386224
IGR-1,9915743,1.9511711316311544
Namalwa,135421197,0.8963594643304925
KYSE-450,9915743,1.0249516523129705
BT 139,9926054,3.0317650629280717
T24,6918638,1.5098375019739547
SNU-601,9868037,3.788839029413147
RCH-ACV,136227924,2.5365542828193957
SNU-449,9915743,1.6643053553641087
RPMI-8402,9926054,1.3971414667672897
DU145,2742550,4.5042202840437975
DND-41,2742550,2.4562180323562326
OCI-Ly10,71751553,4.3682069656519324
BT 330,9884685,0.2489393167095227
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
BC-3C,9911463,4.117920402638588
Mono-Mac-6,100016,3.84240036835353
SW982,2746,3.3231218148802144
Pfeiffer,9926054,1.762205807051045
KE-37,54618771,-2.6599690790186425
PL-21,100016,4.334695208074886
RL,135984461,2.130872276325595
NCI-H526,sirolimus-bortezomib (250-1 mol-mol),1.536405299935234
SNB-75,9884685,-0.3913631936872798
CW-2,1566236,1.6101300904143996
NCI-H2023,2746,4.105485199258473
COLO 678,54618771,1.45327687843265
HCC202,136227924,3.1235993915196723
NCI-H1734,sirolimus-bortezomib (250-1 mol-mol),-0.1121283938952372
MDST8,135421197,2.23565927197073
EBC-1,2742550,2.785221228381935
T84,9884685,0.0950503112207011
NCI-H2170,1566236,4.07378736868643
SNU-620,54618771,0.0782224190169237
HCC1833,54618771,1.9776792637653005
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
NCI-H28,135421197,1.3178315366428714
HCC44,136227924,2.988750330313465
SK-UT-1,54618771,2.629062811355061
Panc 08.13,9926054,1.852191503455224
SNU-489,3854666,2.987559743136252
NCI-H1184,135421197,-1.5924558307630432
A-549,54618771,0.0374822867627876
WSU-DLCL2,10322450,2.94948924271478
HDLM-2,3854666,1.016562395835814
KLE,135984461,1.6662233005465323
SNU-C4,11494412,1.7480299860261157
SUP-HD1,168313307,4.639616266105548
BT 286,2742550,3.3943072978834277
NCI-H889,9868037,2.7171029486851683
SR,11152667,-1.901425979751036
RL,65628,4.074599228005119
HT,sirolimus-bortezomib (250-1 mol-mol),-1.783381881062306
LN-229,sirolimus-bortezomib (250-1 mol-mol),1.3963325511705935
Ri-1,9884685,-4.0721071535449065
COLO 680N,9915743,3.1865022811794006
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
2004,135421197,1.2984734830690137
KP-3,selumetinib-GDC-0941 (4-1 mol-mol),1.1487168771210745
EFO-21,65628,4.296622507427161
BT 145,135421197,2.030859989245954
Calu-6,1566236,3.730929510545656
ONCO-DG-1,sirolimus-bortezomib (250-1 mol-mol),0.4937178485517417
AsPC-1,11494412,3.580103428724827
LoVo,selumetinib-GDC-0941 (4-1 mol-mol),0.7605582392782264
CMK,11494412,-0.0667901955813207
NCI-H661,11152667,-1.7022631730770723
HH [Human lymphoma],6918638,-1.7974497688929272
ECC10,1566236,1.6584200154088518
WT2-iPS,54618771,5.206944426983613
42-MG-BA,2742550,4.771377551035741
L-363,54618771,-0.4858237315579012
42-MG-BA,136227924,3.1509029182486845
SEM,100016,5.238818929389881
HSC-2,11152667,0.3676430135282471
ZR-75-1,9935249,3.721021315564273
LAMA-84,135984461,1.7013411112248076
MDA-MB-361,3854666,3.1830071535055593
Rh41,9911463,2.849226951569497
OVK18,9884685,-0.4598005872394062
NU-DUL-1,135984461,1.2586249642588896
697,2746,0.8778149651277364
SK-N-DZ,65628,4.220030116054574
A-253,135421197,1.6531350819497892
NALM-6,9868037,2.034741540026143
Rh41,tanespimycin-bortezomib (250-1 mol-mol),-0.5617508290284754
TE-6,136227924,2.9118612520968803
BT 271,sirolimus-bortezomib (250-1 mol-mol),0.1057701535973337
CHP-212,2746,0.548553476305332
RERF-LC-MS,2746,3.2731211053052647
BT 498,11152667,1.974918691110967
HT115,11152667,0.332844259056983
BT 139,11494412,3.8637696290948815
NCI-H647,3465537,2.923785800971271
Hs 294T,10322450,5.012803504486345
SK-N-SH,9911463,3.4426003417788618
HCC-56,tanespimycin-bortezomib (250-1 mol-mol),1.6383234075963011
697,3465537,3.3295432366949895
Karpas-422,selumetinib-GDC-0941 (4-1 mol-mol),0.0851273385721037
KP-2,9926054,2.0579312242664645
HCC1954,tanespimycin-bortezomib (250-1 mol-mol),-2.182183839668862
SNU-899,9926054,2.026075556253581
OE19,136227924,3.1692952710595557
SET-2,sirolimus-bortezomib (250-1 mol-mol),0.175715922868153
MKN1,11152667,-0.4741120582989742
JHH-4,11152667,0.8928711048040257
MOLT-16,9911463,3.124866313552043
MCAS,9884685,0.0580097672331096
OCI-Ly10,9911463,5.153566135827512
GSS,54639665,4.407333409116942
TT,selumetinib-GDC-0941 (4-1 mol-mol),2.303935736572117
Hs 940.T,2746,3.6289293164152614
HuT 78,4705,4.420154035532244
KMM-1,selumetinib-GDC-0941 (4-1 mol-mol),3.455450229836309
HCC2935,9884685,0.4654305165451881
BT 498,9926054,3.200560952387037
COLO 800,65628,4.173360308807501
647V,54618771,-0.1034366562319205
697,1566236,0.6800074813339387
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349
PK-1,135421197,2.4270856926792947
SH-10-TC,10322450,5.299988243449435
NCI-H211,73707386,2.5869092574593413
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
HCC1395,136227924,3.3223803208690135
SW1088,tanespimycin-bortezomib (250-1 mol-mol),0.2648421366318154
SNU-1076,2742550,3.052127271141954
HuP-T4,9926054,2.1001790007483843
OCI-AML-5,9868037,3.637294932872617
NCI-H460,11152667,1.2005763717636435
BT 139,9935249,2.9068190210975975
NCI-H2085,3854666,3.930659800096944
BICR 31,135421197,2.236076370585341
MHH-CALL-4,9911463,4.039768304149654
SNU-1,54618771,0.7827346323778329
TE-6,9935249,3.4314047332936264
SR,73707386,3.571733863738371
A4/Fukuda,1566236,1.4071330472860828
JHH-1,2742550,4.071570054771418
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
BT 359,9935249,2.952600079781156
MDA-MB-415,sirolimus-bortezomib (250-1 mol-mol),2.5616194008456916
TE-4,54618771,0.5260278074732754
LP-1,100016,3.986438392754067
TE 617.T,49836020,3.775264114601375
LoVo,65628,4.171555925906434
NCI-H520,9935249,3.10400998228373
BT 239,136227924,1.4188260158561712
JMSU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3740828564312233
NMC-G1,24779724,4.225220713567242
Capan-1,9926054,1.8783300658857656
TE-4,9884685,0.7383489542895525
IM95,1566236,3.9242016220149623
NCI-H1435,tanespimycin-bortezomib (250-1 mol-mol),-3.816394464229111
TYK-nu,selumetinib-GDC-0941 (4-1 mol-mol),1.6731134624767203
KMS-26,135984461,1.0857498172669495
SK-MEL-3,136227924,3.573502388362414
NCI-H1155,54618771,1.281458310238897
MDA-MB-468,168313307,4.437587557581034
CMK,sirolimus-bortezomib (250-1 mol-mol),0.3522446092805081
CAL-33,9911463,3.5337307884792213
L-1236,100016,5.644363792904431
COR-L105,71751553,4.255827287979035
NCI-H1915,136227924,2.449863082820113
RPMI-8402,73707386,2.4280869468438446
JHUEM-7,sirolimus-bortezomib (250-1 mol-mol),-6.320695454237984
MOLM-13,9868037,0.9756233042827712
Hs 746.T,49836020,5.866178883912361
BT 172,selumetinib-GDC-0941 (4-1 mol-mol),1.268434466812915
IGROV-1,9915743,-0.4757488934941289
SNU-16,2746,1.5955901549759912
NCI-H1092,54618771,1.961811722948082
SW1088,1566236,3.5418738685813542
BT 131,9884685,0.9627724880969004
FTC-133,sirolimus-bortezomib (250-1 mol-mol),1.8639176688857977
NCI-H23,sirolimus-bortezomib (250-1 mol-mol),0.1265190636772679
BT 498,3854666,4.451868649055675
SCC-9,54639665,4.512228528266098
NCI-H1694,1566236,0.9563523099739728
Hs 683,9926054,1.7064216062537565
CHP-126,73707386,2.56011600138591
PC-3,135398744,6.536880900821883
Malme-3M,sirolimus-bortezomib (250-1 mol-mol),2.279282073181017
KYSE-140,9911463,3.6059267318888817
GA-10,54618771,-2.458628793316373
Panc 05.04,9935249,5.19537836182522
NCI-H1581,136227924,2.9082899651974734
HCC1428,selumetinib-GDC-0941 (4-1 mol-mol),5.009115635429041
EB1,11494412,-0.5591011576932087
NCI-H1869,2746,3.565752906078767
IGR-37,9915743,1.4211592255405934
VMRC-RCW,tanespimycin-bortezomib (250-1 mol-mol),1.6092697528768949
HCC827,9926054,1.8610804670039272
NCI-H1651,9935249,3.236864659614126
BT 422,135659046,4.905108449533952
SF126,9926054,2.7905707570317686
23132/87,3854666,1.2924616930846544
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
SNU-C2A,65628,5.099663069206163
KMRC-2,11152667,0.1110471147886436
SNU-878,9935249,3.2749809298171457
DMS 114,6918638,1.3129980903302014
HCC1438,135659046,3.8563158871978342
RKO,1566236,3.4833841973625725
SH-10-TC,1566236,3.879679185733888
HEY A8,tanespimycin-bortezomib (250-1 mol-mol),-0.6734038900503383
COV644,135421197,2.2912269565469936
MOLP-2,selumetinib-GDC-0941 (4-1 mol-mol),2.6485727489944555
IGROV-1,9884685,-0.088911709267569
OC 314,54618771,0.7264278872863676
SUP-B15,3854666,0.959316947307526
HEC-151,selumetinib-GDC-0941 (4-1 mol-mol),1.9023911399430904
Pfeiffer,135421197,0.665786429706454
DEL,selumetinib-GDC-0941 (4-1 mol-mol),2.6612594732504475
TE-9,sirolimus-bortezomib (250-1 mol-mol),1.65156532299436
G-401,65628,4.0909837295628275
BICR 6,54618771,1.779612133300688
RPMI-6666,9926054,1.733679521146624
LN-18,9926054,0.598983976680667
NCI-H2171,11494412,-0.1110474347644453
SK-CO-1,3854666,3.8596661393399927
JHH-1,54618771,0.3940537570432531
MES-SA,6918638,1.1340225754768447
Raji,54618771,-0.1378575615243227
HT-1376,9935249,3.971188542533541
PaTu 8902,54618771,-1.3103145579416535
Kuramochi,selumetinib-GDC-0941 (4-1 mol-mol),1.9620820620986936
HLF,4705,3.4184924882313372
MOLM-6,9911463,2.9457292800178605
NCI-H2087,9911463,3.2205698375383935
Hep-G2,54618771,-1.2901934533941846
SU-DHL-10,135421197,2.145200655725533
KP-3,9868037,3.7824186326212494
SW982,tanespimycin-bortezomib (250-1 mol-mol),-1.8662349479314355
BT 147,65628,5.5152381073160655
LAMA-84,136227924,2.847754951874779
BT 147,sirolimus-bortezomib (250-1 mol-mol),0.9412516099169256
BT 224,54618771,1.0609387834532893
TYK-nu,10322450,3.7591527396933895
KMH-2,100016,3.8705403745512017
A2058,2746,3.220065264010931
OCI-Ly19,4705,3.3718260967656715
HCC1569,9884685,-0.2540549319759735
KO52,4705,3.2027960620979576
NCI-H1341,11152667,-1.02440592323998
NU-DHL-1,4705,3.159533609841756
G-361,135398744,6.4148171061967645
BT 498,9911463,3.937995526968798
M059K,9935249,3.033672108656433
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596
KYSE-180,136227924,3.113518519432139
Fu97,tanespimycin-bortezomib (250-1 mol-mol),-2.3506071651033733
ACHN,54618771,1.0716775131315517
BT 164,136227924,2.714674644422482
Hs 852.T,tanespimycin-bortezomib (250-1 mol-mol),-1.155351108191556
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
SF268,9868037,3.0654827755113203
JHH-1,3854666,1.0749390724727717
SUP-M2,49836020,-3.0340639982218898
KE-39,9868037,3.621529869698051
C2BBe1,71751553,3.745740113359517
KYM-1,9884685,-0.7131682804521101
SNU-869,9935249,3.216155235234016
HT-144,9926054,1.741901669011513
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
BL-70,71751553,4.162810725567264
HCC1500,2746,2.6069735713089006
MDA-MB-157,6918638,0.523436976846598
BT 245,9911463,3.0517796790400173
TALL-1 [Human adult T-ALL],54618771,-0.8815186258752705
HOP-62,6918638,0.8791129287698843
KMS-21-BM,54618771,-0.9009155156599936
KP-3,100016,6.07483479536675
Panc 03.27,136227924,3.110606575361216
ME-1 [Human leukemia],9911463,3.822532388207368
TUHR14TKB,2746,3.3342973091296506
A-253,11494412,2.4238653146886
SK-N-FI,9911463,4.1976793255914275
Daudi,135659046,3.1156448500687923
KE-37,11152667,-3.2630425463199884
T-47D,selumetinib-GDC-0941 (4-1 mol-mol),3.2531063352612697
JHUEM-3,9926054,2.0122307954459004
BT-12,9911463,4.073120813742317
BT 147,11494412,1.94524902376892
OE19,6918638,0.8601306195335003
VMRC-RCZ,9935249,3.784816906466892
COLO 792,10322450,2.61287912809147
RPMI-8402,49836020,4.366358527241826
NCI-H2286,135984461,2.8625340358152247
DMS 273,sirolimus-bortezomib (250-1 mol-mol),0.2700618452232576
K-562,9926054,1.8612748023096723
TOV-21G,3854666,2.2368280986346387
CAS-1,136227924,2.284810237581045
22Rv1,54618771,1.0786787609274302
L-540,1566236,1.6540096701346272
SF268,54618771,0.7113827759626075
NCI-H1915,3465537,2.421496271137385
SNU-C5,136227924,3.8791329718590264
NCI-H2110,tanespimycin-bortezomib (250-1 mol-mol),-2.8330652513678274
TE 441.T,10322450,2.5137861182837207
SNU-1105,selumetinib-GDC-0941 (4-1 mol-mol),2.42350207909939
HCC1954,9868037,6.210309136598162
NCI-H650,tanespimycin-bortezomib (250-1 mol-mol),0.4769050892801147
THP-1,2746,1.8092224588916963
BT 147,2746,4.827192237439561
Hs 683,9911463,3.853379830397607
BT 112,2746,3.687274706255036
SU.86.86,10322450,5.077156891369805
SET-2,168313307,4.480873522233062
Ri-1,136227924,2.363884089308993
NCI-H1915,135421197,1.7136891979004163
U-BLC1,9884685,1.006082357042544
UO-31,54618771,0.667805712786254
JeKo-1,65628,2.9302336616000417
OPM-2,3854666,0.6659331794855328
WT2-iPS,sirolimus-bortezomib (250-1 mol-mol),0.4538341173925034
BT-16,54618771,-1.2134331946377312
SNU-308,100016,6.582722131637771
HOS,9911463,3.9584214760624
JURL-MK1,selumetinib-GDC-0941 (4-1 mol-mol),-1.4981298966453434
HCC44,9915743,1.8487357867630132
YD-10B,9884685,-1.5803668389078624
COV644,54618771,0.8361295238713768
WM983B,11152667,-1.3678163730800454
GOS-3,1566236,2.0611902912111013
SW1116,10322450,3.761194873514236
SNU-1033,136227924,2.5540912421490387
COLO 668,71751553,4.5654463925913635
SIG-M5,1566236,1.4914390289257415
KP-N-SI9s,135398744,6.4391278360731246
NCO2,9911463,2.9393398457743163
MKN1,9868037,3.4608837590202746
MeWo,selumetinib-GDC-0941 (4-1 mol-mol),-0.6155502943571556
Granta-519,9911463,3.5000933341892733
SW948,9911463,3.099005262739027
HCC1143,135421197,0.8918606552263807
BT 131,9935249,1.565696008817727
OV56,71751553,4.820824732580885
SNU-620,11152667,-0.9787695629039372
OVCAR-5,54618771,0.5295799029989672
T-47D,1566236,2.191762088104109
K029AX,sirolimus-bortezomib (250-1 mol-mol),0.2512522437134671
SU-DHL-10,136227924,2.6642941314249327
KYSE-30,11494412,4.405043553296497
RT-4,11152667,0.7569607325973031
TUHR14TKB,9911463,3.7384474172031976
IMR-32,1566236,1.2008370083057098
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
MOLT-3,9926054,1.73923619089024
TOV-112D,11494412,0.1754795194968993
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
NCI-H1573,9911463,3.324628771870272
WM266-4,tanespimycin-bortezomib (250-1 mol-mol),-3.087265381880702
LoVo,136227924,4.6796674015936075
K-562,11494412,-0.907204058397288
HCC4006,135421197,1.321900660308596
HuH-1,11494412,1.5429179145787622
NCI-H1105,54618771,0.6246243373087411
HT-55,54618771,1.7226930749216656
HCC-56,3854666,3.3654438500672423
COLO 800,100016,6.663651406564157
HCT 8,2746,2.9621933110100103
HuT 78,2742550,1.9478816710996465
BL-70,2746,1.4659724026992842
Daoy,9911463,4.106155174248402
T98G,tanespimycin-bortezomib (250-1 mol-mol),-0.015927454797827
BT 239,9868037,2.51635002205042
DMS 114,136227924,2.8316140416519664
PF-382,9926054,1.6899693166343082
SNU-899,44494148,4.523585952097628
Mel Ho,136227924,2.792099034627563
SNU-182,2742550,3.101242383691764
8505C,2742550,3.800445536913175
TE-5,71751553,4.947583204218297
JHH-2,11152667,-0.679570545513591
EB1,3465537,1.4429875061757191
A3/Kawakami,2742550,3.663536756053575
SNU-886,9915743,1.7822621128192635
G-402,11152667,-1.9802758600685508
HCC4006,71751553,3.746393975050998
NCI-H1869,9935249,4.228137987840005
NCI-H2081,4705,3.121794828383862
OAW28,3854666,2.969576020962734
TTC-709,3854666,1.2966503099263071
GMS-10,136227924,3.0615637003217433
WT2-iPS,tanespimycin-bortezomib (250-1 mol-mol),-2.960139188693383
HuNS1,1566236,1.8236827924794037
SK-ES-1,9915743,-1.1737874171427145
MDA-MB-157,11494412,-1.4760508995443156
KMRC-2,6918638,2.530608433892335
KYSE-450,3854666,3.622949827534998
JVM-3,100016,3.63486720200834
SiMa,2742550,3.1231022749996917
Capan-1,tanespimycin-bortezomib (250-1 mol-mol),1.8501996853499856
CL-11,2742550,3.86995660017133
BT 340,135421197,2.5749512763200824
ESS-1,24779724,4.457445117995274
NCI-H1435,135984461,4.625083763194788
NCI-H1666,54618771,-1.5571959335462928
A-549,2746,4.106748757541722
DMS 454,9868037,2.022820925899878
NCI-H716,9926054,1.9023068554939984
HCC1195,selumetinib-GDC-0941 (4-1 mol-mol),2.113355514825289
BHT-101,54618771,-0.9032414416493152
VMRC-RCW,54618771,0.4533300000402974
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
OE21,9926054,1.7334869398194368
SCC-25,54618771,-1.4085770807185976
Hs 944.T,4705,3.126834538989372
RCH-ACV,selumetinib-GDC-0941 (4-1 mol-mol),0.9468989618385945
WM983B,2742550,4.170565550824284
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
RL,9884685,-0.1858015850473789
MDA-MB-453,3854666,1.8999840682298523
SUP-M2,135659046,2.724730541134964
OCI-Ly19,135421197,1.1485789152916004
LNCaP clone FGC,135421197,1.5055395740527522
EPLC-272H,2742550,3.751744166545609
LOU-NH91,9926054,3.1176474597994908
Panc 03.27,1566236,2.3499818808083064
MOTN-1,49836020,2.722382817781131
T84,10322450,3.7674280785024976
SK-MEL-3,3854666,3.3514333338797697
SNU-308,54618771,1.0411941789938453
SNU-1066,54618771,0.6033249887552533
BFTC-909,11152667,-0.3524603871752078
786-O,65628,4.397983863237757
Caki-2,71751553,5.140065557527163
JHH-5,10322450,3.916115158181419
YD-15,54618771,0.7976995145825885
Panc 10.05,2746,4.189917582449672
WSU-DLCL2,73707386,1.5634460794946006
REC-1,9911463,3.153332853315619
CA46,9884685,-1.0270691788705264
GaMG,9884685,0.6197999278572434
SNU-182,49836020,5.156218287298631
PLC/PRF/5,tanespimycin-bortezomib (250-1 mol-mol),-0.763786349552494
FU-OV-1,9884685,-0.2158788705773567
EN,9926054,1.746243630057145
JeKo-1,9935249,0.8594033037358069
Rh30,9915743,1.5349254277578692
HCC95,tanespimycin-bortezomib (250-1 mol-mol),-0.0613788307173083
SK-MES-1,2742550,3.2236302544154354
P12-Ichikawa,100016,6.391056060940552
Hs 729.T,100016,6.726636381823557
OV-90,9911463,4.122087400059479
GSS,9926054,1.4316065343869406
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
SW579,3854666,0.6717110182568982
DEL,2742550,3.398292456577154
T84,9915743,0.6360721322539938
CHP-212,10322450,3.626434944218361
HOP-62,3465537,2.2363453693957536
SK-N-BE(2),135659046,3.712639827240539
Kelly,11152667,-4.572350734135745
WM266-4,9926054,1.9241350180859695
NCI-H1693,54618771,1.322684232768969
BT 131,135421197,1.356520545497568
JHH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.61874119121482
OAW42,9935249,3.0438491704796076
C2BBe1,11494412,2.98786476035404
NCC-StC-K140,10322450,2.306971577556796
A-549,135421197,2.4799819746704075
KMS-12-BM,9884685,-1.5036404450716507
RPMI-8226,11152667,-1.9312828713071295
DOV13,sirolimus-bortezomib (250-1 mol-mol),0.9080087228698384
WM1799,9935249,3.982916233384913
SCC-25,sirolimus-bortezomib (250-1 mol-mol),0.9940787042699578
HCC1500,2742550,3.2494473825713026
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
SBC-5,135421197,2.079587314097717
MOLT-3,3854666,-0.0527429362820416
SNU-886,2746,2.8162256970394295
HPB-ALL,4705,3.3035953851942548
HCC1419,9935249,3.389124149949876
HEC-59,73707386,3.788415137761945
22Rv1,11152667,1.3271929435007497
EPLC-272H,selumetinib-GDC-0941 (4-1 mol-mol),-0.4942695564653549
WM266-4,3465537,1.2286223371431932
SW620,65628,4.413668799796276
RS4;11,3854666,-0.0769207651889505
BICR 6,71751553,4.217345085718347
HMC-1-8,selumetinib-GDC-0941 (4-1 mol-mol),-0.1007905970017958
BL-70,2742550,3.282580596685524
HT-144,selumetinib-GDC-0941 (4-1 mol-mol),0.3357004293629391
DMS 114,9926054,1.677325946401266
SF539,136227924,2.8154987155907905
MDA-MB-453,10322450,5.853812101119735
NALM-6,65628,2.4464188338602355
NU-DUL-1,11152667,-4.730563211126392
SU-DHL-8,1566236,1.835793020693765
MHH-ES-1,136227924,2.293763722118734
NCI-H1944,1566236,4.110727011027785
T24,2742550,4.322768033358217
NCI-H929,9915743,0.0759555072139175
U-118MG,10322450,5.196465804540769
KYSE-510,tanespimycin-bortezomib (250-1 mol-mol),-1.5212875758875433
NCI-H2228,1566236,2.805458510432221
Panc 08.13,tanespimycin-bortezomib (250-1 mol-mol),-2.574326454795975
A2058,54618771,1.1536818044190116
HuP-T4,135398744,7.1369518257480475
SCC-4,3854666,0.8904264801390891
DMS 273,4705,3.496116762813734
HuG1-N,71751553,4.683774656749965
LAMA-84,9935249,3.1340525693570167
NALM-6,9915743,-0.4248933620675649
KO52,54618771,1.4631554759036511
ECC10,2742550,3.033123572020692
Hs 683,3465537,3.213284685402938
YD-8,9884685,0.4288602362117117
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
CA46,11152667,-1.1506421067609531
Hs 746.T,71751553,4.777780100201024
HCC202,selumetinib-GDC-0941 (4-1 mol-mol),2.1279074309941413
NALM-6,11152667,-2.6312917838320877
Daudi,4705,2.565440722309658
OCI-AML-5,2746,1.486809354456374
GOS-3,9935249,3.5788705539521315
HCT 8,136227924,3.7452024891634785
PE/CA-PJ41 (clone D2),3465537,3.306521730536944
BT-12,54618771,-0.2566375632021986
VCaP,9926054,1.7541172082533985
KM12,sirolimus-bortezomib (250-1 mol-mol),1.529989038741449
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683
KE-37,10322450,3.174319565832949
CAMA-1,sirolimus-bortezomib (250-1 mol-mol),0.4180423517556048
SNU-C5,3465537,1.1156127237454885
NCI-H358,10322450,3.5952188723285436
OV56,100016,6.603582199202106
BT 248,4705,2.6318547262793386
EM-2,24779724,4.869730500223735
NCI-H1755,2746,2.93988031593663
BT-20,11152667,0.257803129551301
NCI-H841,tanespimycin-bortezomib (250-1 mol-mol),-1.639550345576176
A4/Fukuda,11152667,-2.4230854517211977
Hs 746.T,6918638,0.8539034237562276
MJ,9935249,-0.0346265394865933
CAL-51,9884685,-0.2528326244590672
Hs 729.T,65628,4.328856822619668
YH-13,9884685,0.7618617096747208
MOTN-1,135659046,3.5203350268102978
NCI-H1755,11152667,-0.8607954113291786
Li-7,9915743,1.173340818103225
HEC-108,tanespimycin-bortezomib (250-1 mol-mol),0.6287218196429517
BT 216,tanespimycin-bortezomib (250-1 mol-mol),-1.562937593098705
KMRC-3,2742550,3.5464542059960653
HT-1080,135659046,3.530042119705326
NCI-H1693,3465537,1.3413238246383017
HT-144,tanespimycin-bortezomib (250-1 mol-mol),-0.8683575179427937
NCI-H1915,71751553,4.285363115702843
BT 359,4705,3.8493251509059
NCI-H1694,selumetinib-GDC-0941 (4-1 mol-mol),2.084938486650406
HMCB,9915743,1.6080279846600372
MKN74,135421197,1.917095385489804
SF295,49836020,5.953375339581455
BT 139,54618771,0.6654274606551459
Panc 03.27,71751553,4.542100190957626
OC 314,1566236,1.3422457845436446
NH-6,136227924,2.082013315983653
KM12,9926054,1.9213576714139085
PE/CA-PJ41 (clone D2),6918638,0.5938730898283403
SNU-C4,1566236,1.7829044756286356
KMRC-2,tanespimycin-bortezomib (250-1 mol-mol),2.039285304893744
769-P,136227924,4.180099818093012
EFO-21,9911463,4.46100095082043
NCI-H1703,9926054,1.7378583933423122
TE-8,sirolimus-bortezomib (250-1 mol-mol),1.0878251503851162
647V,9926054,1.756736719694015
MDA-MB-435S,9911463,3.9126633903128143
NCI-H1339,100016,8.285361450373896
HCC2218,9915743,-6.199285187365854
SNU-761,1566236,1.6191563733264562
Capan-2,24779724,5.003902097193099
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188
NCI-H2342,54618771,3.373010202836016
UO-31,10322450,3.2206425207996268
COLO 684,selumetinib-GDC-0941 (4-1 mol-mol),1.3698128792946012
PE/CA-PJ41 (clone D2),2746,3.71543902732957
Hs 766T,9926054,1.7033769922015074
SNU-387,selumetinib-GDC-0941 (4-1 mol-mol),1.4136760504697403
FTC-238,9926054,1.7889944253526169
G-402,tanespimycin-bortezomib (250-1 mol-mol),-2.2331450772750285
PK-45H,136227924,2.93841309707887
NCI-H209,9884685,0.4313294242687383
G-292 clone A141B1,sirolimus-bortezomib (250-1 mol-mol),-0.3022581749422651
SK-MEL-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.2410221738936931
SNU-387,2742550,5.0042131108814
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
NCI-H460,9911463,4.421747687015995
Hs 888.Lu,1566236,4.1191371889760475
SNU-216,11494412,1.6343036804588515
ChaGo-K-1,sirolimus-bortezomib (250-1 mol-mol),0.904309234685044
DV-90,10322450,2.5684087153895447
Tm87-16,9926054,1.142722518421256
PLC/PRF/5,9915743,4.0648434850392
SNU-503,135659046,5.578031724761291
OVCAR-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.7048742493039822
P31/FUJ,9926054,1.2698752833949425
MDA-MB-453,4705,2.8938913201458583
MOLP-2,54618771,0.3344993744663657
NCI-H1339,11152667,-1.000017899668529
BT 440,11494412,3.9335430982852406
JHH-4,1566236,1.7106073845324858
HCC366,9926054,2.0580421664352513
BT 147,3854666,0.1621960582737569
YH-13,11494412,0.8602319711686647
HEC-1-A,tanespimycin-bortezomib (250-1 mol-mol),-0.4943806740107087
HCC2279,9915743,1.7630274974109628
SU-DHL-8,selumetinib-GDC-0941 (4-1 mol-mol),1.9311696765253152
U-118MG,1566236,1.829120516017912
ZR-75-30,sirolimus-bortezomib (250-1 mol-mol),1.7584870714322065
OCI-AML-5,135421197,2.371407792163204
KNS-81,1566236,3.2129969954763973
NCI-H1341,135984461,3.1611856157713607
NCI-H716,135398744,6.457168364956761
JHH-5,3465537,2.9573193940502
MCAS,sirolimus-bortezomib (250-1 mol-mol),0.8032325328072784
BT 147,9915743,2.5746757141413887
PE/CA-PJ49,71751553,4.17175921879406
SNU-16,6918638,-0.935817634094486
P12-Ichikawa,136227924,2.6176590952299477
Jurkat,sirolimus-bortezomib (250-1 mol-mol),-2.067381581487011
Pfeiffer,65628,4.184862068239767
JVM-3,11152667,-1.88724585820006
NCI-H2023,9915743,3.985285977542264
TE-14,71751553,4.6389654689543205
KYSE-70,9926054,2.326174845830733
PK-1,11494412,1.9575571881437173
SNU-1214,135421197,1.3172671598461234
HCT 8,11152667,1.9192978307377688
HCC-56,selumetinib-GDC-0941 (4-1 mol-mol),-0.1385009392783674
TE-1,11152667,-1.3085145016086972
HuG1-N,135984461,3.7113703806960054
TE 441.T,54639665,4.381195082349918
PaTu 8988s,11152667,-2.740642733850453
JHUEM-2,73707386,2.660139253253633
NCI-H2172,650361,3.904571472219665
A2058,136227924,2.613575897416718
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
U-937,3465537,2.9406919869890378
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
P31/FUJ,11152667,-2.5755274762926095
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
FaDu,6918638,1.0818433355899586
LAMA-84,54618771,0.5560134201720579
LCLC-97TM1,1566236,1.804143498427706
Karpas-620,135984461,2.8856459263707213
BT 271,135659046,3.5809922662045137
BICR 18,136227924,3.2249717702756486
BT 131,tanespimycin-bortezomib (250-1 mol-mol),-1.406336138935124
CFPAC-1,11152667,-0.7440904943214312
KMRC-3,1566236,1.699322098754536
GMS-10,11152667,0.1694535094272809
Daudi,2742550,2.6022450411597764
JHH-4,135984461,4.02642317281815
COV434,24779724,4.28393897361134
Ci-1,11494412,0.5037895866991277
MOR/CPR,2742550,4.462061009820355
DV-90,9926054,1.8346982871797115
KMS-28BM,2746,1.511503840028706
BT 422,9935249,1.3442145971797932
SaOS-2,136227924,4.496792726095474
L3.3,135421197,2.5730452840447415
SH-10-TC,9935249,3.302172172490518
SF126,selumetinib-GDC-0941 (4-1 mol-mol),2.749668996319385
RPMI-8402,selumetinib-GDC-0941 (4-1 mol-mol),2.2206105962068645
ACHN,9926054,1.8123369817060109
MOLP-8,71751553,4.257415338539138
WM983B,9911463,4.352284884356164
COLO 829,9926054,1.880005790170633
BT 139,136227924,3.476406727957654
LS513,9884685,0.8647679809690252
NCI-H520,9884685,-1.9980015448993624
DoHH2,sirolimus-bortezomib (250-1 mol-mol),-6.588812122607576
SK-MEL-2,tanespimycin-bortezomib (250-1 mol-mol),2.677378887587516
NCI-H2286,9935249,3.5542516597696543
NCI-H1755,73707386,2.6822536013595895
COLO 699,11152667,-1.5476847653514505
ACHN,9915743,1.4221547150387026
NCI-H2141,11152667,0.4643269234046814
SaOS-2,71751553,4.337892909522829
SNU-46,3854666,3.3615805544302133
A-204,49836020,-1.292663609986573
OVCAR-8,49836020,4.475611867400311
NCI-H1651,24779724,5.019172728435523
UACC-812,135421197,0.8848266315498433
NCI-H1869,54618771,2.934235316942264
L-540,9926054,1.766103135672326
YH-13,71751553,4.865573337264169
MM1.S,9911463,3.396498541948332
COR-L95,9926054,2.0133423062539726
Caki-2,54618771,1.2625964957313875
SH-4,2742550,2.9279609499951222
HCC2935,9868037,3.914000615600812
GSS,2742550,2.9505623218307298
SK-MEL-3,9926054,1.7891311822278144
MOLP-8,44487872,4.385798937588512
HCC1937,3854666,4.439967963275119
Caki-2,9926054,1.76147282411668
JHH-5,9935249,1.9754654494080983
LP-1,49836020,4.554043159133258
Hs 294T,54618771,1.144454520663973
Hs 729.T,9911463,4.317623145839552
AsPC-1,9935249,3.639166614114404
U-937,3854666,-0.0560330485174303
TE-15,135659046,3.5275305939343884
Rh18,9915743,1.1636262664119963
CHP-126,3854666,-0.1747092469759535
OVCAR-5,136227924,3.2070295394145782
SNU-1272,3854666,4.252561459564198
MFE-296,136227924,3.1639946768284672
KALS-1,3465537,2.6305189862843155
JHOS-2,sirolimus-bortezomib (250-1 mol-mol),0.7378509581797704
DOV13,11152667,-1.0068890418824286
MSTO-211H,1566236,2.167071233614174
LOX-IMVI,1566236,1.766970310435897
HH [Human lymphoma],24779724,4.755180644839901
G-292 clone A141B1,1566236,1.5411770521873664
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
CAL-51,11152667,-1.203722258692511
OVCAR-8,selumetinib-GDC-0941 (4-1 mol-mol),3.698487260127977
Hs 822.T,9868037,5.178466658447283
SNU-61,9926054,1.8929452670989917
JMSU-1,54618771,0.1163446167769653
SW1710,24779724,4.364171366545052
T24,11494412,1.5431599577117932
Panc 04.03,11494412,3.764008563191269
Hep 3B2.1-7,136227924,5.40641673036814
SNU-489,selumetinib-GDC-0941 (4-1 mol-mol),2.3199148187504592
YD-15,100016,6.01418803247364
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021
SNU-81,49836020,-3.195484765979539
HOP-92,selumetinib-GDC-0941 (4-1 mol-mol),0.6606964721280018
RKN,73707386,3.296207724675486
SK-MES-1,9911463,3.432548166775373
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512
NCI-H146,selumetinib-GDC-0941 (4-1 mol-mol),2.6749469012990525
Hs 746.T,24779724,-3.709642201579214
TT,9868037,3.136972915519422
TTC-709,9911463,3.2608867997672935
DU145,3854666,2.445661849899651
Li-7,9926054,2.073130645224697
Detroit 562,9915743,0.7221649172673843
NCI-H1666,135421197,0.9962315776177934
KMS-20,6918638,-0.8366604804869239
NCI-H810,100016,4.22640705156995
Rh41,100016,7.167579216403683
NCI-H1623,2746,3.1722069840164533
KYSE-180,sirolimus-bortezomib (250-1 mol-mol),1.6916229080787213
8-MG-BA,49836020,-4.019161217996327
D283 Med,54618771,1.215604089870786
HL-60,9884685,-0.1505385847488882
KYSE-150,9935249,3.2107723044305185
SUP-HD1,54618771,-0.1374288926012433
SUP-T1,2746,1.6864160186054145
KE-37,100016,3.280443906920473
42-MG-BA,54618771,0.7266363256889177
BT 440,9868037,4.283687628506758
JHH-5,65628,4.074084523836835
A101D,11494412,3.85328566830266
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719
NCI-H2342,6918638,1.2820873150212615
SH-4,136227924,2.5718168505003693
YKG-1,2746,3.802533592415727
RERF-LC-MS,9926054,1.8051014319834384
NCI-H1184,11152667,-1.0488387695368542
BT 139,tanespimycin-bortezomib (250-1 mol-mol),-4.226590067496966
T3M-10,2746,5.219719103110665
AN3-CA,6918638,0.8350174262489668
SET-2,100016,6.077577626399248
TE-11,54618771,1.216683446725779
A101D,selumetinib-GDC-0941 (4-1 mol-mol),0.5924729203046659
T-47D,136227924,3.374798567013006
COV434,100016,6.159872289007743
COLO 678,4705,2.6344609779467603
DAN-G,9884685,-0.0367634949535886
Toledo,71751553,4.116950576345889
A-375,2746,3.0738136393469393
Hs 746.T,9935249,2.8365347377791954
GOS-3,selumetinib-GDC-0941 (4-1 mol-mol),2.3911305512377217
COLO 829,3854666,2.075808913393435
PE/CA-PJ34 (clone C12),selumetinib-GDC-0941 (4-1 mol-mol),0.7203053018358525
RS4;11,9935249,2.6128847525207735
HeLa,100016,5.8653655502295
SK-BR-3,9926054,1.6318008391907537
GA-10,11152667,-3.274266411551672
Ci-1,9935249,3.4134945639154526
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766
KMS-18,9868037,2.273728459676758
T84,54618771,0.5762306711501146
MDA-MB-157,2746,2.873003215594031
Calu-3,136227924,3.506459850502243
KMRC-3,9935249,3.2900979171549865
G-401,11494412,0.2825252149996007
BT 320,selumetinib-GDC-0941 (4-1 mol-mol),2.4654879652784447
MM1.S,9915743,0.5251517896588939
BT 172,3465537,1.5223639043000616
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
LS180,54618771,0.643112685351952
253J,100016,6.267948749211356
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
UM-UC-3,2742550,4.216415771783444
M-07e,4705,3.81547426285279
BT 131,selumetinib-GDC-0941 (4-1 mol-mol),2.219067508706083
DMS 114,9935249,2.684737393179628
MOLT-3,135984461,3.930713176256541
Hs 888.T,9911463,4.2898422169426285
BT 440,135421197,3.1509992040487074
NCI-H1869,9911463,4.397307517913515
COLO 205,54618771,0.9873734762739949
NCI-H661,9868037,2.6835007144938032
DEL,9868037,2.284164309985857
RKO,135421197,1.472175761257966
A4/Fukuda,135421197,1.440002399326734
CA46,3465537,3.345448990020783
PL-21,1566236,1.5934473154308642
Capan-2,135421197,1.2802517101193276
SK-N-AS,135659046,4.543052332569712
SK-MEL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.7049789212673134
SW1710,10322450,4.1954905662020305
HT-144,135421197,3.272729024645835
SK-UT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9282697370514716
SK-BR-3,sirolimus-bortezomib (250-1 mol-mol),-3.644794085557173
HOP-92,3465537,1.2768665307356584
TALL-1 [Human adult T-ALL],11152667,-3.0141291554787655
Rh41,9926054,1.5140566326622644
KPL-1,9915743,2.2588912198208595
SF539,9915743,0.9219479584552366
SU-DHL-10,135984461,3.8302995434103138
HCC1500,11152667,3.4439033763408644
ESS-1,9926054,1.828443058535804
OVCAR-4,49836020,-3.3998329005368833
HuCC-T1,2742550,3.2517227525139565
HCC1143,2746,1.9419289545652112
MEC-1,135984461,4.143438780946002
SK-LMS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.0421958472836335
NCI-H28,136227924,2.9733016664554155
NCC-StC-K140,9884685,-1.2435361669128766
DK-MG,100016,7.056187444773538
HH [Human lymphoma],sirolimus-bortezomib (250-1 mol-mol),-8.470809124767328
ECC10,9915743,-1.3646312579395177
HEC-1-A,1566236,2.9371765308534594
SW579,4705,1.9687725092896824
Panc 02.03,9926054,1.881153725115377
A-204,9935249,1.7999718511664184
ZR-75-30,1566236,2.802921383922552
SUP-M2,71751553,4.246289721019636
COR-L105,3854666,3.5309487733662923
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
SK-UT-1,1566236,1.7242203991960865
KG-1-C,9926054,3.438726286073136
KE-39,135659046,4.845551344520264
NUGC-3,54618771,-0.8642995608201182
HCC44,selumetinib-GDC-0941 (4-1 mol-mol),-1.5745455752339166
D283 Med,4705,3.1008912872866325
HT-1080,9915743,2.579690358518253
BT 333,9868037,4.601052403948759
HCC2108,9911463,3.889332679655138
BT 147,71751553,4.775890846508256
SHP-77,9915743,3.2387614248812984
P-STS,11494412,1.4773274535809604
SK-N-SH,tanespimycin-bortezomib (250-1 mol-mol),0.2020120787076161
BT 145,2746,2.646861409473543
NCI-H1703,49836020,-2.068142260286603
SU-DHL-10,tanespimycin-bortezomib (250-1 mol-mol),0.050214335602148
L-428,135984461,4.314670254949914
JMSU-1,135984461,4.473893168113172
MOR/CPR,54618771,0.4872515527398967
KMS-18,sirolimus-bortezomib (250-1 mol-mol),0.6867934925830966
JMSU-1,65628,4.470977639866145
SK-N-BE(2),9911463,3.2648033538854517
HCC44,49836020,-1.9143926504163185
MOLT-16,10322450,3.2788415570807
D283 Med,71751553,4.245405525851178
KYSE-410,11152667,-0.1422079620328849
SNU-C1,9884685,1.2025701916659406
SNU-886,54618771,-0.5899639628082597
KMS-18,54639665,4.4302920956465055
IMR-32,71751553,0.2380209164457374
Ri-1,135984461,2.0671055438536547
PK-59,3854666,3.1918550803858783
Panc 08.13,2746,3.457516363442077
T24,2746,3.727610415765059
HCC366,100016,6.086233690393214
VCaP,9915743,0.8539213695890696
T84,9935249,1.8419022966508296
NCI-H524,3854666,0.1377442015623311
SK-BR-3,11494412,0.3073008464211634
KMS-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.985163652094814
KHM-1B,9915743,0.5787442773030028
TALL-1 [Human adult T-ALL],9911463,3.188580812335009
OCI-AML-5,65628,3.584711118460752
ChaGo-K-1,9926054,1.8139091606673228
BT 216,9911463,3.0589370422001494
NCI-H211,sirolimus-bortezomib (250-1 mol-mol),1.3707117645726492
SNU-503,selumetinib-GDC-0941 (4-1 mol-mol),1.4877260570474324
NCI-H1650,9868037,3.338275078682257
MKN74,9915743,1.5544684592006026
MDA-MB-453,9884685,-1.4419247946131482
NCI-H1155,tanespimycin-bortezomib (250-1 mol-mol),-1.3476430950240228
CAL-120,9915743,1.5300357462743028
HeLa,9911463,4.222129751403694
COLO 320,3854666,1.7292178275601346
HEC-1-A,135659046,3.907670889087363
OPM-2,135659046,2.7260896342727396
SCC-4,6918638,-0.3136358743623781
BT 328,9926054,3.720062864226824
HPB-ALL,3854666,0.8658225320961793
RPMI-6666,9915743,0.6394902381719043
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
NCI-H1869,3854666,4.318290699876198
NCI-H2444,9935249,3.5288049405628437
BT 159,54618771,0.7710223588064036
TUHR4TKB,54618771,1.114218379650299
LoVo,2746,2.3133613771451524
LAMA-84,135421197,2.406961444006632
PE/CA-PJ41 (clone D2),135421197,1.2532047663272594
HCC78,65628,4.210557288257803
LAMA-84,100016,4.28644111913654
NCI-H841,9915743,3.2736348589608606
NCI-H1435,9926054,1.8918877697265553
SNU-761,tanespimycin-bortezomib (250-1 mol-mol),1.2423836146793283
MOR/CPR,3854666,0.693887275502914
SNU-878,73707386,3.9073553748318672
HOP-92,9926054,1.661169949591577
SK-N-SH,selumetinib-GDC-0941 (4-1 mol-mol),1.1074164821021857
BHT-101,65628,4.438959852267732
A2780,selumetinib-GDC-0941 (4-1 mol-mol),-0.1378336599124344
IGR-37,tanespimycin-bortezomib (250-1 mol-mol),1.387795726757113
EM-2,136227924,2.1746228564853864
Granta-519,54618771,-0.1786557603441652
22Rv1,135421197,1.1830541259797036
OE21,10322450,4.259055597018236
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638
ONS-76,54618771,0.5276024038238057
BT 232,71751553,4.301675554416272
SW982,11152667,-1.020934919327518
EHEB,11152667,-1.348021466254982
A-549,100016,7.181380121169662
TCC-Pan2,tanespimycin-bortezomib (250-1 mol-mol),-1.7030002887525872
GMS-10,selumetinib-GDC-0941 (4-1 mol-mol),1.7760805254050829
AM-38,11152667,-1.321239615811224
TE-8,9911463,3.6899987590816687
NCI-H2444,3465537,3.061978524719414
MKN7,2746,3.491753391139794
JHUEM-1,3465537,3.1283604264685403
KATO III,2742550,3.7878556797124254
U-CH1,4705,-0.5183454701294119
TE-14,9926054,1.5943832140078456
OVK18,sirolimus-bortezomib (250-1 mol-mol),-3.215952535759779
CAL-54,9935249,2.6795394357960145
ZR-75-30,selumetinib-GDC-0941 (4-1 mol-mol),2.2960611598253178
NCI-H747,3465537,1.8944570595405523
CW-2,11152667,0.8041866836775025
SK-MEL-31,10322450,4.01395205895819
SUP-B15,1566236,1.4989304787624995
MDA-MB-468,tanespimycin-bortezomib (250-1 mol-mol),0.8210992476411649
MOLP-8,136227924,1.5113872866650588
OCI-Ly10,2742550,6.051416351700485
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
23132/87,9926054,1.8706773159839023
FTC-133,2746,3.487652314498242
NCI-H1341,10322450,2.409871050091722
BT 179,136227924,3.760107948072088
NCI-H1755,3854666,2.659558570060276
JMSU-1,100016,3.921608363156487
SNU-1196,100016,6.169672174830197
DOV13,135421197,2.464750540362873
HuP-T3,54618771,0.8132197250487964
TE-15,135984461,4.740662203651603
DMS 114,54618771,0.497932875253643
HGC-27,11494412,-1.4088898855213312
NCI-H1092,1566236,1.754245151236072
SUP-T1,9935249,2.0968505860065156
SNU-1077,135984461,3.620374859792411
NCI-H23,65628,4.057192567331317
SNU-685,9911463,4.245246526228465
U-251MG,9915743,2.5124314599198407
PE/CA-PJ49,135421197,1.7245990786454344
BT-16,9926054,1.298876500503981
HCC1833,9911463,3.7741336364868943
IGR-37,3854666,0.7173312278766348
UACC-62,136227924,3.255935919058072
WM1799,3854666,2.78635889347835
GaMG,9935249,4.235528927004279
KMS-12-BM,9935249,1.0143045497874623
BV-173,tanespimycin-bortezomib (250-1 mol-mol),-0.4619705859834364
OVCAR-5,9935249,2.5949281328886316
KYO-1,tanespimycin-bortezomib (250-1 mol-mol),0.6215111489817027
SK-MM-2,100016,6.381158442456996
Kasumi-1,1566236,1.005917996817539
NCI-H508,4705,1.5778147513769882
HCT 15,selumetinib-GDC-0941 (4-1 mol-mol),0.3162595465665505
HCC2218,135421197,0.9685735875874713
SNU-761,4705,2.9442474881607676
HCC4006,2746,3.5545517621317586
DLD-1,2742550,3.451094792104627
CHP-212,4705,3.1318410503879717
OV56,11494412,4.390651682494516
BT 172,4705,2.221362713741292
BT-20,71751553,4.468530583756154
G-402,54618771,0.638636579266015
OAW28,9884685,1.3567472374362477
MCAS,135398744,6.37399282177603
P3HR-1,136227924,2.9304577514896466
LOU-NH91,9884685,4.047485572984955
A-673,11152667,-2.304412849002376
SK-MEL-31,selumetinib-GDC-0941 (4-1 mol-mol),3.550007018724769
SK-MEL-24,135421197,2.6941455652105852
Lu-65,11494412,0.9324583231494612
LP-1,65628,4.349583792779986
U-118MG,136227924,3.3662867602003006
A2780,73707386,2.710080958425795
KMS-20,9884685,-0.8480553066997102
U-87MG ATCC,3854666,3.5140340927241267
PC-14,1566236,4.058624946663528
OCI-Ly3,49836020,4.868556688555981
LNCaP clone FGC,9884685,-0.2879888364865913
SK-CO-1,11152667,-1.1935109806009474
MKN1,135984461,5.649993285948901
KMS-21-BM,73707386,2.971597915568964
TE-11,tanespimycin-bortezomib (250-1 mol-mol),-2.7748536147542167
HCC1954,2742550,3.203608466138423
MV4-11,54618771,-0.7918947949340449
SNU-1214,3854666,1.2717797575016767
697,9911463,2.5551719944155016
BT 172,135659046,3.5133066038104355
JL-1,9911463,4.108881360453434
KATO III,4705,2.4067147037992696
JHUEM-1,1566236,1.8042145554615676
TE-14,tanespimycin-bortezomib (250-1 mol-mol),-1.657648162906329
IMR-32,54618771,0.9755251255632068
JHOS-2,9926054,1.95390752128008
NB1,4705,2.5823945012160214
BICR 22,10322450,4.612637955736889
TE-14,135984461,4.3356196573929
PE/CA-PJ15,135984461,4.416241968173964
BT 159,136227924,3.541986211057949
BC-3C,11152667,-0.9624710260076396
Panc 03.27,2742550,3.7369111271801234
OE33,11494412,2.705114225479706
Namalwa,2746,1.3872498592399898
BT 228,9868037,3.723299534994555
Karpas-422,3854666,1.0831762818043358
8505C,11152667,0.3800662842278975
SYO-1,54618771,-0.0439888220829119
FaDu,9915743,0.0595730562348672
SBC-5,9868037,1.591902673624677
NCI-H661,tanespimycin-bortezomib (250-1 mol-mol),0.6505677093345705
PaTu 8902,136227924,3.2072125986231117
UACC-812,11494412,1.976870257251046
MDA-MB-435S,selumetinib-GDC-0941 (4-1 mol-mol),0.7675119040231712
MDA-MB-468,9884685,0.4433272557303077
WM1799,9926054,2.0873998071095685
BT 498,selumetinib-GDC-0941 (4-1 mol-mol),3.507638604673562
WSU-DLCL2,135984461,1.5451272149334774
NCI-H211,9911463,2.7267014601738575
GDM-1,9935249,1.7678028451687384
RVH-421,135659046,3.595946771540715
PL-21,9915743,0.5916230612831309
CCF-STTG1,9911463,4.668972921835481
CAL-85-1,9926054,1.875240534371988
PE/CA-PJ15,136227924,2.633948596133963
BT 224,3854666,2.1377597986560315
BT 139,selumetinib-GDC-0941 (4-1 mol-mol),0.4945119496988254
LMSU,135398744,6.91211293627059
LS513,135984461,3.023375368580486
JHOS-2,11152667,0.4249087048745091
SNU-16,tanespimycin-bortezomib (250-1 mol-mol),-3.234515138053412
YKG-1,6918638,1.332910318202703
DMS 114,9911463,4.412610597961803
Capan-1,9884685,3.5003951132484485
MDA-MB-435S,sirolimus-bortezomib (250-1 mol-mol),0.878398861878788
IGR-39,11152667,-0.525623026371846
P31/FUJ,49836020,4.674155414221834
Caki-1,135984461,1.2044683879292255
KYSE-150,9926054,2.2758457773041645
BT 328,9911463,3.726223215474182
HCC78,tanespimycin-bortezomib (250-1 mol-mol),1.9748974265856916
Calu-3,9884685,3.111229867397832
Calu-3,9915743,-3.447731776127472
SEM,sirolimus-bortezomib (250-1 mol-mol),-0.6909485025943941
NCI-H460,100016,5.855223104671776
SEM,136227924,1.2424830449991908
GP2d,1566236,1.660029832907994
SNU-503,11152667,-0.4742332423584474
VMRC-RCW,selumetinib-GDC-0941 (4-1 mol-mol),3.3415688059991537
LP-1,9884685,-1.812472682789282
COR-L88,sirolimus-bortezomib (250-1 mol-mol),1.8944526230025216
G-402,2746,4.175584503802389
NCI-H647,9884685,1.1799984991000132
SW620,24779724,4.4273355019775265
SW1990,71751553,4.1573307972574485
PL-21,4705,2.342779269332656
HOP-92,2746,3.1946789045133217
ST486,9884685,0.3011062845226507
KMS-21-BM,10322450,3.0637099399177936
TCCSUP,2742550,3.882646249663198
NCI-H929,65628,3.950811987229233
SNU-308,sirolimus-bortezomib (250-1 mol-mol),1.6825510481181765
SW620,2746,3.8356655866874414
HuG1-N,2742550,3.170648842164322
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505
SNU-878,tanespimycin-bortezomib (250-1 mol-mol),-0.1499782135858746
BT 416,65628,3.396680033098099
DMS 114,9868037,3.4094491088437633
NCI-H520,6918638,-0.4821268163650811
DB,9935249,0.9788795503419736
8505C,9935249,3.565227289409523
A4/Fukuda,54618771,0.259551202975953
Panc 05.04,9926054,1.8029787074876424
BT 179,6918638,1.1141974557977532
MDA-MB-157,1566236,1.4232096904008935
NCI-H1693,4705,2.4450047758451054
LOX-IMVI,65628,4.323385700869822
DB,135421197,1.3227021747573118
BT-474,9911463,4.372266907871184
L-428,6918638,-0.3138373301557662
HCC1195,9868037,3.635348829335935
Sq-1,10322450,4.325633425734601
OCI-Ly3,135398744,6.408015135669225
Ri-1,65628,2.1586840271379732
TE-6,10322450,4.821445801682838
NCI-H508,sirolimus-bortezomib (250-1 mol-mol),0.7195278231297386
HCC4006,selumetinib-GDC-0941 (4-1 mol-mol),1.2371025715535526
KE-97,135984461,3.5565388757369014
Raji,sirolimus-bortezomib (250-1 mol-mol),0.8276284938593903
BT 231,2742550,2.753337443391445
BT-549,9915743,2.34179420613382
NCI-H1339,2742550,4.5254309197539735
Rh41,sirolimus-bortezomib (250-1 mol-mol),0.2633406530968948
PK-45H,tanespimycin-bortezomib (250-1 mol-mol),-0.8772986942389263
HCC38,9926054,1.7712684565891563
Hs 895.T,3854666,3.5289829664502568
HCC1438,2742550,5.572019018738765
SK-UT-1,2746,4.836098417840603
HuH-6,2742550,3.1145719555139126
CAL-12T,selumetinib-GDC-0941 (4-1 mol-mol),2.008414160334409
Detroit 562,11152667,-0.9771031381633576
KP-N-YN,2742550,4.250403933342819
JHUEM-3,10322450,4.4054488453060525
A-673,tanespimycin-bortezomib (250-1 mol-mol),-0.1560084319129122
LoVo,11152667,-3.1828514843907967
NCI-H1838,9911463,4.286629824505249
SW1783,4705,3.473081250569121
CAL-54,2746,3.3346441526791306
KMS-18,4705,2.900796291419513
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
Panc 10.05,9926054,2.010421160581402
HEC-151,9911463,4.0043305736729105
WM88,9915743,1.087537207724937
WM983B,135398744,6.927047773444745
TE-15,100016,6.263488161224716
TE-4,3854666,0.4344815210505751
SNU-119,10322450,3.771322180088625
Panc 03.27,100016,6.730276002902577
YD-10B,54618771,-0.547775158029887
OE21,9915743,-2.7713034399639
TE-8,tanespimycin-bortezomib (250-1 mol-mol),1.1915545878263378
EJM,71751553,6.47545049455161
CAL-148,136227924,1.0972662327382037
HCC1171,136227924,3.688896594319452
Detroit 562,135421197,1.0926229563125225
DMS 273,100016,5.677769516399485
WM115,54618771,0.9043395114740442
NCI-H2126,135421197,2.0437497253057137
HEC-1-B,9935249,3.3979686302548413
OVISE,sirolimus-bortezomib (250-1 mol-mol),0.3208269840941957
HEC-108,11152667,0.9436637108805932
BT 359,9884685,1.2132482277376444
HCC1428,10322450,3.77316482135935
Granta-519,1566236,1.1036082649410253
EKVX,9926054,2.0075425899751513
TE-6,9915743,1.0725683226021352
Granta-519,65628,2.6603144373939154
A4/Fukuda,9911463,2.417745886609146
FaDu,71751553,4.416066442268583
MV4-11,9935249,1.024868546026966
HCC44,tanespimycin-bortezomib (250-1 mol-mol),-2.3281487607595515
BT 239,2742550,2.277540170314908
L-540,tanespimycin-bortezomib (250-1 mol-mol),-0.491280358264631
Li-7,9935249,3.5726541001796734
VMRC-RCW,1566236,3.1837632909467497
CHP-212,9884685,-1.3335734130600392
Hs 294T,selumetinib-GDC-0941 (4-1 mol-mol),1.293217302318029
PK-1,9926054,1.83429012816666
Mono-Mac-1,100016,3.734497226962008
Mino,10322450,2.499731281895077
TE-10,9911463,4.005414561442447
Mino,100016,3.8828597807205023
NCI-H1573,11152667,0.2094466733684726
HEL 92.1.7,11152667,-1.275650454905527
HCC2279,3854666,0.8378749167236459
LS123,4705,2.777266406946489
FaDu,11152667,-0.3109618737618113
NCI-H2342,3854666,3.3105988533108777
KMS-20,135984461,4.215331371407202
RPMI-8402,54618771,-0.5360819718373795
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
ONCO-DG-1,100016,7.582922943410799
OAW42,1566236,3.718309855470026
IMR-32,6918638,-2.6640844779638244
T98G,sirolimus-bortezomib (250-1 mol-mol),0.3680606799164068
OVSAHO,sirolimus-bortezomib (250-1 mol-mol),1.2333727480896128
SNU-1079,sirolimus-bortezomib (250-1 mol-mol),-1.4435273189765718
JeKo-1,9911463,3.294378834813148
DAN-G,6918638,0.6024749153933902
JHH-5,4705,1.264083267323837
HEC-6,tanespimycin-bortezomib (250-1 mol-mol),0.7644617965871396
DMS 114,65628,5.583930702955729
JHH-1,4705,3.6727549882245634
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424
NCI-H196,54618771,3.538687286650074
A-673,sirolimus-bortezomib (250-1 mol-mol),-6.228363606010268
WM266-4,9884685,-0.0947823690174165
HOS,2746,3.590009491278375
KYSE-180,9926054,1.7654325832877988
CCF-STTG1,2746,3.7135967128071385
KP-3,135421197,0.5862918255078794
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
LS1034,11494412,1.9461067942011936
BT 164,100016,6.2228733531949505
EB1,9926054,1.6799735914328415
TYK-nu,650361,3.673575203480575
KNS-42,4705,5.099780843040584
NCI-H647,9911463,4.264902637756033
NCI-H1869,selumetinib-GDC-0941 (4-1 mol-mol),2.116437467611717
SK-N-BE(2),1566236,1.702802410845402
LMSU,9884685,1.8441382051797008
OPM-2,2742550,2.8639715022070713
TOV-112D,54618771,0.882664692368087
MPP 89,11152667,-2.4400346442017833
BICR 22,1566236,3.7080344976190434
TOV-112D,10322450,4.283005252404589
LN-18,3854666,2.124963526883118
BT 333,9935249,3.0763319445074124
BL-70,9915743,2.1180817838790658
KE-39,135984461,4.3782777468955745
U266B1,2742550,4.53274163038269
Panc 08.13,9884685,0.2056896463643182
KYSE-140,9926054,1.9800704230635255
SK-BR-3,65628,3.766479538164496
KYO-1,135984461,2.714539808295769
NCI-H1693,9884685,-0.0882247449896871
CL-11,selumetinib-GDC-0941 (4-1 mol-mol),-0.9577137132947868
GOS-3,9926054,2.0544356724695776
SNU-61,73707386,3.625444775073466
COV434,11152667,-2.1073866587536583
KMS-21-BM,9926054,0.3453207317075127
MG-63,9926054,3.1754047574180815
C2BBe1,9926054,1.888966029374552
CAL-148,54618771,-0.772242663626429
COV362,9911463,4.09854826662349
DoHH2,9915743,0.0778019212938174
PK-45H,selumetinib-GDC-0941 (4-1 mol-mol),0.6996398674072702
Panc 10.05,136227924,2.25248962667623
EBC-1,9884685,-0.5072112125161227
IA-LM,9915743,1.455667571666015
SW579,9884685,-0.5742606085453624
JeKo-1,135421197,1.3904667144592064
LXF 289,135421197,2.6553019911408056
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
RERF-LC-Ad2,6918638,1.8472690467547748
NCI-H1155,selumetinib-GDC-0941 (4-1 mol-mol),2.5268470929641964
Panc 05.04,9915743,-0.1908442283292951
YKG-1,54618771,1.607640245193468
NCI-H2087,49836020,4.38375865979883
TE-6,54618771,1.015505758549108
OAW42,135984461,3.763630222707139
NCI-H2087,3465537,1.2179436522568818
NCI-H1184,9911463,3.5599804039419225
HMCB,135421197,2.011360494635396
COLO 680N,11152667,0.9012324673098332
PSN1,44487872,4.3354690925814
CAL-51,9868037,3.5441777448678615
TCCSUP,650361,4.871702860557827
NOMO-1,11152667,-1.8753376491976492
PaTu 8988s,136227924,2.43354349220747
BT 340,4705,3.3902514957212153
WT2-iPS,9911463,4.390053474560322
RCC10RGB,11152667,2.8531679730856268
OV56,1566236,1.8628278563698883
Kasumi-1,9926054,1.808732421420859
ECC10,2746,0.8272304201141983
UM-UC-1,1566236,3.49642764256864
NCI-H522,2746,2.8917767436803414
RERF-LC-Ad2,54618771,1.6045253072760792
PE/CA-PJ34 (clone C12),135659046,3.607473265136562
NCI-H2029,135984461,4.315213112140467
LN-229,65628,4.462977906883874
HT-144,135659046,3.3516643492898477
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528
Hs 766T,9911463,4.174180963053701
ME-1 [Human leukemia],54618771,1.2979456738996673
CAL-54,135421197,1.5931766951689923
Daoy,65628,3.6949596991690976
HOP-62,1566236,4.388769459301917
JURL-MK1,9911463,3.2271794119199293
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
CAMA-1,54618771,-0.4577950074396519
DV-90,9911463,2.614812777882286
YD-8,136227924,3.733712180219105
Karpas-299,100016,4.52969889794102
NCI-H69,selumetinib-GDC-0941 (4-1 mol-mol),3.077666934797567
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
RERF-LC-A1,9868037,1.4970424039127654
SH-10-TC,11152667,-0.1352620924138639
T-47D,54618771,0.7815754342030017
KYSE-30,100016,6.190453384433256
BT 216,136227924,4.751796234635162
SNU-C5,9926054,1.8417265889744416
EJM,100016,6.634092198961092
NCI-H520,4705,3.58444135118044
EKVX,selumetinib-GDC-0941 (4-1 mol-mol),0.6299385991814179
Panc 05.04,135421197,1.7241772934352249
SNB-75,136227924,3.131186635449868
L-540,73707386,3.020953643715912
TCC-Pan2,sirolimus-bortezomib (250-1 mol-mol),2.6812327412010095
NCI-H2110,selumetinib-GDC-0941 (4-1 mol-mol),1.414956690857524
CAL-27,49836020,4.376742607272952
SU-DHL-1,9868037,1.568771805047012
NALM-6,49836020,4.594148282336944
MOLT-3,11494412,-1.4900582448150606
CW-2,9926054,2.0798492458785978
RL,9915743,1.6730730266381315
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
KYSE-510,9911463,4.240688148771923
T-47D,tanespimycin-bortezomib (250-1 mol-mol),1.663799380230643
OCI-Ly10,selumetinib-GDC-0941 (4-1 mol-mol),1.0181444461611715
KYSE-30,9884685,1.4164675900937749
TE-9,9911463,3.937916951140395
NCI-H889,136227924,2.7199111384597447
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
SH-4,135421197,1.5292272501013058
COLO 680N,9926054,2.740733080202674
HCC4006,135984461,1.8301833848087097
TUHR4TKB,tanespimycin-bortezomib (250-1 mol-mol),0.8308277028090468
COR-L88,9915743,2.6531314221419704
A-253,2742550,3.4379925560978406
MV4-11,49836020,2.655795655295622
HGC-27,2742550,2.8025291770000846
SNU-5,100016,6.769356825304223
NCI-H1915,9915743,0.3571601745148741
SK-ES-1,135421197,0.934110711885636
NCI-H841,71751553,4.669276949969767
AU565,4705,1.275846161151896
SNU-738,selumetinib-GDC-0941 (4-1 mol-mol),2.490499311064832
SYO-1,6918638,0.2602930891489552
UM-UC-3,9935249,4.580111467121929
NCI-H2087,11152667,-1.020172453854182
NCI-H647,71751553,4.622172981641497
TE 617.T,3854666,0.5346166749411773
TC-71,tanespimycin-bortezomib (250-1 mol-mol),0.107717273209992
G-292 clone A141B1,9911463,4.73582688224515
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
DMS 53,136227924,2.35473496791988
OCI-Ly19,54618771,-1.0348518015701054
MOLM-13,3854666,0.5101644656521153
OVSAHO,selumetinib-GDC-0941 (4-1 mol-mol),2.882517977180431
NCI-H1105,1566236,0.7862780744513477
HLF,2746,3.261638353143838
RD,sirolimus-bortezomib (250-1 mol-mol),0.3715826338530998
MKN1,9915743,2.5735660173658323
HuCC-T1,3465537,1.6578684986062462
PC-3,1566236,2.121156143550011
KYSE-180,54618771,0.8276624799970426
SK-N-DZ,1566236,1.6850106257935773
HCC95,selumetinib-GDC-0941 (4-1 mol-mol),2.25370960012268
EFM-192A,71751553,5.63854540907664
HuT 78,54618771,-0.2261201753145263
SNU-8,54618771,-0.2346938322915562
JHH-4,3854666,2.756856566368671
FaDu,9935249,3.0876333613815623
EFE-184,54618771,1.5466528492822589
Daudi,2746,0.9195319579001202
SNU-216,9884685,-1.507922407291845
CAL-51,9915743,1.1260994347217144
SNU-61,9915743,-0.5579526190142376
JHH-1,136227924,2.990976056622349
Panc 08.13,135421197,2.5362535902354932
MM1.S,9926054,1.5897504862532963
COR-L88,11494412,1.2749755816381174
HT-1080,2742550,3.555929471473571
EFO-27,136227924,3.515702384882397
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
D283 Med,135659046,3.420100505846104
OCI-AML-3,9884685,-1.3985823695443076
Raji,3854666,1.2627673053798778
YH-13,54618771,3.881155680896358
AN3-CA,1566236,1.2128002285671464
DMS 273,9935249,1.448801275140577
Ki-JK,9926054,1.4842884582556586
NCI-H1623,1566236,4.077529389730835
CMK,9935249,0.8813974275498553
NCI-H23,9911463,3.868491646866135
RERF-LC-Ad1,136227924,3.427007002266959
SNU-620,100016,4.241219903285237
MKN1,3465537,2.2988612958925656
HCC38,135421197,1.646244202411993
SNU-C2A,11152667,-1.3590856917202871
SNU-1272,24779724,4.452113053156204
TTC-709,71751553,4.330479823321924
BT 286,11152667,1.278732358262165
CAL-33,sirolimus-bortezomib (250-1 mol-mol),0.5156392130456946
Granta-519,135421197,0.2234065586927925
LC-1/sq-SF,54618771,0.7298922583446973
SEM,65628,2.5869900174043647
SCaBER,6918638,-0.2327063934194413
SET-2,136227924,2.6175155289445646
LOX-IMVI,6918638,-0.3729962449079992
TCCSUP,136227924,3.28330337763218
SUP-M2,1566236,0.979539411092358
Kasumi-1,9911463,2.7183571819341776
WM266-4,11152667,0.6640088083236647
SNU-601,3854666,2.8190052907424996
NCI-H1299,73707386,3.9485300681626625
NCI-H841,2742550,3.727846047428191
EoL-1,100016,3.3783759894754795
Tm87-16,3854666,2.16285781044172
Hs 729.T,3854666,2.014688118884844
NCI-H526,11152667,0.4389339837373306
SNU-216,9911463,4.000497828097352
SNU-C2A,tanespimycin-bortezomib (250-1 mol-mol),-0.6320265615754446
COLO 320,6918638,-0.2537054006659544
KMS-11,73707386,2.003938683847614
KE-97,73707386,3.3259864219274897
HCC1143,49836020,2.702530837822698
PK-59,73707386,3.024684722161558
NU-DUL-1,sirolimus-bortezomib (250-1 mol-mol),-5.630775475246084
EoL-1,71751553,1.891736650896905
LN-229,44487872,4.461552485906766
NCI-H2110,6918638,0.2299759669474582
RPMI-8226,135421197,1.9475796731003323
U-BLC1,sirolimus-bortezomib (250-1 mol-mol),-1.829710592484544
GaMG,9915743,4.602253717337043
JJN-3,3854666,0.7254434498430801
HPB-ALL,2746,1.2086783297242478
JIMT-1,9911463,4.046723460616858
Jurkat,tanespimycin-bortezomib (250-1 mol-mol),0.7517275719467844
NCI-H716,1566236,2.5544710796905044
SK-LMS-1,11494412,2.2164540785451106
TE-1,9915743,1.1903317834538285
RMG-I,selumetinib-GDC-0941 (4-1 mol-mol),3.743143666757181
VMRC-RCZ,9884685,3.905874897299475
KMS-12-BM,3854666,-0.1079800642722917
Jurkat,73707386,3.139054608217693
SW982,100016,3.947877721573723
SNU-449,1566236,1.8764566240908545
SK-MEL-5,9915743,2.239295477459583
253J-BV,9911463,3.300090280409142
HLF,135984461,4.657471192071366
NCI-H1694,11494412,0.349051552710581
SNU-878,135421197,4.562979063002288
Pfeiffer,135659046,2.6558992288544725
COLO 320,100016,4.196375737127383
NCO2,selumetinib-GDC-0941 (4-1 mol-mol),-0.0014559865533413
M-07e,24779724,5.840780932705825
LUDLU-1,2746,3.195399638512964
A-204,9911463,3.1571313791441407
CGTH-W-1,selumetinib-GDC-0941 (4-1 mol-mol),1.204610504332706
SK-MEL-3,11494412,3.62103205508352
OE21,6918638,0.1632098658801684
Hep-G2,9911463,3.8113421260686735
NCI-H441,selumetinib-GDC-0941 (4-1 mol-mol),1.6335298040025916
ES-2,100016,6.579379467241575
HuCC-T1,3854666,2.02774458559481
SNU-761,9868037,3.0815059044101822
KMS-26,9868037,2.2608372373619035
MeWo,135659046,3.600051172308168
DMS 273,9884685,-1.1971048738595964
NCI-H1155,54639665,4.4838841081587555
SKM-1,3854666,-0.271294085602593
LS513,136227924,2.4637797835127793
MDA-MB-453,1566236,2.5975650319928434
TT,3854666,3.3139239024984586
GA-10,11494412,-0.8165208112665053
MDA-MB-361,136227924,3.324084435927791
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
CCF-STTG1,9915743,3.2198509615239024
SET-2,65628,4.139593667952883
HSC-4,2746,3.845189406581069
MKN45,9911463,4.632909886442526
HuP-T4,135984461,3.493927750187572
HSC-2,selumetinib-GDC-0941 (4-1 mol-mol),0.8174688254253049
PE/CA-PJ15,6918638,0.9363103788474072
A-498,9926054,1.5026788619071982
PK-45H,2746,3.885970840485544
WM266-4,4705,3.3453038415665652
KYM-1,135659046,3.425924566474854
SK-N-AS,9911463,3.98556434214228
Becker,tanespimycin-bortezomib (250-1 mol-mol),-0.8898597294862367
KMS-11,24779724,4.338886383407692
EPLC-272H,54618771,2.195123762717199
JHH-1,6918638,-1.2691376417044395
SCC-9,9935249,4.690276947265519
SK-N-DZ,6918638,-2.181446020930978
KMRC-2,135659046,5.230232657074779
NCI-H226,4705,3.419610218683655
BT 145,sirolimus-bortezomib (250-1 mol-mol),-0.145853867426896
HCC1438,9884685,0.8398898245443017
PE/CA-PJ41 (clone D2),11494412,6.141663454426873
IST-Mes1,9911463,4.127098730346426
CW-2,sirolimus-bortezomib (250-1 mol-mol),1.6646573064439074
DMS 53,2742550,2.93982953242082
TE-6,11152667,-1.5406626235215035
HuP-T4,65628,4.410726137782856
OE21,2746,3.2562317048816363
CAL-78,9884685,-1.1065576377776678
KMS-11,9884685,-2.516546134244935
NCI-H2171,136227924,2.167829841056951
KE-97,tanespimycin-bortezomib (250-1 mol-mol),-0.1953255566925064
EFM-192A,54618771,1.407035681084211
C2BBe1,tanespimycin-bortezomib (250-1 mol-mol),0.2943844142837441
SNU-475,1566236,3.929799458774806
KYSE-520,100016,6.554858217735662
Hs 839.T,11152667,0.795668591768864
TF-1,135421197,2.0817745254871216
SK-ES-1,54618771,0.5955874337790977
HEL 92.1.7,selumetinib-GDC-0941 (4-1 mol-mol),3.657513004741347
TE-11,71751553,4.171165547166187
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SK-N-MC,11152667,-1.1821735930174364
SW1783,2746,4.238030101530504
A2780,3854666,-0.0414990172822217
BxPC-3,135984461,1.8776729747018608
MDA-MB-435S,135984461,3.5983225133232795
RT-112,3854666,1.0623619754138416
T98G,11494412,3.010368499943237
Hs 895.T,selumetinib-GDC-0941 (4-1 mol-mol),2.3327892844393374
SUP-T11,65628,3.35493935784814
BT 330,9911463,3.351892794022171
BT 145,selumetinib-GDC-0941 (4-1 mol-mol),0.1649490649734122
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
HCC1438,135421197,2.9315312537575124
ChaGo-K-1,9911463,3.7968497419655094
NCI-H2126,54618771,2.112004674949257
Hs 766T,11494412,4.28391436408153
SNU-466,54618771,0.431904700089911
KNS-60,3465537,2.201526829680429
K029AX,71751553,4.553165888029419
BL-70,6918638,-1.5969799068966968
DLD-1,9926054,3.0182242883731516
NCI-H146,sirolimus-bortezomib (250-1 mol-mol),-0.0099585964665403
HT-1197,9935249,1.8352479707891152
CGTH-W-1,11152667,-1.852976314266698
J82,3854666,3.07601629027796
SNU-C1,135659046,3.6498249144750656
NCI-H2291,9935249,4.011307681542379
NCI-H1651,65628,6.210976092474593
HCC1954,3854666,1.898706418770946
KP-N-YN,9926054,3.360231389536055
NCI-H1568,135984461,4.216726883570129
NCI-H661,9884685,0.1767392095869446
ONCO-DG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.679099331983427
HT-144,11152667,0.9785925094290924
SK-N-MC,54618771,0.9306599486262166
KMS-28BM,9911463,2.9492767057904583
HeLa,54618771,0.9271666044907572
RERF-LC-Ad2,sirolimus-bortezomib (250-1 mol-mol),2.075251911083675
BT 286,9915743,1.1038828678808648
HD-MY-Z,9911463,3.453159994393753
SW579,6918638,0.7272456776623913
EoL-1,3854666,-0.2024908872180563
M059K,9884685,0.2325695956853431
BT 416,3465537,2.504203056087228
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
LUDLU-1,selumetinib-GDC-0941 (4-1 mol-mol),1.599632203402907
Capan-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.340534390124913
JHUEM-3,71751553,3.8384920336488384
KCL-22,9911463,3.4603287312388415
KMS-12-BM,73707386,2.349774634710614
NCI-H1694,9935249,1.6639617864003344
GOS-3,136227924,2.1351760440562533
Kuramochi,135984461,4.688112275810485
Namalwa,65628,3.512710693266535
SNU-407,2742550,3.2176632042347255
C2BBe1,135421197,0.6239864918667269
LK-2,9915743,2.752054960797746
MCAS,11152667,-0.1014639738878534
BT 145,10322450,2.778545625329855
OE19,135421197,2.291572889832539
HuH-1,sirolimus-bortezomib (250-1 mol-mol),2.2926354506042497
SK-MEL-24,selumetinib-GDC-0941 (4-1 mol-mol),-1.728607730118346
8505C,tanespimycin-bortezomib (250-1 mol-mol),0.1990697698035682
NCI-H810,136227924,1.6901408020045232
UACC-812,9926054,1.7122964049751828
NCI-H1105,135659046,3.0265793516175536
VMRC-RCZ,3465537,3.509493141901576
Karpas-299,selumetinib-GDC-0941 (4-1 mol-mol),2.273668184734746
SNU-C1,2742550,3.130102864096647
SNU-423,11152667,0.7300251820386706
SNG-M,sirolimus-bortezomib (250-1 mol-mol),0.843195777913948
LUDLU-1,9926054,1.8617120828735427
CL-11,9884685,0.1443876486447486
LK-2,136227924,2.893153940116167
TM-31,9911463,4.397855159833588
COR-L51,9926054,1.8572799108466955
NB4,sirolimus-bortezomib (250-1 mol-mol),0.8498736120929098
SW948,9884685,3.1398548031465525
CAL-120,54618771,-0.541329282057163
MKN74,6918638,1.410948460236771
ST486,135398744,6.173673764709001
YD-10B,selumetinib-GDC-0941 (4-1 mol-mol),-2.4124074693543887
SK-MES-1,136227924,2.193847007439744
SNU-46,136227924,3.2751090842747637
HCC1438,9935249,3.1241914241248905
Hs 888.Lu,136227924,2.7652519196534304
NCI-H209,9915743,-2.0620663235985797
LOU-NH91,135659046,3.4412725013745336
SNU-410,9935249,3.802389634291995
HPB-ALL,9926054,1.8714976527379283
MKN7,selumetinib-GDC-0941 (4-1 mol-mol),2.574249068911848
OS-RC-2,135421197,5.318093622175408
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
KLE,9868037,3.52213609317776
SK-MEL-24,6918638,1.430971742186676
MOTN-1,1566236,1.466029037834187
MDA-MB-361,9868037,3.9951939200325057
SNU-878,9868037,3.069026942604855
SF268,1566236,3.2619426521234343
NCI-H2029,9935249,3.1466708658016223
SK-N-BE(2),selumetinib-GDC-0941 (4-1 mol-mol),-2.409093744965772
NCI-H660,9884685,-1.4283332629152754
SNG-M,49836020,6.278284295689695
AsPC-1,3854666,3.565227366628202
HCC1833,11152667,2.1146320609656426
HCC2218,4705,1.2825749224447869
SK-N-DZ,2742550,3.9747270585724577
OVTOKO,3854666,3.283000762867778
NCI-H1573,54618771,0.5890663299030774
NCI-H1563,2742550,3.3220396656862
SK-N-SH,9935249,0.7535155935236955
Becker,9911463,4.366530732677302
NCI-H1355,136227924,5.68794295830134
SK-MEL-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1259535578143995
SW579,135659046,3.634666498260953
MOR/CPR,tanespimycin-bortezomib (250-1 mol-mol),-0.9000697563150304
CAL-33,2746,4.008172318733893
SNU-668,selumetinib-GDC-0941 (4-1 mol-mol),1.744810645163071
SNU-410,9911463,3.9048002645235536
COV644,71751553,4.45251512796569
KP-2,71751553,5.326076847809721
MPP 89,100016,6.902779011713528
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
PC-14,9868037,2.5861209247826644
SNU-81,73707386,1.6277005390789234
LC-1/sq-SF,11494412,2.9399811715980633
COLO 668,9926054,1.8652250146590224
GSS,9911463,2.6255650357234797
AN3-CA,54618771,2.457771155909442
Caki-1,10322450,6.689578466604137
ACC-MESO-1,9935249,4.592258833593908
NCI-H508,135984461,1.3950567746266993
KYO-1,54618771,-0.1196374796023553
Fu97,9935249,3.520902332325934
SK-ES-1,71751553,4.362311909689851
NCI-H28,sirolimus-bortezomib (250-1 mol-mol),0.5571270031367631
SK-MM-2,136227924,3.42367167276636
SNU-869,6918638,0.8592076478427688
NCI-H1563,135421197,1.4749525017569085
VMRC-RCZ,9911463,4.022790104530676
HD-MY-Z,4705,3.2851682687360735
HCC1428,6918638,-0.4708375932365498
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853
COLO 201,9911463,3.786354581854646
MEC-1,71751553,4.055455710580445
BT 328,9884685,2.9316032553217166
SNU-1066,sirolimus-bortezomib (250-1 mol-mol),1.8149944261171216
SNG-M,135398744,7.8429611595155055
COLO 699,9935249,3.446924594700092
NCI-H2052,1566236,2.9608656869976424
T98G,2746,4.022730778919953
5637,100016,5.253062593048346
LAMA-84,tanespimycin-bortezomib (250-1 mol-mol),-0.5777887932469495
TT2609-C02,9926054,1.870565341301735
NCI-H446,9926054,1.7959327761623658
M059K,selumetinib-GDC-0941 (4-1 mol-mol),1.9371226079768809
T84,9911463,2.866030218571942
TE 441.T,11152667,-1.20408962070059
SNU-398,9935249,1.9793428162570832
FaDu,3854666,2.490372797251813
JeKo-1,100016,6.219930850058466
COLO 678,135984461,4.384387771979114
NCI-H747,135659046,3.644022415013725
WM115,11494412,2.975341542339242
NCI-H1568,9911463,2.564901149372131
MKN74,9911463,3.772186916904206
NCI-H526,73707386,2.1101105290421485
PE/CA-PJ15,4705,2.241412647888812
NCI-H1734,49836020,-1.214582633360451
OS-RC-2,135984461,1.5869411346906208
A-172,9915743,0.9354288818920024
NCI-H23,135984461,4.675725917601218
SK-MEL-2,11152667,-0.6797547387468098
NCI-H2291,100016,7.4079580735543695
MDA-MB-453,9926054,1.6596725660557576
G-361,3854666,0.7332994055275925
SK-MEL-3,4705,2.152547921158096
SUP-T11,3854666,0.4319450798488521
KYSE-520,135984461,4.658716640693311
U-118MG,tanespimycin-bortezomib (250-1 mol-mol),0.2197944792007267
HOP-62,9884685,0.5036019018396981
NCI-H2029,135421197,1.9497380661453336
NCI-H1355,tanespimycin-bortezomib (250-1 mol-mol),-4.485986367397168
NCI-H1915,2742550,4.073446103573009
BT 159,100016,7.101052412805122
NCI-H1435,9935249,2.948577558546625
NCI-H28,49836020,4.481045778865963
SNU-466,11152667,1.6720712603186765
NU-DUL-1,4705,2.4106173006018268
SNU-601,tanespimycin-bortezomib (250-1 mol-mol),0.586889084570332
CAL-148,10322450,5.795817783172109
BICR 31,9915743,-0.3251640044425866
Hs 895.T,135659046,5.409831657927163
BT 444,54618771,3.3386759439235267
NCI-H1793,9935249,3.0315194479133276
Mel JuSo,9911463,4.248107858199516
NCO2,9868037,0.9893364674462136
A-549,3465537,3.857188765779011
SK-N-BE(2),9935249,2.6019280874439543
BV-173,9911463,2.9939973484009608
SW579,54618771,0.7719470301120797
C2BBe1,54618771,1.7187966275352082
RVH-421,9884685,0.9486635523553502
CAL-62,136227924,2.2921842664772996
SU-DHL-1,3854666,0.5155348387571919
Hep 3B2.1-7,9911463,3.814987656182777
SNU-182,selumetinib-GDC-0941 (4-1 mol-mol),-0.56211795944893
NCI-H460,54618771,1.6853262233131374
COLO 680N,9911463,4.286168198207007
GCT,9911463,3.61026772748382
T98G,54618771,1.1759260656480666
LP-1,2746,1.409450400710279
GP2d,4705,2.380546540309972
A-172,49836020,6.443724072404216
5637,136227924,2.876940542257041
OC 314,9935249,2.41512675276784
CAL-85-1,4705,1.851642821697695
EFO-21,sirolimus-bortezomib (250-1 mol-mol),2.2010900590086595
COLO 829,selumetinib-GDC-0941 (4-1 mol-mol),-1.0343545456738177
NCI-H292,9926054,1.8794077191249725
SNU-1041,54618771,3.2318145292931195
HuT 78,9884685,0.1724524998439705
SNG-M,3854666,1.233762120612781
OCI-Ly19,11494412,-0.1179063664940395
RS4;11,9884685,-0.8130311792767286
MHH-CALL-3,135421197,1.4359965769543697
2004,6918638,1.2985206929345292
BHY,100016,6.773898116669002
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
TF-1,4705,3.093952009928188
JHH-4,100016,6.356907567320683
HCC1395,135421197,5.533531628940142
A-172,136227924,1.9508876589720905
8-MG-BA,9911463,4.3776650964828985
Panc 04.03,9884685,1.6842032304446288
BT 224,6918638,1.2404651093328147
HCC1143,9915743,0.7364353129897024
SJSA-1,sirolimus-bortezomib (250-1 mol-mol),0.9111785812193088
SBC-5,11152667,-0.3838978082878119
HCC2279,135421197,3.588174017039921
Lu-65,9884685,0.6868572515984375
DAN-G,135984461,4.367213077467543
COLO 684,1566236,1.5720461197639393
MeWo,2742550,3.6892292088743086
COLO 678,9915743,-1.0812060080075532
BT 245,9935249,1.99402432106235
IST-Mes1,6918638,1.4350648787515894
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
Raji,100016,6.465762715187829
ESS-1,135984461,4.427051677708814
RPMI-7951,100016,4.945357769827656
Becker,9926054,2.0290907819284283
HOP-62,24779724,5.1203173517940135
OCI-Ly10,tanespimycin-bortezomib (250-1 mol-mol),-1.3027926249404789
AML-193,136227924,2.0129973822753735
OCI-Ly19,2742550,4.517507112855574
U-BLC1,3465537,1.550402791454292
P3HR-1,9926054,1.7849212389607798
BT 216,135984461,5.695741813463895
HOP-92,65628,6.008725293872382
NCI-H2085,54618771,-1.2353665657353068
A3/Kawakami,selumetinib-GDC-0941 (4-1 mol-mol),2.6174879982933317
NCI-H322,2746,3.8367481879313305
SK-MEL-31,11152667,2.6381894367137777
Ki-JK,9868037,1.5525844066111418
NCI-H1666,3465537,1.89945588348698
BFTC-909,100016,5.8134150302243865
Sq-1,3465537,3.0778623896650386
MCF-7,9926054,1.7310317924725227
SHP-77,100016,6.499498313563913
SK-N-FI,135421197,0.4390653325388048
KYSE-70,9911463,3.4914249269651307
YD-8,9915743,1.4308611377432014
HPAF-II,135421197,2.4273877762947933
KLE,49836020,-2.0520357560351714
KYSE-410,54618771,1.043731623373752
CCK-81,136227924,2.050553135971544
GMS-10,71751553,5.377338497621535
BT 245,2746,2.160904338087323
Kuramochi,11152667,1.7895542205335806
TE-4,9868037,3.2663312680184227
SK-LMS-1,6918638,1.135857739605079
CCF-STTG1,54618771,4.049347271840678
SNU-761,2742550,3.6477900911436967
HCT 15,4705,3.822514103379746
NCI-H1299,3854666,3.0957339105974766
SK-MEL-5,54618771,0.7093345512366925
NCI-H1975,3854666,0.3706009095573263
SW1573,9935249,2.8664920450292852
KM12,9884685,0.5350123780883383
MDA-MB-231,135421197,1.4675791065879262
NCI-H23,tanespimycin-bortezomib (250-1 mol-mol),-3.070808400033709
NB4,135421197,1.336242233620032
H-STS,11152667,-1.2361022970372575
SK-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.5276941672655032
KNS-42,6918638,2.1232444554437926
T98G,9915743,3.11701457310986
EFM-192A,9884685,1.0219370503063232
OCI-Ly10,sirolimus-bortezomib (250-1 mol-mol),-9.44158843717878
SNU-C1,9915743,1.8965789747873807
KMS-20,136227924,2.296093636743899
NCI-H647,sirolimus-bortezomib (250-1 mol-mol),1.438565345282899
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
KYSE-150,100016,4.009775484830176
MEC-1,136227924,1.9415739350117864
NCI-H1623,11494412,1.2552972437851018
A4/Fukuda,9884685,-2.10728676228506
ACC-MESO-1,3854666,3.6033422587717854
KP-2,1566236,3.613978345797679
LCLC-97TM1,3465537,1.1142431298706064
HuH-1,11152667,-1.0247289501781058
HCT 8,9926054,1.7590637787808916
SNU-899,135421197,3.636870006524017
COV644,135984461,4.368014985644984
Hs 578T,650361,5.221503033244948
CJM [Human melanoma],54618771,1.1195989916695683
YD-8,9911463,3.690343271752708
NCI-H1155,2742550,3.5148462774904368
HGC-27,100016,3.78981980973908
PE/CA-PJ15,9915743,-1.4704662389348668
DAN-G,sirolimus-bortezomib (250-1 mol-mol),0.114309742904921
PE/CA-PJ49,135659046,3.5549002552522175
DMS 454,3465537,1.238616523221781
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
M059K,54618771,3.2179449616328775
SNU-423,136227924,3.242018782370702
CAL-120,9868037,3.5025734894646656
MHH-CALL-4,9868037,2.145138443959549
UACC-257,1566236,2.0742825046781963
PC-3,100016,6.704789318152335
RERF-LC-MS,9884685,0.4531053665233772
LP-1,9915743,0.8947745693738212
SW1417,11494412,2.7620074844216345
JIMT-1,135984461,4.835908287513633
WM266-4,135659046,3.439590672760098
HPAF-II,9935249,3.710504446936883
UACC-257,6918638,0.5878135089282499
HEL 92.1.7,4705,5.773447886671419
A-253,9926054,1.90575113373639
BICR 16,71751553,4.300063763079023
23132/87,9911463,3.696162581982579
COLO 792,9935249,1.9723606797901485
HCC1438,sirolimus-bortezomib (250-1 mol-mol),0.8076549533300275
RPMI-8226,selumetinib-GDC-0941 (4-1 mol-mol),1.6638240545531544
BT 320,sirolimus-bortezomib (250-1 mol-mol),1.2360663463766004
KHM-1B,136227924,1.9174951940989704
697,4705,2.278672622564821
SK-MEL-1,9911463,4.223226979936513
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
TF-1,71751553,4.25440409334611
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787
Hs 944.T,tanespimycin-bortezomib (250-1 mol-mol),0.6097209222741542
SNU-601,100016,6.491707225104745
CAL-54,65628,4.404642425429288
KPL-1,135421197,3.0565693123686617
SK-N-DZ,3854666,0.4650532665078188
HSC-2,135421197,2.289170573267479
HCC15,11152667,0.1037945221143532
RKN,9935249,4.428036529076262
JHH-5,54618771,-0.2658300379563106
BT 422,24779724,4.448897225717868
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034
SK-LMS-1,9911463,4.31771461226135
Hs 944.T,100016,5.802201252997301
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
RCH-ACV,2746,0.9590882361015028
B-CPAP,11152667,-0.1979921497288642
OCI-M1,11152667,-1.18912794450191
OC 314,11494412,-1.4137176616387894
EFM-192A,54639665,5.165933724638737
Toledo,sirolimus-bortezomib (250-1 mol-mol),2.5454023047541985
SK-MEL-30,135421197,2.8284209456564025
Hs 578Bst,3854666,3.703046177176273
TCCSUP,9926054,2.5470676869748763
MOR/CPR,11152667,-1.366558612447239
ZR-75-1,54618771,1.401899107302776
SW1990,54618771,1.819696432191247
SW620,9911463,4.067252618204241
Caki-1,2746,3.5868220629550858
SW1088,2742550,4.360123495040072
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
OCI-Ly3,135984461,1.8190519261994496
SK-OV-3,3854666,3.321518045263264
Hs 895.T,9926054,3.037300507007888
KMRC-2,9911463,4.365671191059928
WT2-iPS,135421197,2.4533231744799235
Calu-6,sirolimus-bortezomib (250-1 mol-mol),1.0438055867495408
SF539,135659046,3.181821233210504
Hs 294T,136227924,2.369017342053728
HCC2218,9935249,-1.250761387060799
LS123,135421197,1.188222873463802
BT 359,54618771,0.98089237051643
SUP-T11,9911463,3.242593830976794
BT-549,selumetinib-GDC-0941 (4-1 mol-mol),2.833725023206459
SNU-C1,9911463,2.5734182022274763
COV434,65628,4.436950760352565
PF-382,9884685,-1.5269409733501682
TE-15,135421197,1.6096072932868513
OCI-Ly10,3465537,1.265089065733374
U266B1,135398744,6.53135676756175
NCI-H1435,4705,4.767035431854917
5637,sirolimus-bortezomib (250-1 mol-mol),0.1813560942007127
KMS-26,136227924,1.9705002365993127
SNU-C5,4705,2.835396064750649
DMS 114,11494412,1.119929591096694
NCI-H2029,1566236,1.632401955287535
SNU-C5,11152667,-1.1058691080077447
BT 216,4705,2.9949115895470704
EFO-27,2746,3.149760082978987
MKN74,9915743,1.5544684592006026
MKN74,3854666,2.1744767713942905
A-549,selumetinib-GDC-0941 (4-1 mol-mol),1.3040363367013357
Namalwa,6918638,-1.4599496749108598
BEN,11152667,1.5571390714565738
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
TT,11152667,-0.1087658009608058
RPMI-6666,65628,3.838300823801096
DMS 454,54618771,0.8095302292114137
SKM-1,54618771,0.6725959366795358
U266B1,9935249,2.70146726971407
TE-5,100016,6.463093527046919
HEY A8,49836020,5.6501572313244885
HEY A8,3854666,2.567651740863786
REC-1,2742550,3.767979931246989
L-428,9926054,1.7396260856582195
NMC-G1,3854666,4.917265347218566
A-204,9868037,2.4016455234321694
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
DLD-1,54618771,1.295500773429104
CW-2,73707386,2.405296299062749
ES-2,tanespimycin-bortezomib (250-1 mol-mol),0.7819342630175604
PLC/PRF/5,9926054,1.9278694567430317
SNU-216,54618771,-0.3617470583099299
CAL-12T,9915743,-1.8110199185247196
NCI-H810,6918638,-1.4946550265349503
CHP-126,1566236,1.4388100369243024
SK-N-FI,sirolimus-bortezomib (250-1 mol-mol),0.1232342384365411
BT 440,9935249,2.494987882874959
NCI-H1623,sirolimus-bortezomib (250-1 mol-mol),0.487688387449291
Kasumi-1,9915743,0.5863959367393617
JVM-3,54618771,-1.0453450586020971
U266B1,1566236,1.3827832543916845
NCI-H1734,9915743,-1.4157060227107183
CAL-51,135421197,1.6266864976107616
BT 164,71751553,4.849574531411229
WM793,9911463,3.794379463406426
Mel JuSo,9915743,2.4580846898357547
MeWo,9911463,3.6919226890378942
TT2609-C02,6918638,0.9374667365701628
KP-4,11152667,0.9201986867468503
C2BBe1,selumetinib-GDC-0941 (4-1 mol-mol),0.2357334763777015
KYSE-410,135659046,3.770855239455897
NCI-H1105,tanespimycin-bortezomib (250-1 mol-mol),0.6948185089061538
BT 112,11494412,1.153463963183282
MOLT-16,54618771,-1.933148337810649
CAL-27,6918638,0.7140007001592554
ST486,sirolimus-bortezomib (250-1 mol-mol),-0.4662724333620547
Karpas-422,1566236,1.018431355816045
COV362,9935249,3.245525383557066
HCC2108,54618771,2.799542688239582
Becker,11152667,-0.0638370344727879
BT-549,135421197,3.4062158650675265
FTC-133,135984461,4.350998124633342
BT 440,100016,6.480442369798277
Kuramochi,3854666,3.353903240141939
OCI-Ly19,sirolimus-bortezomib (250-1 mol-mol),0.0855079956722299
G-402,135659046,3.518784307973502
BT 216,49836020,1.982286397666987
SF539,9911463,3.3415175792660854
IGROV-1,54618771,1.2456991772210466
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
JVM-3,136227924,1.9937281150641608
NCI-H292,65628,4.3235700442832625
Panc 10.05,9868037,3.845487816364076
KALS-1,sirolimus-bortezomib (250-1 mol-mol),0.8201349521844062
TUHR4TKB,9926054,1.808622022375876
SW1353,11152667,0.6062945809493967
NCI-H1299,100016,6.953805951258825
NCI-H1355,54618771,0.7096344074223282
JHUEM-1,9911463,4.030543660927087
G-292 clone A141B1,9884685,-1.2189697169963245
HSC-2,54639665,4.488674454832704
ONCO-DG-1,3465537,3.928768905260986
MSTO-211H,100016,4.243846732059744
T3M-10,1566236,4.194013409938231
NCI-H1694,135421197,1.1346758741878853
SW982,2742550,4.283669241388704
TF-1,135659046,3.556796547128311
HCC366,sirolimus-bortezomib (250-1 mol-mol),1.704813233293803
BICR 18,71751553,4.372978120712914
BV-173,9915743,0.6416286379608698
SNG-M,1566236,1.975586698228256
647V,136227924,2.038450233147295
CAL-51,2746,3.539110169106334
CAL-85-1,6918638,0.0860999805829631
KMBC-2,tanespimycin-bortezomib (250-1 mol-mol),0.8255558863308646
Namalwa,3854666,0.1539435938538964
KMS-12-BM,10322450,2.7501974340219575
ECC10,4705,2.6842412149864012
GCT,2742550,3.4044184901576124
HCC1937,9911463,4.268340075854012
SW48,9868037,2.459515994210572
Calu-6,2746,5.003270781401264
BT 271,65628,3.445867348348474
SUP-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.5812487961986226
NCI-H1395,9911463,3.814426972193391
KE-37,65628,2.521719302882167
EHEB,100016,6.596024177667571
M-07e,9915743,1.0767758822983564
HMC-1-8,9868037,2.3858174570633848
DMS 273,54618771,0.8675837195237585
HD-MY-Z,11152667,-1.450671407688362
TUHR4TKB,11152667,-1.5326893310023182
LAMA-84,sirolimus-bortezomib (250-1 mol-mol),0.5037633346566652
LN-18,136227924,2.6730717807576347
PF-382,135421197,0.9667662585436329
Hs 822.T,9935249,3.3041930901497794
KE-97,9868037,2.0832362410238736
Hs 729.T,4705,3.584127080125275
OCI-Ly3,9884685,-0.2062933199760503
BT 286,54618771,0.8427122634128117
SNU-886,2742550,3.913973677845718
HL-60,3854666,0.8436991056497039
A4/Fukuda,9935249,-4.132944592984893
CAL-85-1,71751553,4.145949269472578
CAL-78,2742550,4.1823102450441505
L3.3,2746,3.431089753490113
DLD-1,9911463,4.0801300312150115
NCI-H650,9926054,2.0416939641657175
KP-2,135398744,6.663666573534304
BT 216,selumetinib-GDC-0941 (4-1 mol-mol),3.6929291774805177
WM983B,9915743,1.863557730328146
A-549,4705,3.61311120139633
SW579,65628,4.401264893837287
CAL-85-1,sirolimus-bortezomib (250-1 mol-mol),-0.0188849543206935
GA-10,9915743,0.398325607555859
BT 179,11152667,-0.2700470764101368
THP-1,100016,3.892329450898836
TE-15,tanespimycin-bortezomib (250-1 mol-mol),-0.6249388884216994
RT-112,9926054,1.990332375678948
LS411N,9926054,1.9376785020428349
RERF-LC-A1,sirolimus-bortezomib (250-1 mol-mol),0.1484412834683056
RVH-421,1566236,2.764859572776919
KNS-60,135659046,3.5033473079997273
NCI-H838,6918638,0.9107836938551492
Li-7,selumetinib-GDC-0941 (4-1 mol-mol),0.6490035918823776
NCI-H1944,11152667,-0.9331821189018308
MOLM-13,9915743,0.7456385275428815
SNU-16,136227924,1.93853165721534
SCC-9,11494412,1.4365999648395638
MOLP-2,tanespimycin-bortezomib (250-1 mol-mol),0.214791737845908
SK-MEL-3,135659046,3.5354638551340756
RERF-LC-Ad1,3854666,3.753707482876592
BICR 18,9884685,0.4785445469171743
OUMS-23,3854666,3.3522693308519234
SNU-216,9915743,-0.7074992417120266
SNU-407,3465537,1.295339761164929
SEM,10322450,3.0556839954997685
Namalwa,tanespimycin-bortezomib (250-1 mol-mol),0.1758913407069346
JM-1,9884685,0.5602575931973728
NCI-H1793,9926054,5.214680491004607
TE-5,1566236,1.810150930428808
NCI-H358,9868037,2.709462311550209
Kasumi-2,71751553,4.151047970892257
Namalwa,71751553,4.989934392817737
MCAS,9911463,3.99734234256231
NCI-H2444,9915743,2.889982162911787
BT 504,65628,4.716972580704197
HCC1438,2746,3.591868126146154
JVM-2,selumetinib-GDC-0941 (4-1 mol-mol),-4.259839678662807
DAN-G,9911463,4.055561075678672
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
SNU-668,9911463,3.9434734903909976
JMSU-1,11152667,-1.6700997143159322
EKVX,9868037,3.7956253257863217
JJN-3,selumetinib-GDC-0941 (4-1 mol-mol),1.20099577342293
MV4-11,9911463,2.299906972293434
NCI-H2126,9935249,3.58501111788995
KATO III,6918638,0.282003219023021
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
SK-N-BE(2),135421197,1.0059955397340807
Panc 02.03,1566236,1.9322803720882225
GI-1,100016,6.475829804009189
DMS 79,136227924,2.929954381299975
KMS-27,54618771,0.0520641396166809
PE/CA-PJ34 (clone C12),9884685,0.3333327844016708
NCI-H727,9911463,4.409308573364914
K-562,65628,4.517417686157834
EB1,9884685,-2.5216345274961585
SNU-840,9935249,4.258063861319956
OE21,11494412,-0.1422694910703912
LCLC-97TM1,54618771,0.7707104681824843
A4/Fukuda,9915743,-0.3554458205966057
TE-6,9884685,1.4847603304489934
QGP-1,3854666,3.072510284410307
OCI-Ly3,11152667,-1.1864108780291491
NH-6,71751553,4.4252117067676275
KMRC-2,2746,4.010185211314044
HCC1143,9935249,3.8757786370374303
CA46,tanespimycin-bortezomib (250-1 mol-mol),0.4718837425399894
UM-UC-1,10322450,4.765411515490737
ZR-75-30,9926054,1.848847204207402
MSTO-211H,selumetinib-GDC-0941 (4-1 mol-mol),1.2827616524915244
DAN-G,9915743,1.9935074421825545
NCI-H1299,54618771,0.5506920644788533
SW48,136227924,1.7122170056378203
BT 482,136227924,3.374884803280594
DMS 79,9911463,3.344915999400502
NCI-H929,9868037,2.724281418576466
JHH-1,1566236,3.07431641585211
Hs 683,sirolimus-bortezomib (250-1 mol-mol),1.0884212532476678
EoL-1,sirolimus-bortezomib (250-1 mol-mol),-9.043460932568856
JMSU-1,135421197,1.367458661118936
Namalwa,100016,3.934978584241161
OCUM-1,tanespimycin-bortezomib (250-1 mol-mol),-1.6786100630480447
RERF-LC-Ad2,1566236,1.925261747039256
Rh30,1566236,1.5669773851253712
SNU-1076,9935249,5.6817063643724826
Daudi,135984461,3.9990978127252728
YD-38,9911463,4.143159410614896
U-937,9926054,1.4281376565753103
BT 131,2742550,4.391200704137665
SNU-C4,6918638,1.4968948752394289
SNU-1033,tanespimycin-bortezomib (250-1 mol-mol),-1.1601474483832803
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
CAL-120,sirolimus-bortezomib (250-1 mol-mol),1.988882229228272
BT 147,1566236,1.8849884587533212
DND-41,11152667,-2.545797429507851
2004,selumetinib-GDC-0941 (4-1 mol-mol),4.378845407517423
Karpas-620,100016,5.312019885835398
COLO 678,71751553,4.243067893374363
GB-1,9915743,1.6867043056533375
HEC-251,135984461,5.040099547557525
LOX-IMVI,135398744,6.429324407359154
MHH-CALL-3,44487872,5.322580782897121
MOLT-3,100016,3.7727587478901734
OCI-Ly3,9935249,-2.03534792120864
KP-4,tanespimycin-bortezomib (250-1 mol-mol),-2.4280197504959107
NCI-H1694,4705,3.5318874612096924
KO52,1566236,1.4428264325400242
HT115,9911463,3.084067678745635
IPC-298,100016,6.58023685235314
EBC-1,135421197,2.252820006275089
KNS-60,49836020,-2.408070727278554
BT 444,135421197,2.634348679178173
BT 248,71751553,4.279070264679743
Calu-1,3854666,3.7215465603538727
SUP-T1,3854666,-0.1009501914586207
BT 422,9926054,2.139061359959833
HCC4006,2742550,5.021230654357048
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346
BT 248,135421197,1.5349499708791383
DMS 273,2742550,3.72774264414297
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
BT 179,135421197,2.7508543391500875
PE/CA-PJ41 (clone D2),2742550,5.692172963582456
GP2d,135984461,3.863711386365813
KCL-22,tanespimycin-bortezomib (250-1 mol-mol),-0.2876767287286612
PE/CA-PJ49,135984461,4.387949775407799
NCI-H2110,71751553,4.36348548213894
NCI-H2081,135659046,2.9715500062667455
SNU-423,3854666,1.5881763460824465
NCI-H1975,49836020,-1.0893813245468835
Namalwa,11152667,-1.2838817681822148
MOLT-3,9915743,2.149590681460773
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
KYSE-180,tanespimycin-bortezomib (250-1 mol-mol),-0.8459544412135208
L-428,2746,2.35147790863918
TE 441.T,9935249,2.3228197055940556
A4/Fukuda,71751553,4.0599050322296995
NCI-H1623,6918638,-0.0742651507067239
ChaGo-K-1,9935249,2.017228734725955
OAW28,11152667,0.0990704789630026
HLF,9915743,2.207816370136927
DV-90,9884685,0.8758663515713847
SNU-C4,4705,2.69481257913417
SNU-1077,9868037,3.077547755538649
COR-L105,2742550,3.8597521863519257
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
RS4;11,24779724,4.696874238166559
A-172,9911463,3.965281913049293
SK-N-BE(2),71751553,3.75245641553736
MOLP-2,2742550,4.186750588427236
THP-1,135659046,3.5163432758648256
NH-6,54618771,1.535066774557613
A-375,9926054,2.393426871996004
IGROV-1,9911463,4.195269991960018
LC-1/sq-SF,11152667,0.2715714825449515
LNCaP clone FGC,54618771,1.2210181091381391
MKN1,9911463,4.154655732863371
NCI-H446,tanespimycin-bortezomib (250-1 mol-mol),0.8775659669348672
HOS,9884685,2.221888063930838
MFE-296,selumetinib-GDC-0941 (4-1 mol-mol),2.628937371578258
SNG-M,10322450,3.801998973988302
HCC1419,sirolimus-bortezomib (250-1 mol-mol),0.331590407982584
SW1088,3854666,3.18484653745333
CMK,135421197,2.3308084532247935
MOR/CPR,135421197,2.970176340421023
NB4,54618771,-1.2377399281525494
DU145,10322450,6.851968050616261
SW1990,1566236,1.8608127009436903
RL95-2,9926054,1.9942568161623715
8305C,9915743,0.0007928276495739
NCC-StC-K140,136227924,1.8113931494957989
ECC10,100016,5.627610035010204
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
NCI-H2444,1566236,3.679443534316406
BT 482,3465537,3.495136029701583
KMS-26,9926054,0.2958792952736858
SNU-475,136227924,3.0898415955820715
KP-2,6918638,1.246532088214889
HT-55,54639665,4.445414545651382
TE-8,9926054,1.8785619758496184
EBC-1,9926054,1.6543051302548544
HeLa,54618771,0.9271666044907572
NU-DUL-1,135659046,3.4749068685188176
AU565,6918638,0.3564513775218086
COLO 829,11152667,-0.2700014399675054
UACC-62,54618771,1.116169218616572
MCF-7,136227924,2.325387172028071
EC-GI-10,136227924,3.398194138185936
HOS,selumetinib-GDC-0941 (4-1 mol-mol),2.6717134852728264
Granta-519,9935249,0.0212855082517002
KE-97,11152667,-1.8456942642384448
SNU-620,3854666,3.691648599475937
KMS-18,9915743,2.162276720334097
42-MG-BA,9935249,2.8954336270636576
Hs 888.T,4705,3.9900399475264887
TE-5,136227924,2.0128832307516715
BT 224,11494412,3.1147296058379483
NB1,sirolimus-bortezomib (250-1 mol-mol),-0.0795560213748125
ZR-75-30,135421197,0.9431769837232008
SUP-HD1,selumetinib-GDC-0941 (4-1 mol-mol),2.188403523917611
TE-14,2742550,4.106621802038204
NCI-H358,136227924,2.8821870791202873
NCI-H441,54618771,2.015817613413058
SK-N-SH,71751553,4.86546041028893
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
HEL 92.1.7,1566236,1.5970537122155075
A-204,3854666,1.289524707021466
L3.3,3854666,3.761529361474975
PE/CA-PJ34 (clone C12),11494412,-0.047975107536018
HOS,tanespimycin-bortezomib (250-1 mol-mol),0.2321152572283642
Hs 822.T,11494412,5.061407284482217
TALL-1 [Human adult T-ALL],9868037,2.0698659893863884
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
SK-MEL-5,9926054,2.75949424585879
SNU-407,2746,2.5870056952714777
NCI-H1703,135984461,4.378199750715437
SNU-626,65628,4.324270511481314
CAL-27,11152667,-1.1570264921906133
SUP-T1,11152667,-3.1666536530692477
EHEB,136227924,2.586993854279513
COV362,2742550,4.118954550351592
NB4,49836020,-4.1463475414292
P-STS,6918638,-1.1348204820090546
NCI-H1694,2742550,3.4313593701801732
Kasumi-1,9935249,-0.4567187201555336
KMRC-1,11494412,2.978505743964039
MOR/CPR,selumetinib-GDC-0941 (4-1 mol-mol),2.600932232406458
SUIT-2,9911463,4.378510442631056
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
EKVX,10322450,4.528299789057068
WM115,9935249,2.3950107716018465
CAL-27,71751553,4.275579019580937
HMC-1-8,tanespimycin-bortezomib (250-1 mol-mol),-0.5086629381230219
BICR 18,2742550,4.119213346419039
KYO-1,9868037,1.678802312904593
YH-13,136227924,2.93381240838723
HPB-ALL,11152667,-1.8112650513454247
Pfeiffer,71751553,2.2277672851720647
SNU-1214,9926054,3.9057313084396656
GSS,136227924,2.0459518542117983
OCI-AML-2,sirolimus-bortezomib (250-1 mol-mol),0.9467040078581898
SNU-C4,tanespimycin-bortezomib (250-1 mol-mol),0.700839751007814
JHH-4,selumetinib-GDC-0941 (4-1 mol-mol),1.975979663923368
LUDLU-1,2742550,2.041048832535319
P-STS,1566236,0.9528688802089575
MDA-MB-468,3854666,0.819847867381648
JHUEM-7,11494412,0.4868890434989014
BICR 22,100016,6.157225392196351
KM12,2742550,3.4783528342792103
SNU-5,tanespimycin-bortezomib (250-1 mol-mol),-4.499312047026259
TCCSUP,9935249,4.183000192911627
F-36P,9926054,1.445748070072179
HuP-T3,136227924,2.888640375816574
NCI-H1581,54618771,2.0706230217486468
ME-1 [Human leukemia],135421197,1.4857901642413922
CAL-120,136227924,2.519967645750226
IST-Mes1,135421197,1.925463420817299
SNU-478,10322450,3.5512522353536515
SW579,2742550,3.4497897909573223
SNU-449,10322450,2.7236273289045942
COLO 699,tanespimycin-bortezomib (250-1 mol-mol),0.6482920125737269
SNU-182,100016,8.076902029611453
Panc 04.03,9935249,3.3873751996630177
IMR-32,9884685,-1.1306444874275756
KMS-34,1566236,1.5122865114095023
Mino,9935249,1.3209410835927553
Pfeiffer,3854666,-0.3763392240874574
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992
KMRC-3,10322450,5.943320377485073
M-07e,49836020,-3.7990494796960337
HLF,54618771,-0.5261928492303469
LOX-IMVI,9926054,1.7031980960413209
SNU-387,100016,7.682207014450764
OCI-AML-3,135659046,3.507210713812752
Panc 08.13,136227924,2.4171431229910265
NUGC-4,9935249,3.5425573545623847
TE-11,2746,3.705466590750396
EM-2,3854666,1.1863120866897956
Becker,65628,4.34244809682726
TE 441.T,135421197,0.4096443090762519
CAL-51,65628,4.560195683913681
ESS-1,2742550,4.194579887734085
Namalwa,135984461,4.336205571620734
NCI-H2087,650361,4.093890124173705
HEC-151,9915743,1.4580340601681427
CAL-12T,100016,6.470654025405006
HEC-151,135421197,1.9024476201303135
DU4475,11494412,-0.2036500518736227
23132/87,9935249,3.409197898421799
KNS-81,54618771,0.6221036403024617
SNU-840,1566236,3.632634266236844
JVM-2,9884685,-4.167138100754272
SNU-C1,4705,2.5587329567228414
P12-Ichikawa,135421197,0.8700527660051071
LOU-NH91,54618771,2.8270991446030593
TOV-112D,4705,3.678495004677763
NCI-H23,136227924,2.7523480468192254
KMBC-2,1566236,2.626882312986064
SNU-C1,3854666,3.2898007773487223
SNU-886,3465537,4.952996907212378
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498
NCI-H2122,9926054,1.7352659466482192
HeLa,6918638,0.9489193596088062
HCC-56,sirolimus-bortezomib (250-1 mol-mol),0.5000391743337353
Hs 888.T,11152667,-1.0648621263802394
JK-1,11152667,-3.7517663276424704
Daudi,71751553,3.830487233171358
DU4475,9911463,2.219274285034518
DMS 114,9884685,-0.6854409679622795
KYSE-410,9911463,3.4542799068802696
SK-MEL-24,2746,3.4655100940792254
PE/CA-PJ15,2746,3.741230111498992
ONS-76,9911463,3.87028315643254
DMS 454,71751553,2.689876856029613
Hep 3B2.1-7,135421197,0.863862977673099
MOLP-8,9926054,1.7939353525170396
HT,9915743,0.0669624214071764
NCI-H1299,135421197,1.297843636132371
BICR 56,tanespimycin-bortezomib (250-1 mol-mol),-1.185151115756176
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
WM266-4,65628,3.9802354121666794
NCI-H526,135421197,1.27710242642961
HCT 15,6918638,1.0583340950733469
TT2609-C02,2746,4.994680494565545
NCI-H1755,9915743,0.4239600926886341
SNU-C1,10322450,2.683977813165255
SCC-9,9915743,1.0040050158500469
Fu97,9926054,1.5136567302830126
A-375,135984461,4.563596493696721
SW620,selumetinib-GDC-0941 (4-1 mol-mol),-0.6864895325025141
NCI-H460,11152667,1.2005763717636435
MDA-MB-453,135421197,0.8806711164351635
SNU-C1,9926054,1.821636344159182
HuH-6,tanespimycin-bortezomib (250-1 mol-mol),0.4881830883702249
NCI-H226,136227924,3.4351319272724585
SNU-387,4705,3.526786738032827
LS1034,4705,2.791572248963506
EFO-27,9935249,3.352272124535396
DU145,135421197,3.2080942542888056
NCI-H1105,11152667,-0.3234910570642634
BT 340,9926054,4.031759543162761
OCI-M1,4705,3.4843889260435215
A-204,11494412,0.8963449345422223
F-36P,2746,1.451851668810028
AML-193,3465537,0.6863913104025677
GI-1,65628,5.000190036806228
ONCO-DG-1,11152667,-0.5484669385829071
Hs 888.Lu,11494412,3.655029348626413
DU4475,9915743,0.8769529722012402
SUP-B15,sirolimus-bortezomib (250-1 mol-mol),-0.2788872316489693
JHUEM-1,6918638,0.9428418212694492
Panc 10.05,135421197,2.5618075811816277
PK-45H,sirolimus-bortezomib (250-1 mol-mol),2.3044458204241014
AGS,9926054,2.4402585627733844
EB1,135659046,2.7495616978120543
COLO 680N,selumetinib-GDC-0941 (4-1 mol-mol),2.523373252620712
BICR 6,tanespimycin-bortezomib (250-1 mol-mol),-0.3653020091427266
SK-CO-1,135421197,1.070123520764916
EHEB,9935249,3.177814055372344
OVCAR-5,1566236,3.333028869896027
COLO 741,sirolimus-bortezomib (250-1 mol-mol),1.7364314358901989
ChaGo-K-1,136227924,2.8574479872364247
RS4;11,2742550,3.863093603163464
SNU-626,9911463,4.505405872194439
JHOM-1,sirolimus-bortezomib (250-1 mol-mol),0.2834615362224199
NCI-H1341,sirolimus-bortezomib (250-1 mol-mol),-0.2391500871709352
JJN-3,11494412,0.8289116652067822
JHUEM-2,9868037,1.1428293531660954
Hs 852.T,9935249,3.48401275666249
769-P,3854666,3.5697954228742543
EB1,2746,1.806357780632162
NCI-H1915,9884685,4.1818915574686395
M059K,11494412,1.974522837526778
NCI-H1869,9926054,1.781753958996035
EC-GI-10,4705,0.5713397420594433
G-361,54618771,0.3816147000987149
NCI-H2172,9911463,3.8994270098936745
BT 333,1566236,2.7290285893433173
MOLM-13,136227924,1.704251401840426
OC 314,9868037,3.4198698834926553
HuP-T4,11152667,-0.7857084329923945
NCI-H2405,tanespimycin-bortezomib (250-1 mol-mol),-0.894001775676426
HEL,11152667,-1.5416892011653274
HPB-ALL,1566236,1.32802974463896
NCI-H146,54618771,0.1782763900918093
JeKo-1,135984461,1.9350471702678365
MOLT-16,65628,2.3092388368184937
CAL-85-1,3854666,0.5613093984627853
HEL,54618771,0.7283869495698151
SK-N-DZ,2746,1.2350474359899652
PE/CA-PJ15,11494412,-0.2051245265419709
HCC-56,2742550,3.74024214406613
CHP-126,9884685,0.6738089560085174
PE/CA-PJ34 (clone C12),136227924,2.74058031223244
SW1783,9926054,2.85460969526429
Hs 888.Lu,71751553,4.295902830369434
A-549,136227924,3.1395144761786486
OCI-Ly3,65628,2.4701870047236696
ALL-SIL,11152667,-2.075218964097288
HT-1080,11494412,0.5637126058812378
KYSE-520,sirolimus-bortezomib (250-1 mol-mol),0.4067313196424638
MDA-MB-468,135984461,4.286487577540472
KE-39,9915743,-0.5446321163343049
SU.86.86,9926054,1.8736072532544432
KMS-20,3465537,0.9285591790497558
SK-ES-1,135659046,3.743123640282263
T98G,9911463,4.1746073665153105
CAL-33,tanespimycin-bortezomib (250-1 mol-mol),0.6625956930764642
MDA-MB-157,sirolimus-bortezomib (250-1 mol-mol),1.4679701866850798
COLO 668,10322450,3.302091291225127
CHP-126,9926054,1.6835442403825218
786-O,135984461,4.712417821590371
SK-N-DZ,tanespimycin-bortezomib (250-1 mol-mol),0.4242122917353423
NCI-H2106,3854666,2.945318189575744
EoL-1,9915743,-0.0181598036434267
JVM-3,65628,3.2582906367483857
SNU-478,135421197,1.3858416930524595
KP-4,9911463,4.220672229227994
DND-41,71751553,4.317305171023822
QGP-1,136227924,3.0535414774537424
BHT-101,100016,6.007811941047966
JeKo-1,1566236,1.2971928286160908
KMRC-1,selumetinib-GDC-0941 (4-1 mol-mol),1.816727012202974
MOLT-16,100016,4.920795787487072
MOLT-13,11152667,-1.8178973770803584
ECC12,selumetinib-GDC-0941 (4-1 mol-mol),2.781694050737888
TE-5,4705,3.380562740986189
TF-1,11152667,-0.9808185437399498
HuH-6,135659046,4.749269186947959
253J,9868037,1.5770762651025676
NCI-H2110,9926054,1.839297705521365
JM-1,9935249,0.9666917954448688
CAL-51,54618771,0.0049145289548569
CAL-78,11152667,-0.6927221356851716
SK-MEL-1,135421197,3.405543423729856
L-363,9884685,-0.4512111156416696
Hs 888.T,49836020,6.084092385452033
OVCAR-8,9911463,4.194046142536917
WM266-4,54618771,1.3867437118908044
HEC-1-A,10322450,3.4172941541878705
BT-474,6918638,-0.8202779774932777
NCI-H358,11152667,-1.164579912523402
YKG-1,3854666,1.2272418792594904
SNU-685,11494412,1.6566722740686777
CCK-81,9911463,3.2040299523214304
BT 112,tanespimycin-bortezomib (250-1 mol-mol),-0.1012397521650829
CJM [Human melanoma],selumetinib-GDC-0941 (4-1 mol-mol),2.04616975422909
YD-8,4705,3.8146154447521146
NCI-H1092,selumetinib-GDC-0941 (4-1 mol-mol),3.727074735978538
OE21,44487872,4.4115983844674185
SIG-M5,11152667,-1.411056546270547
SK-N-MC,tanespimycin-bortezomib (250-1 mol-mol),0.3614874661050979
SNU-601,9911463,3.648706440193743
DV-90,3854666,0.9061659566144276
BT-474,2746,-1.392865413318883
A-204,135398744,7.3650683487349236
NCI-H716,9915743,1.329215193121519
Hs 766T,24779724,5.962768678879229
A-498,4705,4.1964696083385595
SNU-1033,1566236,1.8581490134242764
SK-LU-1,9926054,2.124586219371247
SU-DHL-1,9915743,1.482861419138649
MPP 89,9911463,4.3763364691928786
BFTC-905,11152667,-0.7894316986781663
LS123,11152667,-1.6976083930995145
KATO III,135421197,1.1737614873683315
HT-55,9926054,1.864291830267701
HSC-4,4705,3.95336427523857
JHH-5,135421197,0.9598662644879212
SK-MEL-5,3854666,2.922871568885423
CAL-120,tanespimycin-bortezomib (250-1 mol-mol),1.8647047986889285
KMS-26,9915743,-1.9616830637475051
SNU-685,11152667,0.0876165729015351
Kelly,9926054,1.469291049176786
Hs 940.T,136227924,0.9830608526546036
SK-MEL-28,1566236,1.6963201581644038
NOMO-1,100016,4.546215242968586
786-O,tanespimycin-bortezomib (250-1 mol-mol),0.0938204565808633
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
SNU-119,9926054,2.3608984923700036
TF-1,136227924,2.8858592548660766
SNU-1066,9935249,5.759446428936507
PE/CA-PJ34 (clone C12),135984461,4.299717419292052
ACHN,6918638,1.020041941526732
P12-Ichikawa,11152667,-2.1243820214829925
Aska-SS,selumetinib-GDC-0941 (4-1 mol-mol),-0.3966051454003071
SNU-449,9935249,2.650976699885872
BT 286,49836020,4.709879888093613
HMC-1-8,9935249,3.5115160925085047
MeWo,100016,6.619977613887792
KYSE-510,136227924,3.267869272747249
NCI-H1694,9926054,1.45656685953477
JHH-2,71751553,4.333509260153597
D283 Med,9911463,2.6227366888943986
NCI-H747,24779724,5.142586038492887
Reh,9868037,2.2106606169750824
NCI-H1341,135421197,1.8518080327886164
TUHR4TKB,9911463,4.0914884316210145
DK-MG,tanespimycin-bortezomib (250-1 mol-mol),0.5926006673391784
Hs 888.T,selumetinib-GDC-0941 (4-1 mol-mol),2.8983060042425484
SK-N-MC,11494412,-0.6115742998674478
BT 112,71751553,4.665557673334606
SNU-398,sirolimus-bortezomib (250-1 mol-mol),0.7620432052454496
JVM-3,73707386,3.3946866816247168
JHUEM-7,tanespimycin-bortezomib (250-1 mol-mol),-0.0825179950707132
UO-31,9884685,-1.8965253629059915
SYO-1,1566236,3.1317024897927364
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
BT 164,11152667,1.258456029067334
JURL-MK1,9935249,2.8490147187785233
ECC10,9926054,1.849592705301639
NCI-H2444,3854666,3.925544858785653
TALL-1 [Human adult T-ALL],1566236,1.195576285789708
BT 147,135421197,1.4134853513564778
CAL-78,73707386,4.03423025283393
CML-T1,54618771,0.285641515878807
SNU-1,65628,4.167785493547138
SK-MM-2,54618771,0.349796062936111
T84,9926054,1.9260026490734707
FTC-238,135421197,2.4336090665615115
NCI-H1623,135421197,3.7764453326534855
FU-OV-1,44487872,4.488734888040304
BT 504,54618771,0.7999313784166654
BICR 18,9915743,1.102775446718332
NCI-H716,tanespimycin-bortezomib (250-1 mol-mol),-2.992165698836288
MHH-CALL-3,selumetinib-GDC-0941 (4-1 mol-mol),3.01666713959806
MOTN-1,sirolimus-bortezomib (250-1 mol-mol),-0.1578046305827232
KP-4,54618771,2.957585816818264
SF268,tanespimycin-bortezomib (250-1 mol-mol),-0.3321278091609868
ECC12,11152667,1.0156466397145238
YKG-1,135421197,3.1079510852519343
MOTN-1,tanespimycin-bortezomib (250-1 mol-mol),0.3345366577649379
SNU-1077,9935249,3.485135676518772
CAS-1,tanespimycin-bortezomib (250-1 mol-mol),1.4677187949031796
NCI-H1703,135421197,2.2444093773538043
C2BBe1,11152667,0.0079172533868618
HeLa,9915743,4.03760238390019
SU-DHL-6,11152667,-4.5064226702829
AML-193,2742550,2.301530395833896
UO-31,136227924,2.530889708332206
NCI-H661,2746,2.7828270451310786
MOLT-16,9884685,-0.2563886004846691
KNS-42,1566236,2.4771574284534417
COLO 800,9911463,4.009510973901368
KYM-1,3854666,0.6296388431851128
BL-70,11152667,-0.9992900741194192
H-STS,3854666,0.1561624900748555
NCI-H2171,6918638,-1.5146784294865197
KYSE-510,54618771,0.5023256188939713
CMK,9926054,1.7941257572629667
LNCaP clone FGC,9915743,0.7205657109253502
HCC2935,11152667,0.3516453142040726
TUHR10TKB,1566236,3.1698186598160705
ChaGo-K-1,135659046,3.4410165185967743
PE/CA-PJ34 (clone C12),6918638,1.3328388585954094
NCI-H1793,6918638,1.6746912031469072
HMC-1-8,135421197,3.069266594691258
COLO 792,54618771,0.4942463473126465
Hs 852.T,9911463,3.443003634084564
HT-55,2746,2.9467453757111848
SNU-503,tanespimycin-bortezomib (250-1 mol-mol),2.9801728047374527
BDCM,9915743,-0.0089573294150241
KALS-1,2742550,5.776257078576174
MFE-296,65628,4.330181236318155
NMC-G1,135421197,2.4402756951086477
T3M-10,sirolimus-bortezomib (250-1 mol-mol),0.4109261861139289
MKN1,54618771,0.4952124443033494
A-204,2746,2.3964881328568315
JK-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8712031645935759
OAW42,9911463,4.338639640842429
LN-229,3854666,3.037583320137183
L-428,selumetinib-GDC-0941 (4-1 mol-mol),3.762194755166614
MCAS,100016,6.4909883414165135
PC-3,9884685,-0.023104430972579
NCI-H1563,4705,2.6238012803038124
Mono-Mac-1,9911463,2.4863663707883723
HCC1588,selumetinib-GDC-0941 (4-1 mol-mol),-0.6693543343840518
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
JHUEM-2,9915743,-0.2350251959157376
NCI-H1915,9935249,3.246288044473248
SIG-M5,100016,4.056618507771364
BxPC-3,49836020,-2.380895293574403
Rh30,135398744,6.322590827161508
TALL-1 [Human adult T-ALL],tanespimycin-bortezomib (250-1 mol-mol),0.1356817268288457
SW948,9926054,1.8406028662949705
NUGC-3,selumetinib-GDC-0941 (4-1 mol-mol),1.725630389990751
NCI-H2172,11152667,1.0620592795126853
TE-11,6918638,1.4188732058945317
AN3-CA,selumetinib-GDC-0941 (4-1 mol-mol),1.0170906897464025
AsPC-1,1566236,2.844580785967763
L-363,9911463,3.9565669957446423
NCI-H810,135659046,3.1719200378755055
GaMG,3465537,2.957023403681719
SBC-5,tanespimycin-bortezomib (250-1 mol-mol),1.6745298572430678
OCI-Ly3,54618771,0.9426860423184806
BT 422,11152667,1.7355049120029544
SU-DHL-10,sirolimus-bortezomib (250-1 mol-mol),0.6200641507940263
BT 216,6918638,1.5591874228981395
SK-N-FI,136227924,2.3066593011882084
BxPC-3,135421197,1.4419000032460958
DV-90,2742550,2.9708942896917625
Ki-JK,9884685,-1.9228761538828023
Caov-3,9911463,3.58522921506602
CMK,11152667,-1.0104545212357872
GCT,11152667,0.2440943178190859
Hs 839.T,1566236,4.086954474692148
HCC827,54639665,5.801355339134406
Hs 895.T,168313307,4.455541417323381
KYSE-150,selumetinib-GDC-0941 (4-1 mol-mol),2.603924706865474
VMRC-RCZ,11152667,0.1024224557486136
OVISE,tanespimycin-bortezomib (250-1 mol-mol),0.9202514572514084
OVK18,1566236,1.7808365706100535
L-363,9915743,1.0748185712665137
NCI-H2444,11152667,-0.3751475326918679
HCC95,9935249,3.710216243518792
SHP-77,9926054,1.3761087450643723
Panc 05.04,9911463,4.206171655784268
786-O,136227924,4.54082640186513
P3HR-1,tanespimycin-bortezomib (250-1 mol-mol),1.2081674914796665
MIA PaCa-2,100016,4.223400842588871
VMRC-RCZ,4705,5.276450440378561
RERF-LC-Ad2,136227924,3.207411157267862
HuG1-N,6918638,0.9009310032915192
KMS-18,135984461,4.3135759037232635
EM-2,135421197,1.083301811797457
Kasumi-1,tanespimycin-bortezomib (250-1 mol-mol),0.2568876868109762
BT 245,100016,6.42627295768896
HuG1-N,135421197,1.5338215255875798
SW620,135398744,6.387116600988426
KYSE-510,sirolimus-bortezomib (250-1 mol-mol),0.7044078807643728
JHH-1,sirolimus-bortezomib (250-1 mol-mol),0.3653196480685532
NCI-H2196,65628,4.307213942062808
MDA-MB-468,9926054,1.8087827398846443
RD,tanespimycin-bortezomib (250-1 mol-mol),-1.016006094021389
SNU-C4,71751553,6.158441410572784
RS4;11,9926054,1.3996833727357625
SW1990,135984461,4.558882799669272
SNU-407,9935249,2.8918359205304984
SEM,3465537,0.8371255640679629
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
SCaBER,sirolimus-bortezomib (250-1 mol-mol),0.2620178296114504
Sq-1,1566236,2.0721352118450276
MOLT-3,135421197,0.6925394528870177
TT2609-C02,71751553,4.283700752409424
Capan-1,24779724,4.377169410070466
PC-14,3854666,0.2934048653754776
NCI-H2228,54639665,4.4666627207641065
Hs 729.T,sirolimus-bortezomib (250-1 mol-mol),0.5283641874253757
BT 359,100016,6.547217450499836
PK-45H,1566236,1.9523523516451644
Capan-1,135984461,4.359340050025923
NCI-H2126,2746,2.4286105170144587
HCC2935,9915743,-3.080711335255353
RCH-ACV,100016,4.052738843081589
DU4475,135421197,0.912129000759155
LS513,9926054,1.5640640769912204
BT 139,6918638,0.9412017663716644
SK-N-BE(2),4705,3.5810026533743793
ECC10,54618771,0.89322852305294
MOLT-16,4705,2.727533313346627
BT 330,10322450,4.515837789997584
AsPC-1,136227924,3.2025742465891938
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
JHUEM-7,9926054,1.641999407547345
MOLP-2,135421197,1.9402190230236491
NCI-H661,136227924,2.7818959309662183
SCC-25,11152667,-0.6154723920828342
CAL-54,10322450,4.089763150244814
JM-1,11152667,-1.617053586455527
EC-GI-10,11152667,-1.025242413755307
SW1710,135984461,3.1161178091197863
D283 Med,3854666,0.4329488785955893
SiMa,9911463,2.7480230825613488
MHH-CALL-3,24779724,4.5671029590732894
SNU-1196,9926054,2.598124573780665
WM983B,136227924,4.383113443662036
MOLM-6,9868037,1.47878958691074
Hs 822.T,selumetinib-GDC-0941 (4-1 mol-mol),4.199779090816491
KYSE-30,11152667,0.7148136552213618
KMS-27,9911463,4.115013696687494
KALS-1,135659046,3.8631943181286
PC-3,sirolimus-bortezomib (250-1 mol-mol),0.5730469414273184
JIMT-1,100016,6.5721980857327935
LXF 289,3854666,2.0847029854583377
NCI-H716,sirolimus-bortezomib (250-1 mol-mol),0.1986169667929478
NCI-H2228,136227924,2.998313400459559
22Rv1,9915743,0.4549229080465418
HEL,135984461,1.7610482730169696
HEC-1-A,24779724,4.728392002883349
NCI-H2030,135984461,5.0269440888877135
OAW28,3854666,2.969576020962734
EFO-27,2742550,4.50908635993052
JeKo-1,9884685,1.0765625898866802
BT-12,tanespimycin-bortezomib (250-1 mol-mol),0.4298883528890555
PE/CA-PJ49,9935249,3.146155709540263
Aska-SS,9926054,1.7306138768842658
Hs 940.T,sirolimus-bortezomib (250-1 mol-mol),2.1873747359763613
8-MG-BA,11152667,0.13632020716098
D283 Med,6918638,-2.490498776882626
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
VMRC-LCD,selumetinib-GDC-0941 (4-1 mol-mol),3.316694263206271
SK-MES-1,1566236,3.8724426148603706
LS1034,10322450,3.783129685700755
TM-31,selumetinib-GDC-0941 (4-1 mol-mol),1.793600027043238
KNS-62,1566236,3.420118878937147
SCC-4,135421197,1.85399046640426
HT-1080,54618771,1.2813621768338197
Yamato-SS,6918638,0.9950789040001992
HCC366,9911463,4.244130983157471
LS513,54618771,0.3815245482334266
SNU-449,6918638,1.2557717528626495
HDLM-2,sirolimus-bortezomib (250-1 mol-mol),0.137697197491076
AU565,135421197,1.4743648854968991
SNU-1079,11152667,-0.9238055167208472
SU-DHL-1,100016,4.0163007651424945
NCI-H2052,11152667,-1.5494246316581135
NCI-H647,2746,3.2477313608093143
5637,3854666,0.5695697267835587
UO-31,135421197,2.4256878664158443
HEY A8,9911463,4.0239951836348595
8505C,selumetinib-GDC-0941 (4-1 mol-mol),0.125719667045265
ME-1 [Human leukemia],9926054,1.888180715398536
A-204,9884685,-1.0926459148305512
SK-HEP-1,2746,4.04921422913523
KE-39,3465537,4.350124533164427
MOLT-3,9884685,-1.4743376865802589
BT 216,3854666,3.6586729763480337
U266B1,selumetinib-GDC-0941 (4-1 mol-mol),1.5301935614482745
SNU-407,9911463,3.2824377830352818
EB1,54618771,-0.3915386993254522
ONCO-DG-1,136227924,3.186548860778023
Caki-1,136227924,3.8203162456228417
U2OS,tanespimycin-bortezomib (250-1 mol-mol),-0.4956813125549447
Namalwa,54618771,0.6847017954935718
HCT 8,1566236,3.3602911761309375
COR-L279,11152667,-0.9089545810902804
Kelly,9868037,2.3025407636761197
GaMG,tanespimycin-bortezomib (250-1 mol-mol),-0.9299125293643992
COLO 205,3854666,3.737938865903665
OVCAR-4,9911463,3.705471110886421
OCI-Ly10,100016,6.418038918193145
BT-20,6918638,1.2073069769548774
Hs 888.T,135659046,3.9979664612811354
SCC-4,sirolimus-bortezomib (250-1 mol-mol),1.5371967281247725
HEC-108,100016,6.393272881400893
NCI-H226,3854666,3.7383883228891746
RT-4,135421197,2.4643711937197756
SNU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9967147031928247
TYK-nu,3465537,1.2645774096433158
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
VMRC-RCZ,135659046,3.396736562465423
DMS 114,sirolimus-bortezomib (250-1 mol-mol),-2.6988548245768387
A-549,9911463,3.875766071211208
HSC-4,9935249,3.700870290975298
SU.86.86,2746,2.8574990792137234
OVCAR-4,135398744,7.790531663529689
K029AX,135421197,2.4286138926915175
TF-1,6918638,-0.802877327266543
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
SNU-398,54618771,-4.947778172038554
MSTO-211H,9926054,1.9546831701161536
TE-15,11152667,-0.8942963388788865
Becker,6918638,0.8308628231051842
L-428,9884685,0.1797779674831695
NCI-H526,3854666,0.5432695443885891
PL-21,135421197,1.4240798978799187
BT 422,3465537,1.4684918107788285
HSC-4,9915743,0.765957034876682
DMS 454,9926054,2.735237319148254
CA46,4705,3.1649236354970154
647V,9911463,4.409219514766685
MPP 89,54618771,3.5839559613282916
KE-37,135421197,0.0656333668327355
NCI-H2081,selumetinib-GDC-0941 (4-1 mol-mol),2.2419889571626146
HLF,9911463,4.995203426264865
KE-37,9868037,1.7348034211084984
HT,9926054,1.610418759813605
L-540,3854666,0.4369037772014328
LOU-NH91,9915743,1.51930479588737
Karpas-422,11152667,-1.1823612296931902
NCI-H1355,3854666,0.7237353710481594
NCI-H1755,49836020,-0.0301714782676706
NCI-H2196,100016,7.101599749729703
OS-RC-2,11152667,0.1323387245454607
TALL-1 [Human adult T-ALL],3854666,1.0059352605145684
NCI-H446,9935249,2.952195847832737
RERF-LC-A1,65628,4.427259211867234
Fu97,4705,3.9554938740337096
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809
G-401,9915743,0.7240748800691799
CL-11,11152667,-2.0837700149013725
NCI-H661,9926054,1.7811448977738318
SIG-M5,135421197,1.947558909075972
NCI-H1341,2746,1.640350418119998
NCI-H647,2742550,3.61263816541944
SF268,135421197,1.2829440642017702
OV7,2742550,5.380934224392059
FTC-133,9911463,4.36756965003986
EFM-192A,3854666,0.9755146763983704
SCC-9,54618771,0.4910288003516506
Yamato-SS,24779724,-0.903549549711913
NCI-H522,1566236,1.6835491869847783
OAW42,2742550,3.9256565797202776
HuH-28,9935249,3.1558005109772376
U266B1,54618771,0.5848544182666181
OE19,11152667,0.6464409394196118
SU.86.86,9911463,4.35911979104002
RERF-LC-MS,65628,5.693639897620667
UM-UC-3,10322450,3.9081248739671945
HCC4006,135659046,3.6436381784680494
YD-8,650361,3.8896393800715297
BT-20,100016,6.680150665921765
SCaBER,9884685,-0.0878392335196988
RKN,9911463,4.114615883902867
KP-N-SI9s,3854666,0.8601282293978239
HeLa,9911463,4.222129751403694
Lu-65,54618771,-0.448084270947246
Caov-3,100016,5.7781449283056645
KMS-11,2746,1.943011072949534
SNU-466,9915743,-0.0842203347342703
U-BLC1,10322450,3.651002961479182
NU-DUL-1,54618771,-1.656554068738758
NCI-H2171,1566236,1.862945078393334
OCI-AML-3,54618771,-1.4994430738546511
OAW42,selumetinib-GDC-0941 (4-1 mol-mol),2.1178159599202626
SUP-T11,136227924,2.659905722722051
BT-474,71751553,4.578203440139317
DMS 273,9911463,3.7655644930376257
Pfeiffer,2746,2.517649488872207
SNU-475,9935249,4.4332882179625015
UM-UC-1,2742550,3.314005121432249
MFE-296,2742550,4.910167263419947
OCI-AML-5,1566236,1.6568370935553676
HD-MY-Z,9926054,1.8885520747906608
COLO 741,selumetinib-GDC-0941 (4-1 mol-mol),3.828549424884254
SUP-HD1,49836020,4.390823916389519
TC-71,3854666,1.5564077538227652
SK-N-MC,2746,2.1914120575245373
CL-11,2746,2.4152572914027366
MOLT-16,9868037,1.8123148849264936
KYSE-510,2746,3.665067942472177
HT-1197,135421197,1.673772932436652
KNS-62,sirolimus-bortezomib (250-1 mol-mol),1.3906693403770916
Lu-65,sirolimus-bortezomib (250-1 mol-mol),1.2427816713041802
769-P,9915743,0.5554140720620152
Fu97,selumetinib-GDC-0941 (4-1 mol-mol),0.7041233813460074
COLO 699,136227924,2.9902058739506385
NCI-H1838,11152667,0.4729099226601252
BICR 31,3854666,2.26793763186435
HPB-ALL,9884685,0.51403657851557
OUMS-23,sirolimus-bortezomib (250-1 mol-mol),1.7172624252600015
KE-97,136227924,2.279256150432482
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
BT 239,tanespimycin-bortezomib (250-1 mol-mol),-2.6769003708706594
LMSU,65628,4.981021352317802
SET-2,9884685,0.7877386877892533
SCaBER,100016,6.423492154596734
CAS-1,2742550,3.0271705067193144
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
NCI-H2009,selumetinib-GDC-0941 (4-1 mol-mol),-2.07577936678547
BICR 22,9884685,0.2149660223226223
KMS-28BM,3854666,0.5367322792808957
K-562,49836020,4.414855158615189
RD,1566236,1.443604472261318
KE-39,6918638,0.3873788369468276
ME-1 [Human leukemia],9868037,1.581753710265031
CA46,11494412,-0.1540181126177876
SU-DHL-8,100016,4.106875584244309
NCI-H1435,135398744,6.3008870427516115
K029AX,6918638,0.9688280539035616
8305C,9884685,-0.6545120065048111
HT-1080,9935249,3.0025121843193525
JHH-4,2746,2.8564345574200685
KATO III,54618771,1.8555498660455492
BT 444,1566236,3.080515728465438
TOV-112D,1566236,1.6561224717543024
SW982,sirolimus-bortezomib (250-1 mol-mol),1.8750003849027723
KYSE-140,54618771,1.7180424995817132
MOLT-13,3854666,0.8628721884474523
NCI-H2085,11152667,-1.1434648476401426
EFO-21,1566236,2.973739256167703
OCI-M1,135421197,1.730627187910493
SR,135984461,3.8485164299114714
NU-DUL-1,9884685,-1.0623784374180658
HT-144,9935249,2.150553590588431
BT 504,sirolimus-bortezomib (250-1 mol-mol),1.7161873277095432
KG-1-C,tanespimycin-bortezomib (250-1 mol-mol),1.8442829762863937
EJM,11494412,-0.937899289743814
AN3-CA,2746,4.007834108220286
J82,9884685,1.6283766678303309
Peer,3854666,0.4917924912491418
U-937,9884685,0.5979635741027005
HCC1428,11152667,2.498506650796191
CHP-212,9911463,2.7015843726568005
SK-MEL-24,3465537,1.2407688925018412
EM-2,11152667,-2.11262389342865
KMS-27,9935249,2.590998934095406
Caki-2,3854666,4.077354495139288
COLO 800,6918638,0.9384820746097428
K-562,4705,3.481256778033869
KMS-11,9935249,2.0287121726728783
BT 440,9926054,3.075570735220903
ChaGo-K-1,2746,5.131732167485152
HLF,100016,6.001250521147636
EM-2,10322450,3.0285960061439865
Hs 729.T,3465537,3.210090205188344
LOX-IMVI,9911463,3.8715849180913633
IM95,9911463,3.6531576247852153
BL-41,sirolimus-bortezomib (250-1 mol-mol),1.1503434998526136
U2OS,11152667,-1.813326658155893
Jurkat,selumetinib-GDC-0941 (4-1 mol-mol),2.512422287113006
SUP-T11,2746,2.7508028515684457
BICR 16,1566236,3.7013157010931743
Caki-1,selumetinib-GDC-0941 (4-1 mol-mol),2.159609795753867
A-549,4705,3.61311120139633
NCI-H1581,11152667,-0.3315014668198749
RKO,11152667,-2.010180339323448
MOLM-6,9915743,0.4708635426992801
P3HR-1,1566236,2.3415442579386987
2004,100016,6.70935199674954
UACC-812,9915743,-6.921665690083625
RS4;11,135984461,1.068681958562837
UM-UC-3,4705,3.0900844559148632
G-292 clone A141B1,54618771,3.663374867416664
DU145,9935249,3.749003876346386
SNU-449,9926054,1.9385314164963827
DMS 114,tanespimycin-bortezomib (250-1 mol-mol),-0.0529426000704769
PLC/PRF/5,10322450,3.983384699735352
SK-UT-1,tanespimycin-bortezomib (250-1 mol-mol),-0.7154967018113316
JIMT-1,9935249,3.6195859739992544
BV-173,10322450,3.6127329477753327
C2BBe1,3465537,1.3268482843439444
HCT 116,selumetinib-GDC-0941 (4-1 mol-mol),2.1704161349367506
OE19,1566236,2.960522722455562
DMS 53,6918638,-0.2331882953997054
Hs 611.T,9884685,-2.4852647330534383
L-1236,sirolimus-bortezomib (250-1 mol-mol),1.403422736729983
NCI-H2106,selumetinib-GDC-0941 (4-1 mol-mol),2.731448809919849
NCI-H2286,9915743,0.0711668307778549
A-673,6918638,-0.1443248090306654
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189
SR,54618771,1.0757630585056626
CAL-78,135984461,4.031920307936069
HH [Human lymphoma],9935249,1.1534572137581305
TE-8,135659046,3.4515439367981435
SNU-8,135984461,1.5881449503105405
PaTu 8988s,9935249,3.279701271474824
JHUEM-2,100016,5.904304927611702
Pfeiffer,136227924,1.7936916860357504
HT-1080,selumetinib-GDC-0941 (4-1 mol-mol),1.1211488481166476
JL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.640014576160969
HEC-108,selumetinib-GDC-0941 (4-1 mol-mol),4.231361891065658
DND-41,136227924,1.87568318170164
SK-MES-1,11152667,-3.0245097367815172
SKM-1,9915743,-0.8868720134451151
JJN-3,9911463,4.059977429957208
BICR 16,6918638,2.6722716810347205
SNU-878,BRD-K16130065,4.3857850176988125
JHOS-2,9884685,1.5653765415471337
HMCB,9926054,1.939305093595803
CHP-126,136227924,2.2251507312000576
Hs 294T,100016,6.337209257885702
KP-2,selumetinib-GDC-0941 (4-1 mol-mol),0.2413129500799869
SNU-466,65628,3.880758058928387
ESS-1,1566236,1.5560500313895365
UM-UC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.98446738693651
HMCB,9935249,3.1054191675254064
DU145,9911463,4.064467262158392
LCLC-103H,selumetinib-GDC-0941 (4-1 mol-mol),3.056154104463145
BICR 31,9926054,1.721382648019371
BT 248,9868037,3.916296675967623
BT-474,9915743,-4.144721850714229
KYO-1,65628,4.687741125093448
A-204,136227924,2.1384474587970113
MKN7,9911463,4.336260113916537
FaDu,135659046,3.4851599686971544
Karpas-422,9911463,4.381699719624804
VMRC-LCD,1566236,2.051225388786631
GaMG,2746,4.055581358402891
MOLP-2,73707386,3.154347724998132
LC-1/sq-SF,135421197,3.695638130955798
BICR 16,54618771,0.7733031407883998
VM-CUB-1,136227924,2.7643713240945016
HuT 78,135984461,1.9427901339992903
KYSE-510,135421197,2.241265348212864
SJSA-1,9911463,4.067531678479842
LS123,135984461,1.5979297518000015
BICR 18,135421197,2.040633770246715
NCI-H1155,9935249,3.4085854139583507
CAL-120,9911463,4.415772964133076
BICR 22,2746,3.5358057095338404
LC-1/sq-SF,selumetinib-GDC-0941 (4-1 mol-mol),2.9597977830319935
MDA-MB-453,24779724,5.606505141806212
Daoy,9926054,2.457854765834399
J82,selumetinib-GDC-0941 (4-1 mol-mol),2.8384419330971147
DND-41,100016,5.882204784714585
AsPC-1,1566236,2.844580785967763
BT 179,1566236,1.8409261490305735
HuH-6,73707386,2.841389478245076
GCT,71751553,4.654227598204535
NCI-H196,49836020,1.0558785681395022
KPL-1,11152667,3.5133536124099387
NCI-H660,3854666,3.03505528953488
HCC1937,136227924,3.58866664774513
WM88,9911463,3.783818746196605
Hs 294T,135984461,3.742416066345508
MSTO-211H,9911463,2.6842905920893108
OE21,3854666,0.7782353690934734
OCI-M1,135659046,3.73314659306938
KG-1-C,10322450,5.451010729371517
G-361,1566236,1.6393005665211553
KPL-1,9911463,4.601591010161613
CAL-33,9926054,1.6426139792956471
SCC-4,135659046,3.853752534308609
MKN7,3854666,3.49207359928349
MDA-MB-157,136227924,3.402219650297347
EJM,135421197,1.4211538659692204
Ku812,73707386,3.1917387110464666
NCO2,11152667,-1.862283935437442
HSC-4,11152667,-1.532358108136572
ZR-75-30,11152667,3.770951125825099
NCI-H2170,tanespimycin-bortezomib (250-1 mol-mol),-1.8178915881298592
KMS-28BM,135984461,2.268189755697481
Hs 766T,sirolimus-bortezomib (250-1 mol-mol),-1.9217809600428275
NCI-H292,9935249,3.8808310590786
NCI-H1666,sirolimus-bortezomib (250-1 mol-mol),0.7779430535962837
KU-19-19,65628,4.405271017285275
HEC-1-A,9915743,1.9800038677829928
ONCO-DG-1,9915743,0.2840854953845789
Hs 839.T,54618771,1.980967408775539
KU-19-19,136227924,3.1447471190609217
OAW28,9935249,3.684332158484572
M-07e,9926054,1.1111810240373077
Panc 03.27,2746,4.351064714114301
GMS-10,65628,4.321252297896726
2004,135398744,6.587609936981218
SNU-387,2746,4.374506555334325
CCF-STTG1,100016,6.985278157575169
KE-39,2746,3.4287978126101337
NCI-H929,9926054,0.4409605375156073
CCF-STTG1,6918638,2.2635117256438835
Hs 294T,4705,3.364751346281281
AsPC-1,135984461,3.722049898583642
KMS-11,54618771,1.142705350534528
GCT,3465537,2.4303788835325895
TT,tanespimycin-bortezomib (250-1 mol-mol),-0.7119220274254645
BT 504,1566236,1.844513919380763
JHUEM-2,sirolimus-bortezomib (250-1 mol-mol),-3.6728570307591686
TCC-Pan2,11152667,-1.5312652033075302
RCH-ACV,9868037,2.145537179112383
LK-2,11494412,1.1417367850098237
CW-2,100016,4.445901991176778
JHOS-2,6918638,1.6953141096129207
HEC-59,54618771,1.4246899684638197
L-428,100016,6.045371287660442
HCC1195,9935249,4.027609315345556
WM983B,9926054,1.9818225106954688
Karpas-299,3854666,0.1554068619507315
CJM [Human melanoma],2746,4.510121301862787
KYSE-410,3854666,3.296773212929304
MDA-MB-468,11494412,0.2824609467328579
NCI-H747,71751553,4.209240380331091
Ci-1,6918638,-0.1267659134210231
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
WSU-DLCL2,136227924,1.92257757824623
EC-GI-10,sirolimus-bortezomib (250-1 mol-mol),2.282726808437879
RS4;11,10322450,3.4392008344478895
SK-MEL-1,3854666,3.1088864044713747
VCaP,sirolimus-bortezomib (250-1 mol-mol),0.185191058575781
CAL-33,71751553,4.914654901307642
MSTO-211H,9915743,-1.0722844498490078
Panc 02.03,3854666,5.373190444337423
KO52,6918638,-1.0658834160946808
639V,sirolimus-bortezomib (250-1 mol-mol),1.801043547803399
Pfeiffer,9935249,-1.9078957429829817
Hs 934.T,11494412,1.867105540829516
NCI-H1734,9935249,3.3895147226281037
Karpas-299,136227924,2.4546473500331576
Ki-JK,9935249,1.493918091847371
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
NCI-H2085,135421197,1.1751521107550191
SEM,650361,3.800745597928697
HT,73707386,3.008918492813066
GP2d,100016,6.428285689025714
A-204,9915743,1.0041843523053866
CAL-120,9926054,3.430797555245233
TTC-709,135984461,4.327447366032638
OE33,54618771,0.6463967742027482
AsPC-1,6918638,0.7071735542476161
Hs 895.T,9911463,4.380073854320694
SUP-T11,9926054,1.9086268061731997
Panc 03.27,3854666,1.0969733528715877
BT 239,9884685,-0.9552991343653138
SW1417,135421197,1.3555171655865843
GDM-1,9926054,1.958570414824769
J82,sirolimus-bortezomib (250-1 mol-mol),0.3485441031707259
T3M-10,135421197,3.6176522796441546
DV-90,49836020,4.269422045712615
KE-97,100016,5.841816758085698
LN-229,selumetinib-GDC-0941 (4-1 mol-mol),1.343707265826647
Kasumi-2,4705,3.579279614719375
JVM-3,9911463,2.5369754211947217
NCI-H28,9926054,1.6125728317603996
BT 498,135659046,3.899086642972748
HCC38,54618771,2.492060866479401
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425
PLC/PRF/5,2742550,3.829662269991737
NCI-H1395,135421197,1.2810683988074232
SK-N-MC,9884685,-1.1337198062003164
UM-UC-3,11152667,0.5303159770829485
J82,135421197,1.0520459695592828
EJM,4705,3.167336091742425
SKM-1,9911463,3.5328203832136276
NCI-H2228,65628,5.022227644787099
NCI-H2052,100016,6.8923960055757805
EHEB,tanespimycin-bortezomib (250-1 mol-mol),-0.1449440337171298
HCC2218,9926054,1.6047846197702569
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
BT 224,2746,4.512164577407842
HEC-151,135984461,3.687449100902744
Aska-SS,9935249,3.1640243411747666
KNS-42,54618771,1.5414231722108478
SF539,9884685,-0.5281104713803977
COR-L88,11152667,0.0655209576586565
MFE-319,sirolimus-bortezomib (250-1 mol-mol),0.3475063070174586
SUIT-2,9911463,4.378510442631056
COLO 800,11152667,-1.2200838930089684
BT 416,135398744,7.827037669937473
HEC-59,9926054,2.31296864465942
U-251MG,sirolimus-bortezomib (250-1 mol-mol),1.1740336487454477
MOR/CPR,9935249,3.5674307926017415
NCI-H2291,selumetinib-GDC-0941 (4-1 mol-mol),-0.2991032125390215
CAS-1,9911463,4.201825913266076
LUDLU-1,9911463,2.6555573112592494
A-253,9884685,2.3107926636693907
L-363,135421197,1.89182184034138
OCI-Ly19,71751553,4.646570444939478
JHUEM-2,136227924,1.8669676160402808
HSC-4,54618771,2.9865797342969564
KMRC-3,9915743,1.1795230996835706
Rh18,135421197,3.2073141034499577
KMRC-20,54618771,1.1098897337437623
MOLM-6,100016,5.4880920806856865
Hs 936.T,11152667,-0.982911765278613
DMS 114,100016,6.89872652787532
Panc 08.13,54618771,0.3340259245614503
HuH-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3732024399993965
769-P,135421197,1.1178294524098082
JeKo-1,135659046,3.5634335603711995
NCI-H524,sirolimus-bortezomib (250-1 mol-mol),0.5181816489165546
NCI-H1869,9915743,-0.6149308552384661
TC-71,11152667,-0.90552312132183
SK-N-FI,6918638,-0.1979002452406887
IST-Mes1,9884685,0.6527999920478087
Panc 08.13,4705,3.2768687691723395
A-375,1566236,1.7725511656695576
SNU-475,54618771,1.821628813352334
A2780,10322450,2.9165978660974545
HMCB,54618771,0.8772324111806863
Granta-519,3465537,1.1430845598370274
A2058,6918638,1.2547310541014554
Karpas-620,135398744,5.497457460597933
J82,54618771,2.0781543911386264
CHP-126,11152667,-3.0813157517767205
Hs 852.T,135984461,4.050524376376727
COLO 668,54618771,1.2538028479070895
A-549,9926054,1.8971220341716168
HCC827,11152667,-1.8909743220158417
CCF-STTG1,9915743,3.2198509615239024
PLC/PRF/5,2746,3.4483774015176447
SNU-738,9911463,3.7270128558697664
HEC-265,tanespimycin-bortezomib (250-1 mol-mol),-1.1174681512441365
MDA-MB-453,136227924,2.410345496671846
KMRC-20,9935249,4.274093683443108
GI-1,selumetinib-GDC-0941 (4-1 mol-mol),2.406121419892038
UO-31,2742550,2.8360287699975943
JHH-1,selumetinib-GDC-0941 (4-1 mol-mol),2.043129184310282
HEC-108,3854666,0.9548518440486092
Namalwa,2742550,3.645148069005769
TTC-709,11152667,-0.5539552668889595
T3M-10,4705,2.7923170944145643
OE21,9911463,3.2233291636106727
Mono-Mac-6,selumetinib-GDC-0941 (4-1 mol-mol),2.3199178680358683
ChaGo-K-1,3854666,1.588542463335614
Daudi,11152667,-2.9472151872913104
OAW28,71751553,5.303505748888211
BT 333,135421197,2.652327815352438
Calu-6,3854666,0.8971542674673161
UO-31,9915743,-0.5228341735607687
U2OS,selumetinib-GDC-0941 (4-1 mol-mol),1.8236240565324096
BEN,BRD-K16130065,4.206876741952794
UM-UC-1,9935249,3.1268439830894854
SK-ES-1,11494412,-0.0621130910981748
MCAS,24779724,4.433406171067244
PE/CA-PJ34 (clone C12),11152667,0.0112826586729411
T3M-10,selumetinib-GDC-0941 (4-1 mol-mol),0.2338392597437749
A-549,54618771,0.0374822867627876
NCI-H1568,49836020,3.1231470101883336
SU.86.86,1566236,3.226684285708377
BT 131,6918638,1.6036373067765148
JHH-5,135984461,6.19105959090805
NCI-H1869,3854666,4.318290699876198
KNS-60,tanespimycin-bortezomib (250-1 mol-mol),1.2079185483503194
MCAS,2746,3.159271623653468
SEM,1566236,0.4832736150587708
GI-1,135421197,1.6519040465788966
BT 164,65628,2.969610614929698
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
Kasumi-2,2742550,3.256021563602066
NCI-H1573,9884685,-0.054986717819308
SNU-398,9926054,1.6383550213348652
YD-15,11152667,-1.1817729874123373
SF539,1566236,1.697367188486211
SUP-B15,10322450,4.034364888516056
RKN,1566236,1.687441004968786
TTC-709,11494412,1.1773331803884557
Daudi,3465537,3.6729414318228697
SK-N-AS,9926054,1.80921327911472
MOLT-16,9915743,-0.2771679442099183
A-549,136227924,3.1395144761786486
EFO-27,3854666,3.6632128701571194
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
HDLM-2,10322450,3.293303215923486
NCI-H647,54618771,1.14773606602027
SNU-8,9915743,2.7412552085538326
NCI-H2122,54618771,0.6219971058133998
KMS-20,65628,3.828249966077918
GSU,sirolimus-bortezomib (250-1 mol-mol),1.8357391099692455
PSN1,9915743,2.9916709267911084
HT-1376,100016,4.270787672820572
SNU-719,tanespimycin-bortezomib (250-1 mol-mol),-1.2568282299836298
GDM-1,9911463,2.550889213910243
COLO 205,tanespimycin-bortezomib (250-1 mol-mol),-2.2778936602109483
TE-15,65628,4.191504747725539
GCT,54618771,1.7991225479555093
BCP-1,9926054,1.6337686711618178
LN-18,selumetinib-GDC-0941 (4-1 mol-mol),2.471662791203074
NCI-H292,135421197,1.1571557888211337
Tm87-16,1566236,3.2749985953055893
BT 231,2746,2.74381286555369
SK-N-BE(2),9884685,-0.3835133513232162
SHP-77,9935249,3.258969461214577
COLO 668,9935249,1.1947973712890914
TE 617.T,136227924,1.63601430884803
NCI-H1915,10322450,3.706063293985689
BT 320,1566236,4.371560124605876
SNU-16,3854666,1.7329468911720929
G-402,9911463,3.624660620930307
BFTC-909,9915743,2.0959000942543025
SNU-C2A,54618771,1.0947392287826
MJ,tanespimycin-bortezomib (250-1 mol-mol),-0.74419356352866
OVCAR-4,9935249,3.584254547871848
ECC10,135984461,4.0726729521120975
RD,65628,4.606255765609253
OCI-M1,9935249,3.0060343171338624
TE 441.T,6918638,0.7814615450050921
SK-N-AS,tanespimycin-bortezomib (250-1 mol-mol),0.7232551135734744
NCI-H1693,sirolimus-bortezomib (250-1 mol-mol),0.2355785626536786
HCT 15,1566236,1.8792685821972948
MOLP-8,135398744,7.476327693514706
HCC78,sirolimus-bortezomib (250-1 mol-mol),1.3217046818023197
HCC1419,9915743,-4.40313771987628
NCI-H520,136227924,2.065702540466464
SU.86.86,sirolimus-bortezomib (250-1 mol-mol),0.3340737576471567
TF-1,10322450,2.6855110570299696
TC-71,136227924,2.205314859996721
CW-2,54618771,-1.320149123720888
MKN7,54618771,2.9720813941878577
REC-1,73707386,2.7839275654473243
SK-UT-1,3854666,2.1786369520498283
CL-11,54618771,0.9971438816591957
COLO 680N,3854666,4.154438593941972
BT 333,4705,3.363159057665455
KPL-1,3465537,2.5185436279370896
T24,65628,4.261975471430199
D283 Med,135984461,1.545115225409391
SK-MM-2,4705,2.736644708232148
BT 444,3854666,3.4712886438660417
SNU-503,9926054,1.9244850158263864
UO-31,24779724,5.276933608870132
NCI-H1299,9911463,4.155040762407167
HOP-62,136227924,3.3249367186884564
JHH-4,9915743,1.3813494338537873
ST486,9926054,1.8361941441765457
Calu-1,135984461,1.7273977102248494
CML-T1,9911463,2.5893115421622737
SK-N-AS,11494412,-0.8691510414375381
Mel JuSo,3854666,2.774880128423634
SNU-46,9935249,3.0603122105068445
LNCaP clone FGC,9911463,2.657029606210989
BICR 56,100016,6.239283130221144
MIA PaCa-2,136227924,2.1731844460154743
AGS,sirolimus-bortezomib (250-1 mol-mol),0.9913550717108452
PE/CA-PJ49,136227924,2.4190721025981987
G-402,71751553,4.275452856729738
MDA-MB-361,9926054,1.9315814680305097
BxPC-3,9926054,1.7603137158224154
KYSE-510,4705,3.5266968051066856
786-O,6918638,1.6864492481746118
SW1088,9926054,2.0788174328581515
ES-2,selumetinib-GDC-0941 (4-1 mol-mol),6.130354899135342
HGC-27,4705,3.374202647698771
HuNS1,11152667,-1.226453597215441
T84,135421197,1.1926800486380174
NCI-H1299,136227924,3.5346618762414392
A-204,3465537,1.456370701568416
NCI-H1341,4705,2.9971891882923485
Hep-G2,sirolimus-bortezomib (250-1 mol-mol),1.7771755554565365
HOP-92,9935249,3.096811050653779
P31/FUJ,73707386,2.311695228129917
LOX-IMVI,11152667,-0.6802335307199879
JHH-4,sirolimus-bortezomib (250-1 mol-mol),0.3887655009012536
SNU-C4,136227924,2.9928621999202467
KNS-81,9868037,4.212770476057123
BT 131,135659046,3.687491752801227
RL,1566236,1.5616385715057797
MG-63,9911463,4.367195765244299
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
DMS 114,2746,3.518384680762127
CAL-148,9926054,1.1690943917504333
BFTC-909,9868037,3.24226767674478
THP-1,135984461,4.301295147002072
JHOC-5,73707386,5.104699893328899
SW48,3465537,3.829258919586145
HCC4006,54618771,1.138326772964569
BT-16,11494412,1.7201073702019167
SK-MEL-24,9911463,3.297368561955771
OPM-2,100016,3.804278037815123
LOU-NH91,11152667,-0.304989451834292
SNU-16,100016,4.136425652163891
PK-1,2746,4.301846105037093
HEC-151,100016,5.913951457428463
MDST8,65628,4.39024768664476
SaOS-2,9935249,3.097116977919543
SNU-620,49836020,5.484424750861699
G-402,135984461,1.930732604318706
Hs 888.Lu,650361,3.8028163824947967
CCF-STTG1,9926054,1.9394922490252933
B-CPAP,100016,6.506572981316216
P3HR-1,9935249,4.307909434108789
SW1116,54618771,-0.9904180488449444
PK-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3787528368135669
U-BLC1,9926054,1.6248687315541563
DMS 79,9915743,0.1053493686109965
KMBC-2,71751553,4.649110275042704
JeKo-1,tanespimycin-bortezomib (250-1 mol-mol),0.4974732421347879
SNU-840,selumetinib-GDC-0941 (4-1 mol-mol),1.257752895410429
JM-1,2746,0.8560843341026924
HCC1500,9926054,1.7367797854287812
BT 416,3854666,-0.8392418796175438
Ku812,136227924,2.6493599225721742
CAL-62,11152667,-0.846495362159148
NUGC-3,9911463,3.217932170312211
DMS 114,11152667,0.949918299372712
OVCAR-5,11494412,4.220003635064294
ZR-75-30,136227924,3.5756469644058613
OCI-Ly3,9915743,0.6097478926104294
OAW28,9915743,2.8675584787684456
SR,9915743,2.3691370724807985
U-251MG,9868037,3.950547423154838
EBC-1,1566236,2.360259919551262
SK-N-DZ,9926054,1.7056763451018535
KCL-22,9868037,2.068563427073688
SYO-1,135421197,1.7778335849280964
SCaBER,135421197,2.9143213088501794
MIA PaCa-2,2742550,3.852651019611259
769-P,100016,6.594067506922387
KMS-11,4705,3.23194213568903
Hs 729.T,71751553,4.8113442822732155
JHUEM-7,1566236,1.715043210679705
COR-L51,10322450,3.875976126745678
DEL,10322450,3.0359282026720575
MIA PaCa-2,6918638,-0.2858557386208528
T84,136227924,2.5199027398538707
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
Ku812,9868037,1.2688072678140785
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967
42-MG-BA,9884685,-1.3551185166012014
NCI-H1563,9915743,0.028314904661926
EFO-27,3465537,3.52414234339403
UACC-257,11494412,4.416808575611809
DV-90,1566236,1.716628899153487
GI-1,71751553,5.7700397394120655
COLO 668,sirolimus-bortezomib (250-1 mol-mol),1.0327595793559854
AGS,tanespimycin-bortezomib (250-1 mol-mol),-1.1617791040203864
OE21,49836020,4.665936469802933
UACC-62,selumetinib-GDC-0941 (4-1 mol-mol),-0.701178032611257
AGS,9911463,3.955796960522849
BT 145,9884685,-0.6373719469605073
HT,3854666,0.7093323572382654
Li-7,11152667,-0.8164153978529881
MOLT-3,9935249,-1.737643818642649
SK-MEL-30,2746,2.9636242403288344
T-47D,2746,3.323386211929572
SiMa,9868037,1.987643785401739
SNU-182,73707386,2.6235662481878146
SNU-1214,136227924,2.9720785133706213
COR-L47,9926054,1.681825446292649
TE-6,2746,2.631645333531432
KNS-62,11152667,0.7144620946918225
COR-L88,2742550,3.917514421187428
SNU-C4,54618771,0.9535591955957128
SJSA-1,9868037,3.601599013312942
SNU-1033,135421197,1.1443309651958211
NCI-H841,9884685,0.3344171331513928
BT 422,4705,3.053482831247426
SNU-1214,sirolimus-bortezomib (250-1 mol-mol),0.3499333667052599
G-402,9915743,1.3194896557677194
DLD-1,sirolimus-bortezomib (250-1 mol-mol),1.5948066539629249
BT 179,9911463,3.927482199479875
PC-3,9935249,3.435899400354577
HCC1588,9915743,-0.589938249140678
UACC-62,6918638,0.9187226840984998
SNU-61,3854666,2.8565665342705735
AML-193,selumetinib-GDC-0941 (4-1 mol-mol),-1.3342329805744104
KYO-1,3854666,0.614487001981186
HCC44,135984461,3.9649295662301585
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
LUDLU-1,71751553,4.8619324376076785
SBC-5,3854666,0.5257720708282073
ZR-75-1,73707386,2.6324611831301192
U-937,24779724,4.361169405698901
YAPC,135421197,1.6415717791988456
ECC12,136227924,3.114580380384796
COLO 829,54618771,1.3486725115535303
Mel JuSo,9935249,3.4919970972717618
SNU-387,tanespimycin-bortezomib (250-1 mol-mol),0.93646564215711
SK-LMS-1,9935249,3.6088412338145366
ChaGo-K-1,54618771,2.4705381408155183
CHP-212,135659046,3.126756855928974
KE-39,135421197,0.9510973278490732
JHH-2,100016,7.043022520962564
SW1990,sirolimus-bortezomib (250-1 mol-mol),0.2169201029218291
OS-RC-2,54618771,2.9628716823736334
Ku812,11152667,-2.1041122356576127
HuT 78,3854666,0.8787104419208177
BT 231,100016,7.4946101776766385
G-401,2742550,4.179048555325354
NCI-H211,10322450,3.046049170762013
TYK-nu,11152667,-1.4994661185688625
G-402,9884685,-1.1274637875769815
OV7,tanespimycin-bortezomib (250-1 mol-mol),-1.2936042067435187
769-P,11152667,-1.1976521797110848
BC-3C,135659046,3.4176936154501845
Mono-Mac-6,135421197,1.2337860408769474
CAL-33,135421197,1.5184759141231294
KMM-1,9911463,3.7881854047287113
LMSU,9926054,1.9493229998791417
SNU-C4,9935249,3.203269653737987
OCI-AML-2,135398744,6.3440072866172965
IST-Mes1,71751553,5.350652566949457
BT 164,3854666,0.922367981820593
TE-1,3854666,3.3218697538076296
Peer,selumetinib-GDC-0941 (4-1 mol-mol),3.981609189515586
NCC-StC-K140,9935249,0.5138853084156294
IGR-37,135659046,4.488769216179786
TE-15,136227924,4.530652264188515
TE-9,9926054,2.1843594630677674
HOP-92,6918638,0.7630598951940987
TUHR14TKB,71751553,6.485615082435111
Aska-SS,9915743,4.6132993472825765
BT-12,49836020,2.972579306483729
Hs 688(A).T,9884685,-1.0348609535352993
OCI-AML-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.789265040727208
LNCaP clone FGC,1566236,3.496775804541155
A4/Fukuda,100016,4.8831896191852096
EJM,136227924,2.8681258655198367
KMS-18,9926054,1.804034237605838
DU4475,selumetinib-GDC-0941 (4-1 mol-mol),-4.053577940845995
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885
Li-7,sirolimus-bortezomib (250-1 mol-mol),1.648845236287691
MHH-CALL-4,136227924,1.8406000029443903
SNU-719,9911463,3.4585682156791555
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
WM1799,selumetinib-GDC-0941 (4-1 mol-mol),0.0731579232599876
ST486,136227924,1.8715049257554837
HCC1195,tanespimycin-bortezomib (250-1 mol-mol),0.0531375858676879
HT-1080,6918638,0.2598453428268436
CAL-29,2742550,2.973881350945423
SNU-840,tanespimycin-bortezomib (250-1 mol-mol),2.584361399969364
ACC-MESO-1,2742550,5.050370416732392
SNU-5,sirolimus-bortezomib (250-1 mol-mol),-0.1680239232280146
BT 330,3854666,1.6927657875958029
NCI-H1105,136227924,3.5995085606393955
EKVX,135421197,0.902433297386992
ECC12,100016,5.969737428755433
NCI-H1666,3854666,2.4849019558472047
CAL-78,54618771,1.2758318023633108
MDST8,9926054,1.8075400364112937
OVK18,65628,4.603637756279064
SF268,65628,4.3659613726729685
KNS-62,9868037,4.116699778662341
Hs 936.T,100016,5.806135174623166
JHOS-2,100016,8.119351788295337
SK-MEL-5,9911463,3.724914838124911
OVTOKO,65628,5.039210953905471
SW1573,9884685,-1.2788581073527363
Ri-1,135421197,1.0934360104975305
NU-DUL-1,9868037,0.9018542361543456
JJN-3,9884685,0.2310380370022593
NCI-H2085,sirolimus-bortezomib (250-1 mol-mol),0.8300546394702069
SF268,3465537,1.4623363787062609
KMS-20,9926054,1.4765400556600523
NB4,9935249,1.5205044198931177
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646
OVSAHO,9935249,3.7943989352895975
SNU-245,sirolimus-bortezomib (250-1 mol-mol),2.143003825797964
EC-GI-10,9935249,3.8979806422622905
KYSE-410,selumetinib-GDC-0941 (4-1 mol-mol),1.4678317054050969
A-375,100016,6.005492870785018
U-251MG,4705,3.583212540247193
NCI-H2444,10322450,5.0413898485773
DV-90,135659046,3.4000463050083582
SNU-423,9926054,1.7894708985292902
Rh18,9935249,2.794389835248646
NCI-H2052,tanespimycin-bortezomib (250-1 mol-mol),2.581253190791589
Capan-1,9915743,1.7686030457629929
TE-10,136227924,2.8479301717793435
NCI-H1792,1566236,3.2685479943945857
IGR-37,54618771,0.3967957480696406
OAW28,9884685,1.3567472374362477
YD-8,54618771,-1.0700457769979232
Hs 895.T,71751553,4.840538175613458
ES-2,11152667,-1.0665874566143538
Li-7,9868037,2.00817394504418
EN,71751553,4.851604891017641
Caov-3,sirolimus-bortezomib (250-1 mol-mol),1.7880451090258302
SK-N-FI,135984461,4.351093738178911
GSS,9884685,-0.174857877617277
DEL,65628,3.2716270578205866
LP-1,135421197,1.2171511840038625
COLO 320,4705,2.552881427676556
HEL,3854666,0.8085723321900852
NCI-H2081,10322450,4.110472568642291
BT 248,3854666,2.6170510866367955
HDLM-2,9935249,2.6630480358330657
NCI-H661,3854666,2.0669995151297633
OVCAR-5,100016,6.797399029850292
BT 422,9884685,0.8498641278856381
KYSE-140,9915743,-1.963321476047282
Hs 578T,11494412,1.776688404069291
HCC1937,selumetinib-GDC-0941 (4-1 mol-mol),1.9717867215396572
SW579,sirolimus-bortezomib (250-1 mol-mol),0.6765835324099176
SK-LMS-1,2742550,3.9277163858782913
SNG-M,135984461,3.667931124820979
SNU-119,11152667,-1.7505046185564503
NCI-N87,3854666,1.2679317332294615
PC-14,9911463,4.053685719227892
LS1034,71751553,4.24322040850765
H-STS,selumetinib-GDC-0941 (4-1 mol-mol),1.9537724783491248
Detroit 562,selumetinib-GDC-0941 (4-1 mol-mol),2.228637480790017
697,9884685,-1.5792659034584708
BICR 31,49836020,4.313223650735915
GA-10,3854666,-0.056575285481401
BT 428,3854666,1.1222123532361343
NCI-H146,11494412,-1.136229477240518
A-172,54618771,1.0559368295396556
SNU-1079,9911463,2.811910172991152
CGTH-W-1,9926054,2.1439424725815814
BICR 6,sirolimus-bortezomib (250-1 mol-mol),1.9744607450620832
OVCAR-5,9868037,3.692137842921165
HCC1428,11494412,5.984030575865442
LS1034,65628,4.320188837845099
T98G,11152667,-0.8592432480151526
SK-MEL-28,11152667,4.172027715871216
SNU-182,11152667,-1.401202030451144
NCI-H522,135421197,1.9700795220087195
NCI-H1341,6918638,-0.9178094299381953
SKM-1,136227924,2.5339244468963407
HuT 78,9868037,2.4738144029909908
SK-N-MC,49836020,5.673841333096494
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
SK-N-DZ,selumetinib-GDC-0941 (4-1 mol-mol),1.1652159438027232
Hs 852.T,100016,3.86747930561629
NCI-H1838,100016,6.459213557236613
HSC-3,49836020,-1.9036219787804456
Granta-519,135659046,3.900512348834848
P31/FUJ,10322450,3.023071845081992
QGP-1,100016,6.909688760762285
OCI-Ly3,2742550,3.803331365452129
Daoy,tanespimycin-bortezomib (250-1 mol-mol),-0.2871492230613796
KP-N-YN,54618771,4.352699986589353
OVSAHO,54618771,1.1645898575055549
OAW42,9915743,3.0067264030666907
PANC-1,135659046,3.591022095575617
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
YKG-1,4705,3.5798209595137247
A-673,selumetinib-GDC-0941 (4-1 mol-mol),0.7594316863977323
DMS 454,11494412,-0.2610081451364712
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
HCC202,6918638,0.9094073905237152
SK-ES-1,136227924,2.7143313352480143
AsPC-1,9911463,3.4970941612274693
BT 482,tanespimycin-bortezomib (250-1 mol-mol),-0.9105363094795508
BT-20,1566236,3.9435008592905247
KYSE-150,sirolimus-bortezomib (250-1 mol-mol),0.6836910361720296
C2BBe1,9911463,3.464782033118563
BDCM,3465537,1.2996187569558617
LS513,65628,4.8114828061247685
SU-DHL-10,11152667,-1.8313784682506988
NCI-H1703,9884685,-1.4744603676906212
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733
NCI-H2228,10322450,3.891754335699043
JHOS-2,4705,4.289779797821904
KYM-1,9926054,1.655871413890737
NCI-H1703,6918638,1.6559021523664152
NCI-H2029,54618771,1.4933886789628814
CAL-120,11152667,0.6693554019859562
U-BLC1,54618771,-0.2094086487307373
YD-8,1566236,1.8146289426775175
Karpas-620,3465537,3.7195040450487986
SHP-77,11152667,0.6576554567365351
K029AX,3854666,2.8456781664653845
BICR 18,sirolimus-bortezomib (250-1 mol-mol),2.192378588292802
A-204,sirolimus-bortezomib (250-1 mol-mol),0.1160777276351835
SNU-489,3465537,3.741170628687715
HCC1395,9935249,3.722590461759625
SK-N-AS,135984461,4.344661124927598
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
KMH-2,136227924,2.758064098306969
OVK18,tanespimycin-bortezomib (250-1 mol-mol),-0.2590574495112158
HEC-265,100016,5.251492285111922
CMK,2746,1.105123942963827
SNU-C2A,selumetinib-GDC-0941 (4-1 mol-mol),0.0090429135503482
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
OVISE,2742550,5.280611289386831
SUP-B15,9935249,2.106568222732024
F-36P,10322450,3.2432615470800883
GI-1,6918638,0.0741451008048908
SK-N-SH,9926054,1.7311235151913027
NCI-H2023,9911463,3.271912940774434
COR-L47,11494412,0.8798748860776965
NCI-H2009,tanespimycin-bortezomib (250-1 mol-mol),-0.207724504276561
U-BLC1,9911463,3.7218159913620887
G-292 clone A141B1,4705,3.730177058269135
HT,136227924,2.3517784191427613
NCI-H522,3465537,1.2201304719285595
DK-MG,6918638,0.8133882736108148
SW1990,3854666,4.405402240089115
KMS-34,9868037,1.4276182493949865
SW579,selumetinib-GDC-0941 (4-1 mol-mol),1.5749080758485403
DEL,11152667,-1.9938024204279712
MFE-296,9935249,2.6093075530400864
HGC-27,9935249,1.1253542566009878
SNU-899,sirolimus-bortezomib (250-1 mol-mol),1.691778664572397
KMS-26,3854666,0.369015191618214
HEC-1-A,135421197,1.5855088638754589
SW1353,9911463,4.226440696401509
UO-31,9868037,3.0642898749383627
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146
KMH-2,3854666,0.5486625704198924
TE-14,11152667,0.6332718687769578
DK-MG,135398744,6.3715043377255665
SNU-308,9915743,-2.1849760358615296
PK-59,135421197,1.5554330287724354
MG-63,1566236,1.8094317598532976
IMR-32,3854666,-0.9157783750736912
BT 239,11494412,1.0989545703534742
OCI-AML-2,9911463,2.4773286761058992
Hs 683,135421197,1.945110581550152
TT2609-C02,135421197,3.994443505891966
COLO 678,100016,6.808142270815235
CAL-51,9935249,3.84795648434564
EoL-1,135659046,2.6902533100653785
HCT 15,3854666,0.492639302454022
SCC-25,9926054,1.6689856093207305
Mino,9911463,2.4278795242831253
HCC1419,135659046,5.048116193224175
EoL-1,11494412,-1.5028659812721048
Hs 895.T,4705,4.1293689798575794
MM1.S,54618771,0.954891721558104
U-BLC1,1566236,1.8337532039015736
CL-11,1566236,1.7101379821681366
PK-59,9926054,1.7891376671835462
MV4-11,tanespimycin-bortezomib (250-1 mol-mol),-4.482772377599296
C2BBe1,135984461,4.331505253640542
CAL-29,9915743,0.4542192657776882
HDLM-2,73707386,3.1146753521402712
U-118MG,sirolimus-bortezomib (250-1 mol-mol),0.338671350803902
DMS 273,3854666,0.530051590236263
GaMG,9911463,3.671296703751626
ECC12,135421197,3.3964396494270357
Hs 683,135659046,3.747937151940255
MOLP-8,4705,2.7848528520877727
CCF-STTG1,sirolimus-bortezomib (250-1 mol-mol),2.0360820241023876
Yamato-SS,sirolimus-bortezomib (250-1 mol-mol),1.899815056583121
Hs 888.T,9926054,3.017509441424242
SW1710,selumetinib-GDC-0941 (4-1 mol-mol),2.8555583802472277
RL,135421197,1.8322990483714552
MM1.S,9884685,-0.9027319630033926
NCI-H1703,9911463,3.2274875516011257
NCI-H23,54618771,-0.0460259250887816
Hs 888.Lu,9915743,1.135469165316104
SNU-1041,135421197,3.0593389422379293
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
KMRC-2,9915743,0.8631489276658242
NUGC-4,9911463,3.797597719438973
GOS-3,11152667,0.5000513857969126
RCH-ACV,135659046,3.4161353826802783
KCL-22,11152667,-1.7149450247190612
SNU-C1,11494412,1.7066036750459093
ST486,9915743,0.8352161269515779
SK-MEL-31,73707386,4.231736662554632
FTC-133,1566236,2.958331107997485
RCC10RGB,2746,4.042085650474663
JMSU-1,3854666,1.2672758634513397
BT 428,9926054,1.9432227600739695
Hs 578Bst,135659046,3.7214456124706543
A-253,9915743,1.8509292893724236
FU-OV-1,9915743,0.5010130642537969
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
NCI-H520,2742550,4.31238635720589
HCC44,9884685,-1.326885873359785
SK-MEL-24,1566236,2.137151818303078
BT 224,100016,6.546386559669457
AML-193,24779724,5.0401581340070205
NCI-H2452,650361,3.725817753027947
U266B1,tanespimycin-bortezomib (250-1 mol-mol),-0.8017004823688043
F-36P,100016,3.924028764616067
Hs 944.T,3854666,2.005774542899694
M059K,sirolimus-bortezomib (250-1 mol-mol),0.4105527890909189
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403
NCI-H810,3465537,1.1562872459305875
42-MG-BA,1566236,2.996441509240824
Ci-1,2742550,3.4067893087019785
KMRC-20,9911463,4.198821616328526
NCI-H1395,11152667,2.8212920431399597
OVCAR-5,71751553,4.553409828903415
KNS-60,9915743,0.9849454355481576
NCI-H647,selumetinib-GDC-0941 (4-1 mol-mol),1.4549802874182485
HSC-2,9911463,4.049895427785984
OV-90,135421197,1.209947389883954
HCC78,selumetinib-GDC-0941 (4-1 mol-mol),2.9308548857555303
PSN1,9935249,3.2197582498789696
ONS-76,65628,4.406189432641036
MKN7,11152667,-0.2915307424688416
A101D,6918638,2.125640820969418
SK-N-DZ,135984461,1.5493461602233345
MES-SA,tanespimycin-bortezomib (250-1 mol-mol),-2.9811279867981635
MOLM-6,65628,3.2313618395358645
HL-60,135421197,1.9226353151764572
SK-MEL-30,11152667,1.317956981050057
IGR-39,2742550,5.0272104945587035
KMS-27,3854666,0.5713663154579435
Aska-SS,9868037,4.2121131114727435
647V,71751553,4.528566632695141
SCC-4,11494412,-1.2435861209633752
DMS 454,2746,1.9739977196857323
OAW42,54618771,1.2241554078015442
DMS 53,135659046,3.734074928791185
TYK-nu,65628,3.6002403051970733
VMRC-LCD,135398744,6.4569642970049
PC-3,3465537,3.386652661841469
Yamato-SS,selumetinib-GDC-0941 (4-1 mol-mol),-1.5672740621691217
COLO 668,135398744,8.327897360354253
ZR-75-30,10322450,4.312003120067809
SJSA-1,100016,7.674645652371816
Ri-1,sirolimus-bortezomib (250-1 mol-mol),-9.474135938791196
SK-N-SH,4705,2.8516151129930396
L-428,65628,4.3161887010588655
HCC202,9911463,4.016113462481005
K-562,135984461,3.2548026411837787
NU-DHL-1,6918638,-1.28362156468715
NCI-H1694,9884685,0.2353151314762636
AsPC-1,9926054,1.8957621767397328
HeLa,9926054,1.7615972318293558
LOU-NH91,100016,8.416108067142021
Hs 766T,2742550,4.638958882709758
OAW28,2746,2.637952220594215
MHH-CALL-4,9935249,3.1368744392379555
YD-38,135421197,2.8276318584619022
AN3-CA,9926054,1.8039265956503063
SNU-878,9926054,2.3591129664276194
NCI-H2029,tanespimycin-bortezomib (250-1 mol-mol),1.6756703480673036
ALL-SIL,135984461,1.7193250250744925
COR-L88,6918638,-0.7274407096817714
BT 286,11494412,1.6157020309527923
NCI-H889,3854666,0.6908596149728301
NCI-H2170,2742550,3.89101462979228
SK-N-SH,136227924,2.487245372945198
MFE-319,9926054,1.8492827713698956
SNU-398,9911463,3.388057866137583
HCC827,100016,4.431453048958875
L-428,9935249,1.854395336163708
L-428,9911463,3.1303248719612093
CAL-51,65628,4.560195683913681
RL,selumetinib-GDC-0941 (4-1 mol-mol),2.248792439261428
Sq-1,54618771,1.1991492698184876
HSC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.0477994857059647
SNU-869,2746,3.873911314544542
Detroit 562,9911463,2.662493501158816
NU-DUL-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.5711505169578749
M-07e,3854666,0.4503079747875654
23132/87,11152667,-0.9756712768346428
MOLM-13,9935249,2.7939558009041283
C2BBe1,135659046,3.558851122632108
COLO 829,9935249,3.01817640679569
HOP-92,11494412,3.5967755894760645
MOLP-2,9915743,1.124715317065168
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
SJSA-1,4705,2.8709767105947974
Granta-519,136227924,1.3333863896282263
Panc 10.05,sirolimus-bortezomib (250-1 mol-mol),0.3447430037578218
JHOS-2,65628,4.369428236265807
BT-474,9935249,3.4097501700576016
BT 359,3465537,3.812701654960202
A3/Kawakami,65628,3.260470610713876
SCC-4,9911463,4.04011035485065
BICR 16,136227924,2.8848408076895393
NCI-H2141,9926054,1.978492871362738
TOV-112D,135421197,1.1317975787010155
OS-RC-2,9911463,4.41077585460665
MHH-CALL-3,11152667,-4.433514521858705
TOV-112D,11152667,0.4642176888088713
UO-31,9911463,3.1211940874261623
NB1,54618771,1.1360692536684358
ECC10,9935249,2.455654324483876
DU4475,136227924,1.4993153773488237
EPLC-272H,9911463,4.277104632869788
DMS 79,tanespimycin-bortezomib (250-1 mol-mol),0.386728913048693
MG-63,135421197,2.3239487693953627
MJ,6918638,-0.2004138762975409
769-P,tanespimycin-bortezomib (250-1 mol-mol),0.3785474363326266
JHH-2,3854666,3.1841844959157277
KYSE-70,9915743,1.2522553618909642
MDA-MB-361,tanespimycin-bortezomib (250-1 mol-mol),-3.253650081939563
RPMI-8402,100016,6.7779334067701145
WSU-DLCL2,135421197,1.3366887647242718
KP-4,3854666,1.6469581431730445
ZR-75-30,6918638,0.8461701725499111
COR-L95,54618771,1.9587299059916856
HSC-4,136227924,4.2199200707906845
K-562,1566236,1.8179642124055264
DMS 53,sirolimus-bortezomib (250-1 mol-mol),0.155507409478016
DMS 53,9926054,1.7188884438075969
Hs 611.T,6918638,0.1647262246694485
LS123,9884685,-0.4320326525483665
SNU-685,6918638,-0.5860605595397334
MOLT-3,2742550,3.4970391665192175
SNU-738,135421197,2.9898433759416396
NCI-H716,selumetinib-GDC-0941 (4-1 mol-mol),0.5800821260708712
ChaGo-K-1,selumetinib-GDC-0941 (4-1 mol-mol),3.55355178033839
OUMS-23,selumetinib-GDC-0941 (4-1 mol-mol),1.2093335289094016
JK-1,9935249,2.3641418741396527
HEC-108,136227924,3.134071919213167
PK-59,9935249,3.732455742727782
DB,2742550,2.8913384743373536
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
A3/Kawakami,9884685,0.5438529954210741
HOS,4705,3.554341392933483
PSN1,9926054,1.7845816919346065
YH-13,11152667,0.725065654418547
NCI-H520,1566236,1.8490403312922712
A-172,3854666,2.6125463077827664
EFO-27,selumetinib-GDC-0941 (4-1 mol-mol),2.701249599183188
T24,71751553,4.424735740051958
HT-1080,3465537,3.2149756579803404
JM-1,44487872,4.651129481786086
D283 Med,sirolimus-bortezomib (250-1 mol-mol),0.1311503224086672
SNU-478,100016,6.124719500368946
HSC-3,3854666,1.1819322162410355
SU-DHL-10,9926054,1.7621581525939023
PK-59,135984461,4.560793597848683
EBC-1,135984461,4.240736230766537
COLO 201,11152667,0.3098381642234148
SNU-601,11494412,1.3592671808376295
NCI-H2081,54618771,1.045855982244366
CAL-27,sirolimus-bortezomib (250-1 mol-mol),0.4239769214934303
SK-N-SH,135984461,4.272548278190685
Daoy,100016,6.878604021612681
OCI-AML-2,11152667,-3.2738296049895266
OVTOKO,9911463,4.1019339858754025
COLO 699,65628,4.39005504290011
Hs 940.T,2742550,3.5735358604768837
NCI-H23,49836020,3.049554437236292
786-O,11494412,1.5315586966264776
MPP 89,11494412,1.787151667463632
Peer,135398744,6.7016638444522325
CAL-62,9915743,0.6528059847635581
LoVo,4705,1.5085236639058903
T84,2742550,3.5016652738458456
FTC-238,tanespimycin-bortezomib (250-1 mol-mol),0.0088820138944574
Caov-3,11152667,-4.560027237060856
PE/CA-PJ15,9935249,2.936045396377626
MHH-NB-11,9915743,1.606610900960874
HCC38,9911463,3.9831039186193022
JHOM-1,2746,3.154925992332872
LN-229,136227924,2.284287102346984
NCI-H1341,49836020,4.324192381476246
HDLM-2,selumetinib-GDC-0941 (4-1 mol-mol),3.928521461465485
A-549,100016,7.181380121169662
RCH-ACV,135984461,1.5871533406295049
SK-MEL-24,135659046,3.636205861193986
HCC1588,9868037,2.925382992818106
DMS 454,1566236,1.2742388106012354
PK-1,9911463,3.7695460947373784
TC-71,selumetinib-GDC-0941 (4-1 mol-mol),2.572877726139947
WM983B,selumetinib-GDC-0941 (4-1 mol-mol),-4.627362213665692
NCI-H2110,2746,2.5947990205927405
COLO 678,2746,3.5639277993349254
SUP-HD1,71751553,4.0712574517111
EoL-1,9935249,-2.654152668854086
KMRC-3,2746,3.925965159660651
BT 232,9926054,2.340014679513304
NCI-H1105,135421197,0.5397494538103206
PL-21,11152667,-4.55142163084927
Hs 294T,9915743,2.0387924348275734
JJN-3,11152667,-1.6047644991927048
HL-60,selumetinib-GDC-0941 (4-1 mol-mol),-2.2086507819126213
OCI-AML-3,4705,3.3295764443297475
CAL-54,71751553,3.8387639169926326
SNU-466,9926054,2.420216987024882
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
BICR 31,6918638,1.4401869695378149
EB1,100016,6.112181525197604
MPP 89,9935249,3.288216820516572
SNU-478,9915743,-2.1915037699834863
IPC-298,sirolimus-bortezomib (250-1 mol-mol),0.7212424962654913
SK-MEL-5,1566236,2.4643263629353576
PK-1,71751553,5.428390787076589
BT 330,65628,3.9363187212664488
DAN-G,2742550,4.03196202986672
Daudi,135421197,0.2989842149032058
BDCM,9911463,2.647772913572023
RL,71751553,4.25993021394767
IGROV-1,9926054,1.8111808945519428
SNU-1,24779724,6.404579548662128
AML-193,100016,3.9854178308912074
DMS 273,9926054,1.8030373867492464
JHH-5,9915743,-1.119406504769704
NCI-H1105,9884685,1.2486660328700614
CML-T1,9915743,1.9836361869709076
SNU-398,2746,3.3199250937792866
Karpas-422,54618771,1.0964695949683176
MFE-319,54618771,1.5027851162197383
JJN-3,1566236,1.40984776427009
SNU-C2A,3854666,1.1286378609784615
GI-1,136227924,2.879759291125734
NCI-H2122,135398744,6.485849720689022
UACC-257,tanespimycin-bortezomib (250-1 mol-mol),0.2764764402822645
Aska-SS,3854666,3.7773042948558726
BICR 16,11494412,1.740743547951069
Peer,49836020,4.240424721025454
ECC10,9884685,-0.6725691061854394
IST-Mes1,49836020,4.276541253138442
SNU-1214,100016,6.334633199659308
MFE-296,tanespimycin-bortezomib (250-1 mol-mol),-0.069191081241384
HuT 78,10322450,2.3335862951913726
KLE,9911463,3.5004519168580828
NCI-H2452,4705,3.641149380662554
2004,65628,4.602327136017835
Caov-3,135421197,1.5167281474841918
ALL-SIL,2742550,3.1857763586562577
EC-GI-10,1566236,3.222129437181103
PE/CA-PJ15,2742550,4.3930090361473155
VMRC-LCD,2746,2.492181384222375
IA-LM,49836020,4.225846480888235
RL,49836020,3.855414326561088
EB1,54639665,4.325181348836959
WSU-DLCL2,9911463,3.171565801022685
SW948,11152667,-0.307089718187717
RPMI-6666,sirolimus-bortezomib (250-1 mol-mol),-5.127028405484722
KMBC-2,2742550,4.819576117265504
GSS,3854666,0.8019328802169965
BT 172,10322450,4.417951286359916
NCI-H841,9868037,4.373708012827469
PE/CA-PJ49,tanespimycin-bortezomib (250-1 mol-mol),-1.0553859212416536
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
HCC1500,9884685,1.9086372211674376
SNU-407,54618771,0.7273608158174886
HCC1588,3854666,1.0629541303090142
SK-MEL-30,1566236,3.2801192467549836
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837
RVH-421,11494412,2.857089619011577
SNU-61,11152667,-1.0116802565381595
CGTH-W-1,65628,5.036961777585174
COV434,9868037,3.5790100972586867
SYO-1,49836020,4.445841076102608
Capan-1,6918638,0.6786915212188055
NCI-H2052,9935249,4.043899917200753
MOLT-16,136227924,1.8334417676190544
IMR-32,65628,1.73184881776237
HSC-4,9884685,0.6492053944574516
SU-DHL-1,3465537,3.713885766889003
SaOS-2,9884685,-0.6485333929619777
COLO 684,136227924,2.900562305918871
HCC1588,136227924,2.6333776491111585
KYSE-150,6918638,1.3155627931216132
BT-12,sirolimus-bortezomib (250-1 mol-mol),1.3345146082799952
NCI-H1299,selumetinib-GDC-0941 (4-1 mol-mol),0.1290372531898008
SNU-410,9926054,3.256884508245376
DU4475,3854666,-0.0986482056543338
OVTOKO,54618771,1.1892418619446876
MIA PaCa-2,tanespimycin-bortezomib (250-1 mol-mol),-3.0154822613403898
YH-13,3854666,0.9588236597385832
NCI-H2030,9911463,4.399921690700774
Karpas-422,135984461,4.3057747311374746
LS1034,9884685,0.8754277449757942
VM-CUB-1,54618771,0.9006396829235269
ST486,2746,0.9238009694882156
SNU-213,135984461,4.435605101205859
SW579,tanespimycin-bortezomib (250-1 mol-mol),-2.6338348381850283
COLO 678,sirolimus-bortezomib (250-1 mol-mol),2.474512114208449
SNU-449,2746,3.928036011173348
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
DMS 454,3854666,-1.2678102747277342
SNU-620,135984461,2.973595726933627
NCI-H1581,3854666,1.054316312368188
JHH-2,4705,4.1476073277063445
RL95-2,9935249,2.412741265710608
KYSE-150,4705,4.321978699991397
SNU-1076,selumetinib-GDC-0941 (4-1 mol-mol),-0.5128697942190128
A2058,11152667,-0.8357318584187301
HuP-T4,49836020,4.250504685299003
OCI-M1,54618771,0.2801133336374899
RERF-LC-MS,135421197,1.554065103888189
NCI-H2342,135421197,1.9083443664668167
Caki-1,sirolimus-bortezomib (250-1 mol-mol),1.904717275884016
TE-1,sirolimus-bortezomib (250-1 mol-mol),1.4536947416119834
SK-ES-1,2742550,3.875609520275834
RVH-421,54618771,0.9846410856532696
G-292 clone A141B1,9868037,4.069169616789992
HSC-3,135984461,4.3923039521515985
KNS-62,135659046,4.2739779007754
WM266-4,1566236,1.7711273273174748
OVCAR-8,9935249,3.7854627498334343
NH-6,1566236,2.178701901681321
EBC-1,24779724,-4.464226757719938
BT 239,65628,2.367518289741246
A101D,2746,3.2076862054046877
KYSE-520,54618771,1.6405254882986982
5637,9926054,2.1895240062195396
KHM-1B,135984461,4.335909278526869
SNU-878,3854666,1.275422306167658
EM-2,100016,3.5566389909433913
KYO-1,100016,4.086276175586104
IGROV-1,135984461,4.285945029851472
T84,11152667,-1.571698746124204
SNU-C5,2746,3.0959467324138346
NCI-H2196,11494412,3.593697279450839
HOP-92,49836020,5.403656238129832
U-CH1,54618771,1.7714870299819865
SNU-869,71751553,5.7810883558309465
NCI-H522,100016,6.692385014202011
DU145,71751553,4.612532696139562
YH-13,135421197,2.4430977346174165
Capan-1,3465537,2.9960206717772104
KMS-28BM,11152667,-2.3327327995014224
KMRC-2,136227924,3.1141635996197183
OCI-M1,9926054,1.747333325747777
VMRC-RCW,9926054,3.031512586509183
U-BLC1,4705,-2.296462105953433
SNU-601,135659046,3.8023044437748417
Mono-Mac-1,2742550,3.3470269848726004
OVK18,9911463,3.86173311118799
Panc 08.13,1566236,1.9309412684643408
NCI-H2172,135421197,1.3346129669572484
COLO 684,9926054,1.5779304975312065
NCI-H2170,4705,1.2718117604923076
CJM [Human melanoma],71751553,4.441871884843961
CAL-54,9911463,4.0925396787823685
KP-4,selumetinib-GDC-0941 (4-1 mol-mol),0.6661339772202117
HCC2279,sirolimus-bortezomib (250-1 mol-mol),1.5842839132976092
HuH-6,54618771,-1.3988584380495144
SW948,9915743,1.1952390119197474
MFE-296,135659046,3.966575901006911
22Rv1,selumetinib-GDC-0941 (4-1 mol-mol),-0.8202887961023889
CAL-148,selumetinib-GDC-0941 (4-1 mol-mol),1.314198336751646
NCI-H647,100016,4.3873613110575045
Caki-1,9911463,4.3928078257810785
769-P,9935249,3.642920837160134
OCI-AML-2,9935249,1.831954757010996
Hep-G2,9915743,2.3547256655946542
HL-60,44487872,5.591140774264588
SNU-449,9884685,0.40134732620175
YD-8,11152667,-1.506864416830652
MFE-319,11152667,-0.9823368330260248
IGR-1,selumetinib-GDC-0941 (4-1 mol-mol),0.2767905376035742
MM1.S,73707386,0.9217883452214084
EoL-1,49836020,1.4161576765733714
CAL-12T,54618771,2.0833735357091077
KP-3,54618771,0.4281141975114925
NCI-H929,9884685,-3.111418876103824
EFO-21,54618771,1.150184773372703
MKN74,9935249,3.3607171533797127
MHH-CALL-4,73707386,0.2000268022047914
HPAC,100016,6.325474069382135
SK-LMS-1,54618771,1.3800871170557885
SUP-B15,2746,1.2299523793541935
SW1573,9926054,3.1618263718643513
F-36P,9884685,0.0275163434096536
NCI-H1581,tanespimycin-bortezomib (250-1 mol-mol),0.5752068727797862
MHH-CALL-3,2746,2.3163095915542224
HLF,54639665,4.499757528178239
MDA-MB-157,49836020,-4.4611089332084335
SUP-M2,2742550,3.7062792287011175
NCI-H647,3854666,2.4207197319409595
RL95-2,73707386,3.467916185047665
BT 231,4705,1.5996652236036175
LAMA-84,9926054,1.7519699359088703
DMS 273,11152667,-1.0918930552191226
RT-112,54618771,0.4568083672151968
MHH-CALL-3,sirolimus-bortezomib (250-1 mol-mol),2.0420007480682925
NCI-H358,9935249,4.705375933570609
NCI-H1184,73707386,2.391798435242647
NU-DUL-1,2746,1.0800469209102068
G-402,100016,6.451749665500501
SUP-T11,tanespimycin-bortezomib (250-1 mol-mol),1.9096696973942504
BT 340,10322450,6.150676634502763
SK-MM-2,9868037,2.838791027261754
AsPC-1,sirolimus-bortezomib (250-1 mol-mol),0.6140845395504789
BT 131,3465537,1.252065876496985
KATO III,11494412,3.9284377774184063
MES-SA,selumetinib-GDC-0941 (4-1 mol-mol),2.335158862320408
8-MG-BA,1566236,2.0324035604559554
OCI-Ly19,9915743,-0.208935572268568
KYSE-150,135421197,2.7515172040532687
HSC-3,9911463,3.6821530137729983
LS180,44487872,4.564049669792266
T3M-10,135984461,4.376961457869337
EFO-27,71751553,4.378478985868248
PE/CA-PJ49,10322450,5.083749464761158
NCI-H1703,3854666,0.3793069520255608
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
GSS,65628,5.281644335437836
TE-1,9911463,4.060857496316997
HSC-4,1566236,1.9723291328750472
ONS-76,sirolimus-bortezomib (250-1 mol-mol),0.9944674218020764
NCI-H2444,136227924,3.2293818919988153
HCC1195,136227924,3.859466477996048
ME-1 [Human leukemia],2746,2.1142830069466467
J82,9926054,1.9182596726219543
SNU-46,9911463,4.271059077765821
NCI-H69,3854666,0.6814839685498992
DMS 454,2742550,3.819348213912809
Kasumi-1,135421197,1.491198054618576
A-204,2742550,3.2354852525519577
OUMS-23,9911463,3.126412201053572
PaTu 8988s,1566236,3.825164305906747
Rh30,9926054,2.2159405572329143
JM-1,136227924,1.2038413750130548
HCC1588,73707386,4.063531908987796
GMS-10,49836020,0.0918808601925
MOLP-2,4705,2.8444901068578687
Daoy,135421197,1.0307479494466607
BT 328,1566236,2.4214904059930156
SNU-668,11152667,-1.5637713827568929
HuT 78,9926054,1.4431118641564118
NCI-H2030,136227924,3.923759704530775
IGROV-1,135984461,4.285945029851472
A-204,135984461,5.548637311180796
SUP-B15,49836020,5.289684304949365
SK-LU-1,9911463,4.212038568288349
MSTO-211H,9935249,0.534197831206919
RCH-ACV,9884685,-0.7829826614387396
NCI-H1915,135659046,3.854368010615629
U-87MG ATCC,11152667,2.583459941503649
OCI-Ly10,6918638,-0.7396222686177214
HCC44,24779724,5.2401806586282085
IGR-39,9915743,0.9113402553932568
NCI-H2030,sirolimus-bortezomib (250-1 mol-mol),1.8055328698484328
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
TF-1,sirolimus-bortezomib (250-1 mol-mol),0.3198417316245446
MOLP-8,24779724,4.381900106399647
SNU-216,6918638,0.1724072866575592
TCC-Pan2,9926054,2.315773971229038
JM-1,100016,5.094244415703564
SW982,3854666,1.1307369870989918
Granta-519,2742550,3.255820788990773
NCI-H1869,135984461,4.367577543921494
K029AX,9911463,4.292366302219474
697,11494412,-1.3326007243857068
BT-549,11152667,-0.4620191787747055
SU-DHL-8,11152667,-4.648221806130362
NCI-H2291,11152667,2.770715957693989
HCC1833,9868037,3.329588957496932
BT 216,9884685,3.718234384299296
HSC-2,4705,1.5590916600613702
NCI-H2172,selumetinib-GDC-0941 (4-1 mol-mol),3.58741960121688
CAL-51,4705,2.903463840875761
Hs 746.T,135659046,3.4161599287064925
OVK18,selumetinib-GDC-0941 (4-1 mol-mol),1.2512103740452307
KYSE-140,9868037,2.3848747025475343
COR-L105,9915743,-1.8659407955600968
NCI-H520,9926054,1.793691213544428
HPB-ALL,54618771,-0.7909644269662123
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
KMRC-1,6918638,1.621172594092556
VMRC-RCZ,3854666,3.325804998432433
NCI-H2110,11494412,1.0397098548542971
EFO-27,11152667,1.7712187839859168
SK-MM-2,9926054,1.3112248924199803
HCC202,11152667,-0.7446049793504876
RCH-ACV,9926054,1.6841422831368045
TE-5,135421197,1.4018767750008558
JJN-3,9868037,2.860227740471185
BICR 18,1566236,3.8333699769110026
BHY,9915743,-2.760312091830137
WM115,9915743,2.6223908273409515
NCI-H508,9935249,3.1772334043452237
COLO 699,135421197,0.9619259452362175
VMRC-LCD,71751553,5.332417713766258
MHH-CALL-4,9884685,-0.3839194515587534
Hs 611.T,selumetinib-GDC-0941 (4-1 mol-mol),0.4092086039942825
Mino,9926054,1.8004792382140618
PLC/PRF/5,sirolimus-bortezomib (250-1 mol-mol),0.3197220965800605
SNU-16,9911463,2.3292898367461823
LK-2,9926054,1.788707651887683
Kelly,selumetinib-GDC-0941 (4-1 mol-mol),2.978588327990176
HT-1197,6918638,1.042258659945556
HT,135984461,4.608558257937864
RPMI-6666,11494412,0.7865449714736076
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
BT 340,tanespimycin-bortezomib (250-1 mol-mol),0.797080968963508
NCI-H226,9868037,3.726769382585606
MOLP-2,3854666,0.6548902093634233
JHUEM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6430470914092763
PE/CA-PJ49,54618771,0.7503164660158113
JL-1,6918638,1.5598435396772805
EC-GI-10,2746,3.3454005249386243
NCI-H1184,9915743,0.6883439734891695
SUP-B15,9915743,0.9578532779585308
U-BLC1,9868037,3.998089604427344
EJM,2746,1.455612839065016
HT-1197,24779724,4.378865216004622
CML-T1,100016,5.302267949835527
SNU-201,9911463,4.2984017961299035
KYSE-140,136227924,3.3753020930843065
AGS,100016,6.525427767108566
OS-RC-2,9915743,1.7303629724196847
Malme-3M,3465537,2.4992243131735656
KMS-18,136227924,4.439422503928272
Daudi,9911463,2.4252044126403915
MDA-MB-231,selumetinib-GDC-0941 (4-1 mol-mol),2.1561447118873383
PC-14,4705,-3.029150478382576
KMRC-2,54618771,2.1629104463678335
A-673,136227924,1.815433973878695
HCC2279,9911463,3.61509749059407
Kelly,sirolimus-bortezomib (250-1 mol-mol),0.1077150919065075
BT 504,2742550,3.507515217857391
LS513,2742550,3.7446705767698494
HCC-56,100016,6.404810900486153
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
SK-ES-1,4705,2.9772656086028
Becker,2746,3.675450807498904
TE-15,4705,1.329912019407035
SNU-1066,136227924,3.4679855479635644
HuP-T3,9935249,3.692881062494191
HCC1419,9884685,-0.6707632508921959
SF295,54618771,1.9072877365394525
VMRC-RCZ,9915743,2.338225361528291
MKN74,650361,3.7860453637514953
AU565,3854666,0.9438607721687704
VMRC-RCW,sirolimus-bortezomib (250-1 mol-mol),0.7357158276025152
SF126,3854666,2.652504864422733
Becker,selumetinib-GDC-0941 (4-1 mol-mol),1.91048456037032
SIG-M5,9911463,2.49992979660486
BFTC-909,9911463,4.114346930944119
TOV-112D,100016,6.758334848108728
IA-LM,135421197,2.370501142960713
BICR 31,9911463,4.617619725588035
MDA-MB-157,135421197,1.265960780615991
RD,9884685,0.0829186100181427
MV4-11,100016,3.584878230644963
A-673,3854666,0.8608139997201792
TYK-nu,9926054,1.6864170114704335
BT 330,135421197,3.0606427160011433
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
NCI-H1573,9915743,0.8618655163621424
SNU-182,3854666,0.8744500130786221
NOMO-1,9926054,1.6113291347040215
OCI-Ly19,100016,6.584850236816641
U-BLC1,2746,2.5365215352469175
NCI-H2052,selumetinib-GDC-0941 (4-1 mol-mol),-0.0438612547991499
NCI-H1339,54618771,2.498525802737919
BT 245,9884685,1.0158676742482895
AN3-CA,9884685,-1.0076208994656373
HuG1-N,3854666,3.578012994225317
NCI-H2444,sirolimus-bortezomib (250-1 mol-mol),0.8470480091874228
SNU-C1,sirolimus-bortezomib (250-1 mol-mol),0.1319095851992196
IGROV-1,2746,2.8413672686351212
JM-1,54639665,5.005029028557516
CAL-29,tanespimycin-bortezomib (250-1 mol-mol),-0.8282025305629461
NCI-H2081,11152667,0.3314648978290519
TE-14,100016,6.976624848230786
Kelly,135421197,1.3669012525071198
DV-90,135421197,0.8587381868219376
NCI-H810,4705,3.09227910852851
DND-41,6918638,-0.9223144661019224
CAL-33,selumetinib-GDC-0941 (4-1 mol-mol),-0.2245005212599697
639V,tanespimycin-bortezomib (250-1 mol-mol),0.3038823340698895
SIG-M5,6918638,-0.9320116161211188
DMS 53,65628,4.630893368202044
KNS-42,2742550,4.472356160469779
OVISE,selumetinib-GDC-0941 (4-1 mol-mol),0.6038813555942163
RD,136227924,2.2627633289805424
HSC-4,650361,3.951915492066197
NCI-H1944,11494412,1.0398128267017497
HDQ-P1,sirolimus-bortezomib (250-1 mol-mol),1.8478988823662197
TOV-21G,1566236,1.9185710355129983
COV434,11494412,0.9260092674058792
T3M-10,9884685,1.5536647474926049
KG-1-C,9868037,4.232023281385857
GI-1,9884685,-0.1673991964560569
Peer,9868037,0.9246335266521049
TE-15,3854666,-0.2434846174212646
SNU-398,3854666,1.3633746323858775
G-401,136227924,2.3105932180874365
BT 333,6918638,1.7862101251077225
BFTC-905,54618771,-0.6913922246342757
CHP-126,54618771,-1.2207824703172212
LoVo,9935249,1.1872155844887071
GP2d,135421197,2.1727622250503607
HCC15,136227924,3.0147456858017923
CAL-78,2746,3.5103539544732745
HuG1-N,9884685,3.387846210164392
8305C,9926054,1.435515250555218
2004,4705,2.464885912287897
Caov-3,65628,3.782061082694565
HEC-1-A,9926054,1.9825174619243453
PSN1,selumetinib-GDC-0941 (4-1 mol-mol),0.7617880642657375
NCI-H1869,11152667,0.433153558661154
SW579,71751553,4.230632785990304
EoL-1,136227924,1.175653355009707
SNU-626,54618771,3.903853524129119
CA46,10322450,2.6264913036213606
UM-UC-1,135421197,1.1725143747551234
KMRC-20,9915743,2.261900740642606
HSC-2,65628,4.197445162801139
OCI-AML-3,136227924,1.3599145322416812
2004,1566236,1.5535605371575574
COV362,selumetinib-GDC-0941 (4-1 mol-mol),2.9953812620195066
DU145,3854666,2.445661849899651
Jurkat,9911463,3.146935995662798
CCK-81,54618771,1.3252136057849369
Hs 888.Lu,6918638,1.6527379036504295
CAL-62,3465537,1.3103085266470418
L-540,11152667,-1.9469048056861156
ONCO-DG-1,9911463,3.9906358040746417
HOP-92,9911463,3.5299931958283093
B-CPAP,10322450,5.621210843033534
RL,tanespimycin-bortezomib (250-1 mol-mol),0.0166541585574005
BT 286,3465537,0.9211618438378432
Mel Ho,tanespimycin-bortezomib (250-1 mol-mol),0.3102733441080628
QGP-1,9926054,1.84722301836143
SNU-626,9926054,2.31791428562488
JJN-3,135984461,3.369618368566917
TE-10,sirolimus-bortezomib (250-1 mol-mol),0.6005656385189257
JHUEM-1,3854666,0.8383851323648895
ZR-75-1,3854666,3.378187889004693
TE-9,54618771,0.2399637036570816
Ki-JK,9915743,-0.1988023014574486
SUP-M2,2746,1.4359324283751405
NCI-H1944,4705,2.455781593710475
RT-112,sirolimus-bortezomib (250-1 mol-mol),0.4814883462366654
RPMI-7951,3854666,0.7955375468414883
BT 139,9915743,2.3473723766604833
MOLM-6,tanespimycin-bortezomib (250-1 mol-mol),0.1329164696894222
SH-4,sirolimus-bortezomib (250-1 mol-mol),0.5100564849810528
KMRC-20,100016,7.210629640241846
K029AX,2746,3.0884726506960805
BT 286,2746,4.414216796759687
NU-DUL-1,9926054,1.630316493703293
Hs 683,135984461,3.956952055268157
JHH-5,3854666,3.08058465542435
NCI-H520,54618771,1.0653077757718592
TE-14,sirolimus-bortezomib (250-1 mol-mol),0.5600865408130824
Kasumi-2,135398744,8.02054113805855
JHUEM-3,11494412,-0.7196564295735808
HCT 15,71751553,3.9981225717046858
BT 504,135421197,2.466290644112219
NCI-H2081,9935249,2.3780454134873263
WSU-DLCL2,9915743,0.1660660253888135
SNB-75,tanespimycin-bortezomib (250-1 mol-mol),-1.317235314034222
SW1573,3854666,2.927116287337192
NCI-H841,9911463,3.5951842135342145
NUGC-4,3854666,3.7030088458950914
NCI-H69,136227924,3.1937315471147443
KYSE-180,9868037,4.629723429656334
L-428,9868037,2.0739066262106265
RERF-LC-Ad1,54618771,3.6047591405088673
MOLM-13,9911463,2.5287579203643986
SW620,9935249,3.3377661554746956
SNU-1076,tanespimycin-bortezomib (250-1 mol-mol),1.399348377657982
CAL-27,135421197,2.124038194027939
EC-GI-10,6918638,0.7617636190742709
RERF-LC-MS,3854666,0.8294073497518095
NCI-H520,9915743,1.4167224147327635
SW1417,71751553,4.180023380180108
KHM-1B,10322450,2.734741066135324
8505C,9926054,2.4332368789969734
HGC-27,24779724,5.013063083172612
HCC2218,2742550,3.114607696672168
TT,9935249,3.4910310127288073
BT 422,1566236,1.9031196665814163
HEY A8,65628,4.133816964756257
HD-MY-Z,2742550,3.521539986674307
COLO 792,135984461,4.281305530768826
NALM-6,135421197,0.6704764022840549
BT 271,selumetinib-GDC-0941 (4-1 mol-mol),1.6032684287566925
253J,11152667,-1.7218129506088469
MKN74,9935249,3.3607171533797127
NCI-H1703,2746,3.536107682516814
PC-14,9926054,2.1919524814380846
SW579,49836020,3.73786460957764
Caov-3,135398744,6.775001868991772
THP-1,tanespimycin-bortezomib (250-1 mol-mol),-1.1093068334471472
BHY,9935249,4.74012310047911
UACC-257,4705,3.5446001139477197
SNU-C2A,9915743,0.5240422710487646
ONS-76,135421197,2.4329108516652775
MSTO-211H,sirolimus-bortezomib (250-1 mol-mol),-4.356348785591885
EFE-184,11152667,2.2340596962566703
RPMI-8402,3854666,0.737448430208504
SK-HEP-1,6918638,1.490993863020431
SW1353,136227924,3.029116785491403
GDM-1,136227924,3.363011715884638
LUDLU-1,54618771,1.3669770958947776
VMRC-RCW,73707386,3.661601615077718
TE-15,11494412,-1.732621371792193
NCI-H1568,2746,2.7741418395417163
CA46,135659046,2.986085914123542
OE33,selumetinib-GDC-0941 (4-1 mol-mol),1.7622700953788215
A-204,tanespimycin-bortezomib (250-1 mol-mol),-2.803355347845335
BT 504,9926054,1.7523750045888775
BT 228,6918638,2.21176132394779
LCLC-97TM1,73707386,3.587652793939767
Ri-1,100016,4.838113149785687
PSN1,3854666,1.2146416795166468
HCC1833,65628,4.511213018881878
ZR-75-30,9911463,4.362849921974398
NCI-H322,135659046,3.4659012632221695
BT 428,65628,3.929247019179895
TE-5,11152667,-0.0661782736435693
J82,9911463,4.397317703164105
Panc 10.05,1566236,1.7597115131165313
KMBC-2,sirolimus-bortezomib (250-1 mol-mol),0.4292158066242218
TE-9,65628,4.309705001267168
EB1,9935249,-0.4672615921444373
SW579,11152667,-2.578295959963482
NCI-H1299,73707386,3.9485300681626625
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
SR,136227924,2.657612515566446
HuT 78,sirolimus-bortezomib (250-1 mol-mol),-0.0760803060705267
HCC44,10322450,3.2615133519838775
BCP-1,54618771,1.535577379039456
JJN-3,100016,3.8434142095984303
SEM,3854666,0.6904434014299387
OS-RC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8729257102095325
Mono-Mac-6,73707386,1.6241068743605291
NCI-H2196,54618771,3.689475396494767
Panc 04.03,11152667,-0.1106415062306802
BT 286,1566236,1.6712159772486277
KMRC-3,11494412,0.9425287375632188
Jurkat,3854666,0.1907683336293414
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
HCC1428,135984461,5.872132902333047
YD-8,9926054,2.068126295394322
CAL-33,2742550,3.386545431599898
DMS 273,136227924,2.538513279360657
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
EFO-21,9926054,1.8086504581736744
JeKo-1,9926054,1.771855949205148
SNG-M,9911463,4.222801467969213
SNU-620,9911463,2.718235223469864
KYM-1,2742550,4.241157390185703
Hs 852.T,73707386,3.700283239805054
HCC2108,100016,5.291323338255078
HT-144,3465537,2.6376255723865865
NCI-H1944,10322450,4.686726867812177
HuH-1,6918638,1.1599636412838177
SNU-886,sirolimus-bortezomib (250-1 mol-mol),1.314176922115052
KM12,100016,6.486077549174115
SW982,71751553,4.266101673204756
EN,9911463,4.4052301302232415
NCI-H660,6918638,-0.1001418926217168
NCI-H1581,sirolimus-bortezomib (250-1 mol-mol),0.461020209130116
DMS 454,135659046,3.663027273300578
WM266-4,71751553,4.434367335384286
SNU-869,sirolimus-bortezomib (250-1 mol-mol),1.7458276464025495
KG-1-C,9911463,4.124800665042544
NCI-H2196,4705,3.044507714028595
NCI-H441,sirolimus-bortezomib (250-1 mol-mol),3.489880905955473
SNU-1033,3854666,3.138218307419996
OCI-Ly10,49836020,3.5902164250425503
EC-GI-10,54618771,2.241833399474009
G-401,135421197,1.4306754302223277
NCI-H1341,136227924,2.213362476241057
LAMA-84,11152667,-1.6044591200200753
TYK-nu,9935249,3.27204815047351
IPC-298,9911463,3.847943729471794
NCI-H520,11152667,-0.8111617843564765
SNU-407,3854666,1.54781446028366
IGROV-1,4705,3.3098412390054603
PANC-1,4705,3.930019058376023
VMRC-RCW,135421197,2.019130008458573
ONCO-DG-1,9868037,1.829035514218224
SaOS-2,100016,6.565789067704999
Hs 729.T,9926054,1.9199617191316192
RMG-I,9935249,3.733298041701348
NCI-H1694,9868037,2.26987701984991
HEC-59,9868037,3.1649055297895483
22Rv1,tanespimycin-bortezomib (250-1 mol-mol),0.2637398344293039
SNU-620,9926054,1.6234040218368857
SR,135398744,6.424256669199728
Calu-3,9911463,3.153404929849599
GI-1,3854666,0.8777053912165353
NCI-H2085,9911463,4.028733410205104
T84,3854666,0.9881989979716492
NCI-H2291,9911463,4.278294670111937
MKN74,1566236,3.387752601691297
IM95,135984461,1.6793347325377754
BHT-101,136227924,2.4401355841785173
SNU-182,9884685,-1.6897357849624497
MG-63,136227924,3.2795436313273685
UO-31,100016,6.129898752942045
NCI-H28,9911463,4.1891652273823015
MG-63,3854666,1.0280422807059248
BT 248,65628,4.438815715072134
A2058,11494412,0.9278027425359372
HCC1806,sirolimus-bortezomib (250-1 mol-mol),1.669162775720282
LUDLU-1,100016,6.796390484470128
GDM-1,9868037,0.3465772020912164
T24,9911463,4.359537886200324
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
JL-1,11494412,3.122839444279875
CCF-STTG1,tanespimycin-bortezomib (250-1 mol-mol),-1.580978522433375
CFPAC-1,54618771,0.7086931491389132
RERF-LC-A1,54618771,2.031168626063029
WM266-4,11494412,3.195977931192662
LS180,9935249,3.57280690269837
L3.3,9935249,4.2075706542966955
PK-45H,135984461,4.36472213501135
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711
PE/CA-PJ49,4705,3.0123221957178017
Karpas-620,9926054,3.72255119036043
Kasumi-1,3854666,0.6053881674524748
LNCaP clone FGC,135659046,3.5330322853898957
P-STS,54618771,0.5747646300183281
G-401,71751553,4.092007605377758
MFE-296,9884685,1.1807568276780505
23132/87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1204952013387844
OCI-Ly10,54618771,1.2684517844951826
42-MG-BA,11494412,1.955126057661204
EB1,1566236,0.9429423424199086
Capan-1,2742550,4.040805186459864
MDA-MB-361,11152667,2.2451523747224114
SK-CO-1,65628,3.554197618459022
EM-2,9868037,1.5238018435010934
P3HR-1,136227924,2.9304577514896466
UM-UC-1,6918638,0.4127396353013411
BL-41,135659046,2.671916295491686
CAMA-1,9935249,4.786232529876141
SJSA-1,1566236,3.0284015213116415
697,2742550,2.4843478572758357
NCI-H211,24779724,4.306409832686191
SH-10-TC,54618771,0.3960881038412169
CML-T1,2742550,2.9758871773228366
SNU-601,9935249,3.074055139432478
SNU-213,9915743,1.2181447895342674
OE19,3854666,3.0187887298383926
OCI-AML-2,3854666,0.7636875666723406
COLO 699,9911463,3.7196306171977183
MCAS,49836020,4.94613909678053
LS123,2742550,5.908804831704125
HH [Human lymphoma],100016,3.957825935624259
MOTN-1,6918638,-1.3378384389105569
NCI-H661,9935249,3.279757521015836
BT 498,1566236,3.668153571841636
OCUM-1,1566236,1.275292241534932
PaTu 8988s,135421197,1.1460063606701134
NMC-G1,136227924,2.469359539544405
HCC1428,54618771,4.504577297987602
NCI-H2228,9868037,2.633347793828571
NCI-H2452,1566236,3.5735792412039022
BT 333,9926054,3.6254500020575366
JMSU-1,10322450,3.467232689574709
NCI-H1869,11152667,0.433153558661154
SNU-81,11152667,-1.3658791794225291
Hep-G2,9926054,1.3870503906392218
LOU-NH91,2746,5.002248002286792
BT-12,3854666,3.044277454915718
COR-L51,2742550,3.971917509503878
786-O,9915743,1.0501009752042196
Hep-G2,11152667,-0.2869645192447481
TTC-709,136227924,1.406309539576174
NALM-6,9926054,1.499716705925791
LNCaP clone FGC,10322450,2.7673995360058954
SUP-T1,54639665,5.160624619206478
SNU-601,65628,4.852093885842574
BT 498,54618771,3.343910197755889
THP-1,135421197,0.9721009186640236
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
SF268,6918638,0.7896548541911668
SNU-761,2746,2.9250609675985917
647V,tanespimycin-bortezomib (250-1 mol-mol),0.053073240777135
PLC/PRF/5,9911463,3.7898292588985862
HOS,100016,6.425173790511516
Tm87-16,sirolimus-bortezomib (250-1 mol-mol),0.5846669503763354
KMS-20,135398744,7.132407790781497
Kasumi-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1995459699844852
Capan-1,135659046,4.622208259682843
SW1417,9911463,3.860832052888163
GCT,3854666,0.8803972511425264
RCH-ACV,3854666,1.1311620148963422
HCT 116,54618771,0.4629468645075349
NCI-H446,650361,5.808661894862166
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398
Lu-99,3854666,0.8555462935732805
COLO 201,9926054,1.9430022433891496
SK-HEP-1,9926054,1.934364320328667
HCC1171,9935249,4.44081832650938
COR-L95,6918638,0.5429028056483723
Hs 688(A).T,54618771,0.2687022491152004
HEL,100016,4.260371486080393
SNU-719,sirolimus-bortezomib (250-1 mol-mol),2.0194347248370432
KP-4,9926054,2.5953636784587877
RVH-421,10322450,7.0717457529323875
SU-DHL-1,9935249,2.376788737359572
BT 286,tanespimycin-bortezomib (250-1 mol-mol),-2.64428689398821
CAL-33,9884685,-0.0221160143719173
UM-UC-1,9926054,1.7733389617998403
T-47D,65628,5.946495806512569
Hs 746.T,9915743,2.055973723979153
NCI-H1975,9915743,-3.928107410623461
DU145,1566236,3.495730163617442
SK-N-AS,10322450,4.76025598295129
BT 359,10322450,5.961347508750194
NCI-H1355,135659046,3.71812862658832
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
NCI-H1092,3854666,1.7831562708521254
MeWo,9926054,1.733945316459816
HCC202,1566236,1.9965281595401527
RPMI-8402,136227924,2.2526718879349694
Pfeiffer,54618771,-1.2193011849050512
SNU-899,tanespimycin-bortezomib (250-1 mol-mol),0.5360677802944718
HEC-265,11152667,1.5972160577959365
NCI-H1694,24779724,5.057231476341762
KNS-60,2746,2.742254085521436
EJM,11152667,-2.5425383772209393
NCI-H2228,9911463,3.8620959723614474
OV56,4705,5.529436174824006
HCC1428,9915743,2.613420698751445
NCI-H838,136227924,3.210993191129446
HOS,2742550,4.342501392061334
HCC-56,2746,2.5868502665085615
Caov-3,1566236,2.912009247754364
G-401,135984461,4.271777659576195
OE33,6918638,-0.1523417231642655
Hs 683,tanespimycin-bortezomib (250-1 mol-mol),-2.2425112205370388
SNU-886,tanespimycin-bortezomib (250-1 mol-mol),0.3789441066781652
TE 617.T,sirolimus-bortezomib (250-1 mol-mol),0.0331781036900695
A-549,9911463,3.875766071211208
JHUEM-2,135421197,0.9907591998948792
DU4475,9935249,-0.972287605705258
BT 179,11494412,1.90608905728386
DU145,9884685,1.2239638281476493
RMG-I,4705,2.197778207097114
TUHR10TKB,4705,2.6546560293729677
SF268,selumetinib-GDC-0941 (4-1 mol-mol),2.7601032387039433
OV7,135984461,1.9074868372682827
CCK-81,4705,0.3214356139711527
DU145,11494412,1.9147313694004515
LS1034,6918638,1.0848877258969036
HuH-28,65628,4.297810748025056
KYSE-150,3854666,3.0365911002629553
JHH-5,2746,3.1730265714990047
KYSE-410,2742550,3.0781954877880797
Raji,9915743,1.7375595717981451
NCI-H69,135421197,1.0126694729048382
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
SaOS-2,11152667,-0.1732170298835725
COLO 684,tanespimycin-bortezomib (250-1 mol-mol),-1.1171395210873645
CAL-78,9935249,4.073656052732806
8-MG-BA,2746,3.598296066021755
HCC1588,135421197,1.0846790192354827
KYSE-520,135398744,6.453499706252085
OCUM-1,9926054,1.1512095062885492
SNU-869,100016,6.487538118719535
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
HCT 8,54618771,0.896470905316868
NCI-H1666,136227924,2.19834773760599
AsPC-1,2746,3.619198032462304
MKN1,9926054,3.700935468951971
Mel Ho,9911463,3.195934345244136
HOS,6918638,1.052559651861536
L-428,10322450,3.383753825926629
SBC-5,54618771,0.9612938071948806
CCF-STTG1,4705,3.7462462996550534
MOLP-8,11152667,-1.9226575172330305
HL-60,9915743,0.8108920758640651
MOLM-6,9884685,0.1809773777392092
ESS-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1616208595010966
WM1799,54639665,4.532721587133595
HuH-6,1566236,2.9155001663313542
RD,100016,6.5954800872388155
COLO 800,136227924,2.9949932078985437
EBC-1,tanespimycin-bortezomib (250-1 mol-mol),-3.429772106953884
NCI-H1869,sirolimus-bortezomib (250-1 mol-mol),0.1597527928454194
NCI-H1693,9935249,1.052551842926199
SNB-75,selumetinib-GDC-0941 (4-1 mol-mol),0.9916175958844948
NCI-H1869,136227924,3.4575085361719955
D283 Med,selumetinib-GDC-0941 (4-1 mol-mol),1.1541990578163812
NU-DUL-1,9915743,-0.5036069794958961
U-937,9911463,3.0033248654394944
MFE-319,2742550,4.226299136306918
NCI-H1563,selumetinib-GDC-0941 (4-1 mol-mol),0.8971079477843085
NCI-H1573,10322450,3.3091904926766835
TYK-nu,135984461,4.470061724636727
BT 112,9915743,1.837502115717176
LS513,3854666,1.2742578609019837
PaTu 8988t,54618771,0.599962301527202
U266B1,9868037,3.3366436031438034
MOLT-3,1566236,0.8792744178265615
TC-71,65628,3.786909553172794
CAL-85-1,135659046,3.2911060115493487
THP-1,9926054,1.7604592205221938
SUP-M2,4705,3.1560884673066765
HT-1080,9926054,1.8253134121716592
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
MDA-MB-453,11152667,-1.4808178636693017
CAL-12T,49836020,4.6523718910669745
A-375,9926054,2.393426871996004
KM12,9915743,2.3506580045121948
A-375,11152667,-0.6556318193430793
BT 482,sirolimus-bortezomib (250-1 mol-mol),0.6907201532102293
OVCAR-5,6918638,0.1206125609110546
EHEB,3854666,0.7564347377790305
UACC-62,9926054,3.2338645061682914
HuT 78,11494412,0.3707002136667609
WM266-4,2746,2.9939940640061495
HEL 92.1.7,tanespimycin-bortezomib (250-1 mol-mol),0.3488899515335228
NCI-H526,136227924,1.9152739000663332
KMS-27,9868037,2.1445614612253614
SNU-1079,136227924,2.5648904820695693
DMS 273,1566236,1.8001113918747356
Kasumi-2,2746,1.0036072682129122
FaDu,136227924,3.658135500280057
Panc 04.03,3854666,3.6180263181428622
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286
MPP 89,3854666,2.9002727572082705
NCI-H1105,3465537,1.3223684650477756
RPMI-8226,2746,1.5846721201375709
A-253,135659046,3.360976512621253
HuCC-T1,9935249,3.5788863262421216
BT 224,136227924,4.003699925469014
NCI-H226,sirolimus-bortezomib (250-1 mol-mol),1.5737469522318486
LP-1,6918638,-1.2002393899697523
SYO-1,9926054,1.4051151618362918
AGS,3854666,3.591609764349203
NCI-H2029,10322450,2.79312710605276
BICR 22,11494412,0.8036857209518554
Reh,136227924,1.9009503552795357
MV4-11,selumetinib-GDC-0941 (4-1 mol-mol),-2.1623049126826372
GMS-10,9935249,3.247903389257114
SK-MEL-24,9915743,1.6776285599749
G-292 clone A141B1,selumetinib-GDC-0941 (4-1 mol-mol),0.4997156895846377
F-36P,135398744,6.4039586130062505
JHOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.3752490539264866
TE-9,9935249,3.618595502089871
RD,135421197,3.4107276707770864
L3.3,1566236,3.261153981033622
RCH-ACV,135421197,1.024054023197644
SK-MM-2,2746,0.987120657113426
Hs 940.T,135659046,5.2418708204303615
NCI-H520,71751553,4.213251672590111
NCI-H1975,9911463,3.169797897462341
KNS-60,9926054,1.3283551370415152
SiMa,selumetinib-GDC-0941 (4-1 mol-mol),0.1893088365447134
DEL,73707386,2.3391393619741416
MG-63,2746,4.323476175039674
DOV13,tanespimycin-bortezomib (250-1 mol-mol),0.5750258227871521
BT 147,4705,1.580019140366276
COLO 792,9884685,-0.452379287079953
BT-12,135398744,6.373256605371206
HCC2935,54618771,0.7337310107674532
BL-70,136227924,2.857298369944604
LS1034,tanespimycin-bortezomib (250-1 mol-mol),0.2308030361348307
CL-11,135421197,1.4144894380219903
SK-ES-1,3854666,0.6093716991358727
JL-1,9926054,1.8045722808491491
DMS 454,tanespimycin-bortezomib (250-1 mol-mol),2.8093099362578746
SNU-407,9915743,0.256973573653406
G-402,135421197,2.1545147661375275
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
SaOS-2,65628,4.208345318362158
NCI-H146,9935249,1.0600603569941576
DOV13,54618771,0.905613637796649
KE-97,9915743,-0.9585907230635954
UACC-62,11494412,3.786718982439659
RERF-LC-MS,135984461,4.284403636339015
SNU-466,135421197,3.5326251478471877
SNU-387,9926054,2.4528482629879655
MM1.S,65628,3.725915125304722
647V,9884685,0.1816455497455283
RL95-2,selumetinib-GDC-0941 (4-1 mol-mol),-1.0392511344110156
HEC-251,136227924,4.831338089277502
OCI-AML-3,71751553,4.438951947729107
RD,9926054,1.756104923287422
NCI-H2286,54618771,-1.3554512222972157
BT 131,sirolimus-bortezomib (250-1 mol-mol),-0.1353843120079282
HuH-6,10322450,3.486001071319901
AGS,135421197,2.7162637897993123
BT 112,sirolimus-bortezomib (250-1 mol-mol),0.0905666857071608
LK-2,2746,3.266884411488981
BT 271,9915743,1.1851402962233049
UACC-257,11152667,1.927303386211879
BICR 6,9935249,3.132544852482652
SNU-719,135984461,4.329152044939095
HOP-62,selumetinib-GDC-0941 (4-1 mol-mol),0.8398551306230168
NCI-H446,11152667,-1.5976182081930357
EM-2,9915743,0.5726352403116545
Hs 940.T,54618771,0.7106983337265675
Yamato-SS,9911463,4.3796041086014
BICR 16,selumetinib-GDC-0941 (4-1 mol-mol),2.023123629912069
NU-DUL-1,100016,4.060799847781438
Capan-2,11152667,-0.1737244436389105
SW1710,sirolimus-bortezomib (250-1 mol-mol),0.811654459506224
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
KE-97,135421197,1.12759931417641
RPMI-7951,135421197,2.3107830834906324
QGP-1,sirolimus-bortezomib (250-1 mol-mol),1.0320237802548329
PC-3,54618771,1.1708182294918184
KM12,54618771,2.3555448487565247
TOV-21G,sirolimus-bortezomib (250-1 mol-mol),-0.0646182362217989
H-STS,1566236,1.8552051664221092
A-253,tanespimycin-bortezomib (250-1 mol-mol),-0.0985571483289859
HCC4006,9935249,3.1496211616534273
SUP-T1,9884685,-0.9230730282342138
NCI-H2087,2742550,3.773914514591571
SNU-C2A,sirolimus-bortezomib (250-1 mol-mol),0.2009996133577312
FU-OV-1,9911463,4.1305925074662575
MM1.S,11152667,-1.9350060885580451
IST-Mes1,3854666,2.0681561223579075
TF-1,tanespimycin-bortezomib (250-1 mol-mol),0.3682708588950815
PL-21,3854666,0.4528352950899395
MFE-319,135984461,4.655775210040696
HCC202,9915743,-1.8631873030547408
NCI-H69,65628,4.288655327852399
SK-MES-1,3465537,2.1833251870865595
HH [Human lymphoma],10322450,2.565345423842302
LAMA-84,9911463,3.2110209522938247
OVCAR-5,11152667,-0.1360191619178498
HCC1833,49836020,-1.119955366422227
ECC10,136227924,2.5549710603978366
Li-7,136227924,3.3307357238068818
KMS-27,9915743,0.5712823893171636
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826
REC-1,24779724,3.0011490046538407
SCC-25,136227924,2.958495944269512
U-CH1,tanespimycin-bortezomib (250-1 mol-mol),-2.1423466451005524
DK-MG,sirolimus-bortezomib (250-1 mol-mol),0.0484701224362502
BT 232,9868037,4.279293873867471
SNU-466,sirolimus-bortezomib (250-1 mol-mol),-0.4040247740859908
BT-16,tanespimycin-bortezomib (250-1 mol-mol),-2.3872852877546062
COLO 829,6918638,1.0233016863586175
NCI-H508,54618771,1.4622256000794474
HT-1197,135659046,3.3219776451446923
CAL-29,9911463,3.8262240253801623
SNU-601,54618771,0.1352260287728254
NCI-H146,11152667,-0.8780602169524299
NCI-H1105,9935249,0.0872849260187398
WM266-4,9911463,4.039840859111318
NCI-H2085,9915743,0.6026125220601625
HEC-6,3854666,2.6571461904309723
U-251MG,9884685,5.8675878787053035
MHH-ES-1,54618771,0.4734030568205798
OAW28,9935249,3.684332158484572
NCI-H2030,54618771,3.292263250244386
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
FaDu,135421197,1.369051763273762
SNU-407,sirolimus-bortezomib (250-1 mol-mol),0.8562288670922468
OAW28,6918638,0.0048657249331401
TE-9,selumetinib-GDC-0941 (4-1 mol-mol),2.552175387754049
HCC15,2742550,3.2685764522673972
SNU-46,54618771,3.9719869663653578
JK-1,9926054,1.218283183105194
RL95-2,9915743,-0.1806547920270402
HEC-108,9926054,2.177226179063823
TE-14,10322450,4.592810153102171
Mino,135398744,6.764750512167438
KMH-2,selumetinib-GDC-0941 (4-1 mol-mol),1.8839311590073071
COLO 684,100016,6.373471933627605
MG-63,54618771,1.3665941956425405
SNU-1079,9915743,-4.016291754559019
UO-31,1566236,1.6794024876094742
OCI-AML-3,9911463,2.5081471019206014
SNU-C5,sirolimus-bortezomib (250-1 mol-mol),1.5938355123050036
AU565,11494412,-0.7938994603064
SNU-61,10322450,3.828611192492266
ACHN,65628,4.557904719615972
SNU-1272,11152667,1.552242826912863
SK-MES-1,9884685,-0.7643025392616056
KMRC-3,71751553,3.7430804034732783
HCC1438,100016,5.852637802531623
Peer,73707386,2.3378342217205015
NCI-H2171,2746,1.1013983502046127
OCI-M1,11494412,-0.1293133865918841
KMS-28BM,136227924,3.12099798130619
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585
AML-193,9926054,0.8292500331421907
SNU-899,9935249,3.658894921708273
8505C,9911463,3.9204213231071527
HuT 78,6918638,-1.8650927856269544
Tm87-16,11152667,-0.8154575220171274
TE-11,sirolimus-bortezomib (250-1 mol-mol),1.0808686364833595
HD-MY-Z,9915743,1.384717362630253
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404
KATO III,11152667,-1.077676049163545
KYSE-510,9884685,1.452172872973614
HEC-151,2746,2.893075641123897
HCC366,9915743,1.377762778734198
NCI-H522,3854666,0.0482767863302698
ES-2,sirolimus-bortezomib (250-1 mol-mol),1.1433658443254404
SNU-1,9915743,0.7760871972168086
B-CPAP,135984461,1.7006873444468935
KALS-1,73707386,3.625166654480883
NCI-H1944,9935249,2.9934786320739772
Hs 688(A).T,71751553,4.068289679020872
NCI-H460,136227924,3.925006850615035
697,6918638,-1.9247711806790853
253J,9926054,1.3748639406347178
SW1271,136227924,3.2074421772411372
HCC1438,11494412,0.0406589697755076
LN-18,54618771,-0.903169975136804
8-MG-BA,9935249,5.559500366284677
NCI-H2087,4705,3.3747422843456185
JHH-4,135421197,2.467716742231404
CGTH-W-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1580124006071881
RVH-421,9911463,4.042729397827981
YD-38,3854666,0.4955683731799087
RMG-I,9911463,3.4639746242491545
HEC-1-A,136227924,3.4085098693584603
KYO-1,9915743,0.2540895185471781
OE21,9884685,-0.6560236160170761
KMBC-2,9935249,2.7698221479828726
SCC-25,3854666,1.9347031057126212
COLO 678,6918638,0.5482139794843425
HEL 92.1.7,135984461,3.406492111199009
EB1,9915743,-0.0076946910500104
NCI-H2106,9935249,3.2299572797389096
SNU-119,2742550,2.8976089932934883
CCF-STTG1,11152667,0.6516582666822289
SNU-620,selumetinib-GDC-0941 (4-1 mol-mol),-2.4786489689796554
PLC/PRF/5,3854666,0.918467942921984
NCI-H1666,100016,7.086863626956854
HT-144,54618771,1.2488424909624232
SK-N-FI,100016,6.445734787344034
OV56,11152667,0.7027706335700444
Hs 729.T,54618771,1.7662519209313146
HOP-92,135659046,3.870872238104053
KMS-18,100016,3.3973864073508864
PE/CA-PJ41 (clone D2),3854666,3.9258785658494166
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026
WM115,135984461,4.094268409164816
SNU-216,100016,6.2010021575017085
D283 Med,11152667,-1.23900039901842
HCC2218,1566236,1.7509931914659491
NCI-H522,135659046,3.4944475458884012
NCC-StC-K140,sirolimus-bortezomib (250-1 mol-mol),-1.963369351991784
NCI-H1793,3465537,3.669471583064163
MOLT-16,135984461,1.926751672348732
SNU-1196,11152667,-0.7933973738301417
HCC15,9884685,1.2743229964902805
Kasumi-2,65628,2.2018759133614987
BT 482,9884685,0.8554628610116185
MKN74,9926054,2.8513802079001844
RS4;11,selumetinib-GDC-0941 (4-1 mol-mol),0.8544814441739125
CL-11,3465537,1.1526064329860466
OVCAR-4,selumetinib-GDC-0941 (4-1 mol-mol),3.050941054620586
SNU-46,9926054,2.489766142928295
LK-2,3854666,0.2625984273437197
OE21,71751553,4.442993146906493
NCI-H1651,135421197,1.3042680543887686
COLO 678,11152667,1.0419437000778482
JHH-5,sirolimus-bortezomib (250-1 mol-mol),0.7972150153767945
PF-382,9935249,1.8009635209130423
Karpas-299,9868037,2.0515454012978176
TE-8,73707386,3.752182289773797
NCI-H716,3854666,1.816337211721982
HPAF-II,sirolimus-bortezomib (250-1 mol-mol),1.6842797227364328
Panc 10.05,54618771,0.7242321681283157
SNG-M,9926054,2.579798992981947
YKG-1,9915743,1.478165176900873
MFE-319,6918638,0.7924367103155517
BT 359,135421197,1.2544226030548953
COR-L95,1566236,1.7351682171374878
SNU-5,65628,4.310461356065421
SK-CO-1,9926054,2.0008566323964576
PF-382,73707386,2.646630293561946
COLO 684,135421197,1.6241995142011054
NCI-H2126,9911463,3.5992006521825317
TE-8,11152667,-1.9127933488083488
NCI-H1666,tanespimycin-bortezomib (250-1 mol-mol),-4.94228815381926
T24,1566236,1.9228008753437764
EJM,3854666,0.5770225844187807
SiMa,11152667,-1.8318254504900469
NCI-H2052,54618771,-0.8339738497532683
NB4,9915743,0.5883941664739625
EPLC-272H,135421197,1.5481264659951517
SNU-840,54618771,2.041373861449483
TE-15,54618771,1.8265153099983404
NCI-H747,9884685,-1.1997486818556398
CAL-85-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1820592337314743
GA-10,135984461,1.4208058611129633
NCI-H2196,9935249,1.3463658676393593
IGR-39,9926054,2.0144252699344176
Capan-2,9868037,4.081009798039869
Hep-G2,135421197,1.3335693407455125
VCaP,4705,2.864443182344748
NCI-H1792,100016,5.097619126157972
SNU-C5,9911463,3.786526891589904
U-118MG,selumetinib-GDC-0941 (4-1 mol-mol),2.998678120294993
LNCaP clone FGC,11152667,0.3595402317003787
OS-RC-2,136227924,4.587923384885118
SNU-1,6918638,0.043682815737195
HCC38,11152667,-0.905518740650514
TOV-112D,9926054,1.7834686388264986
SCaBER,9935249,3.150717155032017
KHM-1B,54639665,4.391144139421017
PK-45H,54618771,1.4553505750064293
Jurkat,136227924,2.4803602069258712
IA-LM,6918638,0.61198230609435
SUIT-2,11152667,1.417612600480328
T24,selumetinib-GDC-0941 (4-1 mol-mol),2.57595628877945
GI-1,1566236,1.393655472136886
SNU-213,3854666,3.663424826303367
MOLM-13,11152667,-8.249378694414048
A-549,11152667,0.4045052003861268
TT,9915743,-0.2506861046068376
LS180,135421197,1.2375553911833763
HCC38,100016,6.688694515924342
DU145,9915743,3.139044524773344
BC-3C,11494412,2.054977599436637
SF268,135984461,5.451116229998117
SEM,135398744,6.34358667151958
ST486,4705,3.1106371129539325
MDA-MB-361,2742550,4.4584287487827945
OCI-AML-5,136227924,1.61818972770755
GaMG,3854666,1.9172841085475143
SK-N-DZ,54618771,1.6513533063720298
SK-N-SH,11152667,0.0675911998351618
EC-GI-10,9884685,1.441134902570653
HuP-T4,3854666,3.1047417632515986
EFO-21,selumetinib-GDC-0941 (4-1 mol-mol),2.070102563498296
BT 147,2742550,3.5945516662037846
GSU,11152667,1.006110243453895
DB,2746,2.552003566153149
SNU-1066,9911463,4.257839675478274
TALL-1 [Human adult T-ALL],9935249,2.492316336854245
RVH-421,3854666,2.5302343976603656
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
Caov-3,2742550,5.8507463294718605
OAW28,11152667,0.0990704789630026
CAS-1,3854666,3.1720263873322194
Hs 944.T,selumetinib-GDC-0941 (4-1 mol-mol),0.0800181936999451
HCC1143,135984461,4.873829103860087
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
BxPC-3,9915743,0.4274244099837221
JHH-2,135421197,1.6322230690261417
MKN74,135421197,1.917095385489804
HGC-27,135421197,0.8927042884556606
Capan-2,9911463,3.916008821715387
HeLa,100016,5.8653655502295
FaDu,selumetinib-GDC-0941 (4-1 mol-mol),1.0128048472171496
COLO 668,135659046,3.450093755240726
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784
KMH-2,73707386,2.2684707650817453
HSC-2,6918638,1.1394559383012468
OV-90,54618771,1.0119398680970997
SCC-9,6918638,0.4192666549800527
OCI-Ly3,9911463,2.5217077768511635
RVH-421,4705,3.3547577531124175
BICR 18,11152667,-1.4287836453350045
KE-97,9911463,3.4009628133959713
RL95-2,135984461,4.241681706125587
22Rv1,9911463,3.7822745291397646
TUHR10TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.6041094312427258
JHOM-1,4705,3.029937408009012
LN-229,9935249,3.4182081996918794
PE/CA-PJ41 (clone D2),1566236,3.025698807379891
JMSU-1,9926054,1.0458929376132455
Aska-SS,11152667,-1.72297256980761
HCT 116,9868037,2.1391599474791394
IM95,54618771,0.6089600215622465
LK-2,11152667,1.1499971917861662
RPMI-6666,2746,2.3385323995154033
SNU-719,9926054,1.5286214740335768
SW1088,54618771,1.1113850453219438
BT 145,9911463,3.096023169309247
HL-60,1566236,1.591886995939466
PLC/PRF/5,100016,6.529147023700783
Calu-1,100016,7.639038839177244
MDA-MB-231,11152667,-0.1909288238816012
8505C,49836020,5.7227071797800235
NB4,100016,6.294523599868374
COLO 792,3854666,2.1804770549972514
NCI-H2029,11494412,1.7688671482320395
HCC38,136227924,2.8991930932960983
Capan-2,9926054,1.7295951578081552
NCI-H650,136227924,4.852289363773007
COLO 680N,sirolimus-bortezomib (250-1 mol-mol),1.5905576307574611
GCT,11494412,0.2192094321151819
647V,135421197,1.6081071378201617
SU.86.86,135659046,3.4966511693155637
EHEB,9926054,1.8810570858595552
NCI-H1838,65628,4.38525152721343
PLC/PRF/5,9935249,3.446956558470987
MKN74,1566236,3.387752601691297
NCI-H520,9935249,3.10400998228373
HH [Human lymphoma],135421197,1.0671301978035626
SJSA-1,2742550,5.0115207110356295
HT115,136227924,1.4968152830691424
KYSE-150,9868037,4.171183799285216
NCI-H647,135984461,5.580010344943138
HT-144,10322450,4.703374814219381
NCI-H520,9884685,-1.9980015448993624
NCI-H1944,9911463,2.563983379964603
NCI-H1568,3854666,0.7326561551321923
GP2d,11494412,0.0345645894259447
HCC78,54618771,0.9247891976251188
Hs 683,136227924,2.524769704566026
HCC1569,9935249,3.5629865818868613
IPC-298,9935249,3.634833619141818
5637,135984461,2.794564016216432
Rh18,2746,2.848745725372627
TE-15,49836020,0.684840592082847
BT 231,6918638,3.0604187031451437
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
MeWo,11152667,-0.8999084829893459
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
NB1,9935249,3.348619595020339
CAL-51,9884685,-0.2528326244590672
NCI-H2030,11152667,0.1486125355085492
HOS,1566236,3.95322165315026
BT 231,54618771,0.7922646437361874
ChaGo-K-1,135421197,1.864105940411698
NCI-H1694,168313307,4.392519657750419
HT-1197,9884685,0.7490718797514191
KE-39,9911463,3.415693188275342
HCC1806,9911463,4.318466961943044
KMS-18,selumetinib-GDC-0941 (4-1 mol-mol),2.1372948898179462
SW982,9911463,4.45911198153204
HCC1428,3854666,3.671770908312049
LN-229,9911463,4.132714937024961
UO-31,11494412,-0.0705899636432608
BT 333,11152667,1.6479441253937606
COLO 320,selumetinib-GDC-0941 (4-1 mol-mol),1.1921670353492264
OC 314,9884685,-0.4241645607826622
MOLT-16,sirolimus-bortezomib (250-1 mol-mol),-5.402934760182518
EKVX,49836020,5.428301745137177
DEL,9926054,1.477463428719593
D283 Med,9884685,0.4652080192462777
8305C,11152667,-0.8944679868957458
NCI-H2126,11152667,0.7845952457095523
NCI-H929,54639665,4.443848049019438
SNU-387,9915743,2.531778656004573
SEM,135659046,3.5193041881341087
BT 232,tanespimycin-bortezomib (250-1 mol-mol),-2.012927947463912
MOLT-13,9915743,-0.4312567007691435
SNU-81,3854666,0.9917295007006844
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
BT 245,1566236,1.7422793804281065
LOX-IMVI,9935249,3.870791681758961
NCI-H211,tanespimycin-bortezomib (250-1 mol-mol),-2.6494968987318517
OVCAR-4,136227924,3.1468518699477097
HuT 78,tanespimycin-bortezomib (250-1 mol-mol),-1.2620001487699233
HCC1569,tanespimycin-bortezomib (250-1 mol-mol),-0.2642860947186173
C2BBe1,2746,3.6409486434648706
MIA PaCa-2,2746,3.119583352790748
OPM-2,6918638,-1.573449675489913
CML-T1,135421197,0.9317392273651705
EPLC-272H,3854666,2.0784340754619826
JHOM-1,9915743,4.157597716548686
CL-11,9935249,5.287545766743186
MFE-296,sirolimus-bortezomib (250-1 mol-mol),-4.372432753750482
SNU-213,9926054,2.110529432598139
KNS-62,tanespimycin-bortezomib (250-1 mol-mol),-0.0918486546852887
RERF-LC-A1,136227924,2.978723056085531
MDA-MB-231,3854666,4.122425724106694
NCI-H1155,10322450,3.1814270570709766
WSU-DLCL2,3854666,0.519326937779907
KYSE-180,11152667,-0.8702132503194517
KNS-62,6918638,1.7300620365189876
HEC-251,selumetinib-GDC-0941 (4-1 mol-mol),3.2910402284708757
MES-SA,9915743,3.475302692532233
NCI-H1155,9926054,2.490439813838108
OVCAR-5,tanespimycin-bortezomib (250-1 mol-mol),0.8786451228856517
MDA-MB-157,9915743,0.9957990206413116
SK-MM-2,9884685,0.3555545930345702
RPMI-8226,135398744,6.232374281438443
MDA-MB-231,sirolimus-bortezomib (250-1 mol-mol),1.1512355372843297
SNU-8,9884685,1.4758258715385455
AN3-CA,9915743,2.510213815091878
FTC-238,4705,3.281251392763017
NCI-H1703,54639665,4.494588545198389
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
KYSE-450,9926054,1.8553044985655331
COLO 668,4705,2.9161430559961588
A-375,135984461,4.563596493696721
HuP-T4,1566236,2.6794264754900325
SNB-75,1566236,4.191791620259989
RKO,9915743,2.8851858618766957
KO52,136227924,2.4006650771153923
NH-6,selumetinib-GDC-0941 (4-1 mol-mol),1.9246197081776155
HCT 8,11494412,3.7529349259758114
HSC-2,2746,4.285336510819298
EC-GI-10,3854666,1.1347089817031333
BT 228,1566236,1.8075699945716677
KYSE-30,135659046,3.903698290168812
JM-1,9926054,1.6867956204893688
A3/Kawakami,135984461,3.954538611976779
8-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),0.0897901825982692
TYK-nu,4705,3.3824774754373
L-540,9868037,1.7753670524076954
Hs 852.T,11152667,-1.6035219297014784
Hs 936.T,2746,2.6919045473185284
DB,9911463,2.6003327839693244
JJN-3,9935249,1.5049332115943086
GB-1,9935249,3.420618097201761
L-428,1566236,1.3847183242842775
RPMI-8226,sirolimus-bortezomib (250-1 mol-mol),-1.8682631606171884
P-STS,9915743,0.8915414353493989
Tm87-16,54618771,0.1838114986679219
KNS-42,135421197,1.7884636185596865
Mono-Mac-6,9868037,1.4226493594623044
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
SCC-25,44487872,4.502394555510824
NB1,3854666,0.2195348196747777
KYM-1,tanespimycin-bortezomib (250-1 mol-mol),-2.3069485733891155
KYSE-520,9915743,1.755136902967863
PC-3,71751553,4.3090170557564145
AsPC-1,9926054,1.8957621767397328
KYSE-520,6918638,1.4732887931926149
A-498,11494412,3.741733086313002
SNU-423,9911463,4.2882741176819446
MOLP-2,135984461,5.292222187732742
TM-31,9935249,3.1549341902639054
HT-1197,selumetinib-GDC-0941 (4-1 mol-mol),0.2261426645121145
SNU-216,49836020,4.392080781330326
Hs 766T,4705,3.67943819927122
JM-1,4705,3.374089362448498
BC-3C,9935249,3.143232042704622
SW1088,650361,3.877818258700098
WM88,6918638,-0.228247400007117
Rh18,9884685,-0.3844851965964752
NCI-H1694,9911463,3.249384626336109
EPLC-272H,49836020,-3.920805882597204
BHY,9926054,1.5277493877995152
HSC-4,10322450,4.749470049467763
BT 330,sirolimus-bortezomib (250-1 mol-mol),0.7092263662862476
VMRC-LCD,sirolimus-bortezomib (250-1 mol-mol),2.1405006369000232
G-292 clone A141B1,9926054,1.742102063355914
ONCO-DG-1,2742550,5.6054605972439875
SNU-5,44494148,4.421256906479104
MKN74,3854666,2.1744767713942905
HCC1428,71751553,5.401847453673522
NCI-H1568,11152667,-1.392140833696634
NCI-H716,135421197,1.426114705682071
TC-71,9911463,4.31174852976799
DK-MG,136227924,2.9692161266572707
786-O,selumetinib-GDC-0941 (4-1 mol-mol),2.324696492331355
BT-12,71751553,4.308313811110702
BICR 6,100016,5.983099357165641
NALM-6,24779724,4.859133768812742
YKG-1,9884685,-0.1545508204895388
KM12,9911463,3.8225148805957465
CJM [Human melanoma],sirolimus-bortezomib (250-1 mol-mol),0.403265479261487
KNS-62,9926054,2.478814606658306
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
CMK,9884685,0.94035273426848
CHP-212,135421197,1.019713131092093
BT 271,10322450,5.076233079663244
HCC827,tanespimycin-bortezomib (250-1 mol-mol),-1.554763152633591
AsPC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.9679789776412068
NCI-H2110,9884685,0.5868574340900204
NCI-H1573,3854666,0.891504736627984
LS123,2746,2.8702857681070064
Jurkat,9926054,1.8890918367446592
WM793,selumetinib-GDC-0941 (4-1 mol-mol),1.528214563174997
COR-L105,6918638,0.8528151020185122
F-36P,54618771,0.2911241423131909
NCI-H841,3854666,0.1332516295685137
Mono-Mac-1,54618771,1.1455775902832934
ACHN,9911463,3.895747404778365
SK-MES-1,9915743,0.4302153441445988
RT-4,9926054,1.7601963161522494
NALM-6,54618771,-1.340027714929621
BT 145,9915743,0.579862863836084
U-937,11152667,-1.7473082418218258
NCI-H1693,135659046,3.507522004254733
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
BFTC-909,3854666,1.1654585644167257
KYSE-150,tanespimycin-bortezomib (250-1 mol-mol),-0.0451263891138861
NCI-H841,9935249,1.8463416409566311
JM-1,135421197,0.410328587733175
NCI-H1092,11152667,0.3392565176972865
SNU-840,24779724,5.873236558361466
CHP-212,3854666,-0.8182055422302374
Hs 729.T,tanespimycin-bortezomib (250-1 mol-mol),1.0644356767516514
RCH-ACV,11152667,-4.538548761334481
SNU-668,54618771,1.3172714373164345
COR-L95,9915743,0.942320604231091
253J,BRD-K16130065,4.180822895879859
LN-229,11152667,-1.783834293697264
AU565,54618771,1.1954147839624212
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
COLO 684,10322450,3.614358100313302
COV362,9884685,-0.0915196949765083
SaOS-2,11494412,0.4895123820960489
NCI-H23,135421197,1.340316450445973
IGR-37,selumetinib-GDC-0941 (4-1 mol-mol),-0.4447244170730294
MDA-MB-468,54618771,2.476122879099443
BT 504,9935249,2.8901634129680764
NCI-H358,9926054,2.488331292072961
MKN74,4705,5.009866699561135
BT 231,65628,6.2549230990110605
22Rv1,100016,5.084356097831624
MOLP-8,54618771,0.2679151571300236
TYK-nu,2746,4.272425827953672
WM793,136227924,4.7819042035619255
KYSE-510,selumetinib-GDC-0941 (4-1 mol-mol),1.3541576401803423
NCI-H1838,selumetinib-GDC-0941 (4-1 mol-mol),2.2361071015638445
LUDLU-1,sirolimus-bortezomib (250-1 mol-mol),0.877597095580597
NCI-H520,135421197,1.6066426721545042
JHUEM-1,9884685,-1.0339537431528274
A-549,9926054,1.8971220341716168
NCI-H524,9915743,-0.1513844458241534
KM12,11152667,-4.273444919213735
PC-14,24779724,4.4167236388652364
HCC1806,135984461,4.428357366686186
DB,136227924,2.1225886217744376
NCI-H1299,11152667,0.5765175859368963
BT 328,71751553,4.608962030519419
KYSE-520,2746,5.1336312613599295
DMS 114,4705,3.4227674177619187
BICR 56,11152667,0.0702266217115395
SNU-489,sirolimus-bortezomib (250-1 mol-mol),1.5186743345934282
KE-37,9915743,-1.0787732351752954
SNU-1196,9911463,4.32461924704032
SH-10-TC,9926054,2.8749564288273604
LS180,9926054,2.059729849775666
CAL-51,sirolimus-bortezomib (250-1 mol-mol),1.3660023430250434
SK-MEL-3,10322450,3.9048135305000624
RL95-2,54639665,4.517806910494635
TE-11,100016,3.880053912311749
MKN74,9926054,2.8513802079001844
Daudi,10322450,2.3131627402631905
SaOS-2,9868037,3.691858985861763
CAL-85-1,135421197,1.4377656539975323
NH-6,65628,3.5010382729298133
WSU-DLCL2,65628,3.2794423535209947
AML-193,3854666,-0.1541161036359395
NCI-H1355,10322450,3.720862951663928
COLO 680N,100016,6.604594090356929
NCI-H1395,3854666,3.0219534193280637
ESS-1,9911463,4.377027533841143
NOMO-1,136227924,2.5449106490851263
KO52,135659046,3.503950077041595
NCI-H520,135421197,1.6066426721545042
GMS-10,2746,4.267808418736884
HCC1195,2746,3.3067232318452895
Rh18,9926054,2.105597282648335
NCI-H522,6918638,0.2628749411775776
MDA-MB-468,136227924,1.762243520931147
Raji,9935249,3.258166700499432
SU-DHL-8,9935249,1.218820963316766
DND-41,9935249,1.6830323290551856
BT 444,3465537,1.7178503845935178
TE-9,135421197,3.747020112935066
SIG-M5,2742550,3.8599440330266432
CGTH-W-1,49836020,5.717814266829885
NCI-H1568,6918638,-0.3782949656582497
BT 224,9911463,3.280505090907216
Rh41,44487872,5.324428070047643
P3HR-1,sirolimus-bortezomib (250-1 mol-mol),0.1161782637204882
HOP-62,3854666,3.243198417563859
SF295,9926054,3.0771086967152845
VMRC-LCD,11494412,0.3498055732572009
BICR 56,9911463,4.962922659402967
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
DU145,4705,5.59514886378127
THP-1,9915743,0.7907463858245806
SK-MEL-30,9935249,5.245383940669338
HCC366,9884685,2.0785174453269937
KMS-27,3465537,3.890176803896576
BT 112,11152667,1.095866512531577
HCC2218,136227924,2.978872567688762
MDA-MB-415,11494412,3.530335819236776
BT 224,tanespimycin-bortezomib (250-1 mol-mol),-3.111223300831193
LUDLU-1,4705,2.2241864664767013
KNS-62,2742550,4.248627568743254
NCC-StC-K140,24779724,4.87573915744582
DBTRG-05MG,sirolimus-bortezomib (250-1 mol-mol),2.2547470483609637
A2780,100016,4.757543521992015
OE21,tanespimycin-bortezomib (250-1 mol-mol),-1.6225844369747413
BT 320,6918638,3.210777195522013
TUHR14TKB,136227924,3.4575547117836836
BT 328,100016,6.778172011931934
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
SH-10-TC,135984461,4.500134355480999
SK-N-FI,2746,2.6055222437505248
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
NCI-H2029,sirolimus-bortezomib (250-1 mol-mol),0.2827623623245045
OUMS-23,100016,6.512546818056364
NCI-N87,73707386,2.4106113659233723
Hs 940.T,11152667,-0.0455223883696226
VM-CUB-1,3854666,0.7459181413886853
Hs 729.T,49836020,4.229774154263897
CAL-85-1,9911463,3.700883327445061
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
SNU-410,73707386,2.4851962355672956
IMR-32,135421197,0.1202799185207932
ST486,71751553,4.101372984675863
F-36P,135984461,3.5381976593553444
JHOM-1,selumetinib-GDC-0941 (4-1 mol-mol),2.18755430310554
JHUEM-3,650361,3.6848753876902767
GSS,9915743,0.3423445319525382
WT2-iPS,1566236,1.6707145987469252
KNS-42,9911463,4.405771521475071
CHP-212,11494412,-1.604846658421623
THP-1,3465537,1.1164105126480133
Kasumi-2,54618771,-0.6876381814105375
BV-173,2746,1.3543374496057554
NB4,135984461,4.636533285990447
FTC-238,9911463,4.0725433031762694
Hs 746.T,11152667,-0.4528987545325829
MIA PaCa-2,9911463,3.5885490135085663
COLO 320,1566236,1.500506254136779
SNU-489,9911463,4.33052136373557
NCI-H1755,tanespimycin-bortezomib (250-1 mol-mol),-0.7433958922894784
NCI-H1395,10322450,2.951434286433811
EoL-1,135984461,1.5166332685892363
SUP-B15,135984461,1.5774458339349344
NCI-H2196,2746,3.7981769416630193
697,tanespimycin-bortezomib (250-1 mol-mol),0.0075427877175817
SK-MEL-24,2742550,3.6014189128850216
CMK,71751553,4.313223146712625
Hs 729.T,9935249,2.8329935941223567
TE-5,sirolimus-bortezomib (250-1 mol-mol),-0.3603080832286391
AML-193,11152667,-3.2233662083382297
Calu-6,selumetinib-GDC-0941 (4-1 mol-mol),1.8439594255895029
A-549,3854666,3.2699518455850964
NCI-H889,selumetinib-GDC-0941 (4-1 mol-mol),5.471466100727687
TE-15,9935249,2.05768814929574
KLE,selumetinib-GDC-0941 (4-1 mol-mol),2.44507657684364
A-549,136227924,3.1395144761786486
BT-474,9926054,2.0382536553726207
BT 286,9926054,2.06315076189255
GCT,9935249,2.2487886001651263
NCI-H1341,3854666,0.1266388074278771
COLO 320,54618771,1.0088130808392026
H-STS,2746,2.861217997075228
Jurkat,135984461,1.8556253442912225
BT 172,11494412,2.393309931030472
RPMI-7951,selumetinib-GDC-0941 (4-1 mol-mol),1.7374138302319462
NCI-H2030,100016,6.672614959068411
BT 416,100016,4.165407662771479
NCI-H1975,54639665,4.272009655983378
AN3-CA,168313307,4.649989431692814
U266B1,71751553,4.293573976078506
IPC-298,9926054,2.387739594101664
NB4,9911463,3.3051650807142514
HOP-62,54618771,0.1660184306238314
RMG-I,3854666,2.558829585712286
SNU-668,sirolimus-bortezomib (250-1 mol-mol),1.8089907805416063
ST486,54618771,-1.8169523642360077
SNU-46,135421197,1.3377995260402369
SW1573,1566236,3.3872191513469025
MOLM-6,135984461,3.5601883048539635
NCI-H1355,11152667,-1.9063918526279175
NCI-H1944,2746,3.2082243372495354
SK-LU-1,11152667,-2.9662561957508906
LNCaP clone FGC,136227924,2.6855023326383387
DU4475,11152667,0.3173121741310821
LXF 289,4705,5.10311909598278
L3.3,100016,6.042484334243821
A3/Kawakami,1566236,1.0129797315712863
RERF-LC-MS,100016,6.56071523320666
SNU-719,136227924,2.577096412948206
HCC366,11152667,1.1664557661226933
HuG1-N,135398744,6.4115232793077235
JHH-5,6918638,1.17562922333198
MOR/CPR,100016,6.350482300205422
CMK,135984461,1.8069857121104629
KMS-12-BM,2742550,3.02175924738708
U-118MG,6918638,1.3922699547909616
NCI-H446,54618771,-1.076941007220397
HT-144,71751553,4.953969663873573
K-562,71751553,5.367911183247371
Capan-1,2746,3.367877422922766
D283 Med,tanespimycin-bortezomib (250-1 mol-mol),-0.3446270457541043
BT-12,136227924,2.3126118312621404
BFTC-909,136227924,2.3418993883842134
HOP-92,sirolimus-bortezomib (250-1 mol-mol),1.0049376292822905
SW982,6918638,1.6388429790879695
697,11152667,-2.390714900309964
NCI-H889,9926054,1.840125789909785
OCI-Ly10,3854666,2.717312719982327
CAL-148,65628,4.514684852840301
Capan-1,sirolimus-bortezomib (250-1 mol-mol),0.7071415431289269
Hs 888.T,100016,7.920695284419831
NB1,9911463,3.710884488807899
MES-SA,71751553,4.3664020443524105
SK-ES-1,100016,7.4795645853927475
SH-4,11494412,4.155864270127312
L-540,135659046,3.3513489819639837
LS513,tanespimycin-bortezomib (250-1 mol-mol),-1.0041137629262296
WT2-iPS,2746,4.7130481819205015
SK-HEP-1,9911463,4.3683168964450125
BICR 16,11152667,-0.4064565156133361
LUDLU-1,9915743,0.4461040293600573
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
NCI-H1694,6918638,-0.6027220987996394
Hs 940.T,9915743,0.0875879000353744
SK-MEL-3,9911463,3.4367416892485556
AsPC-1,4705,5.582464580618905
NCI-H2170,9884685,0.3769031267544711
SNU-878,100016,5.516104284834857
COV434,9911463,3.0126718428319905
NCI-H1650,9926054,2.506807917571585
T3M-10,6918638,0.3791169249150829
SEM,4705,3.2789499070594816
SYO-1,11494412,0.2771607459161898
HMC-1-8,54618771,0.1355198199402433
SNB-75,6918638,2.2878300521074246
KYO-1,2746,2.1757976930185854
PC-14,9915743,-2.4249555987147615
SNU-1,9926054,1.7218155896190992
Hs 888.Lu,9884685,1.1513032262047451
OPM-2,2746,0.9082445461467812
DV-90,4705,1.8434366903908024
OVISE,11152667,1.81896217810704
SNU-16,9926054,1.81351744877406
BCP-1,6918638,-1.8466999206036412
KE-37,136227924,2.0912429237758796
KYSE-30,54618771,0.4265256767943792
KMS-18,tanespimycin-bortezomib (250-1 mol-mol),0.4216929170783136
COLO 668,3854666,0.8964487913111397
M-07e,10322450,3.3333673801284944
FTC-133,9935249,4.194644265855045
NCI-H1838,10322450,3.614692228512862
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
SNU-C5,9884685,0.2599835482766612
IA-LM,71751553,4.579394980470846
SNU-668,9935249,3.727070375636441
TE 441.T,1566236,2.5728062109815335
Caov-3,24779724,4.476615145928651
P12-Ichikawa,9926054,1.82657661814102
PF-382,54618771,-0.2642287573533248
CAL-29,135421197,2.48018015495381
Panc 10.05,4705,4.9433650756166685
GSU,tanespimycin-bortezomib (250-1 mol-mol),-0.9312032825444012
NCI-H747,9935249,2.157652912221255
HCC202,tanespimycin-bortezomib (250-1 mol-mol),-2.788227280084804
TE-11,3854666,0.6923023078298671
HEY A8,1566236,2.198789562474832
T3M-10,9935249,3.366318489883339
NCI-H1581,9911463,2.8150360294016927
MHH-ES-1,9926054,1.555405413320919
HCC1419,9911463,4.378443603359897
OCI-Ly10,9926054,1.7793271735454907
KMS-34,4705,2.7646110447825647
Capan-2,3854666,3.9240543200315026
Kasumi-2,11152667,-1.6921100461719016
NCI-H1339,3854666,1.1163933455881117
EFO-21,6918638,1.430978330266965
TM-31,54618771,1.840176176931743
RERF-LC-MS,11152667,0.0782441689403026
EKVX,sirolimus-bortezomib (250-1 mol-mol),1.945724198864232
MOTN-1,9915743,0.6517075840543033
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
AU565,135659046,3.967998335471068
MDA-MB-361,9884685,-0.7513711106213427
SW1710,9915743,1.0949390608186476
786-O,11152667,-0.8998458405595287
NCI-H226,9911463,4.360420570038796
MPP 89,tanespimycin-bortezomib (250-1 mol-mol),-0.3809360105117337
WSU-DLCL2,100016,5.8333868406138585
KMH-2,135984461,4.570908568849745
MIA PaCa-2,9884685,0.7084207681532095
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
HMC-1-8,3854666,1.172285232162034
Calu-1,9935249,4.740703039266813
JHOC-5,11152667,-0.9759245542637908
UO-31,71751553,3.4066570222974466
EFO-21,11494412,3.1959267599217047
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
647V,4705,2.7300428943650044
NCI-H2291,54618771,2.606874288662127
NCI-H520,54618771,1.0653077757718592
8305C,3854666,0.2716677714836975
RPMI-6666,71751553,4.036502684153802
NB1,100016,5.984902151942781
Namalwa,9926054,1.683884099727144
SW48,9926054,0.5681768331785455
EN,135984461,4.3188637411869255
MOLP-8,135421197,1.7506124789909805
Kasumi-2,24779724,5.733659143451784
HCC2218,9884685,-1.464365341774582
Granta-519,49836020,3.8229564713378057
HuNS1,9884685,1.7669935378589272
M059K,1566236,1.7750147325704222
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
KMS-28BM,9926054,1.6939379684191658
BT-474,135421197,1.065092434126716
GCT,24779724,4.780911773379765
NALM-6,100016,5.173644166821544
PC-3,9915743,3.040450489306842
SNU-C1,54618771,0.8389876741679191
HH [Human lymphoma],9911463,2.7803451597373887
JHH-5,tanespimycin-bortezomib (250-1 mol-mol),-2.9889336169985454
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635
SNU-407,9926054,1.9660241476439948
TC-71,sirolimus-bortezomib (250-1 mol-mol),0.6072005287356511
HCC1954,136227924,3.208934620428715
OCI-AML-5,6918638,-0.9986415463571308
DMS 273,6918638,-0.6329393875591668
NCI-H1693,65628,6.204473532146459
A-253,135984461,4.591715883678831
NCI-H838,54618771,3.458197236352402
OCI-M1,2746,2.0288899582402165
IMR-32,135984461,1.157056096731398
DU4475,9926054,1.608890542810364
RERF-LC-A1,9935249,3.663083529492861
OCI-AML-3,100016,6.665392900980702
HCC1171,9911463,4.341484075283008
Daoy,136227924,3.329647267316264
RERF-LC-Ad2,11152667,0.7033188335171204
NCI-H1651,sirolimus-bortezomib (250-1 mol-mol),1.0347909654714795
GDM-1,11152667,-2.8208505664126435
K029AX,11152667,1.6125860914830858
ESS-1,100016,6.502595194480242
OVISE,9911463,4.4041109725525525
PE/CA-PJ49,1566236,1.7621483938715563
SU-DHL-1,9911463,3.067527187401269
CML-T1,9868037,1.2045012402986977
HCC78,100016,6.366939598030235
B-CPAP,2742550,3.2183332694531677
HEC-151,9868037,0.6566472366149405
MKN74,9884685,2.0469611247981625
NCI-H522,136227924,2.2034936459857506
Hs 683,9884685,-0.0613437771219763
HuT 78,11152667,-1.8885306635916228
KU-19-19,9911463,4.338553857034003
Granta-519,9884685,-0.5481626961732873
HCT 8,selumetinib-GDC-0941 (4-1 mol-mol),2.0495496026415307
NU-DHL-1,9884685,-1.1010004281847865
HuH-28,11152667,0.3540574012859301
HEC-251,tanespimycin-bortezomib (250-1 mol-mol),0.0186342591611023
MKN45,135421197,1.3599393151619537
A-549,11152667,0.4045052003861268
KHM-1B,11152667,-2.085888250346346
NCI-H28,3854666,0.2888629492877926
BT 416,9868037,3.6297803130488377
EPLC-272H,sirolimus-bortezomib (250-1 mol-mol),-1.4049400380442874
TUHR4TKB,sirolimus-bortezomib (250-1 mol-mol),1.666673224601644
BT 232,9911463,3.3781399253099256
OCI-AML-2,135984461,3.686177545558833
DU145,4705,5.59514886378127
RKO,54618771,2.3159310195777985
253J,sirolimus-bortezomib (250-1 mol-mol),1.7518558579799193
B-CPAP,3854666,1.7042245826351512
U-87MG ATCC,selumetinib-GDC-0941 (4-1 mol-mol),3.2770460011243308
SNU-8,9911463,4.350153434001515
GP2d,3854666,0.4643191826857844
NCI-H211,135421197,0.3603373283624291
IGR-37,11152667,-1.3185458372175074
TE-6,tanespimycin-bortezomib (250-1 mol-mol),-0.454134198851735
OCI-AML-3,2742550,2.8792511739592728
KALS-1,3854666,1.8076760580597435
F-36P,11152667,-1.3463503839028206
SIG-M5,4705,3.652896158282669
NCI-H1944,sirolimus-bortezomib (250-1 mol-mol),1.314144105484395
NCI-H1915,9926054,1.8603630934731663
ESS-1,11494412,1.0604335653802026
COR-L51,9935249,1.489900132842433
MG-63,135398744,6.808455799902383
NCI-H838,71751553,4.290826471669843
DMS 273,tanespimycin-bortezomib (250-1 mol-mol),1.3026014961511128
Pfeiffer,10322450,2.3368906147857693
BT 224,1566236,3.339343318797912
PaTu 8988s,3465537,1.2834975763885186
L-428,71751553,4.538965099068746
639V,11152667,0.5009160292642465
SK-N-SH,2746,2.865356656524813
NCI-H292,3854666,3.3764205876154074
KP-N-SI9s,135421197,1.130974840483334
HCC1806,selumetinib-GDC-0941 (4-1 mol-mol),2.757254827906479
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
KP-N-SI9s,11152667,-1.205697383084552
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
NCI-H2110,136227924,4.625762146403413
MOLM-13,54618771,-0.6841479707721928
NCI-H716,54618771,0.9147566577185032
MKN7,6918638,1.0804402687871355
Malme-3M,135421197,3.050817856383808
SEM,9884685,1.4949119152013906
NCI-H1581,10322450,2.9109511498380485
SNU-1076,sirolimus-bortezomib (250-1 mol-mol),0.4980535505825825
JJN-3,2746,1.639686724346065
KO52,11152667,-1.2056266729151108
Hs 839.T,100016,7.045878686884313
TF-1,54618771,1.249031073864191
RPMI-7951,11152667,-2.388321573678012
CAL-51,136227924,2.079284078064279
HCC-56,9926054,1.8387784948097223
SK-LU-1,49836020,-1.7403396635124715
Pfeiffer,1566236,0.9583867480822434
OCI-Ly10,54639665,5.195826059453437
SCaBER,2746,3.471134652471349
KMS-18,1566236,1.6034758875219752
PE/CA-PJ34 (clone C12),sirolimus-bortezomib (250-1 mol-mol),0.9308222519351572
SNU-620,9868037,3.01129610064575
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
SW1417,1566236,1.950642609595583
TE-11,65628,5.742213297143678
Hs 688(A).T,selumetinib-GDC-0941 (4-1 mol-mol),3.4396417778201305
HD-MY-Z,3465537,2.9850007343449003
SK-MEL-3,selumetinib-GDC-0941 (4-1 mol-mol),0.6060957157966415
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
BT 271,9935249,1.8959027291266075
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
COLO 678,9884685,1.636173828507052
LS123,54618771,1.1296400370948565
BT 139,11152667,1.692404589023897
SK-N-MC,136227924,2.70298794492574
BT 228,2742550,2.4792885987707605
SK-N-AS,3465537,3.1460094304770387
BV-173,135984461,2.039918751992627
HOP-92,1566236,3.231225690393918
CAL-29,49836020,4.434653881531219
KMH-2,11152667,-1.1792266264119935
U-CH1,2746,3.3579143403808995
KMS-20,71751553,3.937106268474675
JHH-5,11152667,-0.2906740707907462
COV362,9915743,1.8157277713688496
ACC-MESO-1,tanespimycin-bortezomib (250-1 mol-mol),1.746490159634885
SBC-5,sirolimus-bortezomib (250-1 mol-mol),0.8879652697006557
KYM-1,1566236,1.0824430309271504
MCF-7,11152667,1.662528672458487
Pfeiffer,54639665,4.400648169756794
SNU-C5,54618771,0.8135546853425193
SU-DHL-10,selumetinib-GDC-0941 (4-1 mol-mol),2.1131040208605576
BT-474,3854666,3.675072420225406
Yamato-SS,135421197,2.276835379752713
KMS-18,9935249,3.004576680840286
MES-SA,1566236,1.8383207711013103
KM12,4705,2.9738555795227093
MOLT-16,3854666,0.1998287701213994
OV-90,3854666,3.230215800724518
TUHR14TKB,1566236,3.406104899548504
SNU-738,tanespimycin-bortezomib (250-1 mol-mol),1.4501924886201147
KG-1-C,selumetinib-GDC-0941 (4-1 mol-mol),0.970562535367186
COLO 684,3854666,0.6969509433091737
COLO 320,9884685,-1.3641958570159751
U-118MG,11494412,3.4425661243736503
JHUEM-3,54618771,0.1338872502491787
BICR 31,65628,4.368112552275168
HCC2935,4705,1.0369145434655835
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
UM-UC-3,65628,5.657575837936911
SF295,100016,6.949657377166824
TE-15,2746,3.020954904357082
COLO 800,11494412,3.09129887824684
KE-37,sirolimus-bortezomib (250-1 mol-mol),-5.227534595798211
PC-14,11152667,-3.213893550122198
HCC44,2742550,4.03995268983579
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
NCI-H1373,9926054,1.8231885221159896
AU565,10322450,3.206832643999438
FaDu,9926054,1.9668207116492555
LS1034,54618771,0.9023023463820332
SUP-HD1,100016,7.0046366432620735
WT2-iPS,3465537,3.265223297454724
KMRC-20,136227924,3.298573049161518
WT2-iPS,9935249,2.882456991655045
SCC-4,9868037,1.8621190248013155
Pfeiffer,9911463,2.288637526190458
A-172,135984461,4.014453553183264
G-401,9911463,2.712760379614347
DU145,2742550,4.5042202840437975
Capan-2,136227924,3.162135891621308
G-292 clone A141B1,136227924,3.074698527992838
HCC1937,54618771,3.213475189198509
JVM-3,10322450,3.1045130110101335
SNU-1214,3465537,5.236709132299774
NALM-6,3854666,0.6417754224123796
NCI-H146,3854666,1.3221451848305394
BT 231,71751553,4.584826391566352
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
COR-L105,2746,3.1035280268076217
Ri-1,9915743,-1.2170005610109595
Hs 578T,11152667,-3.116369263954623
NCI-H1694,3854666,0.1968088036326413
COLO 320,sirolimus-bortezomib (250-1 mol-mol),0.8564336763022389
K029AX,1566236,1.7525838021386102
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713
KNS-81,9911463,4.180814120115767
VCaP,100016,6.449384825808392
Lu-65,9935249,3.101131829236005
OVCAR-5,3854666,3.3204773535647916
PC-14,2742550,4.050636111371891
BT 139,10322450,4.915425697373417
JHOC-5,9926054,1.8776072884950488
HH [Human lymphoma],49836020,3.7105679750249663
HOP-62,sirolimus-bortezomib (250-1 mol-mol),-1.0582430769109517
SUP-T1,136227924,2.470227214750311
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308
KMS-20,9915743,0.2569666585707142
SNU-899,136227924,3.189426259363562
PLC/PRF/5,54618771,1.111508720136614
OE33,11152667,-0.6577753900315373
IM95,9884685,2.9986081253440644
DAN-G,135421197,3.0058015912267475
Lu-65,3854666,0.9157071351936018
SKM-1,135421197,1.6359213938027426
NUGC-4,54618771,0.2838784179231751
WM266-4,selumetinib-GDC-0941 (4-1 mol-mol),-1.002003549431085
LMSU,9911463,4.298553287365515
KE-39,11494412,5.804036993573256
WM266-4,2742550,3.9652001129463863
HT115,135421197,2.47112158690729
KG-1-C,54618771,0.7082793216949752
KMS-28BM,1566236,-0.3708562680621429
MSTO-211H,65628,3.7458295220001
Aska-SS,49836020,4.404663805549638
DU145,9926054,1.942219630113699
SK-N-BE(2),65628,3.4369981362561703
KHM-1B,135421197,0.982032972009238
HT-1197,3465537,3.2276782151604877
BICR 31,2742550,4.742856926113666
AU565,136227924,2.2371309282915184
A2780,4705,2.567744201920244
COLO 684,9935249,2.5534920000178816
IGR-37,sirolimus-bortezomib (250-1 mol-mol),0.8968777908953848
BT 245,65628,4.476006410833118
JURL-MK1,2742550,3.380705100447993
G-361,73707386,3.203260265102939
COLO 201,136227924,3.2878786819809105
8-MG-BA,3854666,3.167803657238392
RVH-421,3465537,3.326597966026809
GOS-3,sirolimus-bortezomib (250-1 mol-mol),0.3031881482046261
SK-BR-3,49836020,6.022467534114696
SW1783,136227924,2.7676121780420364
LP-1,11152667,-1.0091547787337771
HCC827,9868037,2.0129298599097227
BT 159,65628,6.014934419792849
BT 444,11494412,4.738516696174284
LCLC-97TM1,9926054,1.7367616025320842
NCI-H2081,135984461,4.3718384438901285
NCI-H661,4705,2.5155315968978127
SNU-407,10322450,3.446523216641638
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906
JHH-2,9884685,3.029241450708335
BT 271,9926054,1.6411198648288656
8-MG-BA,136227924,3.3968176736472446
DU145,selumetinib-GDC-0941 (4-1 mol-mol),2.8367199519336324
HEC-1-A,4705,4.084299527202415
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386
JHH-1,11494412,1.1358911008605377
NCI-H1581,2742550,2.98284330301107
SNU-478,11152667,-1.2324145231760475
TE-15,9926054,1.8189889434505215
Hs 888.Lu,tanespimycin-bortezomib (250-1 mol-mol),0.5097438432490347
HPAF-II,9911463,4.010750287703811
NCI-H2170,135421197,1.5856670633650565
BT 320,11152667,2.8584362453350427
OUMS-23,9926054,1.8521308155808696
Hs 940.T,9935249,3.1065250184638673
HMC-1-8,100016,5.583587343649554
42-MG-BA,3854666,2.0337567414641184
CJM [Human melanoma],1566236,1.8000677209088238
TE-15,9911463,3.694434531668693
EFO-27,tanespimycin-bortezomib (250-1 mol-mol),1.741135148136739
SK-N-AS,9884685,0.5788482092816835
NCI-H2087,135421197,1.3607762118240936
OVSAHO,136227924,3.9451154225840783
PK-45H,9915743,1.737886794631877
HPB-ALL,tanespimycin-bortezomib (250-1 mol-mol),1.0478674895496405
HT-55,selumetinib-GDC-0941 (4-1 mol-mol),0.6831799344698409
Hs 766T,100016,6.453782329995662
MDA-MB-157,tanespimycin-bortezomib (250-1 mol-mol),-1.1455809440560911
HT-1080,135421197,1.6974023477762936
Mel JuSo,135659046,5.566553580989515
IGR-37,2746,2.835708308282215
SCC-25,1566236,1.5434275794698058
COR-L279,135421197,1.2327200147457915
OVCAR-8,24779724,5.1657808765026285
RKO,100016,5.817852214634293
TYK-nu,3854666,2.0587210859588407
NCI-H1694,65628,2.2458505354729854
DU4475,sirolimus-bortezomib (250-1 mol-mol),-1.4046623953130444
SNU-46,sirolimus-bortezomib (250-1 mol-mol),2.213576797303729
KATO III,10322450,4.372347394636034
COV644,9884685,0.7515598041461382
Kuramochi,10322450,3.6258037590655383
NCI-H1734,selumetinib-GDC-0941 (4-1 mol-mol),-0.5700124177299448
NCI-H2452,9884685,3.2183676658345868
GCT,1566236,1.4105252742075816
SNU-1033,6918638,0.9929294920003592
HEC-6,selumetinib-GDC-0941 (4-1 mol-mol),2.6580781853062887
MOLM-6,9935249,2.359977585309934
NCI-H1092,4705,2.99261822421246
Tm87-16,selumetinib-GDC-0941 (4-1 mol-mol),0.1421801276665628
MDA-MB-468,1566236,1.4532799362924351
BT 482,9935249,2.8918115184774305
Kasumi-2,49836020,6.151495097204233
BT 340,selumetinib-GDC-0941 (4-1 mol-mol),2.751381864792414
HT,3465537,3.9314731876792695
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158
NCI-H2023,3854666,3.016095382213318
NCI-H1651,6918638,0.1812573070199931
MDA-MB-157,100016,3.517936084480814
SNU-840,9926054,2.11865142604258
CAL-54,4705,3.029255173670364
U-937,65628,4.428967957842935
SET-2,1566236,1.327292849582041
SKM-1,2746,1.6032420730880204
253J-BV,9935249,4.200094629242131
U-BLC1,24779724,5.444020620154264
NCI-H1869,9926054,1.781753958996035
HCC2218,135984461,4.242222575016064
JM-1,9915743,0.8499678141273637
AN3-CA,sirolimus-bortezomib (250-1 mol-mol),0.0528830702221854
NCI-H2023,135421197,2.5449046355332436
Karpas-422,9935249,3.5194679685123695
LNCaP clone FGC,71751553,4.050545611826545
MSTO-211H,tanespimycin-bortezomib (250-1 mol-mol),-0.4503897657817667
NCI-H2196,1566236,1.8128230891442871
BT 131,9926054,2.1358376599970397
M-07e,2742550,2.9985200083609014
CAL-29,136227924,2.032112399542908
BL-41,1566236,1.0273686221427951
Panc 02.03,54618771,1.0884531427161812
HD-MY-Z,136227924,3.0737298330446103
JVM-3,135984461,4.680195748314229
MHH-NB-11,136227924,1.3020282745517038
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
MDA-MB-453,9911463,3.8683390626627454
SK-N-MC,135421197,1.0109878230238314
BT 228,11152667,1.5826836079285618
OE21,selumetinib-GDC-0941 (4-1 mol-mol),0.0714781013058572
SNU-201,9935249,4.988925782011606
SNU-423,sirolimus-bortezomib (250-1 mol-mol),0.1869702268124788
NCI-H2087,3854666,1.5016469134351038
BHT-101,3854666,1.5142603567930877
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
PC-14,sirolimus-bortezomib (250-1 mol-mol),1.4531465186128956
TOV-112D,sirolimus-bortezomib (250-1 mol-mol),0.8859708240687075
SCC-25,9884685,0.9824143256806416
MV4-11,44487872,4.715588525495155
COV434,2742550,2.924605049724598
NCI-H1339,2746,3.2710965804253633
RMG-I,650361,3.81864593195537
HLF,sirolimus-bortezomib (250-1 mol-mol),0.7648448061241114
NCI-H1650,9935249,3.669332383907399
DLD-1,9868037,3.074628293738507
NCI-H1755,135421197,1.7196206530846876
MCAS,135421197,1.955288267695935
JK-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404611397538406
SK-BR-3,1566236,2.316860466268058
NCI-H520,9926054,1.793691213544428
SNU-840,2742550,6.426027402701062
COV434,1566236,1.6792163956062065
DB,135398744,6.337933152850909
KMM-1,73707386,2.6585902947393216
KYM-1,9935249,2.52533764683477
MOLT-3,9911463,4.579256279183223
Karpas-422,136227924,2.027369566350396
SNU-216,selumetinib-GDC-0941 (4-1 mol-mol),-0.3522125644534081
LS123,73707386,1.910994196621481
Detroit 562,135984461,4.371525738638509
L-540,65628,2.916098116617406
MKN7,9926054,2.9968312406373574
Hep 3B2.1-7,9935249,3.6352240530651008
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
SR,49836020,-3.5786730229489603
IGROV-1,49836020,5.658436828096057
UM-UC-3,9911463,4.051295962185813
ESS-1,71751553,4.681072103352448
CHP-212,3465537,1.2207374723965898
MCF-7,135984461,4.749341125159992
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
P12-Ichikawa,2742550,3.252408328818169
Hs 888.T,136227924,1.939793098771597
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
AML-193,1566236,0.9779280105236772
K029AX,9926054,1.886633217948548
NB4,9868037,2.03614451589969
EPLC-272H,9884685,-1.556981990897552
SUP-HD1,3854666,0.4718894570556139
BT 187,sirolimus-bortezomib (250-1 mol-mol),0.4911829416060825
SUP-T11,10322450,3.259585661278822
BT 286,9911463,3.0735360087935364
NCI-H1755,9935249,3.3261262266034577
HCC1143,selumetinib-GDC-0941 (4-1 mol-mol),1.964789015650302
A2780,9868037,1.6123332444026346
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
KE-39,1566236,2.837512341107075
ONS-76,9935249,3.5330143946083874
HOP-92,3854666,3.1115994029267413
NCI-H1666,54639665,4.462050745406922
TE-11,4705,1.37332661199947
SNU-685,54618771,0.6420391462722509
AN3-CA,11152667,-0.493921351954846
TE-6,135659046,3.478655108369394
TE-1,54618771,1.3906017960660586
Yamato-SS,9884685,-1.879911266317303
PE/CA-PJ34 (clone C12),1566236,1.827252089315036
Daudi,49836020,3.49644839546437
TE-4,selumetinib-GDC-0941 (4-1 mol-mol),0.9436267923396215
BxPC-3,54618771,0.182098153600537
NUGC-3,sirolimus-bortezomib (250-1 mol-mol),0.5062722406192697
SF539,6918638,1.218816827551867
NCI-H1838,136227924,4.034071845409975
EFM-192A,135659046,3.6859856473219175
JHUEM-2,9911463,2.885358490635734
PC-3,135659046,4.742697246450577
NCI-H2110,9911463,4.283441783130732
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896
KE-39,100016,6.665188081944046
BC-3C,tanespimycin-bortezomib (250-1 mol-mol),1.3285525848592783
SNU-620,sirolimus-bortezomib (250-1 mol-mol),0.2829661483143316
OCI-Ly10,9884685,-0.5960730002236428
A-673,2746,1.857945511282164
COR-L51,2746,1.8698991434806345
NCI-H1385,1566236,1.8640603152545463
VCaP,11152667,-0.5682983840571335
NCI-H1184,135984461,3.671317509665682
SW1088,sirolimus-bortezomib (250-1 mol-mol),0.8011613247197977
AM-38,9926054,1.7644212109272557
KE-97,54639665,4.464069438264846
IM95,tanespimycin-bortezomib (250-1 mol-mol),-3.0654337981747273
Sq-1,100016,4.274424361552861
SNU-182,650361,3.213355032316707
SaOS-2,4705,3.668938036329027
KMRC-3,135984461,3.851943021545312
HEC-151,9926054,1.821769205783168
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
PE/CA-PJ34 (clone C12),4705,1.0597990978306746
BT 239,11152667,1.551234478397614
23132/87,sirolimus-bortezomib (250-1 mol-mol),0.0673890059049479
Panc 10.05,135659046,4.933394914057929
CCF-STTG1,9926054,1.9394922490252933
BT 228,3854666,1.688749434997188
NCI-H1944,9884685,1.1029349994643696
HLF,1566236,1.6568268509267354
HCC1954,selumetinib-GDC-0941 (4-1 mol-mol),0.8258284821582321
A3/Kawakami,11152667,-1.367626298154913
ONCO-DG-1,9926054,2.478958665773676
JHH-4,9926054,1.9011355280949385
NCI-H211,3854666,0.5598756025462432
HCC1588,54618771,0.4261259622820442
Li-7,100016,6.9157107863456915
KP-N-SI9s,9911463,3.657189132130691
KMS-34,tanespimycin-bortezomib (250-1 mol-mol),0.6300462572492305
NCI-H522,11152667,0.761836671652074
CW-2,4705,1.5406950136134017
NCI-H1793,4705,3.730029638704029
COV362,11152667,-1.7293670609022522
CAS-1,3465537,2.4572660302658607
FTC-238,9915743,0.6345085116820538
OVK18,136227924,2.593591625928113
P31/FUJ,100016,5.4217002529902185
CCF-STTG1,136227924,3.7108552267199504
NCI-H2009,54618771,-0.2233577251443086
CL-11,136227924,2.4405671689998027
NCI-H647,tanespimycin-bortezomib (250-1 mol-mol),-3.1460893933580727
Hs 822.T,135659046,5.0235627389760715
EJM,9911463,3.809334952263978
PSN1,3465537,3.294093255917581
A-172,selumetinib-GDC-0941 (4-1 mol-mol),2.629230075004273
GOS-3,71751553,4.284016393111424
SNG-M,2746,3.2265366784113914
M059K,2746,3.2617211369125383
JeKo-1,71751553,4.358287051916344
WM88,135421197,2.6537583925781054
NCI-H211,49836020,0.8643825091547783
UACC-62,3854666,2.8561673070888034
SK-MES-1,9935249,2.2482629589570804
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872
Hs 746.T,2746,3.181547233706405
VMRC-RCZ,9926054,3.085597836740958
MFE-296,54618771,1.0202577840468772
Hs 940.T,9884685,0.681854393088184
GI-1,9911463,4.305477844403804
EFE-184,sirolimus-bortezomib (250-1 mol-mol),0.9563190078492846
BT 328,4705,3.594890989297502
OPM-2,11494412,0.3054873199299708
TE 617.T,9911463,3.539966110266211
BT 224,selumetinib-GDC-0941 (4-1 mol-mol),3.286346759744933
LS123,100016,6.571994849278421
DB,1566236,1.3179912110212906
COV434,136227924,1.351853150285656
GDM-1,135421197,1.3394592190633656
KYSE-150,9911463,4.274881584609526
BCP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.866380650613888
NCO2,9884685,1.5735117508455894
ST486,135984461,1.4882803556489697
OE19,135984461,5.542264217224972
THP-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.4555480818826622
CAL-12T,9868037,3.211288861847722
SUP-M2,9935249,-1.4542663708308443
A-673,135984461,3.9402009784769745
SW48,9935249,1.3330175828473068
SW982,9926054,1.795372121114862
HCC1500,1566236,1.5057997400762737
Hs 746.T,9911463,4.2317998219247785
COLO 684,11152667,-1.1782172222202727
IMR-32,9911463,2.6287307610589172
ST486,11494412,-0.4970972218954756
Hs 578T,6918638,0.545294838071351
K-562,54618771,1.1969173800987956
KYO-1,sirolimus-bortezomib (250-1 mol-mol),0.6931512347685437
Capan-2,1566236,2.8956582475218906
GMS-10,54618771,2.907722210856396
8505C,135984461,1.800698479354495
BT 440,135659046,3.614381775691437
TF-1,9926054,1.8165915475907757
KMRC-3,9868037,4.35268371291099
SUP-HD1,65628,3.5504679742815792
A2058,tanespimycin-bortezomib (250-1 mol-mol),-0.4864507990371403
NCI-H226,9935249,4.613737226682963
SNU-478,9911463,3.926310960218254
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
BT 179,tanespimycin-bortezomib (250-1 mol-mol),-3.1981676947705564
NU-DHL-1,54618771,-0.7819429035186433
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
SF539,3465537,2.1777468091875125
NCI-H1755,2742550,4.204893958331653
TUHR10TKB,54618771,-1.4225066809641267
RMG-I,2746,2.7034933006437023
OV-90,tanespimycin-bortezomib (250-1 mol-mol),-2.825248650811712
VMRC-LCD,135421197,1.103585656826272
HuH-1,100016,6.427674645277276
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
SEM,selumetinib-GDC-0941 (4-1 mol-mol),0.0721321703925677
A101D,135984461,2.9923151826586474
8305C,9935249,3.4966518610298833
SW620,9926054,2.9151394622237823
VCaP,49836020,3.7297112197262337
BC-3C,4705,2.713954554956948
HMCB,3854666,0.4980905922324143
COR-L47,3465537,2.8794248279849217
OE33,3854666,4.486907351479266
NCO2,2742550,2.371256887035148
RKO,9911463,3.963116579454927
YKG-1,9926054,2.005416681797869
WT2-iPS,11152667,-1.4090250835135414
AsPC-1,3854666,3.565227366628202
NB1,9926054,1.7584183979270531
DV-90,71751553,4.251894226569197
JJN-3,71751553,4.601473128898884
BT 328,selumetinib-GDC-0941 (4-1 mol-mol),2.0917542081125067
LK-2,4705,3.2443649801870382
BT 359,2742550,3.7696896418502432
Calu-6,100016,6.484915939204548
KE-39,selumetinib-GDC-0941 (4-1 mol-mol),2.2885736306774076
IM95,9915743,-0.1388033573785565
SNU-5,54618771,-0.9797108545959382
Karpas-299,9915743,0.0717302917443794
NCI-H69,9868037,3.2675827879881556
Fu97,11152667,-0.4985838721886936
U-251MG,71751553,5.496604209232847
HGC-27,9868037,2.329533656521022
T-47D,11152667,2.977233468307929
Kasumi-2,9911463,3.4999156831259524
ST486,9911463,2.5005951178615775
Ri-1,4705,2.754354482473573
KMS-34,11152667,-1.7848864383845235
U-251MG,11152667,1.4499699740293923
LOX-IMVI,9915743,1.7866984805438202
DMS 53,54618771,0.8665759166845977
BICR 22,2742550,3.9616050819266326
BT 416,2742550,2.5913413615570087
KMRC-1,136227924,2.9529226708788734
NCI-H2085,9926054,3.027383511126382
BT 159,1566236,1.632057569895571
SUP-T1,9915743,0.2147589739019727
UACC-62,1566236,3.0141386967262687
PLC/PRF/5,71751553,4.875285495081073
U-251MG,6918638,1.4300554442043
UO-31,135984461,0.7514155990157345
Mono-Mac-1,9926054,3.1061890381784187
AGS,54618771,0.8602025015707093
HCC2108,11152667,0.6161783395316693
NCI-H522,9926054,1.815484319665427
SNU-478,135984461,4.6270303617123165
BT 482,selumetinib-GDC-0941 (4-1 mol-mol),-0.4370874918517858
A4/Fukuda,11494412,-1.359408079628026
HPAF-II,selumetinib-GDC-0941 (4-1 mol-mol),0.3156523393039555
COLO 792,2746,4.014850740160219
MDA-MB-157,11152667,0.7570225590856333
SIG-M5,71751553,4.293006286134242
NUGC-4,135984461,2.7361037757189184
PE/CA-PJ41 (clone D2),136227924,3.7691635351021855
23132/87,100016,5.572734576179291
OCI-Ly10,9915743,3.628362232198514
BT 422,71751553,4.340972602813402
BHT-101,9935249,5.00813048060855
SU-DHL-1,10322450,2.9485372728674473
NCI-H1339,9884685,1.174532924558328
KMS-26,44487872,4.333552536617936
MFE-296,1566236,1.6615174208061805
SW620,sirolimus-bortezomib (250-1 mol-mol),0.6778769985308863
SK-N-FI,11494412,-0.1872095873392484
CAL-33,9915743,-0.5523572938486134
HSC-3,100016,6.558832951826536
OVTOKO,136227924,4.392974848141837
HCC38,3854666,0.590612515412198
NCI-H2110,9935249,3.1608776626158432
Hs 888.T,6918638,2.9621316525739885
SK-OV-3,9911463,4.2249846626647125
NCI-H1869,1566236,2.8728790566593747
BT 286,9868037,4.125737289056318
BT 245,54618771,0.8318467537608688
EBC-1,135398744,6.3334705093468235
G-292 clone A141B1,11152667,0.2395732211281228
TM-31,136227924,2.988827636595516
M-07e,135984461,4.142111283006845
SNU-1079,9926054,1.5049009904469195
8505C,65628,4.25039511481597
SNU-869,9926054,1.9894355639340104
NCI-H446,4705,3.0322510190148795
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034
Kuramochi,2742550,3.727558787016432
MPP 89,9926054,1.8831902537321672
JHH-6,sirolimus-bortezomib (250-1 mol-mol),2.5293285021396277
NCI-H2170,6918638,0.3062237011393727
NCI-H520,selumetinib-GDC-0941 (4-1 mol-mol),1.617810838341725
COLO 699,selumetinib-GDC-0941 (4-1 mol-mol),0.865445033104183
U-937,9935249,2.745882291823877
YD-15,sirolimus-bortezomib (250-1 mol-mol),1.709895595212298
JK-1,9884685,0.0147881533582394
NCI-H1703,136227924,2.979921585365296
T24,135659046,4.4485705776291935
SW620,1566236,2.632666707678549
BICR 56,9926054,1.8423418764912696
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
Panc 03.27,6918638,1.3027265452400043
THP-1,73707386,3.039946481349438
Kasumi-2,11494412,-0.1140662522158316
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
KG-1-C,9935249,3.19520490423661
KYSE-450,100016,6.589468110151047
NCI-H2405,135421197,1.0087242199460646
MIA PaCa-2,1566236,1.8703719885196528
Tm87-16,11494412,2.181680767540109
JHOS-2,9915743,3.2140989729370273
SW579,9926054,1.761228342294705
K-562,9911463,2.5078915917546336
NCI-H2106,9926054,3.0044250532123735
CA46,100016,3.773189878640827
BT 248,11494412,3.557230805764516
PLC/PRF/5,9884685,0.8097728854232519
SNU-201,9926054,3.435558365800804
NCI-H647,9926054,1.878907234482811
EFE-184,2742550,4.5004666344414765
MOLT-3,4705,3.045598390925212
HCC1500,136227924,2.675203690625814
ACC-MESO-1,9911463,4.148709224081578
COLO 320,tanespimycin-bortezomib (250-1 mol-mol),1.191439437056519
MOR/CPR,9911463,3.708088966162912
BT 444,9935249,2.9286697760241176
COLO 684,9884685,-2.257049363366989
LMSU,sirolimus-bortezomib (250-1 mol-mol),0.3355197835459403
JVM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.7253415150610979
EKVX,9915743,0.527963418662055
BT 232,4705,3.775264883664604
SW1573,65628,4.136448104244246
NCI-H1793,71751553,4.881121266496761
RCC10RGB,135659046,5.776465120313546
PE/CA-PJ34 (clone C12),2746,3.651379195242312
Hs 729.T,11152667,-0.1585094610562804
EBC-1,4705,2.4186429670201153
WM1799,11152667,-0.0315249727126408
OCI-Ly19,selumetinib-GDC-0941 (4-1 mol-mol),-1.7363769217481064
MFE-296,9911463,3.764855426656665
BT 320,3854666,3.86904800273952
RPMI-6666,49836020,4.712616665171358
TE-14,9868037,4.140324513825515
MIA PaCa-2,3465537,1.2213186133491942
NCI-H2081,1566236,1.4725524820150873
MDA-MB-231,54618771,1.2900163685753538
JK-1,73707386,2.7182097499320874
Panc 03.27,10322450,4.4639775206651295
SNU-869,54618771,1.00410575890065
CA46,9911463,2.565133854881976
LAMA-84,9915743,0.3935059145962964
KMS-34,10322450,2.8971491774933553
TYK-nu,2742550,3.415381611681683
SNU-1,10322450,2.9825136311356055
G-361,2746,2.496090432084752
BT-16,sirolimus-bortezomib (250-1 mol-mol),3.18518711060972
L-428,sirolimus-bortezomib (250-1 mol-mol),-6.443786074450703
BFTC-905,136227924,2.194418567728585
NCI-H2342,11494412,3.810299583777443
OVCAR-5,135421197,1.110544860283993
SNU-216,135984461,4.361470667524811
KG-1-C,2742550,3.940460773716529
Mino,54618771,0.6228570132231963
LS1034,136227924,1.69162800732405
HH [Human lymphoma],71751553,2.3299764959766107
MHH-CALL-4,100016,6.461754156645112
SNU-475,71751553,4.845221607036342
HCC1195,54618771,3.4499455256162475
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192
HuP-T3,135421197,1.625440100707307
SK-LU-1,65628,4.370272148908934
SF539,2742550,3.134990737020823
HT-29,11152667,1.0220849180343163
NCI-H1869,6918638,1.090174259453097
DMS 53,11152667,-0.3155259461808404
SNU-1,49836020,4.400146563188995
PE/CA-PJ41 (clone D2),9915743,0.2241511570918921
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
HEC-108,54618771,2.78064765565191
EFO-27,100016,6.711163327148508
CAL-33,9935249,2.6612309023726723
Rh41,65628,4.1511023714523025
PSN1,4705,3.10830122261482
NCI-H1693,2746,3.264827301273958
MEC-1,9884685,-0.5815283881591208
U-251MG,9911463,4.11693061123882
JHH-6,9911463,4.586704502262201
NALM-6,135984461,1.4298238990327978
NCI-H1355,sirolimus-bortezomib (250-1 mol-mol),1.1332482572843785
SK-N-SH,9915743,1.1616840064565594
HEC-1-B,135984461,4.439754583263078
NCI-H1693,71751553,6.177840358634376
Karpas-299,9926054,1.611454190499719
NCI-H1793,9884685,-0.7653178122103681
T3M-10,54618771,0.7014662357085544
JMSU-1,136227924,3.0914793862161747
TM-31,9926054,1.8520077619388624
SNU-503,9911463,4.508813956754841
MHH-NB-11,2742550,4.089431061262103
Detroit 562,100016,6.391000104824681
NH-6,tanespimycin-bortezomib (250-1 mol-mol),0.3512808047097303
OE33,136227924,2.987067512543954
F-36P,3854666,-0.4499689748762866
JK-1,1566236,1.2840602067740463
786-O,9926054,1.9189583630988831
SH-10-TC,4705,3.0238585653901655
H-STS,135984461,1.3384437031548353
COR-L47,11152667,-0.7609778276005695
NU-DHL-1,135984461,1.11873859248707
PaTu 8988t,135421197,1.788370067257354
NCI-H810,11494412,-1.110991109290378
NCI-H2106,54618771,2.789728608480185
SNU-1214,9935249,2.745312094811984
BV-173,2742550,3.230844784705435
EoL-1,1566236,0.4316252370968399
TE-8,9868037,2.984578465657965
HSC-4,2742550,4.46855499399167
TUHR10TKB,sirolimus-bortezomib (250-1 mol-mol),1.3489758983524096
SK-MEL-3,6918638,0.5772610172488114
KP-N-SI9s,selumetinib-GDC-0941 (4-1 mol-mol),1.114910325038949
AML-193,9911463,2.567392494652272
IGR-37,9884685,1.000968603362932
SNU-C4,2746,3.564383627090603
MFE-319,9911463,4.372172899539541
SNU-61,1566236,1.9599867850180668
MOLT-3,3465537,3.351210335156386
Daoy,9935249,3.744593484818124
NCI-H520,3854666,-0.551991556599842
SNU-1272,9926054,2.4790221898932283
REC-1,9935249,3.294492382049569
U-BLC1,2742550,3.0998896662106676
OCI-Ly3,6918638,-1.72449157217465
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
HuT 78,3465537,2.3062408835575923
BV-173,49836020,4.1850611213091105
SUP-B15,71751553,5.338056707616089
Kuramochi,sirolimus-bortezomib (250-1 mol-mol),2.121194092694626
Mel JuSo,sirolimus-bortezomib (250-1 mol-mol),1.422716190739553
SF268,9926054,1.8343424406702535
MSTO-211H,11152667,-3.5300772231011703
NCI-H1869,9911463,4.397307517913515
AsPC-1,9935249,3.639166614114404
KO52,9911463,3.5355164060453004
TE-6,9926054,1.628264374651606
Hep-G2,136227924,2.2133800896817304
BT 159,9935249,2.6944472929674226
PE/CA-PJ15,9911463,4.11474968197752
NCI-H1838,9935249,3.7675840247786248
NCI-H1568,71751553,3.6437596116554887
MG-63,selumetinib-GDC-0941 (4-1 mol-mol),2.7889103104471227
SW1990,136227924,4.2742525725591864
NCI-H841,136227924,2.950651455010232
BT 179,9935249,3.0053860414976135
PK-59,9915743,1.423625885080464
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
JL-1,3854666,3.213509564597454
BT 333,2742550,4.922305550414676
HuH-6,2746,2.1362629951594396
KMS-20,1566236,0.9059478778030634
BT 333,9911463,3.323400968043226
M-07e,11494412,-0.4352811650560824
ME-1 [Human leukemia],sirolimus-bortezomib (250-1 mol-mol),1.2847340597652257
IPC-298,tanespimycin-bortezomib (250-1 mol-mol),1.4855938894276637
SaOS-2,2746,3.4161371679978436
HEC-151,1566236,1.8834874590606951
SK-LMS-1,tanespimycin-bortezomib (250-1 mol-mol),0.2402445839028043
HCC2935,6918638,1.4896193076974535
VM-CUB-1,9911463,3.9957694448680265
SNU-1076,9926054,2.0143618167190493
SCaBER,3854666,0.3065476859554776
ACHN,11152667,-1.1903462602323582
NCI-H727,54618771,2.7901712320729333
BT 239,54618771,0.6858691475419959
MHH-ES-1,9911463,3.923380979166965
SK-MES-1,71751553,4.12788922702423
KMRC-2,3854666,3.8888485200781377
NCI-N87,11152667,-0.2953714197447944
TM-31,71751553,4.644454824252927
RERF-LC-Ad2,65628,4.3888994667995815
Hs 888.Lu,9926054,2.118592716385535
NCI-H2081,135421197,1.057518505455496
LN-229,54618771,1.209787731976597
SJSA-1,54618771,0.8793199356074002
TF-1,selumetinib-GDC-0941 (4-1 mol-mol),1.467323615098958
BT 172,6918638,2.2314251276093415
KP-4,9935249,4.396743844440814
FaDu,1566236,1.9343580286240425
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703
SNB-75,10322450,5.848985655680984
TE-11,135984461,4.268125230338474
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
NCI-H322,9915743,-1.5185613747470492
A-673,9911463,3.7053308577681583
HSC-4,3465537,2.7025414883497443
EFO-21,135984461,3.9887102664802807
SNU-1,9911463,2.449424301931946
DBTRG-05MG,9926054,3.4438340523747955
COLO 684,sirolimus-bortezomib (250-1 mol-mol),-6.565635252448311
NCI-H2342,9915743,3.0177583918562303
EC-GI-10,9926054,1.9054317321627203
RS4;11,100016,4.815282587104974
42-MG-BA,71751553,4.358509915414978
MOLM-6,selumetinib-GDC-0941 (4-1 mol-mol),0.1291930510848496
8-MG-BA,135984461,4.363641187325639
HuG1-N,100016,5.877444193140431
P-STS,3854666,1.06404979900826
Toledo,9911463,4.445021234029437
TOV-112D,2742550,4.171017848046487
SEM,2742550,2.6060865780770293
HGC-27,71751553,3.896602890461538
NCI-H1155,11152667,-0.9195037787444386
NCI-H1395,9884685,-0.0679636269907438
PL-21,54618771,-1.4027013448904684
HEC-1-B,135421197,1.3262919275478138
BICR 6,selumetinib-GDC-0941 (4-1 mol-mol),1.9156863537341864
NCI-H2141,3854666,2.106417752865544
A3/Kawakami,3465537,1.3050221927736254
SNU-16,135421197,0.9463670972041712
BT 147,9935249,1.8557182731997623
NB4,136227924,2.0986844076590616
WSU-DLCL2,2742550,3.021872637867583
JHUEM-3,6918638,0.235039867332202
NCI-H1299,100016,6.953805951258825
Sq-1,9884685,5.552272252484493
BT 416,135421197,2.461654603646364
NCI-H522,11494412,-0.7022253688217924
Lu-65,4705,2.2628868276979404
SK-MEL-2,1566236,1.8049776049740816
CAL-27,4705,0.9855510405669268
KMRC-1,71751553,4.436686890494674
COR-L279,54618771,0.9541573251908244
SNU-869,10322450,4.162727619764448
BT 224,168313307,4.4908402152924785
BT 416,9926054,1.8827513028201357
SNU-503,6918638,0.4427810712385108
BT 216,3465537,3.501074047645802
OAW42,9926054,1.8927643653266228
SUP-HD1,2746,2.2026290919231055
JHUEM-1,2742550,3.845716488362213
KMS-12-BM,9868037,1.5063019992906226
CHP-212,71751553,4.254165776093673
SNU-1033,54618771,0.4334411730243536
PE/CA-PJ41 (clone D2),9935249,3.298572074942043
Hs 766T,65628,4.740759619513126
A-673,4705,3.2416788332737454
Caov-3,tanespimycin-bortezomib (250-1 mol-mol),-1.0739653599444468
PE/CA-PJ41 (clone D2),9911463,4.289796480511007
WM793,9935249,4.106686148008307
BT 245,11152667,0.6307471035808881
LP-1,2742550,1.8998426324012776
DU4475,6918638,-1.1708823120268763
HEL 92.1.7,9935249,1.0850600770193293
NCI-H929,136227924,1.899057841083653
SK-MES-1,11494412,1.2665104699184024
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
HEC-59,135421197,2.778714880666289
JHOM-1,71751553,4.814264639455068
NCI-H1694,135984461,1.8368991431523527
Calu-6,9935249,2.2343949143207236
Hs 578Bst,9868037,5.270219324127126
P12-Ichikawa,sirolimus-bortezomib (250-1 mol-mol),0.3718187399928814
MIA PaCa-2,10322450,3.5979699373077585
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
Hs 888.Lu,4705,3.630552951351385
BT 416,9911463,2.4624621217887457
PC-3,selumetinib-GDC-0941 (4-1 mol-mol),2.4972652387658174
SNU-1079,3854666,1.692119471543111
LOX-IMVI,9915743,1.7866984805438202
LUDLU-1,10322450,1.9625689447261536
BT 416,6918638,-2.563404601621211e-06
NH-6,2746,1.9017163102404129
HEC-265,3854666,1.062389994601968
RT-112,11152667,0.0286911001185177
HCC2935,11494412,6.077431072444395
HCT 8,tanespimycin-bortezomib (250-1 mol-mol),0.9236703838462946
Jurkat,135421197,1.0042206438045034
RERF-LC-A1,49836020,4.4326562717782005
KYSE-150,1566236,1.943778647833198
Yamato-SS,54618771,0.3737524907753581
KYSE-450,136227924,3.5350495950730645
DU145,65628,4.2291081704038325
MKN7,sirolimus-bortezomib (250-1 mol-mol),1.1357480366001242
SK-MEL-24,9926054,2.7611591641517323
BT 248,3465537,1.7130202551321618
PaTu 8988t,9935249,3.4642640806067897
639V,selumetinib-GDC-0941 (4-1 mol-mol),4.596668684568556
NCI-H1792,9935249,4.999628575749727
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
DU145,11494412,1.9147313694004515
SNU-1,9884685,-0.7770944312630863
HCT 15,9911463,2.535565798999095
HL-60,54618771,-0.823810735668653
DBTRG-05MG,135421197,2.57791349467794
BT 330,3465537,1.066825715550645
HCC4006,100016,6.421907923076987
A2780,9926054,1.5482217772077662
JL-1,100016,8.572446789328106
EB1,9911463,2.50745807911791
SF126,sirolimus-bortezomib (250-1 mol-mol),1.2366353132911738
G-361,135421197,1.3668023463515628
DV-90,sirolimus-bortezomib (250-1 mol-mol),0.1354476911070701
NCI-H1703,4705,3.628855745395659
MKN45,11152667,4.066950092294402
SNU-407,136227924,2.9703344519672785
MDA-MB-231,9926054,2.3849554736036613
OAW42,3854666,1.601770174817354
NCI-H1666,4705,1.0065866231900624
253J-BV,3854666,1.39668141347677
HCC2935,135659046,3.704118522372791
Hs 578T,2742550,3.5663140561815525
NCI-H810,9911463,2.4681079610517394
WT2-iPS,11494412,4.82247788096836
EFO-27,9911463,4.361076045114702
PF-382,135984461,1.6582229573318208
NCI-H1563,9911463,4.06391181051362
T24,9926054,1.988465622132668
NCI-H520,1566236,1.8490403312922712
SK-ES-1,2746,2.7060210922441463
BT 145,54618771,1.0324414673710869
SK-MM-2,9915743,1.9327552948519848
HCC1833,100016,6.427561679501585
NCI-H1568,9935249,0.3822057580098375
KMS-34,2746,1.024640964168084
AU565,9911463,3.1332064122278687
SW1271,54618771,-0.1319273231055389
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
647V,sirolimus-bortezomib (250-1 mol-mol),0.3544770314623594
BT-549,100016,6.139281322747303
ChaGo-K-1,11494412,-1.211362160076409
IM95,3854666,2.5844605567324925
IA-LM,9911463,2.6703246121465436
NCI-H1703,tanespimycin-bortezomib (250-1 mol-mol),-3.1681297716810692
NCI-H810,9884685,0.0292455778048883
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
WM88,2746,2.5770363002684555
SCC-9,136227924,3.721677265331546
CHP-212,9926054,1.886787046066781
NCI-H1563,100016,6.550294719377214
SNU-C1,135421197,0.9147895752646428
BT 231,1566236,1.681485280274636
LN-229,9915743,-0.4123038394428829
KMS-12-BM,9911463,2.0749809508981256
RPMI-8402,65628,2.821796268032044
NCI-H358,9911463,4.09003122269505
B-CPAP,9926054,2.1103473685311043
NCI-H889,54618771,1.1876594721233993
KMBC-2,4705,2.3520992205272395
KATO III,1566236,3.1364594748652666
HuCC-T1,9926054,1.7884670483643574
NCI-H23,3854666,0.0313541683344203
NCI-H647,10322450,4.351576478086524
COLO 205,selumetinib-GDC-0941 (4-1 mol-mol),-0.1404403717614667
LS411N,9911463,4.267700407985282
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
SYO-1,100016,3.831378840669671
NCI-H23,2742550,5.761822709981514
Pfeiffer,2742550,2.1700000700098445
NCI-H2009,135421197,1.5480281661357902
NCI-H727,9935249,3.73205967923935
NCI-H747,2746,2.5698832282909665
RERF-LC-Ad2,selumetinib-GDC-0941 (4-1 mol-mol),0.4804595733416271
MDA-MB-415,6918638,0.6587420657172316
HLF,tanespimycin-bortezomib (250-1 mol-mol),-1.3704475916887384
RS4;11,9911463,2.865814362111231
Mono-Mac-6,9935249,1.9756983103736592
Kasumi-2,9935249,-0.6704419087402653
DLD-1,136227924,3.626313463652563
EC-GI-10,9911463,4.066814548265045
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
HCC1171,11152667,1.4462544365482133
AML-193,11494412,-0.7844966821773789
A-253,3854666,2.445612996132141
HuP-T4,selumetinib-GDC-0941 (4-1 mol-mol),-0.95779192570868
NCI-H441,9911463,4.313275778321212
PSN1,6918638,0.0567405704969879
Hs 944.T,9915743,1.2530099192350108
DAN-G,2746,3.5284338969271265
D283 Med,9935249,1.011376298828927
RD,9911463,4.091242805100522
JHH-5,135659046,3.6151990449321705
KYSE-30,9911463,3.831121744516391
G-361,sirolimus-bortezomib (250-1 mol-mol),0.933443297731252
JHUEM-7,100016,7.782886537779513
PaTu 8988t,9926054,1.9241127892750265
Karpas-620,1566236,2.834005518083698
BT 164,selumetinib-GDC-0941 (4-1 mol-mol),1.5214027789841535
Mino,136227924,1.7493984310197022
JURL-MK1,11152667,-3.3450890935441713
Malme-3M,11152667,3.7755207733410647
SK-MES-1,135421197,1.0053632050719472
SNU-620,tanespimycin-bortezomib (250-1 mol-mol),-1.6605884966990527
HCC1171,selumetinib-GDC-0941 (4-1 mol-mol),-0.4155569356036221
PLC/PRF/5,11494412,2.4031877451972754
COV362,100016,7.994124175315401
TE 617.T,9915743,-4.6063841978227
OV-90,sirolimus-bortezomib (250-1 mol-mol),0.2139978702426217
KYSE-140,135421197,1.0055598212916683
MeWo,2746,2.380002507942182
YD-38,9915743,-2.811758020987732
SF126,11152667,0.4115032346348637
MOLM-6,2742550,3.618071762117163
SW1271,4705,3.86061099620112
KYSE-410,3465537,2.783776931016741
Hs 294T,3854666,1.2484666832223503
42-MG-BA,tanespimycin-bortezomib (250-1 mol-mol),-2.385025804605588
SK-MEL-2,2746,3.33396317139844
Panc 04.03,9926054,1.9560696374821285
Hs 294T,6918638,1.5500466074402643
T-47D,44487872,6.149738415961402
OCI-M1,135984461,1.8150878916625208
HPAC,9915743,0.7621805259187995
NU-DHL-1,65628,2.3268847474457317
IGR-1,9935249,3.4531896518082745
HCC4006,9884685,1.1563651228927987
HCT 15,3465537,2.265148035694417
SNU-423,2746,3.5801912517104695
HEC-251,9935249,3.6457865673090097
CAL-33,3854666,0.8364949890662897
SU-DHL-8,9926054,1.545172236486763
A101D,3854666,3.889882258102607
COR-L105,11152667,-0.3968124554752262
Mel Ho,9935249,3.5260132794046597
KMS-18,11152667,-0.8948965427332419
RKN,3854666,2.132003481112045
HOP-92,135984461,4.9526709086531415
F-36P,49836020,5.768901368593018
EPLC-272H,9926054,1.8633723849420136
NCI-H1573,100016,4.561614919470221
LUDLU-1,1566236,4.083550355743597
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
HCC1419,4705,1.9049721189242583
Calu-6,9926054,1.940861811750295
NCI-H1184,4705,5.16871662983158
Hs 852.T,3854666,1.6640156687386156
ACHN,selumetinib-GDC-0941 (4-1 mol-mol),3.1627804075909727
BT 340,1566236,2.190598640135625
TE-11,9926054,1.7898768600573436
NCI-H1385,135984461,3.701163403463682
SNU-475,100016,7.606290519099935
C2BBe1,9884685,-1.1193256567794436
GMS-10,sirolimus-bortezomib (250-1 mol-mol),0.908148060868429
PC-3,6918638,2.0608196100088336
CAL-120,135398744,6.432645448228996
KYM-1,9911463,3.4885377293018154
COLO 320,11152667,1.0063426184228563
KCL-22,9935249,3.2284716714967296
Calu-3,9868037,2.901548984515766
HL-60,11494412,0.7668465686912257
SNU-1079,2742550,1.6275760819084113
NCI-H1693,2742550,3.606618769057063
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384
JHOM-1,9926054,2.608228459897926
OC 314,9926054,1.7783261777640869
BT 172,136227924,2.3975770198101545
YAPC,3854666,3.60977300269674
NCI-H2405,9926054,1.7306933863874645
SNU-5,9911463,3.488493689315011
AU565,1566236,1.7493429265082687
RPMI-7951,9911463,4.017661136446782
G-401,6918638,0.0373379560261908
COV434,135421197,0.3873638415100381
HuP-T4,2746,3.1090463727506257
BICR 18,54618771,1.6226277377850309
OVCAR-5,9884685,1.3438944937186146
EN,54639665,4.409810078244538
HuT 78,135421197,0.0616295171222303
OC 314,4705,3.18423368229223
NCI-H526,selumetinib-GDC-0941 (4-1 mol-mol),3.379534287031186
PK-59,9911463,3.8863333115764416
KMS-11,9868037,2.8057737885411855
NCI-H810,selumetinib-GDC-0941 (4-1 mol-mol),2.904538887533327
OE33,135984461,4.2867065871619445
MOLT-16,1566236,0.8818560395757914
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
NCI-H1373,135398744,6.356905852078599
KG-1-C,136227924,2.6958486075351944
NCI-H1435,54618771,-0.0103086846499203
SNU-503,9884685,0.6988570756468532
EBC-1,9915743,1.337451785479007
PC-3,tanespimycin-bortezomib (250-1 mol-mol),1.8125784159372291
NCI-H1623,65628,4.265717950525356
SU-DHL-8,73707386,1.513049090975232
8505C,100016,6.577733697234268
IGR-39,71751553,5.513684955203546
SNU-C2A,9911463,4.1542386249666094
HuH-1,2746,2.931726924620674
RVH-421,11152667,0.9057369680302438
Lu-99,2742550,4.2970950808030715
Malme-3M,selumetinib-GDC-0941 (4-1 mol-mol),-2.272222861013609
HCC202,135421197,1.3435596040644655
BT 330,9915743,0.5029117023680005
MDST8,9915743,3.1722151191536607
KG-1-C,4705,4.10841801715904
LMSU,44487872,4.479427716264116
WM983B,1566236,4.024003638692175
HLF,49836020,3.6461336560985087
JL-1,71751553,5.12535964256515
NCI-H661,selumetinib-GDC-0941 (4-1 mol-mol),1.8607941121872416
HD-MY-Z,100016,6.5820470291511555
Peer,2742550,3.1352268495567244
HL-60,2746,1.7934505084154275
MDA-MB-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.5607130395634891
MOLP-8,1566236,0.7132031003128095
SNU-387,1566236,3.889303411236744
Rh18,9911463,3.04547091228865
HuNS1,71751553,4.7444430749787445
EPLC-272H,10322450,3.877521478432198
KNS-62,9884685,1.806452906595739
NCI-H322,selumetinib-GDC-0941 (4-1 mol-mol),1.023926311645034
SK-MEL-1,9935249,4.4226392340907825
Hs 578Bst,9911463,4.212238001895026
ONCO-DG-1,54618771,2.377307525963503
Karpas-299,9935249,2.202712445766307
TE 617.T,135659046,3.676706194159886
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306
HD-MY-Z,6918638,0.9232072898358828
IGR-37,24779724,4.966607724183206
SNU-182,9926054,1.7680094082282705
HCC2218,9911463,3.007199101123831
SCaBER,1566236,1.7257780630033532
U2OS,136227924,2.232158663555595
ESS-1,11152667,-1.1144895141014577
NCI-H1944,71751553,4.042430534033758
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
Hs 766T,9935249,3.1459516171029924
TOV-21G,6918638,1.3242301911997263
HL-60,11152667,-0.8354420378718092
TE 441.T,9915743,0.2395120621423657
NCI-H1869,100016,6.8338343579730285
A2780,2742550,2.799223861459344
EFO-27,9915743,1.432055126276498
BT 139,9868037,3.9588523345635376
GA-10,49836020,3.868484173874789
HCC44,135421197,1.110305691716081
MOLT-16,9935249,1.302591205382856
SNU-601,9926054,1.5128291451092608
BT 216,9926054,2.3183160666654783
SUP-HD1,9926054,1.7829346209502994
EHEB,9911463,3.619047359567488
BT 172,tanespimycin-bortezomib (250-1 mol-mol),-3.8739618006203655
CAL-27,54618771,1.1214145254285035
TE-11,1566236,3.9613648784907625
CAL-33,6918638,1.6029165317197565
JHH-5,selumetinib-GDC-0941 (4-1 mol-mol),1.0650507170556407
Ki-JK,11152667,-2.3089641882656977
Hs 895.T,9884685,1.2058829180471424
U-937,1566236,1.2304884719985758
SNU-1033,2742550,3.4354448610207555
DAN-G,1566236,4.031993556597769
A-498,sirolimus-bortezomib (250-1 mol-mol),0.4701899983837266
DEL,9911463,3.5570893591949932
HT,9884685,-1.5332342214712364
OCI-Ly3,71751553,4.255231078422555
Caki-1,71751553,5.630510939066582
KMS-20,11152667,-1.0661904813825076
KO52,9884685,2.8647583667584553
TC-71,4705,3.1245427089592757
NCI-H1944,selumetinib-GDC-0941 (4-1 mol-mol),0.8132454381958738
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956
HCC1428,9911463,4.299453342074575
OV7,sirolimus-bortezomib (250-1 mol-mol),0.4269208814409986
OCUM-1,11152667,-4.397219169137368
RERF-LC-A1,selumetinib-GDC-0941 (4-1 mol-mol),3.459186933832629
EPLC-272H,135984461,4.356023711246228
IGROV-1,135421197,1.96820638017286
NCI-H446,73707386,2.6989989368624476
SW1417,9926054,1.9097255829508144
SNB-75,3854666,4.127790081674319
A2780,3465537,2.6217509140821247
Yamato-SS,1566236,3.4847720151894395
BT 444,11152667,1.5346821618799644
SNU-1272,10322450,4.07877256776116
ESS-1,9884685,0.689834242395422
BICR 16,100016,8.634217681257812
TCCSUP,11152667,-1.0569561728619483
MOTN-1,11152667,-1.6889217949973774
NCI-H1092,6918638,-0.0011423595466388
SUP-M2,135421197,0.9814934118096088
Hs 688(A).T,11152667,1.3458070732124674
HOP-62,tanespimycin-bortezomib (250-1 mol-mol),-2.1315828929129332
COLO 800,3854666,3.110464063654363
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
BT 164,9915743,0.6934008137449594
SUP-HD1,sirolimus-bortezomib (250-1 mol-mol),-0.240213465841402
RPMI-8402,tanespimycin-bortezomib (250-1 mol-mol),0.8651644866846245
J82,2746,4.586638058567165
A-549,sirolimus-bortezomib (250-1 mol-mol),3.1342605307432567
NCI-H1155,136227924,2.9905910988633653
G-401,11152667,0.9519757620011424
J82,136227924,3.3108045260668564
Hs 895.T,9915743,1.4498545473897326
PSN1,9911463,4.382520563111527
HDQ-P1,9926054,2.660031643800519
SK-MEL-3,1566236,2.444556915654436
NCI-H2228,4705,2.420157544814273
SW1271,3854666,4.252835819462087
SIG-M5,9935249,-2.10947388119983
Karpas-620,9911463,4.471669059123084
5637,9868037,3.3749998871313127
TE-14,2746,3.3749666856765304
BHY,136227924,2.366046867351899
NCI-H1339,selumetinib-GDC-0941 (4-1 mol-mol),1.2226355569779708
BT 139,3854666,3.266069647715192
BT 228,9915743,2.3964891014052943
SK-MEL-28,3854666,3.183656457854027
UM-UC-3,54618771,3.8430059461326658
SBC-5,9911463,4.310936662946409
OAW42,100016,6.607597097790758
PE/CA-PJ49,9915743,0.4153900299925456
HuP-T3,11152667,0.3145958176635
RS4;11,sirolimus-bortezomib (250-1 mol-mol),0.1711857782285224
CAL-29,11152667,-1.4112558222688478
HuP-T4,2742550,4.819776074763647
EFO-27,10322450,4.618987367546035
Hs 578T,9911463,4.370366906905746
KP-3,9926054,1.9542215923866435
JURL-MK1,sirolimus-bortezomib (250-1 mol-mol),0.9558536767512098
YD-15,136227924,2.6934840054154834
SaOS-2,135984461,4.8186429168984475
KATO III,9884685,3.32909591420453
ECC10,11152667,0.6554196221982307
F-36P,71751553,4.682679613514395
A2058,sirolimus-bortezomib (250-1 mol-mol),2.018085480755274
SF268,2742550,4.301402217118159
HCC-56,71751553,4.790643666333034
LS411N,136227924,3.1900427132689724
NCI-H1563,sirolimus-bortezomib (250-1 mol-mol),2.9865151808582615
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
BT 145,11152667,1.0829552728349376
HCC4006,9926054,1.7314546414063618
CAL-54,9915743,0.6596692010948818
KP-2,9935249,3.768117101530522
RERF-LC-Ad2,2746,5.029161088145208
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
CFPAC-1,3854666,3.9218760682690545
MOLP-8,2742550,3.824247044326815
HOP-92,2742550,6.370201560373045
ZR-75-1,135421197,1.3077773564492
TE 441.T,3854666,0.9289040865316472
UACC-62,9911463,4.3555610990342615
ME-1 [Human leukemia],135984461,2.3168305015054793
HCC2279,selumetinib-GDC-0941 (4-1 mol-mol),1.829926030012146
LP-1,9911463,2.6220620880442773
NCI-H322,2742550,4.207154778137866
KALS-1,650361,4.294663890793572
J82,11494412,3.499670592008664
SNU-308,tanespimycin-bortezomib (250-1 mol-mol),-1.0172716653448413
KCL-22,9926054,1.5140986246434818
Kasumi-1,11494412,0.3722538658063193
SK-MEL-24,sirolimus-bortezomib (250-1 mol-mol),0.9554095387328968
QGP-1,selumetinib-GDC-0941 (4-1 mol-mol),1.3136510607151746
HCC1937,sirolimus-bortezomib (250-1 mol-mol),0.6036989015606368
SU-DHL-8,9868037,2.223027391830787
COLO 684,54618771,1.417005870587021
TE 617.T,11152667,-1.0765284818833325
NCI-H69,9915743,1.0136854730638705
EFE-184,3854666,3.747321393651702
L-540,4705,2.669607218607157
BT-16,1566236,4.246582335480924
TE 617.T,54618771,-2.3163435045847436
RPMI-7951,136227924,2.219680452566263
OCI-Ly3,selumetinib-GDC-0941 (4-1 mol-mol),1.725768146081181
SNU-449,selumetinib-GDC-0941 (4-1 mol-mol),2.576796761551289
Daudi,54639665,4.383406013207389
SNU-1076,11152667,0.2599051324779742
MOLT-3,2746,1.7836701533013988
PLC/PRF/5,1566236,1.8943301700866575
JURL-MK1,9915743,0.946381424496901
NCI-H2141,11494412,0.5114354173300891
NCI-H1105,2742550,3.8038005756853575
HEL,9926054,1.596813412273358
CCK-81,selumetinib-GDC-0941 (4-1 mol-mol),1.1249387686067662
NCI-H2291,sirolimus-bortezomib (250-1 mol-mol),1.1125015078342035
TT2609-C02,54618771,3.852922772730834
RD,11494412,1.018514928419539
DAN-G,71751553,4.949444751940985
WM266-4,9935249,2.973624182923004
Lu-65,9926054,1.7186862089776234
OCI-AML-3,9935249,-0.327940311351079
Rh30,135421197,2.937313489864044
NCI-H1092,65628,3.8308798172666183
SNU-5,9935249,3.5189415375312696
BICR 56,selumetinib-GDC-0941 (4-1 mol-mol),-1.0561550719087085
SNU-C5,3854666,1.9958774012372615
HeLa,3854666,0.8309069429521455
TE-5,tanespimycin-bortezomib (250-1 mol-mol),-0.0271595153409523
PaTu 8988s,100016,6.475282567189534
BFTC-905,9911463,3.2243947261734114
NCI-H1693,selumetinib-GDC-0941 (4-1 mol-mol),1.7777896818074843
OCI-M1,71751553,4.386393852068909
BICR 18,tanespimycin-bortezomib (250-1 mol-mol),-0.1167236068858008
COR-L105,9884685,2.6443959528770167
GSU,9911463,4.305557619693962
HCC1954,9911463,3.8607019439121046
23132/87,54618771,0.9253043807120772
MHH-NB-11,11152667,-1.8020603345616932
DAN-G,11494412,2.594711153246368
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258
IST-Mes1,9926054,1.778703370274458
Ri-1,9868037,1.6681879870423917
Hs 729.T,9915743,2.696415858684256
Hs 822.T,9884685,2.2881978726594028
RT-4,65628,4.4679434201664945
NCI-H1355,9911463,3.4182526352072458
MOTN-1,4705,3.315167180619075
U-251MG,2746,3.594174971863172
HGC-27,selumetinib-GDC-0941 (4-1 mol-mol),-0.8359606589249554
HCC1954,135984461,4.275090239717432
BICR 31,2746,4.041774334142006
NCI-H1693,6918638,0.9296427342900364
BT 164,9884685,0.1084711288481639
CAL-54,selumetinib-GDC-0941 (4-1 mol-mol),0.8998815087239347
TF-1,9911463,2.560339190284904
PE/CA-PJ34 (clone C12),9915743,-2.2300833448892985
LN-18,11152667,-1.441877874591565
SUP-T11,selumetinib-GDC-0941 (4-1 mol-mol),2.192774933353548
NCI-H1373,selumetinib-GDC-0941 (4-1 mol-mol),2.438730896518944
HEC-1-A,11494412,2.510528357240151
NCI-H1341,100016,3.8327529210726903
TE-11,135421197,3.0798207714757906
NCI-H2126,135984461,4.348748825653974
NCI-H1694,100016,6.457618599357896
P12-Ichikawa,73707386,3.4499084060111445
SH-4,9926054,1.7270263084889954
COLO 320,9935249,2.096184530518157
HCC1833,135984461,4.342714287426043
BT 164,tanespimycin-bortezomib (250-1 mol-mol),-0.668704186369019
GA-10,65628,2.41107724577683
SNU-398,135421197,1.394943523979563
RL,11152667,-0.9516536352115936
PK-1,sirolimus-bortezomib (250-1 mol-mol),1.545806469698299
NCI-H1341,selumetinib-GDC-0941 (4-1 mol-mol),0.3827497304694547
MOLP-2,9911463,4.414943905167103
F-36P,11494412,-1.3209854958695244
SNU-1079,54618771,-1.146333378136814
PC-3,9911463,4.050651586625943
NUGC-3,11152667,-0.5905276129747937
NCI-H2081,11494412,-0.0076516448343769
SK-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.3293932534534852
KYSE-30,136227924,3.298083829392356
HCC2935,sirolimus-bortezomib (250-1 mol-mol),0.5945661645124948
HT-55,sirolimus-bortezomib (250-1 mol-mol),0.7805175960520967
HuT 78,65628,5.4520261644264165
8505C,73707386,3.3239741118236044
SNU-C4,135659046,3.741001197926473
WT2-iPS,9915743,3.010959085060511
DB,4705,3.0475659193893296
Calu-6,54618771,1.0169937306444143
HEC-151,3854666,1.712269153838878
MKN7,65628,4.295843593821497
NCI-H1694,tanespimycin-bortezomib (250-1 mol-mol),-0.386320713281567
PE/CA-PJ15,100016,6.230779358531284
SK-N-MC,selumetinib-GDC-0941 (4-1 mol-mol),1.42335889342789
MDA-MB-435S,2746,3.2936917461422426
NCO2,100016,5.1199760357582385
OC 314,3854666,-0.6017079238350578
F-36P,135421197,1.230502256000523
ACC-MESO-1,135984461,6.029797163877839
BT 228,9926054,2.418157139092261
EJM,2742550,4.0665181922374805
EKVX,9911463,3.45817686520516
CAL-120,selumetinib-GDC-0941 (4-1 mol-mol),2.9364136017139932
Hs 766T,1566236,3.04131244391702
Becker,9884685,-0.0960658377350512
MIA PaCa-2,3854666,0.8531836291018433
NCI-H23,9935249,1.5546274820807884
HCC2108,tanespimycin-bortezomib (250-1 mol-mol),-0.3667697976747508
NCI-H1435,9911463,2.965679998241422
SW48,2742550,3.28553671385033
MFE-319,9935249,3.387887066953814
LUDLU-1,136227924,3.2639698653649254
SNU-899,9868037,2.9097531186900536
JM-1,54618771,-0.5043757930015165
COLO 668,1566236,2.0753956808057072
CA46,6918638,-2.155597959241919
SW1353,135984461,3.620259529955406
BT 333,136227924,4.6219554593863075
SNU-1033,sirolimus-bortezomib (250-1 mol-mol),0.349990621506149
LNCaP clone FGC,sirolimus-bortezomib (250-1 mol-mol),-6.240208819655782
MEC-1,135659046,3.430654530654597
LC-1/sq-SF,1566236,4.426287640720265
IM95,71751553,4.314578700875926
HCC827,9915743,-2.5410079672049446
HDLM-2,54618771,0.2228052898730796
HGC-27,9911463,2.724483471079002
Calu-1,9911463,4.35367590047306
SW1573,9911463,3.734935340044018
BT 440,sirolimus-bortezomib (250-1 mol-mol),2.4257327980261936
U-CH1,9911463,3.7817201694123432
HT,9935249,2.103185333162581
UACC-62,sirolimus-bortezomib (250-1 mol-mol),1.7829668045842757
JHUEM-7,135398744,6.411220982649173
Peer,65628,4.247857610781868
OCI-AML-3,11152667,-2.175996552901593
BT 232,54618771,0.7442415190466014
MHH-CALL-3,1566236,1.809290756960591
HL-60,100016,6.415560767920564
RERF-LC-Ad2,9915743,1.500109019763864
MEC-1,49836020,4.363121412189612
KP-N-SI9s,9935249,3.2907228390265084
KALS-1,11152667,-0.748944464329897
A-498,168313307,4.423397924448837
K029AX,135398744,6.420759462552213
NCI-H1869,135984461,4.367577543921494
NCI-H1299,9926054,1.7323284970245385
AML-193,135659046,2.987496818828137
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
HT-29,9911463,4.192139664463844
PaTu 8902,11152667,1.2355675895718252
KYSE-510,6918638,1.620078603816946
UM-UC-1,3854666,1.8827049614808689
NU-DUL-1,1566236,0.5337861668433016
SNU-407,1566236,1.7858742258512093
Tm87-16,71751553,4.289418278764033
NCI-H1869,1566236,2.8728790566593747
Caki-2,136227924,3.8399348879900854
T84,6918638,0.2315605213048026
MOLT-16,135421197,0.9266017011835492
Kasumi-1,9884685,-1.171230132839738
SNU-387,9911463,4.312383544863764
Toledo,2742550,4.189693729696579
SK-MEL-5,9935249,4.115682360197781
NCI-H2081,2746,1.7876165118995768
SU.86.86,tanespimycin-bortezomib (250-1 mol-mol),0.1396013159425142
647V,9935249,3.25283943928746
CAL-54,100016,6.472919480601912
K-562,6918638,0.0740833242167517
Hs 934.T,3465537,2.411494715947719
SYO-1,2746,1.3641867767791351
JHH-2,9911463,4.025209032029127
Hs 822.T,71751553,4.5741055393957515
VCaP,9911463,3.952912743808643
42-MG-BA,135421197,1.023186017239741
Hs 888.T,10322450,3.2748281083496114
BC-3C,9915743,1.1334859275806484
Rh18,11152667,0.4315995494314446
NCI-H1869,11494412,4.466275600700225
A101D,9911463,4.385774367797012
GP2d,11152667,-1.1349019914223002
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
OVK18,135421197,1.6539511410681966
NCI-H1838,135421197,3.0892223680095077
PSN1,2746,4.086398996517882
FTC-238,6918638,0.6994122204113324
COLO 668,2746,3.082307436589746
CAL-12T,3854666,1.7732900295256924
HCC38,1566236,1.6073129295205384
DEL,9935249,3.169689797008309
SNU-478,9935249,3.458613578481264
JVM-2,11152667,-2.7222121764526372
Aska-SS,9911463,4.275261976243402
BT 320,11494412,4.421767883618589
SK-HEP-1,1566236,1.7725788045776691
CAMA-1,73707386,3.5601870738851997
UM-UC-3,9926054,2.187616038354346
KE-37,9911463,3.0387406165945383
CAL-85-1,136227924,2.9828253747888067
HGC-27,54618771,0.7122849148463839
CA46,9935249,0.2545497442771542
LP-1,135984461,3.5540732743417665
BT 145,49836020,5.352704973250576
Mino,11152667,-1.4239628293556983
U-251MG,135659046,4.3313031112664095
639V,54639665,5.761167112647425
HCC1438,54618771,1.468368103137055
SNU-81,9926054,1.3093723678717843
MEC-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4728620848599026
GDM-1,10322450,3.191264659365354
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
HCC1500,54618771,1.4039271563223086
LK-2,10322450,2.8029884793598177
KMRC-1,100016,6.458679548763862
SK-LMS-1,3854666,1.8023710888832385
HLF,44487872,4.498501289677035
KCL-22,136227924,2.6502010503693016
BL-70,9884685,-1.719750861009791
SNU-1076,3854666,0.6976917906829407
MM1.S,49836020,3.8296017324588942
A-172,135421197,2.0454281917849357
MKN1,135421197,0.9793646210495068
Panc 04.03,10322450,4.721553837851545
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
EB1,135421197,0.2915543489276729
KM12,9935249,3.2460042952821024
BT 179,71751553,4.552917707943204
SET-2,135659046,3.4006834919950006
TUHR10TKB,49836020,-1.137446729131538
BT 416,54618771,0.7344198776151593
RPMI-8402,9884685,1.0462032171352182
COLO 680N,136227924,3.1124323049819003
CAL-54,11494412,1.9724294528675907
U-251MG,3465537,2.0313719983720633
HT-144,2742550,3.8917870100143257
HCT 15,9935249,2.820339042692745
GCT,9884685,2.068707809781696
DBTRG-05MG,1566236,3.403448822293681
SF126,54618771,1.1174524755985609
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175
SNU-478,136227924,2.019778672481118
NCI-H1339,tanespimycin-bortezomib (250-1 mol-mol),-2.1721885896548514
C2BBe1,6918638,0.4020582532011564
L-428,3854666,0.4436949042034823
COR-L279,9884685,-1.0321126972364183
NCI-H1299,65628,5.181040397435313
KG-1-C,11152667,0.3070141898417881
KE-37,2742550,3.1393906639463
HSC-4,135659046,3.804399419736421
BT 444,135659046,3.767514231738307
NCI-H322,3465537,3.325986658577423
EFO-21,10322450,5.02193128329613
HEC-265,136227924,3.2525592636436405
EFM-192A,sirolimus-bortezomib (250-1 mol-mol),-0.607233737838293
SK-LU-1,4705,2.465937162773369
253J-BV,2742550,2.542605823634484
EBC-1,9911463,2.6275230759379933
KYSE-520,71751553,4.200829163158519
HT,9911463,3.44376520524061
BT 112,3854666,0.1986005618410543
U-87MG ATCC,9926054,2.857820648476152
SK-N-BE(2),9868037,2.6667298506556447
UACC-257,selumetinib-GDC-0941 (4-1 mol-mol),-0.8117172075049729
RL95-2,3854666,0.9415814942039398
L-428,9915743,0.0978026688985125
SK-MEL-3,11152667,1.7453060671217775
SK-MEL-31,3854666,3.574297358855384
HCC1438,9868037,4.0008009235248005
PC-14,100016,6.551425062945198
PSN1,2742550,4.257797435139967
U266B1,3854666,0.4975147801712618
HD-MY-Z,54618771,0.9859939173589182
OV56,tanespimycin-bortezomib (250-1 mol-mol),1.0708573891285402
PaTu 8988t,6918638,2.256433939948275
NCI-H1792,selumetinib-GDC-0941 (4-1 mol-mol),1.680387740806623
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407
Li-7,135421197,2.8637872744317763
CAL-85-1,9915743,-0.3969926925010483
NCI-H1623,selumetinib-GDC-0941 (4-1 mol-mol),0.8054769318526331
Calu-3,54618771,0.5501561277635466
HSC-3,11152667,0.7686574426782067
FTC-238,2746,3.1491636542411605
LS411N,54618771,1.0517408544895162
TT,136227924,2.992692937715844
YKG-1,1566236,3.4432239781359577
LOX-IMVI,136227924,2.635687863612288
OAW28,2746,2.637952220594215
FU-OV-1,136227924,3.2834953568281597
NCI-H2196,9915743,2.494227946954125
Panc 10.05,65628,4.812367305175919
NCI-H841,135421197,2.4797318977451095
DU145,10322450,6.851968050616261
RD,49836020,4.595069513532316
EN,54618771,2.591553593247422
HEC-151,tanespimycin-bortezomib (250-1 mol-mol),0.2767790074283919
42-MG-BA,24779724,4.9915900210245105
MJ,9915743,1.766638415426978
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
NCI-H358,selumetinib-GDC-0941 (4-1 mol-mol),-1.5970203411339507
JHOS-2,135984461,4.415400974704629
SW948,6918638,-0.8188756331889222
GA-10,71751553,3.203587324288507
DB,54618771,1.151207273522801
SNU-C1,6918638,-0.1919705082946097
Hs 944.T,65628,3.908889176196175
T84,100016,6.649554415164183
SNU-761,selumetinib-GDC-0941 (4-1 mol-mol),3.4718208794514167
YH-13,135984461,4.0881390777757245
SK-HEP-1,135421197,3.339831791709741
T24,9935249,4.082261815978772
FaDu,65628,3.984705708438991
BT 271,11152667,0.7182560535051697
TE-1,9935249,3.915142612487917
OCI-AML-5,9911463,4.375280736441336
FU-OV-1,73707386,2.8924737769549633
KMS-34,65628,2.7326154382917607
HCC1438,136227924,3.0530124683265725
NCI-H1339,135421197,3.8934160378835054
MDA-MB-435S,54618771,0.9964394209064932
MeWo,9915743,1.4031179966359888
HEC-108,9868037,3.1019775097215554
OCI-Ly19,2746,2.185882112946918
NCI-H1650,54618771,3.34176248194117
LNCaP clone FGC,tanespimycin-bortezomib (250-1 mol-mol),-2.6061183463030138
NCI-H1650,11152667,-1.7139939862640134
A-549,1566236,4.271699172517002
BT 444,136227924,3.5279486847576886
MOLM-6,sirolimus-bortezomib (250-1 mol-mol),0.6452652216759648
Pfeiffer,11494412,-1.5298938903732595
SU-DHL-10,9911463,2.7102339081267948
SNU-899,9915743,1.4111818856730072
GCT,tanespimycin-bortezomib (250-1 mol-mol),0.7186181372238337
RPMI-6666,9911463,2.703428779423556
MDA-MB-453,54618771,-0.4179555738274852
NCI-H1650,tanespimycin-bortezomib (250-1 mol-mol),-0.4838646802432306
KMS-28BM,selumetinib-GDC-0941 (4-1 mol-mol),1.2761888843371896
AsPC-1,54618771,1.0442216511349782
OE21,11152667,-1.518661040860189
SW1116,2742550,3.2977805707201675
NCI-H841,1566236,1.6695329258140523
HCC95,11152667,-0.1847959805543043
8505C,9915743,3.019446627889447
NCI-H1563,135984461,5.495757685430573
KYSE-520,selumetinib-GDC-0941 (4-1 mol-mol),2.0690481757247037
SNU-423,10322450,4.431866174300737
ZR-75-30,100016,8.126082181881081
NCI-H2286,3854666,0.7538606981908345
SNU-398,135984461,5.493775428408586
JJN-3,135398744,6.34309809291168
KMS-20,54618771,0.3177440488164709
MG-63,65628,4.3545217389034425
SF268,11152667,-0.399676086943417
BT 428,135659046,3.573763038343519
KMRC-2,sirolimus-bortezomib (250-1 mol-mol),0.567306978247713
RPMI-7951,650361,3.986097803134267
NUGC-4,9915743,-4.1416967256258275
SK-CO-1,2742550,3.074063089907043
J82,11152667,-0.0912735424219637
SKM-1,9935249,2.0831236560196147
WT2-iPS,65628,3.328166240276732
SNU-601,sirolimus-bortezomib (250-1 mol-mol),0.628067282313429
U-251MG,24779724,5.1714808067165
HCC95,9926054,2.566209783667777
MFE-319,3854666,1.5302957515422178
JK-1,135421197,1.447193045378296
Mono-Mac-1,4705,2.1526940159262593
NU-DHL-1,135421197,0.761695548293036
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
KMS-21-BM,136227924,2.0166655260293487
DMS 273,71751553,4.31191978803821
DMS 114,135398744,6.443015881513616
OV56,135421197,2.071998378530058
WM115,9911463,2.5241618652619007
NCI-H460,3854666,3.1385110084048065
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
NCI-H28,11152667,-0.8241097892639433
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
KMH-2,9868037,1.8367202409128176
JHH-4,6918638,0.0313135424356484
JHOC-5,135984461,1.694493037424127
CAL-33,11152667,-1.543751172579295
Malme-3M,9868037,3.7927874033279703
NCI-H2196,9884685,-0.5196236885071903
KALS-1,9926054,2.3431755062482487
UACC-812,9935249,3.1921366544842
G-402,1566236,1.655640146211604
SNU-216,136227924,2.452598137182288
YH-13,2746,3.803826628530811
NCI-H661,135421197,1.0600684669241136
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
TE-1,selumetinib-GDC-0941 (4-1 mol-mol),3.018112465414828
NCI-H810,1566236,1.1113162433781687
SF126,9935249,3.7437112279707185
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
SK-BR-3,9915743,-3.880272444164353
SK-MEL-3,sirolimus-bortezomib (250-1 mol-mol),0.3038157322659797
SKM-1,9926054,1.2950133266657913
SU-DHL-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6950122900269923
U-118MG,3854666,2.832586657113328
NCI-H1395,54618771,3.4411900765558125
HT-1197,135984461,4.813315019512045
U-251MG,136227924,4.317491880233533
LOX-IMVI,9935249,3.870791681758961
NCI-H2106,136227924,2.8262070038466955
HEL 92.1.7,9884685,1.1070075347275754
BT 359,9868037,4.109229289751441
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
COR-L95,135421197,1.4504202802892363
DMS 273,135659046,3.477426326571923
JHH-6,3854666,4.002777094361515
LS180,136227924,2.415770069388299
NCI-H446,2746,2.3498670428559807
NCI-H1435,selumetinib-GDC-0941 (4-1 mol-mol),1.0023239879000474
AGS,9868037,3.4891422873048046
HT-144,9911463,4.304760863766968
COLO 678,136227924,3.6500617296173288
SNU-410,2742550,3.711358313306516
COR-L95,9911463,4.18924595414168
OPM-2,135421197,1.341685947169011
NCI-H2110,135984461,4.3368706411004325
VMRC-RCW,9911463,3.519354422119686
LMSU,2746,4.6094970791668315
RS4;11,136227924,1.742872720779967
CAL-85-1,49836020,1.7789600466695898
T3M-10,11152667,-0.370129452740934
MOR/CPR,9868037,3.699217434711235
UACC-62,2742550,3.809853081967923
HCC-56,135984461,4.583376296349448
YAPC,9915743,1.8269757962027744
SNU-C1,tanespimycin-bortezomib (250-1 mol-mol),-0.731545490498155
LS513,73707386,4.571028126982481
IA-LM,11152667,1.0642318645878492
SNU-449,11152667,1.3844218204303944
Reh,9915743,0.535170068043037
CAL-51,2742550,4.689941422286605
Calu-6,136227924,5.658776934081175
NCI-H2286,9911463,4.284933717494527
NCI-H2170,sirolimus-bortezomib (250-1 mol-mol),0.3634507455744757
Capan-2,135659046,4.498205375540461
IPC-298,selumetinib-GDC-0941 (4-1 mol-mol),-1.1184200059628775
HT-29,selumetinib-GDC-0941 (4-1 mol-mol),2.4520768151927976
CA46,9915743,0.7447060154867644
SK-BR-3,3854666,0.6288211894501958
NCI-H1623,9926054,1.7409203229588674
SNU-899,11152667,0.5219214178176714
A-498,6918638,1.620608219340894
HuNS1,9915743,0.7777068121651658
NCI-H508,9926054,1.9520179071989003
BV-173,9935249,1.1911732484782378
KMBC-2,135659046,3.5104960306219155
SNU-1079,selumetinib-GDC-0941 (4-1 mol-mol),-2.187846560815933
PE/CA-PJ34 (clone C12),9911463,3.905990041696765
BT 330,11152667,1.4109610692427392
SNU-869,135659046,3.721754177816309
CAL-54,135659046,3.5874305591890256
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392
MOLT-16,49836020,4.026167262908274
Tm87-16,49836020,-0.9947449056575012
C2BBe1,4705,2.8323844421338324
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
NCI-H1693,49836020,4.720041053935088
SNU-685,3854666,2.1125077744933
JK-1,100016,6.141145240463154
PE/CA-PJ41 (clone D2),65628,4.385016080496858
P3HR-1,9884685,0.0475249216128984
Kasumi-2,9926054,1.3771704127752784
HCC1419,54618771,0.889402864117146
SNU-886,9884685,0.7167053677402274
LNCaP clone FGC,9935249,1.606284127709269
SNU-878,54618771,0.5665140825302253
NCI-H1755,9911463,3.444248819442768
NCI-H1703,9915743,0.7424925656484964
SW982,135984461,2.5678712779652364
COLO 320,11494412,1.2110746429620267
NCI-H1944,135421197,1.84181744698867
SNU-449,9911463,3.778924364931394
JHUEM-3,9935249,3.4231296114502068
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
NCI-H1650,2746,3.978561009929137
HuH-1,4705,4.381282786595648
Malme-3M,6918638,1.0970595783496475
NCI-H1395,9915743,5.704472879097531
MOTN-1,100016,6.2802968176710445
NCI-H1666,9935249,2.383353166083433
IM95,100016,6.474511795509729
BT-20,9884685,0.8317755642556006
NCI-H2196,9926054,1.658766361497933
BT-549,49836020,-1.94641857460656
L-540,135421197,1.2106932508822246
NCI-H2171,11152667,-0.915095731247344
KMS-11,44487872,4.082164397360745
RCC10RGB,9915743,0.9759946846108524
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
SCaBER,9915743,-1.392407899834092
BT 232,9935249,2.6697754129604183
PaTu 8988t,9911463,4.367264855700764
42-MG-BA,6918638,1.602058040932412
SaOS-2,1566236,1.7620742085681662
KMS-26,73707386,2.0283413542396365
COV362,24779724,4.394288527377943
SK-MEL-31,9926054,3.613636907383419
EKVX,11152667,1.24553116907644
U-BLC1,3854666,3.2538263988952534
OE21,135984461,4.867121216346128
PaTu 8988s,6918638,1.3708196410669105
SNU-308,selumetinib-GDC-0941 (4-1 mol-mol),1.3521020528190912
ME-1 [Human leukemia],3854666,1.822762737344071
Karpas-422,49836020,3.572840137931533
NCI-H2170,3854666,1.5230641106876586
Calu-6,11152667,-1.6386205302726315
MKN74,4705,5.009866699561135
NCI-H441,9935249,4.015307304312089
WM115,4705,2.3860154683324897
EKVX,6918638,2.279509875261518
OE19,sirolimus-bortezomib (250-1 mol-mol),2.347707563651812
BT 330,11494412,3.1533604427813833
BICR 6,65628,4.292883800732888
Karpas-620,136227924,3.0310478312116467
Tm87-16,9911463,3.8938855092804454
IM95,136227924,1.5571875137371276
U-251MG,selumetinib-GDC-0941 (4-1 mol-mol),1.876710388033308
A-375,9935249,3.760967262961611
OE19,71751553,5.043181894493393
BT 286,10322450,5.184244057340175
SNU-C1,135398744,6.35894151615267
SK-BR-3,71751553,4.291196523141903
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
DB,49836020,4.238014398783195
CAL-62,2742550,4.603848898842044
KG-1-C,9915743,2.9302265350196315
HuH-28,54618771,1.3880976899184387
BT 228,tanespimycin-bortezomib (250-1 mol-mol),0.2023623064786018
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034
SNU-869,11152667,0.3812635199782596
MDA-MB-435S,9915743,4.554328214645058
BT 428,6918638,-0.3537388396166394
BT 228,9911463,2.83539892477779
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
SCC-4,11152667,-1.3827031006544217
HEC-251,135421197,1.306349279370071
BT 504,136227924,2.4961671253802957
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044
BICR 16,9868037,4.084276624251401
A-375,9911463,4.039687099931349
NCI-H1105,49836020,4.351413850540497
SK-N-SH,65628,2.1902058343213655
SK-N-FI,4705,2.5887830768874993
A-498,54618771,1.1394352833671273
GSS,selumetinib-GDC-0941 (4-1 mol-mol),0.7443695681674949
SEM,9935249,-3.4494441375925153
HCC1569,135984461,4.511721689442577
TT2609-C02,4705,3.2623564948908106
LoVo,9911463,2.8816718818913176
Hs 940.T,10322450,5.493990907316365
LS180,11152667,-1.0678137233062412
TCC-Pan2,135984461,4.348420574958303
MV4-11,9884685,-1.1493564195895725
Ki-JK,65628,3.9116740915216894
NCI-H1299,2742550,4.427150184712593
YD-8,9935249,3.870405994417823
OE21,4705,-2.1528136210817324
LoVo,49836020,1.6927786584323
TE-10,9915743,-1.7671163693014442
SNU-466,9935249,3.051741222660739
TT2609-C02,135984461,4.527681424871781
NCI-H28,tanespimycin-bortezomib (250-1 mol-mol),-3.05578817250867
HDLM-2,9911463,3.4490026877809674
NCI-H1650,136227924,4.84526698521074
HEL,65628,4.10911337005638
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
Detroit 562,tanespimycin-bortezomib (250-1 mol-mol),-0.6563279140280487
MKN45,54618771,1.1504604366979514
BT 330,2746,4.080308483434876
OPM-2,9926054,1.8132463747821628
KP-N-SI9s,100016,6.171993249574907
OPM-2,4705,3.10353547990691
DMS 454,selumetinib-GDC-0941 (4-1 mol-mol),0.8231378505894382
OCI-AML-2,9868037,1.5356230496639076
NCI-H1650,1566236,2.485076362735835
Hs 578Bst,sirolimus-bortezomib (250-1 mol-mol),2.6578506949502416
IGROV-1,1566236,2.765820903157784
SNU-1105,sirolimus-bortezomib (250-1 mol-mol),1.4785919320575531
TE-5,9884685,1.3127368947926776
CAMA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.627092897381015
U-CH1,71751553,4.767713851069639
JL-1,136227924,2.288232757655929
NCI-H460,sirolimus-bortezomib (250-1 mol-mol),2.546511274566793
Hs 852.T,49836020,3.510211812103559
253J,2742550,3.1297466195096537
KYSE-510,135984461,4.447866088850815
SNU-878,10322450,4.398776492188379
DB,71751553,4.024428323991343
SaOS-2,135421197,3.6760992974277817
Panc 04.03,71751553,4.683117627568525
DU4475,135659046,2.7286473029025675
SUP-B15,136227924,1.2725004934322246
HCC202,11494412,2.145306314869007
SK-ES-1,6918638,0.0671447143005349
LOX-IMVI,1566236,1.766970310435897
SUP-B15,tanespimycin-bortezomib (250-1 mol-mol),0.1434284566489843
JM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1559529879995699
SNU-478,54618771,0.1182109485114638
WM983B,6918638,0.63474278918499
SUP-T11,9915743,0.5825260386012178
AsPC-1,11152667,-0.9426796832875202
VMRC-RCW,100016,5.733604538717687
NCI-H1563,11152667,1.175264521222522
SNU-1272,9911463,4.2598402664697685
KLE,136227924,3.154327848580928
HuH-6,24779724,4.249580878490073
CA46,2746,0.9501634288999758
RMG-I,11152667,0.0642721521014258
NMC-G1,54618771,1.359129875373881
SNU-869,3465537,3.3177024921498575
A3/Kawakami,135659046,2.928957386337573
EKVX,54618771,-0.0209843896322389
EFO-27,1566236,1.9834366009012432
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
FaDu,tanespimycin-bortezomib (250-1 mol-mol),-2.9915431159716603
BT 147,136227924,1.9245142249128984
SU-DHL-8,9915743,1.1928625100006218
NCI-H358,9884685,0.3952053274664801
NCI-H2009,136227924,2.9896301065010933
HCC1954,9915743,-1.9238050645061189
WT2-iPS,selumetinib-GDC-0941 (4-1 mol-mol),0.0160943327982104
RKO,24779724,5.847036108864024
EoL-1,9911463,2.487921562669019
HCC95,54618771,0.2896337021071054
JHUEM-7,54618771,2.242796216513649
COV434,6918638,0.3564723109557184
Lu-99,sirolimus-bortezomib (250-1 mol-mol),1.6973589425418654
SW1710,73707386,-5.927041257386023
P12-Ichikawa,9935249,2.689969364287355
BT 164,sirolimus-bortezomib (250-1 mol-mol),-0.1632601406357518
ZR-75-30,71751553,4.500324132162376
CAL-51,tanespimycin-bortezomib (250-1 mol-mol),-0.8716399049469353
SK-N-AS,4705,3.5227875242438103
NCI-H520,135659046,3.9949277821053704
SNU-201,3854666,4.676040623574546
AsPC-1,54618771,1.0442216511349782
EPLC-272H,11152667,-0.8972804727996353
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
NCI-H1155,9868037,2.157837609238264
CAL-85-1,11494412,-0.0950460839554517
JHUEM-7,71751553,3.8993350668195874
MOLT-16,135659046,3.348397173147883
OVCAR-4,9926054,2.3051007827251095
BT-20,9911463,4.1322446502045285
BT-549,9911463,4.268645247281358
K-562,11152667,-1.0937594737206502
UACC-257,9926054,1.800588068202944
786-O,sirolimus-bortezomib (250-1 mol-mol),0.3515124224328601
SNU-16,135659046,3.4263831246491367
BT 248,9884685,-0.279602051509792
JJN-3,54618771,-0.9152585642725306
Rh41,9915743,0.4194124468243376
Rh18,sirolimus-bortezomib (250-1 mol-mol),0.7964593742547511
TE 441.T,54618771,1.354234974700439
NCI-H522,tanespimycin-bortezomib (250-1 mol-mol),-2.8316369576725284
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133
ZR-75-30,9884685,3.5597047060324445
KNS-81,tanespimycin-bortezomib (250-1 mol-mol),2.206166956375568
Hs 611.T,1566236,1.2731219518363013
AN3-CA,tanespimycin-bortezomib (250-1 mol-mol),-2.8889708448552196
SUP-T1,9926054,1.5313307080964844
NCI-H1944,3854666,1.9975132180667243
BL-70,11494412,-1.22344895039541
DBTRG-05MG,selumetinib-GDC-0941 (4-1 mol-mol),1.9211216865971592
Kasumi-2,135984461,1.6284116850001094
PK-1,9915743,1.3307464414908754
U266B1,9926054,1.2913740580373996
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
JJN-3,9926054,1.1995633611794354
GSS,9868037,1.8794585438915803
SNU-719,9935249,4.380712428445992
OCI-Ly19,1566236,1.0614433704498352
BICR 18,9911463,4.416579979715041
MOTN-1,136227924,2.565430053126423
SW948,2746,1.2183078272507333
CAL-148,9884685,-1.3771109426757842
DoHH2,9935249,1.4071678940232923
JK-1,2746,0.8600907908975023
MKN74,650361,3.7860453637514953
KO52,9935249,-1.4350246650055785
JVM-3,9926054,1.6493371537606276
GSU,54618771,1.7980525914601972
CAL-51,135421197,1.6266864976107616
NU-DHL-1,10322450,3.582925513183909
HCT 116,9911463,4.389845100856259
NCI-H2052,135984461,5.580046564229557
HCC1500,135659046,2.9858139057826905
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
Hs 729.T,136227924,2.3598946894515014
253J,9884685,-1.1911858764968464
Ki-JK,9911463,2.4210836276003755
SNU-8,sirolimus-bortezomib (250-1 mol-mol),0.5784576721065883
RVH-421,9935249,2.635649117696883
SH-4,100016,6.480724052638794
HCC44,65628,4.349401919276432
HSC-2,9935249,3.203277250045846
KYM-1,136227924,2.3887987595454594
CCK-81,9935249,2.2164809803205703
VMRC-LCD,9926054,1.8620502952585032
NCI-H196,9926054,2.525003076989932
MFE-319,10322450,5.941485697503465
LS513,9915743,-0.1928520394279614
BT 216,9868037,4.409348845364788
SNU-308,9911463,4.030831002886429
ECC10,3854666,0.7424887644114392
SEM,54618771,-1.6874791122177024
MHH-CALL-4,135984461,1.796074414413381
JHUEM-2,tanespimycin-bortezomib (250-1 mol-mol),-2.8441025270456097
BICR 31,136227924,2.8140968842668923
A2058,9926054,1.7529225868456957
647V,100016,6.109475002217934
HCC1428,9935249,3.209642355584571
KE-39,sirolimus-bortezomib (250-1 mol-mol),2.142327162680567
HEC-108,9911463,4.37199271437254
SK-CO-1,9911463,3.850014047184169
UACC-62,9884685,1.2635848184496714
HPB-ALL,2742550,3.552331603688017
SBC-5,65628,3.417870630997437
COLO 829,9884685,1.90207337330007
KMS-18,9911463,3.17333222126381
Mino,9915743,-0.1014414753917248
KMS-20,4705,2.611307391977677
NCI-H1568,135421197,1.29303587511011
NCC-StC-K140,54618771,0.2055366704850876
NCI-H2170,71751553,4.39124421441993
KP-N-YN,650361,3.8016345293446743
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
COR-L51,6918638,-0.9148184553572968
SW948,9935249,-1.8483271913214137
KYSE-70,54618771,1.1170424016733127
SIG-M5,9884685,0.6191669126899408
Jurkat,9868037,1.5278313323124582
NCI-H1573,selumetinib-GDC-0941 (4-1 mol-mol),-0.038011367109904
A-673,135421197,0.3124298336996849
Hs 611.T,2746,3.500782789021053
SW1417,sirolimus-bortezomib (250-1 mol-mol),0.2535776257809292
LS180,49836020,0.6204023867713871
SNU-761,11152667,0.2423844419785793
COV362,65628,4.318237963578557
HuP-T3,9884685,1.9355517940144655
RERF-LC-Ad1,11152667,0.5366755842825199
SNU-466,tanespimycin-bortezomib (250-1 mol-mol),-4.621211093162312
BT-12,1566236,1.8346698509370287
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
JHUEM-1,tanespimycin-bortezomib (250-1 mol-mol),-0.535997961075801
GOS-3,6918638,1.663921744527482
DMS 454,9884685,0.3984651636391856
TE-4,136227924,2.9171247501964945
NCI-H2342,9911463,3.680960249446254
CMK,136227924,3.317343215770968
PE/CA-PJ34 (clone C12),65628,4.231511653332105
PK-1,54618771,1.395529069214854
BT 228,54618771,0.9979024036150752
ZR-75-30,11494412,3.375465721476885
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
KMS-34,sirolimus-bortezomib (250-1 mol-mol),-7.371271931180508
KYM-1,54618771,0.695388101268428
Panc 10.05,100016,7.2735240015579645
SIG-M5,135984461,4.131261553814095
DU4475,10322450,2.3984430458592385
MES-SA,sirolimus-bortezomib (250-1 mol-mol),0.1069072940558757
BHY,135984461,4.3306625702035575
697,9915743,-1.2877511169277274
DK-MG,9911463,4.35158589399959
BT 187,65628,4.295313885744154
SNU-119,9915743,-0.9461018440857424
THP-1,2742550,3.28458957438955
OVISE,3854666,4.260793298508907
G-292 clone A141B1,6918638,1.851561084162043
GA-10,100016,3.803284916821312
SK-ES-1,49836020,6.460464214010888
KYSE-520,1566236,3.7886958488528832
SNU-16,24779724,4.843312236489717
SK-N-FI,1566236,1.4625632666872723
SNU-119,135421197,4.049091304293704
EPLC-272H,2746,3.4040670746589523
SNU-245,selumetinib-GDC-0941 (4-1 mol-mol),-0.1076829246144878
SCaBER,tanespimycin-bortezomib (250-1 mol-mol),-1.0690096997886145
G-402,2742550,3.748755543521402
K-562,2746,2.4328857060914797
OCI-AML-3,135421197,1.1151677608997974
U266B1,136227924,2.814695997301776
EFO-21,2746,3.739979027331037
HT-1080,2746,2.8042774445835397
MDA-MB-453,6918638,-1.2403270134347248
MOLP-2,9884685,1.3188927269907686
CAL-148,73707386,2.7699850376563075
NCI-H1435,1566236,1.899438674459205
VMRC-LCD,9915743,2.4183813584018616
U-118MG,9884685,0.538617237870011
BV-173,selumetinib-GDC-0941 (4-1 mol-mol),0.1025224911363418
NCI-H2106,9868037,1.1316953676895871
SNU-213,9911463,3.827165589896959
HCC366,9935249,3.9678422341456665
EB1,selumetinib-GDC-0941 (4-1 mol-mol),0.2218139267104855
KYSE-150,2746,3.6554538134101255
SNU-489,2742550,6.440892359279651
HCC1428,1566236,5.933889412294908
SNU-1214,54618771,-0.4857643216446591
Toledo,1566236,1.5557950289614797
EJM,9884685,0.026997005394607
FTC-238,1566236,1.6472945299152564
Hs 766T,11152667,-1.5545196561885208
WM115,71751553,4.133313051647094
HGC-27,6918638,0.210335220598235
HCC4006,sirolimus-bortezomib (250-1 mol-mol),0.6132308595616923
CAL-51,136227924,2.079284078064279
ESS-1,9935249,3.3777402733386617
HPB-ALL,9915743,0.6969273375453205
JHOC-5,sirolimus-bortezomib (250-1 mol-mol),1.676278524948005
OV56,2746,5.269655177673237
SNU-886,9868037,2.869419012431549
HuH-1,71751553,4.274429516830916
23132/87,9915743,3.213624563446712
KYM-1,2746,1.273696140003964
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
LXF 289,tanespimycin-bortezomib (250-1 mol-mol),-1.4479595903244196
EoL-1,10322450,2.2148801830684097
COLO 741,9915743,3.842124253309565
RPMI-7951,9915743,0.6767769344324703
SW1353,9926054,2.273911586274605
HPB-ALL,10322450,3.7687188105178206
NCI-H747,2742550,3.088890414220319
GI-1,tanespimycin-bortezomib (250-1 mol-mol),0.3009698031973534
TE-14,135398744,6.394251875306054
SNU-1,136227924,2.7041604085298205
SK-N-FI,9915743,0.2439816221510078
NCI-H2052,3854666,4.351538961130796
KMS-12-BM,49836020,4.363885927749537
HD-MY-Z,3854666,0.9362531303701136
COV644,49836020,0.1306983764226103
NCI-H526,65628,3.508124639606281
SNU-899,3854666,4.196460373735126
BT 239,10322450,3.395640435178443
HCC202,sirolimus-bortezomib (250-1 mol-mol),0.0889077055626295
BT 422,selumetinib-GDC-0941 (4-1 mol-mol),3.332699583710218
P3HR-1,9935249,4.307909434108789
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238
BT 159,9911463,2.981994023267703
MOLP-8,9915743,0.5160575940701332
Hs 746.T,135421197,2.8198811275725206
HLF,71751553,4.640978665963766
BT-16,4705,1.941125757653359
SNU-1066,9915743,2.3115456271865664
SaOS-2,6918638,1.2055090485954645
NCI-H1184,3854666,1.1815941086455106
U-BLC1,6918638,0.4166229945457058
HPAC,11152667,-1.496468536370371
SNU-1214,9911463,3.639683247778992
LP-1,136227924,2.2350423658008416
FTC-238,sirolimus-bortezomib (250-1 mol-mol),0.2541232172189812
BICR 22,9911463,4.403388511465592
BT 333,65628,4.53575381255774
BT 428,54618771,1.9125909448822425
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673
NCI-H1792,9926054,2.787600202110533
A-673,49836020,4.096681472773702
DMS 79,73707386,2.699728745482677
CCK-81,9915743,-3.5525770077735555
MDA-MB-453,11494412,1.83607541398336
NCI-H1092,9935249,2.293612828813301
A-172,9926054,1.9975239370798743
CGTH-W-1,135421197,2.895305047489035
BICR 6,6918638,1.0635609098647931
DBTRG-05MG,11152667,-0.3425807079935632
Caki-1,3854666,3.843299414220747
Hs 944.T,136227924,3.55320847384718
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
NCI-H1092,sirolimus-bortezomib (250-1 mol-mol),0.4958114346992872
SYO-1,71751553,4.299871511856913
IGR-1,4705,3.3965723543512647
EFO-27,9926054,1.857839666788878
SNU-761,9915743,0.9081807401116692
SNU-761,9926054,1.7039655374796845
U-87MG ATCC,135421197,3.5274943050860874
BCP-1,9884685,-1.059831110427225
Hs 934.T,9868037,4.303687473486903
PK-59,54618771,0.2590305123117813
SK-N-DZ,4705,3.245242705626778
KNS-60,9868037,3.077370485876798
HCC2218,6918638,-0.2279728548913661
COR-L51,135421197,2.6598803683271965
THP-1,136227924,2.5094113505430737
MM1.S,1566236,0.950221343647725
KYSE-410,9915743,-1.3205440456701116
MJ,24779724,5.157647123549832
NCI-H1105,9911463,3.5192324604951533
VCaP,44487872,4.231150871019104
SNU-C1,selumetinib-GDC-0941 (4-1 mol-mol),-7.034120569721028
Ki-JK,135421197,1.017420564830507
SK-HEP-1,136227924,3.6301481247272287
BICR 16,135984461,4.382455604132067
KMS-18,3854666,1.9037855185817367
HCC1395,9926054,1.865398038154908
SK-LU-1,135984461,4.3992720133799725
CAL-27,tanespimycin-bortezomib (250-1 mol-mol),-0.409380186496711
Kuramochi,9926054,1.9908985756300632
ONS-76,9884685,2.079600161824297
KG-1-C,3854666,4.168870008885518
GaMG,135421197,1.593389235572815
A2780,136227924,2.141563547945887
SNU-C5,10322450,3.582539499597872
HCC2935,9926054,1.9348902152341665
KYSE-30,4705,4.659105063071051
BC-3C,10322450,3.9889152923020537
DMS 273,135984461,4.327877942465965
EN,selumetinib-GDC-0941 (4-1 mol-mol),3.4742194134426168
HCC1395,11152667,-2.038239333441405
BT 224,9915743,3.066397544250084
Capan-1,135421197,1.617926303344926
HEC-59,11152667,0.382877882866184
COLO 792,tanespimycin-bortezomib (250-1 mol-mol),-2.234001402971202
BHT-101,11152667,-0.0403503112468694
HCT 116,135421197,1.1800274219002476
HDLM-2,136227924,3.1256787357030937
MEC-1,4705,3.2350662901156264
KMS-11,9926054,1.1489638287123365
FTC-238,54618771,3.2424899672946195
Rh30,136227924,4.165333500464175
EM-2,2742550,3.298238405542188
SNU-182,9911463,2.9412810978967867
KM12,3854666,2.1035139353174372
HuP-T3,6918638,1.0959798369911515
OV7,49836020,5.356073606057271
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
TT2609-C02,1566236,4.89299711958549
KMRC-2,71751553,4.728116551648532
SiMa,tanespimycin-bortezomib (250-1 mol-mol),0.5523677352528538
JHOM-1,1566236,3.808049799944417
MDA-MB-435S,73707386,3.113131049817223
KYSE-450,6918638,1.5500469019976144
NCI-H1666,2746,2.9810334185845617
NCI-H23,selumetinib-GDC-0941 (4-1 mol-mol),-0.1629435385383226
GaMG,11152667,0.163513537406371
HD-MY-Z,11494412,0.5861901428023402
Hs 683,65628,4.4952708080724495
SNU-5,3854666,0.8939164456438955
KYSE-410,136227924,3.831866760516254
SET-2,9935249,0.876527985665801
JK-1,9868037,1.2248431410806535
WT2-iPS,9884685,1.6129793208812115
NCI-H1693,tanespimycin-bortezomib (250-1 mol-mol),0.5051860079997127
FaDu,11494412,4.222913714689007
BT 504,9911463,3.2688065154654287
SH-4,selumetinib-GDC-0941 (4-1 mol-mol),-0.2287581368829222
COR-L88,54618771,0.6942100062595253
NCI-H747,9911463,3.270591530161213
SW1990,9926054,1.8053433824091036
Panc 10.05,71751553,4.352315782049923
VMRC-RCZ,sirolimus-bortezomib (250-1 mol-mol),0.0993693702457471
Ci-1,9911463,3.2890552525793395
SNU-C1,11152667,-1.3604211574664309
DB,9884685,0.0125098764631308
KMRC-3,135421197,4.3103204050054345
HT-1197,3854666,2.5073606400565143
T24,100016,6.183675550900896
SNU-61,sirolimus-bortezomib (250-1 mol-mol),1.753090501474884
CL-11,sirolimus-bortezomib (250-1 mol-mol),0.3846215058454166
NCI-H1573,tanespimycin-bortezomib (250-1 mol-mol),-1.6539350682626517
SW1783,54618771,3.657201070811366
OE21,135421197,1.5054570422138
SK-N-AS,3854666,0.6008769130221079
NCI-H1975,selumetinib-GDC-0941 (4-1 mol-mol),-2.1756384403206326
HCC-56,11494412,1.5604105617758193
TE-8,136227924,2.7469773037217715
HuH-28,9911463,4.067632897122288
NCI-H929,3854666,0.9590353539059504
SNU-61,4705,2.600761934037586
EFO-21,9884685,3.376545063394627
KMRC-2,1566236,2.2234157510538832
RKO,136227924,3.256787131627037
BT 428,2742550,3.051967949404776
Kuramochi,9915743,0.8375201089369183
Calu-1,4705,3.5470871536142563
JHOS-2,3854666,3.9223909271833546
A-253,11152667,0.6040839569955214
IM95,selumetinib-GDC-0941 (4-1 mol-mol),-0.8100536248662729
JHUEM-2,135984461,4.241514174817559
SK-N-BE(2),2746,1.332316139919228
MKN74,9911463,3.772186916904206
F-36P,4705,3.5916410235221914
BT 271,1566236,1.8489883376842131
LAMA-84,3854666,0.7757174142172463
ME-1 [Human leukemia],9935249,2.5760324068309455
JM-1,3854666,0.4999957819555636
Caov-3,9935249,4.3792566326143385
KYSE-150,11152667,1.0905080839242076
OVCAR-8,9926054,3.028637084123283
SW1271,2742550,3.530952260660614
SNU-719,11152667,2.1367048146797294
JURL-MK1,9868037,1.498600945744401
FTC-238,9935249,2.9756911354849143
NCI-H446,9868037,2.387486859676029
G-401,9884685,-1.463173781220529
OCI-AML-5,135659046,3.671994608621507
KP-2,2746,4.5923372847517765
NCI-H524,135421197,1.1654489956873584
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
Mino,2742550,2.804646277870024
RT-4,9915743,2.2914033994891847
KYSE-510,9926054,1.8672783124576204
MV4-11,3854666,0.6291218486966372
PSN1,135659046,3.366359260152028
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
GOS-3,9911463,4.370946765627494
HEC-1-B,9926054,2.0295913011539173
RCH-ACV,tanespimycin-bortezomib (250-1 mol-mol),0.4817586938326316
RPMI-7951,9868037,2.673802488787611
EM-2,54618771,-0.9805043805831684
RERF-LC-A1,9911463,3.9529854896489782
NU-DHL-1,135398744,6.409233084142903
TOV-112D,6918638,-0.2708686651634265
MDA-MB-361,11494412,4.099226139153975
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
SW1417,9915743,0.7399869758043424
DoHH2,11152667,-2.4116880189602643
Rh41,135421197,0.890799382686484
BT 145,136227924,2.723434550490864
NCI-H1792,sirolimus-bortezomib (250-1 mol-mol),1.8777414374963155
NH-6,135421197,0.8889429247891555
697,3854666,0.199250665245893
HCC44,9868037,1.8192522790953956
TE-1,tanespimycin-bortezomib (250-1 mol-mol),-1.7455027047349927
KMS-27,65628,3.4273380344864233
Lu-65,2746,3.448286012693329
KMS-18,54618771,-1.0350203667424809
L3.3,54618771,1.1558037208399272
HEL 92.1.7,9911463,3.2489228387503486
AML-193,54618771,0.4173774880605814
OV-90,6918638,0.8312701026022422
UACC-257,3854666,3.66425519078933
HGC-27,135659046,3.397555397732454
U-BLC1,135421197,1.4306901409483936
MKN7,11494412,4.037198779666313
WM88,11152667,-0.5209926910891152
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
SNU-601,10322450,3.697276990394465
JHUEM-3,9915743,-0.9592300023642776
NCI-H1299,2742550,4.427150184712593
Calu-6,9915743,-0.5707645596602849
CW-2,9911463,3.3999880147048795
DMS 79,9926054,1.7240828255931135
PaTu 8902,135421197,2.3024316473658004
MKN1,3854666,3.3252090270596777
TE-14,6918638,0.7581256744070354
HEC-251,9926054,2.414490090670839
KMRC-3,3854666,0.9965380576700774
KE-97,65628,3.692213431422058
SW1990,4705,4.395682074596428
A-375,4705,2.938448414109293
SNU-475,sirolimus-bortezomib (250-1 mol-mol),1.5218514057883192
BHT-101,selumetinib-GDC-0941 (4-1 mol-mol),-0.4263486280129431
HH [Human lymphoma],11152667,-0.6696779635320641
MDA-MB-157,71751553,2.589623955944651
YD-15,9911463,3.7436865426032786
NCI-H211,9926054,1.5085991120248008
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
Daudi,11494412,-0.3802447608890573
LK-2,selumetinib-GDC-0941 (4-1 mol-mol),2.476952398707666
H-STS,9915743,1.4562053378516668
SK-N-SH,1566236,1.1494040104220686
PE/CA-PJ41 (clone D2),135659046,4.325865774807889
EKVX,1566236,3.271748104536343
T84,2746,3.6506002682923926
GCT,sirolimus-bortezomib (250-1 mol-mol),1.1354554226801
NCI-H1734,54618771,0.2470181202194854
SCC-4,3465537,2.011653473536215
JIMT-1,136227924,4.112902711551938
NH-6,9911463,4.337318302270048
HCC1588,65628,4.850372204262946
HCC1937,44494148,4.424262012108153
KE-39,44487872,4.457727251314366
OCI-AML-5,10322450,3.661053822054087
RERF-LC-Ad2,3854666,2.675858231607706
NH-6,sirolimus-bortezomib (250-1 mol-mol),1.143169079314691
MHH-ES-1,9935249,3.1458992380926616
SK-LMS-1,136227924,4.704854352606181
SNU-1077,54618771,3.2500418975361347
KP-N-YN,1566236,2.0598398462410215
TE-9,tanespimycin-bortezomib (250-1 mol-mol),-0.7055515782179059
L-540,9915743,0.3390225663294273
KMRC-3,54618771,0.1504826951638593
T24,54618771,1.5069365622547568
B-CPAP,9911463,3.799628401356715
Tm87-16,2742550,4.403843434069264
COV434,71751553,4.197696410536109
JHH-5,2742550,3.699420936679788
HuH-1,9935249,3.147472490702491
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249
Kasumi-2,9915743,-0.5759730647314978
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333
NCI-H1755,135398744,6.361982871837632
Hs 611.T,9911463,2.4472090052981104
MEC-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1834550186065348
Daoy,135984461,2.2950744051926497
Hs 683,2742550,3.2253237968684134
Hs 294T,9926054,1.7844528476619044
NB4,3854666,-0.3062621244403906
22Rv1,136227924,2.1207718843699
NU-DHL-1,100016,6.7557445252971355
RKO,4705,3.750134101835121
BICR 56,2746,2.65605235072967
NCI-H520,11152667,-0.8111617843564765
A2780,65628,0.1843862993724733
NCI-H2110,2742550,3.917163865497912
COV434,54618771,-1.0404001935191405
KYO-1,selumetinib-GDC-0941 (4-1 mol-mol),1.8614571416094257
MIA PaCa-2,11152667,-2.2461765608848663
BT 504,135659046,3.5842907457354376
MM1.S,136227924,2.5395832269167027
CMK,6918638,-1.0640278448730467
KALS-1,54618771,1.5195853448840246
NCI-H838,9926054,1.8305885270474245
OCI-AML-3,2746,0.9833779922081392
NCI-H1105,6918638,-1.2664288249273916
NCI-H929,135421197,1.062377968485951
Kasumi-1,136227924,1.874085610777816
SW1417,6918638,0.2566537635355694
SNU-685,71751553,4.38772919784633
COLO 205,136227924,2.4867417586096416
CAL-148,3854666,0.9870114885277602
ChaGo-K-1,9884685,1.4931363766033252
WSU-DLCL2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2724910625039847
DMS 53,135421197,0.687232619284389
JURL-MK1,100016,3.373338788856286
SCC-25,tanespimycin-bortezomib (250-1 mol-mol),-2.0789545653070856
Mono-Mac-1,3854666,0.6969728274023116
RPMI-8402,135421197,0.8834932639167268
TE-4,11152667,-0.0224679138001448
EKVX,3854666,3.2297546672389243
AU565,2746,2.9112036552039737
SW1116,135984461,2.388083333366143
SNB-75,11494412,4.209755113489716
TE-10,tanespimycin-bortezomib (250-1 mol-mol),0.6297749244951121
KP-2,sirolimus-bortezomib (250-1 mol-mol),1.2004115712626864
EHEB,135984461,4.428627188495882
PANC-1,1566236,1.9012203857252232
Panc 05.04,selumetinib-GDC-0941 (4-1 mol-mol),0.8434992349336349
HT115,9915743,-3.7208520870958286
M-07e,1566236,1.062564677028791
KMS-27,100016,3.811410813700335
SJSA-1,9884685,1.785229116734418
KP-N-SI9s,136227924,1.797924144791439
OVCAR-4,54618771,1.8457330551632656
KMS-34,136227924,2.5847633588950147
NCI-H1915,sirolimus-bortezomib (250-1 mol-mol),0.5181778086955178
HCC44,3854666,0.5435532196199894
Rh30,9884685,-0.1007455789627698
Karpas-422,135421197,2.168063446429243
NCI-H211,2742550,2.7483286250684573
MOLT-16,2746,1.4936688600740762
NCI-H889,2746,2.2836430328377997
OCI-Ly3,4705,3.087724315846988
HCC2218,11152667,3.74490271643498
SNU-878,2742550,3.061498936852825
Karpas-620,135659046,3.5237997077765275
SJSA-1,3854666,2.6670180544231914
TE-15,2742550,3.96805077868976
BT 504,11494412,1.1419728911910534
HCC366,9868037,6.006558205006566
JHUEM-1,9926054,1.7870789981263362
WT2-iPS,100016,6.129452507999119
HT-1376,2746,3.1690827101181736
MCAS,selumetinib-GDC-0941 (4-1 mol-mol),0.6896207239253057
YD-15,3854666,0.780361863126364
WM266-4,sirolimus-bortezomib (250-1 mol-mol),0.2916280413347675
NB1,135421197,1.388835024026268
MV4-11,135984461,1.5625386820387543
COR-L95,4705,3.007858501345706
SNU-840,3465537,3.512409198925668
U-937,54618771,0.4735715356031699
HCC1500,3854666,1.4433352503078565
LoVo,73707386,4.416344333605744
SEM,6918638,-1.2521894984782256
YKG-1,9911463,4.439291278473792
NCI-H446,3854666,-0.7214547473284718
BT 359,136227924,4.313964424354799
G-401,tanespimycin-bortezomib (250-1 mol-mol),-1.7315974865132566
BT 159,9926054,3.0118614770860286
PL-21,9935249,2.29170119673888
Hs 578T,49836020,0.6847429303234678
COV644,sirolimus-bortezomib (250-1 mol-mol),0.1029805647741307
NCI-H23,1566236,1.1335950409984874
DU145,9935249,3.749003876346386
NCI-H2286,selumetinib-GDC-0941 (4-1 mol-mol),2.0876737367962495
LCLC-97TM1,4705,3.0319662392534057
RERF-LC-Ad2,100016,6.703705933143471
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
NCI-H1838,sirolimus-bortezomib (250-1 mol-mol),2.042115006385595
OVK18,3854666,2.1766896267890816
EoL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0548301208208537
KP-2,3465537,3.946728673772689
Mono-Mac-1,73707386,2.736178467367938
MDA-MB-453,2746,1.6853152695376463
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
Hs 729.T,selumetinib-GDC-0941 (4-1 mol-mol),3.0623228913945684
HT-29,54618771,-0.2374080700541868
RL,2746,2.394974113272841
MHH-CALL-4,1566236,1.2228321668732802
SU.86.86,3465537,2.251677692666755
TT2609-C02,11152667,0.559349969972072
NALM-6,9911463,2.9275320549499613
NCI-H1581,9935249,3.181386202860213
SNU-C4,11152667,-0.8356210085556769
SET-2,9911463,3.8788092570896184
RPMI-8402,11152667,-1.9551493741804535
SK-N-FI,3854666,-0.1881636838326112
BV-173,3854666,0.5295371069760887
AGS,65628,4.4065157996976945
SUP-B15,9911463,4.29291953210489
BT 440,6918638,3.62148033116424
WM115,6918638,1.2765614986990457
253J-BV,54618771,0.8699065308229518
WM793,9915743,2.18814480431127
MKN74,54618771,1.3558742291917982
MDA-MB-453,sirolimus-bortezomib (250-1 mol-mol),-2.416971902682566
SK-LMS-1,9884685,0.6915267736542438
CL-11,10322450,3.8898071669578
HCC2279,tanespimycin-bortezomib (250-1 mol-mol),0.9868379448514812
CCK-81,9926054,1.6277365454540644
VMRC-RCZ,selumetinib-GDC-0941 (4-1 mol-mol),2.964733367482892
NCI-H1869,tanespimycin-bortezomib (250-1 mol-mol),-0.2076934173227629
HOP-62,135659046,3.835086594204883
KMRC-3,65628,6.285670036063726
L-363,135984461,2.740673882414865
HD-MY-Z,135659046,3.544790983777307
HT115,9935249,2.785249692793322
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
SK-MEL-2,11494412,4.029789291760362
LCLC-103H,136227924,3.302464114309801
MOLM-13,49836020,-0.1965532240483963
OV7,9884685,0.1253380741957696
SNG-M,135421197,2.4480650600360705
OCI-Ly10,1566236,3.348368105621456
BT 228,10322450,4.52310265932876
253J,10322450,3.648031599175377
TOV-21G,tanespimycin-bortezomib (250-1 mol-mol),-2.720450448840342
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933
Tm87-16,9868037,4.7880424925648715
HCC2935,9911463,4.226502617966516
NCI-H1373,135659046,5.766842578733638
PC-3,2742550,4.163134998379986
PaTu 8988s,54618771,-1.1165982816182902
SW1990,135421197,2.4673652362446887
MDA-MB-453,selumetinib-GDC-0941 (4-1 mol-mol),1.2517967202260842
RKN,54618771,1.93479648501244
VCaP,2746,1.3458949391757813
CAL-54,tanespimycin-bortezomib (250-1 mol-mol),2.1097630424969593
TUHR4TKB,9915743,2.327900585898517
JHH-2,tanespimycin-bortezomib (250-1 mol-mol),1.6682234532456457
KYM-1,49836020,-6.165786834710826
GDM-1,sirolimus-bortezomib (250-1 mol-mol),1.1359317053602838
MOLT-16,44487872,4.467679467136648
PE/CA-PJ15,10322450,4.3579745096101075
786-O,9911463,4.177709508458616
DMS 273,2746,1.8465116882146249
NCI-H520,4705,3.58444135118044
A101D,9926054,1.713643305346107
SW948,135984461,4.375312800732864
SK-N-DZ,9935249,1.2631361781648536
U-118MG,11152667,0.4804391951353036
A-172,11494412,1.9795109251160852
CJM [Human melanoma],9911463,3.8597474778035217
NCO2,3854666,-0.3022721957151304
MDA-MB-453,135659046,3.699316020945489
IM95,49836020,4.204800354439791
SUP-T1,sirolimus-bortezomib (250-1 mol-mol),-0.9944486722205774
HCC1143,sirolimus-bortezomib (250-1 mol-mol),-0.8248046184342958
JM-1,1566236,0.6280103536338946
FTC-133,71751553,4.47121108066688
ONCO-DG-1,135984461,4.389696319058022
HCC2218,11494412,1.7192366491368396
L-1236,selumetinib-GDC-0941 (4-1 mol-mol),3.573145022328455
U-CH1,selumetinib-GDC-0941 (4-1 mol-mol),2.4998386609630834
U-118MG,2742550,3.858663232806478
NCI-H520,135659046,3.9949277821053704
EFE-184,135421197,2.5178551703046277
SW620,135421197,1.4472362766412623
COV644,1566236,1.8684526207467456
HCC1143,11152667,-1.9901975183751028
LOX-IMVI,100016,4.319089113839007
SK-MEL-1,100016,6.470813601542051
NCI-H2196,9911463,3.768579820818315
BHY,135421197,2.210170489791885
OV56,135984461,4.418964616172034
SU-DHL-8,135984461,2.059848227553284
COR-L51,135984461,4.507897023169623
SNU-216,135421197,1.0326096520006542
KE-39,100016,6.665188081944046
HCC4006,3465537,3.3364041305290004
BT-20,3465537,4.429607875792749
NCI-H1341,65628,3.962003306488367
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
BT 416,9935249,0.9588167986090808
C2BBe1,49836020,4.36863555932656
BDCM,selumetinib-GDC-0941 (4-1 mol-mol),0.2374601063606183
SNU-308,9926054,1.9749915644839853
NCI-H647,6918638,1.1619683266292729
BICR 56,3854666,1.0101510025798168
SNU-1272,selumetinib-GDC-0941 (4-1 mol-mol),3.373247687277942
JURL-MK1,3854666,0.543256648206117
Hs 294T,11494412,1.2087769391494103
MDA-MB-415,3854666,2.669945376708198
EB1,3854666,0.1328331375955075
NCI-H322,100016,6.362238943247445
Daoy,9868037,3.1554114600396725
SNU-1076,136227924,3.042119222699605
SNU-16,54618771,0.522197701958757
BT 228,65628,4.442361591085553
KYSE-520,3854666,2.9600275476239957
SU-DHL-8,136227924,2.244700910858823
FTC-133,tanespimycin-bortezomib (250-1 mol-mol),2.589157052333849
BT 228,selumetinib-GDC-0941 (4-1 mol-mol),1.920248435578852
PC-14,136227924,3.162840410264972
SNU-1196,sirolimus-bortezomib (250-1 mol-mol),2.2031976803647075
L-1236,9915743,1.4582710578381164
SK-N-FI,54618771,1.4169008036751305
TE-5,2746,3.896227334745537
KMS-12-BM,11152667,-2.0033121328533054
YD-15,65628,3.895219828692723
Raji,136227924,2.5188827267380116
HDLM-2,9926054,1.2404831446966105
BT 440,9911463,3.153626294049379
NCI-H2087,44487872,5.468068577588152
NCI-H2228,54618771,2.218595953642778
DMS 454,136227924,3.2899111891910424
MES-SA,2742550,4.347572570535663
Panc 03.27,49836020,2.722888568283256
COV644,9926054,1.7976744262803612
BT 498,135421197,2.801881228152874
Ku812,135984461,1.927355885078453
HeLa,selumetinib-GDC-0941 (4-1 mol-mol),4.580619415349248
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017
NCI-H1581,9915743,3.627185987098802
NCI-H1568,9926054,1.8156743035592564
Calu-1,9868037,4.36020250982657
JHUEM-2,9935249,3.290906411802745
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
JM-1,135984461,1.552881480804892
Ku812,49836020,4.574644913995472
EM-2,65628,3.859788884791103
Lu-65,11152667,-1.8224670022620897
BT 416,11152667,0.4556152500975832
SET-2,2742550,3.6204915074122814
TM-31,1566236,1.750364202680973
OC 314,sirolimus-bortezomib (250-1 mol-mol),0.336828605445857
HMC-1-8,11152667,0.5419777398264091
TT2609-C02,3465537,3.455701552021007
HT-1197,1566236,1.7604501004419797
KNS-81,49836020,5.788020143086265
L-428,11494412,0.039932037975066
NCI-H2170,135984461,4.266034929534041
MDA-MB-231,49836020,-4.061290256388782
OCI-M1,9911463,3.27082780782835
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
KMS-12-BM,135984461,1.7287315424792562
NCO2,sirolimus-bortezomib (250-1 mol-mol),-0.0508749295611852
CAL-33,135398744,6.573384587063474
EBC-1,49836020,4.041761576127936
OUMS-23,2742550,2.4373114846272586
SH-10-TC,2746,4.061240756381498
CW-2,10322450,3.213941293379877
Rh41,54618771,-0.2470499473038629
RVH-421,2746,3.1689695044320056
HT-1197,54618771,2.611053325854013
KE-39,54618771,0.8543301924142261
KNS-62,9935249,5.766503523403454
SUP-T11,100016,5.673603064365157
YD-15,135421197,2.516828006554414
JHH-4,71751553,4.2835287364171055
TTC-709,9926054,1.3747627831999318
A-204,65628,4.317611163757104
DU145,135659046,3.5568052359419604
Calu-3,9926054,2.517272987008367
HuNS1,11494412,-0.2614588159632262
HOS,11494412,1.9544385789907803
SW1271,65628,4.408026608161547
MHH-CALL-3,9926054,1.9964305651779948
WM115,2746,3.2273654457979957
HSC-4,3854666,2.969420021692798
NCI-H1435,9915743,-1.162246321840318
Hs 611.T,9926054,1.8280926290746755
NCI-H2110,sirolimus-bortezomib (250-1 mol-mol),0.8725557491519701
BT 147,135659046,3.464945185211132
COLO 792,11152667,2.5246510568234193
BT 330,1566236,2.4105147195149694
SCaBER,71751553,4.44084569502903
BT 330,135659046,3.618868703955065
L3.3,9911463,4.128757247123474
NCI-H2141,6918638,0.0318107940340185
JHH-2,sirolimus-bortezomib (250-1 mol-mol),0.503615314024041
COR-L95,65628,4.016533332946612
BT 359,9911463,3.139748899568744
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556
KATO III,9926054,1.9057208307143456
SJSA-1,136227924,3.1619398784526176
M059K,9911463,4.34253595851811
ES-2,2742550,5.454114961101578
HD-MY-Z,71751553,4.240197659195247
MOLT-13,135421197,0.8546862359015375
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
SNU-620,24779724,-2.929464717918514
BICR 22,136227924,2.105383482893856
WM115,135659046,3.4373276092449667
DMS 53,100016,7.1608088069035185
Hs 611.T,11494412,-0.0466996238947274
EN,9915743,1.169812706824078
YD-38,100016,6.21667674155364
RPMI-6666,1566236,1.297677417550993
TE-5,24779724,4.3731418653710445
BT 239,sirolimus-bortezomib (250-1 mol-mol),0.5713357079761969
SK-N-BE(2),2742550,3.013955161893337
Panc 10.05,tanespimycin-bortezomib (250-1 mol-mol),-0.5396853932122618
BxPC-3,9911463,3.950256717526944
KMH-2,9926054,1.558336314725876
TT2609-C02,10322450,4.933026976290495
IPC-298,54618771,-0.94588727453768
KMRC-2,9884685,0.9059778924037538
NCI-H1563,136227924,3.549094897051017
Jurkat,100016,5.920987823967134
WM793,3854666,3.254480086465336
HCC2218,65628,6.436563943794135
Caki-2,selumetinib-GDC-0941 (4-1 mol-mol),1.5536102429563667
EHEB,73707386,3.258970186799186
IA-LM,9926054,3.212619063516659
KATO III,3465537,3.500965141259956
MFE-296,135421197,4.335521235356187
HuNS1,9935249,0.4549731816761326
BT 328,sirolimus-bortezomib (250-1 mol-mol),2.117607620911863
HCT 116,135984461,4.355158085376645
PaTu 8988s,sirolimus-bortezomib (250-1 mol-mol),0.5300595749454592
P-STS,tanespimycin-bortezomib (250-1 mol-mol),0.1209880905816519
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422
MDA-MB-415,9935249,3.953903060274233
SNU-685,selumetinib-GDC-0941 (4-1 mol-mol),4.064777169332982
NCI-H508,9915743,-3.0595011879146967
NCI-H650,100016,5.632760623979546
HCC2279,11152667,0.2450924496054455
SUP-T11,9884685,-1.4007483875875175
MDA-MB-415,9926054,2.772494701182559
NCI-H1581,9868037,1.2648285588909711
FTC-238,9884685,3.0053387857331963
SNU-C5,1566236,1.7369222481964657
BT 228,11494412,2.9985974737490557
SNU-1076,9911463,3.975744841196654
HuH-1,9926054,1.861851059546876
THP-1,9911463,2.82598855830453
BT-474,136227924,2.4914554847870187
786-O,100016,5.342252836782742
PE/CA-PJ49,sirolimus-bortezomib (250-1 mol-mol),0.2701469855669
NCI-H2023,11152667,-0.1011481552792021
NCI-H2106,sirolimus-bortezomib (250-1 mol-mol),0.8781181431398268
KG-1-C,6918638,1.2884838473807014
BT 131,71751553,4.311619191931445
HEC-108,65628,4.442011228839073
NH-6,11152667,-1.25503210276294
Ki-JK,73707386,2.487291163163647
COLO 800,9926054,1.9844303127825855
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671
SK-MEL-24,tanespimycin-bortezomib (250-1 mol-mol),-0.1831765254782449
IGR-1,135984461,4.582629731672088
UO-31,9926054,1.6709527378064972
253J,9935249,3.7967052414935223
LS513,9911463,3.8575108406588705
Granta-519,11152667,-3.975154363660797
HOS,3854666,2.0706469924501474
SNU-216,3854666,1.5615804262646893
HEC-1-A,9935249,2.849198991074919
OCI-AML-3,11494412,-0.6961081339076156
BT 498,4705,4.208148450276773
JHH-4,54618771,-0.357256318884579
Pfeiffer,9884685,-2.975976494157007
HCC2218,selumetinib-GDC-0941 (4-1 mol-mol),1.5702207772151422
SNB-75,54618771,2.061985596678881
DU145,54618771,3.337458824494602
SNU-213,selumetinib-GDC-0941 (4-1 mol-mol),-0.6282749341279102
LMSU,6918638,1.4149573073550044
WM115,9926054,3.0880179510914454
NB1,136227924,2.7984479768491335
COV644,2746,2.991747419191786
KALS-1,tanespimycin-bortezomib (250-1 mol-mol),0.1032603454372563
EKVX,tanespimycin-bortezomib (250-1 mol-mol),1.3495515941174134
OPM-2,54618771,0.7318105179081044
SEM,9926054,1.3281424685311425
NCI-H522,71751553,5.137300136027492
SIG-M5,54618771,-0.4946927468469176
Reh,135984461,1.6180740266430926
THP-1,54618771,0.1282958307593316
G-402,136227924,2.8538202085088185
NCI-H2087,2746,2.6080456190013632
MJ,11152667,-1.2121300476072767
CAL-27,9915743,-3.4733954540635015
KYSE-510,2742550,4.37690819597459
OE33,9911463,4.318006925608157
BT 239,1566236,1.2451641316505642
SNU-182,9868037,2.968787964623164
BT 147,135398744,6.518001641470466
TE-11,136227924,3.028335758763499
JVM-3,9884685,-0.7569385790622597
SK-MEL-31,9911463,4.28610993232139
RMG-I,54618771,1.320928613305781
EJM,1566236,1.0332712944799087
NCI-H1355,2742550,3.68494332628851
SNU-410,9915743,1.505425413193383
SUP-T11,9868037,1.5602991106462112
JHUEM-1,2746,3.5357921784869775
786-O,9884685,1.3533328898647403
JM-1,49836020,4.6064946369246025
BV-173,11152667,-2.8644264072030623
SNU-407,11152667,-0.0617753170704596
BT 340,9935249,2.1443978497861504
SNU-213,sirolimus-bortezomib (250-1 mol-mol),1.705548716075845
WT2-iPS,3854666,3.293035472406592
SK-N-BE(2),sirolimus-bortezomib (250-1 mol-mol),1.0543507239868668
HEC-1-B,54618771,2.2656883390933342
RCH-ACV,54618771,-1.6129004186602771
D283 Med,2742550,3.5680258108109975
JMSU-1,9915743,-1.579364390846883
JHUEM-1,135421197,1.216827050882974
COLO 829,136227924,3.354215786550203
NCI-H716,6918638,0.7980253522475573
DV-90,54639665,4.358893407876041
BT 428,135398744,8.121810698450407
COLO 668,135421197,1.2477515484477224
SK-ES-1,65628,2.5290006136482868
KYM-1,4705,3.22823778940345
WM983B,11494412,2.4978869334252143
HEY A8,2746,3.567367579370524
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
SUP-M2,11494412,-1.6860756358527853
GA-10,3465537,2.6293508447683376
RERF-LC-A1,135398744,8.259619126952485
Pfeiffer,6918638,-1.780695741068461
Hs 766T,tanespimycin-bortezomib (250-1 mol-mol),-1.398950675536224
KYSE-510,135659046,4.68799289750423
BT 245,135421197,1.3239460835535384
JHH-1,9911463,5.178733241899389
DU145,9926054,1.942219630113699
RS4;11,49836020,6.257665529441248
MCAS,54618771,1.3372810495752594
MCAS,9926054,1.882674367902201
TCCSUP,54618771,0.6448534643306117
SBC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.377221196755023
TE 617.T,135421197,0.8388775868881587
JHOC-5,9911463,4.507364247607918
LOX-IMVI,tanespimycin-bortezomib (250-1 mol-mol),-2.013401423677256
SNU-668,135421197,2.8470371844107274
Hs 888.Lu,65628,4.350003437777803
SNU-423,4705,3.684586446624816
HEC-1-B,100016,7.817681002018073
WSU-DLCL2,49836020,-5.951866834778445
COLO 792,6918638,1.1737976996738528
LNCaP clone FGC,4705,3.099970805518314
DU4475,tanespimycin-bortezomib (250-1 mol-mol),-2.7587555584503853
LN-18,100016,6.511039950794577
Lu-65,2742550,4.528880941958593
22Rv1,135984461,3.7893154959585735
Hs 940.T,9926054,2.0266998753682324
NCI-H1563,3854666,3.3782655568775932
BT 112,9911463,2.5169416957375015
SNU-182,9915743,-0.6528575435960152
SNU-182,sirolimus-bortezomib (250-1 mol-mol),0.3656732555283032
KCL-22,65628,4.308150173969958
CJM [Human melanoma],9935249,3.667632457160335
NU-DUL-1,136227924,1.961051427269065
SK-N-MC,sirolimus-bortezomib (250-1 mol-mol),-0.0028242639035691
PK-45H,6918638,1.185943066859981
UACC-257,9935249,3.33799622234966
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
SCC-4,9926054,1.835519091908301
VMRC-LCD,100016,6.5149453048399515
TYK-nu,100016,5.6630271022409495
KMBC-2,9868037,4.318288154925569
KCL-22,sirolimus-bortezomib (250-1 mol-mol),-0.943153613452708
DB,9915743,0.3856668875763299
SNU-1272,135421197,2.338787330458388
UM-UC-1,65628,4.132094852649124
NCI-H358,100016,4.0854531303861155
C2BBe1,9935249,3.1734347371744036
NCI-H292,selumetinib-GDC-0941 (4-1 mol-mol),-0.4502449233555984
Jurkat,11152667,-1.1847034322437038
ACHN,1566236,1.6353428003471475
Sq-1,tanespimycin-bortezomib (250-1 mol-mol),0.5619260521481989
Ki-JK,sirolimus-bortezomib (250-1 mol-mol),-5.576010633092176
NCI-H28,10322450,4.072990606284223
DMS 114,9915743,2.4307544773783465
HCC1428,135421197,1.8247359563067895
HEC-1-A,100016,7.347183870003149
NCI-H322,135421197,2.22865477281611
HGC-27,9884685,-2.183204546291056
FTC-133,6918638,0.7173410835371117
KMS-11,9915743,0.4869298751458265
HCT 8,6918638,0.8681641222033742
JM-1,10322450,2.576608882705072
Hep 3B2.1-7,9926054,2.8753203525792026
2004,sirolimus-bortezomib (250-1 mol-mol),0.3524960836924493
SNU-719,9915743,1.2257458937302947
MES-SA,11152667,0.5364963747831863
CMK,100016,5.771362707779288
COLO 684,2742550,3.773525644725552
OE33,9926054,1.932041644306032
Kasumi-1,2746,0.7375663953189775
M-07e,9911463,2.8967882241025995
Hs 766T,6918638,1.6874780240509222
ESS-1,10322450,4.730793151305824
SNU-16,135984461,3.245976227672491
LOU-NH91,9868037,3.6278868560603574
CAL-85-1,2742550,3.495700065332706
DK-MG,135984461,4.5873435094388215
NCI-H810,135398744,5.260119762115652
CCF-STTG1,100016,6.985278157575169
SNU-1,9935249,2.5676508314094866
Panc 08.13,sirolimus-bortezomib (250-1 mol-mol),0.500337549713312
NCI-H747,10322450,3.8486702496060463
CA46,selumetinib-GDC-0941 (4-1 mol-mol),2.557872196645032
Hep 3B2.1-7,9915743,1.8474397407384695
MM1.S,135984461,3.1063926235928703
COR-L51,11152667,-0.8150408073965146
KALS-1,9911463,4.316842396735623
NCI-H1694,sirolimus-bortezomib (250-1 mol-mol),0.6427280207840891
SNU-466,selumetinib-GDC-0941 (4-1 mol-mol),2.355398867195719
DV-90,54618771,-0.717052278919437
G-401,4705,3.1032512954578415
IMR-32,9926054,1.7425604419011955
SK-MM-2,1566236,0.3685804031223497
Hs 746.T,3854666,2.6045097457620465
HEC-251,9911463,4.214524932841787
EJM,135659046,3.4058346184663693
Aska-SS,2746,3.0488180575917463
BT 482,9911463,4.164033493319952
SK-N-AS,1566236,2.45590112845104
KP-4,9868037,2.659555107849518
CML-T1,9884685,1.1136090650670494
OV56,6918638,2.271106971688871
OV-90,2746,3.04639214002508
SW1710,9926054,2.792354936189826
NCI-H1623,11152667,-0.7587975819891684
SK-MEL-30,54618771,0.8383532620392692
LNCaP clone FGC,54639665,5.111125595868773
HCC1588,sirolimus-bortezomib (250-1 mol-mol),0.5991119753615496
NCI-H460,9911463,4.421747687015995
SNU-449,135398744,6.632733291537939
253J-BV,135421197,3.2645583108657217
GB-1,9926054,2.832614445271179
LS513,sirolimus-bortezomib (250-1 mol-mol),0.1168577806704952
BL-70,3854666,0.0420244539233536
OAW28,9915743,2.8675584787684456
A-172,1566236,2.7054654358022345
U-118MG,9915743,2.4267236248915753
NCI-H1650,9911463,3.9017952806831313
HSC-4,sirolimus-bortezomib (250-1 mol-mol),1.2607817332731768
Hs 688(A).T,9926054,3.3187342382489255
NCI-H747,54618771,0.1335600477139397
SK-N-MC,65628,2.481985889078365
SNU-216,9868037,3.645721485009989
KYSE-70,11152667,0.5949086715112851
MHH-CALL-3,65628,0.4360080488789846
JHUEM-7,2746,3.3298840403754153
RCH-ACV,9911463,3.0164495694829903
NCI-H1793,10322450,3.1720779233297405
WM1799,4705,4.447302669477667
L-363,1566236,1.639224714587579
L-363,3854666,1.384061455726828
SK-UT-1,65628,4.642853879953485
GaMG,136227924,2.741790754216058
BT 164,9911463,2.6939037161672617
SK-N-MC,9911463,2.6824462579046755
SNU-738,3854666,2.877216929749153
RL,2742550,3.1981240154048134
SNU-119,9868037,3.103417825493656
SUP-M2,tanespimycin-bortezomib (250-1 mol-mol),-1.1687996119846569
SK-BR-3,9935249,2.056401078503904
KP-3,sirolimus-bortezomib (250-1 mol-mol),1.5261353801171291
SNU-423,tanespimycin-bortezomib (250-1 mol-mol),0.0994607736746136
JIMT-1,sirolimus-bortezomib (250-1 mol-mol),1.70536390931118
A-673,9915743,0.6829950735134661
ESS-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8573739995038356
JHUEM-3,1566236,1.872999267753902
CHP-212,6918638,-1.8920767869906776
NCI-H838,100016,5.521581837907123
JK-1,65628,2.528699450938154
SW1573,4705,3.887877577681455
KU-19-19,9926054,2.3371072555508445
MOLT-3,6918638,-1.6571682023232988
SU-DHL-1,135984461,1.9491307161872016
TE-6,4705,1.909603555694431
Kasumi-2,9884685,-1.7492969798518767
NCI-H1651,1566236,3.5266167122475
JHUEM-2,3854666,-1.0160197071128136
HOP-92,10322450,5.279706344713567
SNU-738,73707386,3.659830894488395
WM1799,136227924,5.317137472440357
SK-MEL-24,54618771,0.9964231192757652
SU-DHL-1,9926054,1.6936537424309908
42-MG-BA,sirolimus-bortezomib (250-1 mol-mol),1.266614497912793
FTC-133,135398744,6.510037604259866
BT 179,54618771,0.9924128093703488
BT 147,9911463,2.928240500663929
COLO 205,11152667,-0.0947339237953433
KP-2,9911463,4.372716241316865
DBTRG-05MG,9911463,4.332332359679133
Mel JuSo,selumetinib-GDC-0941 (4-1 mol-mol),1.489805359284141
BT 320,9935249,2.6939509810826294
BT-549,sirolimus-bortezomib (250-1 mol-mol),0.3371996014711167
BT 239,9915743,1.0912084303287637
CCF-STTG1,136227924,3.7108552267199504
KP-N-YN,11494412,3.870145712967313
KMRC-2,9926054,2.0216271093968263
MIA PaCa-2,11494412,0.4238198089736678
NCI-H2087,135659046,3.4152304488602727
NU-DHL-1,11494412,-1.1621345375437304
HOP-62,9935249,3.1113084784743
Kasumi-1,135398744,7.461687299190896
NCI-H747,9868037,3.413430732582287
G-292 clone A141B1,11494412,1.715634331094443
CHP-126,9935249,4.007708055794919
HCC2108,selumetinib-GDC-0941 (4-1 mol-mol),1.612699878393228
BICR 22,11152667,-1.8276171650012312
BT 359,tanespimycin-bortezomib (250-1 mol-mol),1.7721099348871308
HEC-265,9911463,4.29184324369936
C2BBe1,9915743,2.975671813944452
HEL 92.1.7,9926054,1.77080435305732
NCI-H2087,9935249,2.1855057709444092
HEC-59,136227924,4.443118393205084
NCI-H2110,135659046,4.755266203031495
HCC1428,2746,2.7120939724972444
F-36P,9915743,0.3844593263484804
NCI-H1792,54618771,0.988608164360901
BT 179,sirolimus-bortezomib (250-1 mol-mol),0.6409612230554944
NCI-H929,54618771,0.737310556758401
COR-L88,10322450,4.2439806030503915
L-363,9868037,2.573634031756044
SH-4,49836020,4.187960947372796
BDCM,11152667,-2.033195724638313
WM983B,2746,3.5652531947368495
A-172,71751553,5.172716040481698
COLO 320,9911463,3.3012856335719096
NCI-H1341,9884685,-0.5514971191572201
SEM,71751553,4.239243086655999
HuCC-T1,54618771,0.1107160240770854
COLO 205,9926054,1.7915651258593497
SNU-869,9911463,4.356989154503334
KCL-22,100016,3.971728515649248
KYSE-450,9911463,4.540289012412596
KNS-42,9926054,3.077818601925372
MOLP-8,9884685,-1.6145757941110517
MFE-319,9884685,0.756895604366277
LS1034,selumetinib-GDC-0941 (4-1 mol-mol),-0.3273277386123449
HT-1197,11152667,1.4681222423137998
MES-SA,135659046,3.2856375054871436
G-361,4705,3.3559681127377936
BT 228,sirolimus-bortezomib (250-1 mol-mol),-0.6325726268478239
OC 314,65628,3.7936421143756145
T98G,9926054,1.93846990860498
MPP 89,6918638,0.8493258123756348
OV7,135659046,3.534077236182633
Kasumi-1,135984461,1.8896899929854232
NCI-H647,9935249,3.357508970290888
BT 164,54618771,1.1636109320756167
NCI-H2122,9911463,3.941857850856705
A2058,4705,3.593116670395646
VM-CUB-1,100016,6.234028822794693
SK-N-BE(2),3854666,0.893693804231817
HPB-ALL,selumetinib-GDC-0941 (4-1 mol-mol),3.2361225802608593
JHUEM-1,54618771,0.4332987252464321
UACC-62,9915743,3.9206443408409455
Karpas-422,11494412,1.1821757343676855
UO-31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0895128254081629
Calu-3,10322450,4.307462921709786
NCI-H810,24779724,4.409374552120998
JHH-4,9911463,3.8474740585863785
OVK18,9915743,2.5814540538306012
WM1799,54618771,2.4607401092815677
SNU-840,9911463,4.425436668411372
HOS,9926054,1.8874056753100945
U266B1,6918638,-0.6016513516102697
NU-DUL-1,9911463,2.736663650607352
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736
GaMG,2742550,3.1284657448768054
NCI-H647,11494412,2.106693333692888
CAMA-1,135421197,1.145586441403014
NCI-H211,136227924,1.9167606171360705
Hs 766T,9915743,-0.5263602870781319
Mono-Mac-1,tanespimycin-bortezomib (250-1 mol-mol),-1.759960835446177
639V,3854666,3.290280806070441
Hs 895.T,9935249,4.499234655323106
VCaP,11494412,1.610321577610624
MES-SA,9884685,1.4540909419303651
SIG-M5,10322450,3.963755242230549
BC-3C,9884685,2.9353156431975393
SNU-1041,11152667,-0.085013189644464
COR-L51,9884685,0.271374180223106
YH-13,9935249,4.648604322917456
NH-6,11494412,0.0442527385928499
SW1271,2746,3.8382249001906814
SNU-601,135421197,1.035367817666236
NCI-H358,135421197,3.655226783621308
HPAC,9935249,3.1967144578068294
SCC-9,2746,3.644005246156997
SNU-C4,3854666,3.1013249794927846
HT,135421197,1.8590236680580152
NCI-H1693,3854666,2.669312044507388
BT 422,tanespimycin-bortezomib (250-1 mol-mol),0.0760958733861235
MOLT-13,sirolimus-bortezomib (250-1 mol-mol),-0.8755495405790606
SNU-175,100016,4.815284438481943
U-118MG,100016,6.712569444944465
IGR-1,136227924,2.467918205864833
Hs 688(A).T,135659046,5.661695633132947
SK-UT-1,9884685,5.1525602917749875
NU-DUL-1,135421197,1.0938833376467747
SU-DHL-8,4705,3.58469118843627
Daudi,9935249,-0.0031627785077317
G-292 clone A141B1,tanespimycin-bortezomib (250-1 mol-mol),-0.2188717779378038
DEL,136227924,2.1995562608544494
SH-10-TC,6918638,1.0653110676660122
253J,tanespimycin-bortezomib (250-1 mol-mol),-0.9234008422745912
Rh41,10322450,3.0581399607102773
SF126,2742550,4.653066114574705
COR-L95,11152667,-1.0192155235937173
KMRC-1,1566236,3.0378094444517645
SNU-626,49836020,-1.879821731308555
ESS-1,sirolimus-bortezomib (250-1 mol-mol),0.3261097694928553
WM1799,2746,3.8578156417169542
FaDu,49836020,4.381495172511739
42-MG-BA,9926054,1.7568260355296932
Raji,9868037,1.949547656703084
PE/CA-PJ41 (clone D2),selumetinib-GDC-0941 (4-1 mol-mol),0.5865157800426535
RKN,65628,4.337575078598336
EFO-21,11152667,0.2535336606337931
OE21,sirolimus-bortezomib (250-1 mol-mol),-0.2095744240897051
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
SNU-213,11152667,-0.7142929754084242
NCI-H1155,sirolimus-bortezomib (250-1 mol-mol),0.0856236991825952
HDQ-P1,135421197,5.294865947723562
OE21,136227924,2.0991161235844404
NCI-H226,11152667,2.5295492164700977
253J-BV,136227924,2.6085874458601066
NCI-H2405,selumetinib-GDC-0941 (4-1 mol-mol),-1.6328323472989523
NCI-H2023,54618771,0.8725356592337147
DLD-1,9915743,3.4458544437920784
NCI-H1666,9911463,2.79017781981442
HOP-92,4705,3.0147714927694387
SW1463,11152667,-0.1903484351781526
KNS-81,selumetinib-GDC-0941 (4-1 mol-mol),3.534657473122144
HCC1588,9926054,1.7105432403142011
OCI-AML-5,4705,4.476386157060081
NCI-N87,136227924,3.040461203265333
UM-UC-3,sirolimus-bortezomib (250-1 mol-mol),1.1405696257506746
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
BT 131,4705,3.217253929262008
CJM [Human melanoma],11152667,0.0216601684739394
COLO 205,135421197,2.4843493589992125
WM88,9935249,1.762742740497851
SNU-840,9884685,2.581610284096353
T24,sirolimus-bortezomib (250-1 mol-mol),0.798518469796891
COLO 668,9915743,2.0243501166827924
SCC-25,2742550,3.0640378690909023
SK-MM-2,sirolimus-bortezomib (250-1 mol-mol),1.09289711908984
NCI-H2405,9911463,3.94220055080447
YD-38,9926054,1.970357209117647
CGTH-W-1,100016,5.226111530095554
Kasumi-2,9868037,2.67651294484719
DMS 53,tanespimycin-bortezomib (250-1 mol-mol),0.0429262611809588
SK-N-MC,4705,3.836161182771402
SH-10-TC,3854666,3.043135915172001
SW1710,2742550,4.744380514553192
ACC-MESO-1,54618771,0.8381740730227087
KE-97,selumetinib-GDC-0941 (4-1 mol-mol),2.3217302036143295
JM-1,71751553,4.311473922741218
Panc 05.04,11152667,0.5937527047443664
Lu-99,9935249,3.4193801310758105
NCI-H650,54618771,-0.8168884104410387
LP-1,54618771,-0.0349126371834358
MKN7,9915743,1.455342343306638
HT-55,135421197,1.3327520491863434
NCI-H1299,11152667,0.5765175859368963
YD-10B,11152667,-0.8619602748650732
SYO-1,136227924,1.0009147925604558
VMRC-RCZ,71751553,4.4517301361944694
BT 145,4705,0.7034961776372417
HuP-T4,tanespimycin-bortezomib (250-1 mol-mol),-1.134384257023078
HEC-1-B,sirolimus-bortezomib (250-1 mol-mol),1.0526143004361572
NCI-H889,9915743,1.0430914945054055
HLF,135421197,1.600730736912683
Hs 611.T,3854666,0.606015378482523
CML-T1,10322450,3.1347292789416934
OCI-Ly10,11152667,-2.5286147720755943
IGROV-1,9915743,-0.4757488934941289
FTC-238,3854666,0.5562513966266507
SNB-75,9868037,4.435778123125775
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
SW982,1566236,3.274409185853836
KE-39,44487872,4.457727251314366
BT 482,6918638,6.285533973123243
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617
SNU-1066,135421197,3.020792561550821
AML-193,9884685,0.1171363640105301
AsPC-1,136227924,3.2025742465891938
KMS-26,54618771,-0.1721472849955331
K-562,3854666,0.2872946014041473
OVSAHO,9926054,2.353589005438
BL-70,49836020,4.386780315181427
GA-10,2746,0.7729221646050856
BT 231,9868037,3.3180720809611137
SK-MEL-31,tanespimycin-bortezomib (250-1 mol-mol),2.560525845699468
NCI-H2170,100016,6.477443817994488
UACC-62,2746,3.149907742936544
HeLa,3854666,0.8309069429521455
HCT 8,9868037,4.173444279573331
EFE-184,135659046,5.053439307588332
NCI-H1703,1566236,1.934428397387429
HCC1419,6918638,0.6452864183541364
SET-2,3465537,3.762273356710905
Hs 746.T,9884685,-0.72643676564829
HOP-92,9884685,-0.9123746680711942
IGROV-1,135398744,6.402844237905131
Mino,135421197,1.5483687621841111
SUP-B15,11494412,0.7807550096042158
SNU-1,11494412,1.5103919119470426
647V,1566236,1.696707922435322
NCI-H747,11494412,1.949841115292288
SK-N-FI,tanespimycin-bortezomib (250-1 mol-mol),-0.0515208796010249
OVCAR-5,9911463,3.385912841679363
COLO 792,1566236,1.718125081191272
LXF 289,100016,7.121965810949268
KCL-22,54618771,-0.0982742970998633
COR-L105,9935249,3.5389604716579175
NCI-H1581,135421197,1.183263993717128
VM-CUB-1,tanespimycin-bortezomib (250-1 mol-mol),-0.9212762336148834
CAL-62,9911463,4.371192134502622
Ki-JK,3854666,-0.1739211329910635
KMS-34,9911463,2.3879833599840934
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
JMSU-1,2742550,3.14564169590764
Granta-519,3854666,0.1662242620713641
KYSE-70,2746,2.8005709054024224
IPC-298,11152667,-1.5670594784434084
Hep 3B2.1-7,selumetinib-GDC-0941 (4-1 mol-mol),1.4217677888938105
Kuramochi,9935249,4.025943917149305
HLF,9935249,3.066009874384815
NCI-H2196,135659046,3.3895978567837073
SU-DHL-10,9868037,2.3348220475042343
PL-21,9868037,2.018011914645477
TCCSUP,3854666,3.617075113283279
LoVo,100016,6.001395250082881
MOLP-2,sirolimus-bortezomib (250-1 mol-mol),0.2890446382441622
JHUEM-3,4705,2.325459550435627
DMS 53,4705,3.2924346460856015
EM-2,9926054,0.5147420382885298
LS411N,3854666,3.592971008902542
HPB-ALL,sirolimus-bortezomib (250-1 mol-mol),0.9475176932995892
639V,9926054,0.5445384370060099
LUDLU-1,3854666,1.3097190271987702
CL-11,100016,6.945803371228119
MES-SA,11494412,0.938409593954222
FaDu,24779724,4.73773020769498
TE-5,54618771,0.4798060513951584
CAL-51,9911463,4.251278022142156
Panc 02.03,6918638,1.5939476449475074
LK-2,100016,5.670732740144693
TC-71,100016,6.681443396825605
SNU-213,136227924,3.1812992174761696
SW1088,9884685,0.5024488647997187
SNU-878,9915743,3.52259328044215
MeWo,54618771,2.702523015833562
KO52,65628,3.991598666523216
KNS-60,3854666,0.0716701028086042
HMCB,11152667,-0.8228544828189237
IM95,11152667,-0.330952579269037
DMS 454,9935249,1.8638785090695316
RCC10RGB,136227924,3.611686331312014
A-204,1566236,1.9335732426445524
CAL-27,selumetinib-GDC-0941 (4-1 mol-mol),-1.559817490656083
Karpas-299,11152667,-4.530059155107273
JHUEM-2,9926054,1.5571026590008097
RMG-I,73707386,3.131829712185126
HCC95,2742550,2.964424160692779
DU145,11152667,0.2266180408489874
TE-15,9884685,1.0908801329755264
MIA PaCa-2,135659046,3.7193443303471727
MHH-CALL-3,9915743,1.3835239256634295
GB-1,tanespimycin-bortezomib (250-1 mol-mol),0.6130587014327358
SW1710,135398744,7.400823424142947
DMS 79,3854666,3.294297622052333
SW1417,tanespimycin-bortezomib (250-1 mol-mol),-2.5738545143684064
Karpas-422,sirolimus-bortezomib (250-1 mol-mol),-8.407469772088508
NCI-H23,11152667,-0.8798455367060118
L-1236,9911463,2.598114748272053
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
SK-N-DZ,9911463,3.9970399765376423
HT-1376,9911463,4.13018577448945
HSC-4,9911463,3.832706037448295
HCC2108,135984461,3.878993075429708
Karpas-422,6918638,-0.9922508328121828
NCI-H1105,selumetinib-GDC-0941 (4-1 mol-mol),2.7215813635503165
SNU-423,54618771,0.8845738276291084
PSN1,tanespimycin-bortezomib (250-1 mol-mol),-1.4884042212108968
SK-UT-1,11152667,-1.0251821128308043
ST486,6918638,-1.4802112864016868
EB1,65628,2.3225973087067255
WM983B,sirolimus-bortezomib (250-1 mol-mol),1.0166833684300536
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
KE-39,9935249,3.082096285966509
HuH-28,9926054,2.302050382507772
A-673,135659046,3.595490040408381
SNU-475,2746,3.808468111093762
NOMO-1,135421197,1.2386186938920458
NUGC-3,9915743,-0.9717204559547163
PE/CA-PJ15,65628,4.3455180568825025
BT 359,6918638,2.662687063562674
TE 617.T,1566236,1.7943954235614814
LS513,135421197,1.126111149798444
BT 330,9868037,3.503197969188101
RL,11494412,0.0299021136601704
HCC1954,10322450,3.841021204455557
NCI-H1339,71751553,4.829519613793705
HT-55,9911463,3.2790943482968986
U-BLC1,135984461,1.880488153301068
BT 422,9868037,4.234688123695473
NCI-H1385,135421197,0.1924120036443515
PC-14,tanespimycin-bortezomib (250-1 mol-mol),-0.4303356181915626
Capan-2,tanespimycin-bortezomib (250-1 mol-mol),-2.4756483134960385
Ku812,9926054,1.5145588468111315
VMRC-LCD,136227924,2.9641387298533868
NCI-H1792,135398744,6.377997167001959
LOX-IMVI,selumetinib-GDC-0941 (4-1 mol-mol),1.2506716089378382
Granta-519,9926054,1.8135939424605243
NCI-H2444,selumetinib-GDC-0941 (4-1 mol-mol),3.5798793535857625
SW620,135984461,4.297796341732351
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
NCI-H1666,1566236,1.9953376747700329
AU565,9915743,-3.6885201415408098
DV-90,3465537,1.1955098369709305
LC-1/sq-SF,9926054,1.8795702077099137
SK-OV-3,49836020,-5.2191550029019025
COLO 800,selumetinib-GDC-0941 (4-1 mol-mol),-0.6648524830772472
KM12,10322450,3.9627058318193495
DND-41,49836020,1.1250375058635431
HCC2935,tanespimycin-bortezomib (250-1 mol-mol),-2.9372994580333947
SW1417,136227924,2.767989145735224
SW579,2746,2.8077894693149017
HCC2935,136227924,3.4382607017764473
NU-DUL-1,9935249,2.5570443888862737
SNU-886,selumetinib-GDC-0941 (4-1 mol-mol),1.2837780593407424
NCC-StC-K140,9915743,-4.061475008678285
HEC-151,4705,2.9357366805195735
YD-15,selumetinib-GDC-0941 (4-1 mol-mol),0.264386559718112
DU145,6918638,0.5820093502251232
MSTO-211H,73707386,2.8647689708389943
COLO 800,sirolimus-bortezomib (250-1 mol-mol),0.359649452523933
MOLP-8,6918638,-1.572747132532541
BICR 31,1566236,4.637821170940002
SNU-216,10322450,3.800791101615317
RVH-421,2742550,4.124489101542342
OVTOKO,tanespimycin-bortezomib (250-1 mol-mol),0.5504148489500027
JHOM-1,6918638,0.1301206862216937
HCC15,9868037,2.5640614102548556
VMRC-LCD,9911463,3.586787073438602
SNU-878,65628,4.1894016478203095
OC 314,71751553,4.2935684369934
MKN74,71751553,4.911455575935293
SNU-899,54618771,0.9144402364445118
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
SUP-T11,1566236,1.3558207096631127
Lu-99,9884685,-1.574037677667807
JHH-1,100016,6.434861287132587
SNU-489,650361,3.775081020904096
TE 617.T,9935249,2.123679604144266
SNU-449,71751553,4.402646349497825
NB1,11152667,-1.640539309256127
IM95,135421197,1.82803770659542
NCI-H2122,135421197,1.54063176818906
L-363,4705,4.264725490975614
HOS,71751553,4.86028944300483
BICR 16,9926054,1.5790536370066437
MDA-MB-157,135984461,1.8807242402896556
CAMA-1,11152667,3.9116421057380193
HSC-4,135421197,2.1482643592466495
NCI-H2106,11152667,0.9326509304786484
LOX-IMVI,73707386,2.553135353706567
EC-GI-10,11494412,-0.3258090559677851
A101D,sirolimus-bortezomib (250-1 mol-mol),0.247462078551585
NCI-H727,3854666,3.6466691501950512
BT 231,9911463,2.979244544193708
SUP-HD1,tanespimycin-bortezomib (250-1 mol-mol),-0.2470989811885863
RPMI-6666,11152667,-2.0860196323814697
Pfeiffer,3465537,1.0799742381514623
SNU-761,3465537,0.6076384821970646
A-549,9911463,3.875766071211208
DMS 53,11494412,1.0144009801512948
J82,6918638,1.767532826285683
NCI-H1666,11152667,-0.2091625365803616
SiMa,136227924,1.9858625956320377
SW948,136227924,2.9576701343794145
UO-31,tanespimycin-bortezomib (250-1 mol-mol),0.458183553535823
NCI-H841,65628,4.282861178298196
HOP-92,tanespimycin-bortezomib (250-1 mol-mol),0.1347275198729775
MV4-11,10322450,2.830685267799283
MDA-MB-435S,11152667,-0.6282120536011198
Becker,11494412,0.142625338466196
639V,136227924,2.8924456476929605
Rh18,selumetinib-GDC-0941 (4-1 mol-mol),2.126634875194983
SK-MEL-5,sirolimus-bortezomib (250-1 mol-mol),0.9353591049866828
MDA-MB-468,2746,3.461391528245753
SNU-387,3854666,3.852007749514328
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
BT 440,49836020,4.914023334980662
Peer,sirolimus-bortezomib (250-1 mol-mol),-1.139363807048106
BT 187,11152667,2.627435911702914
253J-BV,44487872,4.358270003385931
BICR 6,3854666,0.6221366242380308
GMS-10,9926054,1.955397909013321
BICR 56,sirolimus-bortezomib (250-1 mol-mol),1.89463967365671
BT 187,1566236,2.9307051706234986
KM12,135421197,2.2620714252127336
NCI-H2110,54618771,2.4596551535175504
Tm87-16,6918638,1.685877377601704
Peer,9926054,0.3844122788400798
HCT 8,3854666,3.4092895535150083
LMSU,10322450,5.4992145641719095
Hs 934.T,11152667,0.4096473732828699
HCC202,135398744,6.455993552330763
A-375,selumetinib-GDC-0941 (4-1 mol-mol),1.473699633531409
Sq-1,135421197,2.584547393194889
HuG1-N,9911463,3.1610800611840366
HEY A8,11152667,-0.054665065354644
Sq-1,9915743,-0.0182413792869356
YD-38,11152667,-0.8447422607526522
CAL-120,9884685,3.43304722885063
NCI-H1838,54618771,1.6121528318079854
MEC-1,100016,3.995806762220144
WT2-iPS,9926054,1.80219025961501
SF539,135984461,4.130188481564332
U-BLC1,9935249,1.956441197069186
LCLC-97TM1,9911463,3.937478558519083
SNU-886,3854666,1.448080837770843
UM-UC-3,135659046,4.064951020836241
SK-N-DZ,sirolimus-bortezomib (250-1 mol-mol),0.4176185816300255
KMRC-20,9926054,2.16526453404653
MCF-7,9911463,4.323534340426757
HCT 15,tanespimycin-bortezomib (250-1 mol-mol),-0.1755556188950918
OUMS-23,136227924,2.42742246798026
GB-1,135984461,4.369160227652603
KMS-28BM,9868037,2.7524179653938172
BT 340,9884685,2.0684109733399323
SW1088,3465537,2.9925231341209964
TE 441.T,71751553,4.471943805545609
EC-GI-10,100016,6.57909581265972
NCI-H196,9884685,-0.0340951711946578
OCUM-1,4705,2.5400266776319067
SK-MM-2,11152667,-1.4514217856008986
253J,3854666,0.8471444686993981
SH-10-TC,9884685,3.631476367936063
IST-Mes1,44487872,4.402175961022997
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125
BICR 56,9884685,-0.7491894375183117
MEC-1,11152667,-1.5556986034524167
CAL-54,1566236,1.9405181909145055
SCC-25,2746,2.621805832840377
BHY,sirolimus-bortezomib (250-1 mol-mol),0.9100094711799346
RPMI-8226,73707386,3.162899044408619
IGROV-1,9935249,3.330117761231163
GA-10,1566236,0.5449565889355672
KCL-22,3854666,0.7303027216654703
HT-55,1566236,3.1458064864445197
L-363,11152667,-4.496955803562482
DMS 454,6918638,-0.5364847082053857
Detroit 562,sirolimus-bortezomib (250-1 mol-mol),0.7815437350354109
LP-1,71751553,3.851521724606858
647V,6918638,0.3753177333233063
MHH-CALL-4,9926054,1.817922343737897
KMS-11,100016,4.183673123455152
UM-UC-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8990264790704343
WM266-4,6918638,0.8919001534334414
Hs 729.T,135659046,4.671594069025629
BT 131,11152667,0.986821674709279
NCI-H322,71751553,4.705668316435038
EN,6918638,1.0700608344727125
8305C,tanespimycin-bortezomib (250-1 mol-mol),1.1491228196694627
BT 239,selumetinib-GDC-0941 (4-1 mol-mol),-0.9250239368821744
BT 172,100016,6.450201924949107
BT-549,9926054,1.9687680834705423
HuG1-N,sirolimus-bortezomib (250-1 mol-mol),-0.2161746161621927
CW-2,54639665,-0.4017445704850298
HT-1080,71751553,4.199253292607991
KYSE-510,100016,5.186546688011686
IGR-37,135421197,1.178661342091473
T98G,1566236,4.934328741372893
VMRC-RCW,135398744,6.359457324257638
Hs 611.T,136227924,1.5120677878583844
KMS-26,9884685,-2.486464178547567
A101D,9935249,3.2332188881135147
PSN1,71751553,4.565522907457272
Lu-99,tanespimycin-bortezomib (250-1 mol-mol),-2.7467052265090723
Panc 04.03,selumetinib-GDC-0941 (4-1 mol-mol),1.425782410580866
CHP-126,sirolimus-bortezomib (250-1 mol-mol),1.5217609730856023
SUP-M2,9884685,-0.7258224085380136
NCI-H1355,4705,2.565459964061863
UACC-62,71751553,5.228907111872232
SK-MEL-5,11152667,1.6641946386501631
BT 416,4705,1.1449833696295684
LOX-IMVI,71751553,4.503158231702006
NCI-H1355,9926054,1.8192914468713284
KNS-62,71751553,4.396119226436637
KHM-1B,65628,3.60559222842334
OCUM-1,sirolimus-bortezomib (250-1 mol-mol),2.078884953433103
HCC1833,9926054,1.8132192248663452
SNU-601,9884685,1.2283568058466754
NCI-H2170,11152667,-1.0107802099537535
JHH-1,135421197,1.7316230199472116
HT-1376,1566236,2.1181506136413635
SNU-761,3854666,2.764365196176534
JVM-3,2742550,3.0127935695747023
NCI-H522,44487872,5.4176039717063915
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487
L-540,sirolimus-bortezomib (250-1 mol-mol),-4.16248218477803
MDA-MB-361,2746,1.2909021690228906
BT-549,54618771,1.4883156908959423
LUDLU-1,3465537,3.523806799822874
P-STS,11152667,-0.9281446368525446
Rh18,10322450,3.5568914493716712
COV434,3854666,0.915604279747924
WM115,2742550,3.774256401917875
HOP-62,9926054,1.899267170249981
HCC2108,136227924,3.562843531024723
HCC2935,71751553,3.94725782245623
TE-10,9935249,3.642626385966905
DB,tanespimycin-bortezomib (250-1 mol-mol),-0.1936867614029041
UM-UC-1,9911463,3.4816748285227055
Kasumi-1,54618771,-0.5933473150200181
IGR-1,6918638,-0.5793236649070632
OCI-Ly19,65628,1.529458135947593
COLO 829,9911463,4.4284990844241126
PaTu 8988s,135659046,3.7225208809385073
GP2d,9911463,3.4287638364332333
SNU-201,11152667,1.3436502466257625
MSTO-211H,3854666,2.1662920246080963
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
MDA-MB-453,100016,6.0730906594859215
HEC-151,10322450,3.547902209799766
L-540,10322450,3.2951827838559895
HGC-27,1566236,2.3802027184021037
PaTu 8902,9911463,4.390925153080421
SW620,54618771,1.1689155284524844
PE/CA-PJ34 (clone C12),9935249,1.3468495063678572
NCI-H460,100016,5.855223104671776
JIMT-1,54618771,0.8201229283888136
TE-14,135421197,1.7423329869648043
SK-MEL-1,11152667,1.128621157478479
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
WM983B,54618771,1.7213296960323683
SNU-398,11152667,-0.7435304087318404
JK-1,4705,2.217809938793497
SNU-C4,9868037,3.980442058485963
LS411N,135984461,5.061110843141604
SW948,10322450,3.138867511839475
NCI-H146,tanespimycin-bortezomib (250-1 mol-mol),-0.2657593294173981
VMRC-RCZ,2742550,4.506974409997668
TF-1,100016,6.442708110888471
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557
LCLC-97TM1,49836020,1.9924259842665932
WM88,11494412,0.914272881101828
BT 231,136227924,3.1954768658582378
DV-90,650361,4.027920817519659
GCT,9868037,3.729944078778933
CHP-212,1566236,1.526376682720088
SNU-503,9935249,5.308308259709731
EC-GI-10,71751553,4.470484975486233
OCI-M1,100016,6.862784368685653
EHEB,9915743,0.5785876427148751
A2058,135421197,3.1634124303989273
DK-MG,71751553,4.329180053945678
BxPC-3,sirolimus-bortezomib (250-1 mol-mol),-0.2731425990324966
QGP-1,11152667,0.9572583178254478
CJM [Human melanoma],24779724,4.49881872320391
SUIT-2,selumetinib-GDC-0941 (4-1 mol-mol),2.4482295182309257
ONCO-DG-1,49836020,4.455184005808947
HT-1080,1566236,3.9096687939469135
LS123,tanespimycin-bortezomib (250-1 mol-mol),0.0311387625429896
HCC1419,selumetinib-GDC-0941 (4-1 mol-mol),1.9715069787616553
HCC1588,49836020,4.436779912961811
KNS-60,65628,4.405089731015004
A2780,54618771,-0.248592168161829
OCI-M1,9915743,0.9472890233124052
CHP-126,135421197,1.2464718397024956
GB-1,sirolimus-bortezomib (250-1 mol-mol),0.3465048040128788
THP-1,65628,3.276100390761181
KP-4,136227924,3.1314573836961235
KP-N-YN,136227924,3.0572578369433376
JHUEM-2,selumetinib-GDC-0941 (4-1 mol-mol),0.855828928912332
KMRC-1,54618771,0.2036698487849761
SNU-761,9935249,3.1228430287660354
A3/Kawakami,11494412,-0.0217688682403614
769-P,54618771,0.1291484559700657
CAL-51,9911463,4.251278022142156
NCI-H1299,135421197,1.297843636132371
NCI-H2170,9935249,3.196642717423438
HT-1376,54618771,1.723140489486428
SK-OV-3,73707386,3.7899266428434233
SNU-16,11152667,-1.4150266390059103
Daudi,136227924,1.3476403322374937
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
DAN-G,4705,3.464155926779532
GMS-10,6918638,1.6892515574733475
BT 164,9926054,1.7569954478000085
HuH-6,4705,2.6985150624088967
A-498,tanespimycin-bortezomib (250-1 mol-mol),1.6557393213217402
HT-55,9915743,-1.6854357534662117
WM793,54618771,0.892561932009902
HuH-6,9935249,3.1892050642519756
OVTOKO,100016,8.078720974707625
OCI-Ly10,44487872,5.449648812232099
MOLP-8,11494412,0.4734092912657368
A-498,3854666,2.914304878080617
VCaP,selumetinib-GDC-0941 (4-1 mol-mol),1.6951262679306962
OAW28,9911463,4.007690751229585
EKVX,9884685,0.0650856407845384
HCC78,9935249,4.286479592386118
MV4-11,9926054,1.3518163817603386
KMS-28BM,9915743,0.6729564679567067
CMK,54618771,0.9710170961013548
PaTu 8902,3465537,3.540732953494624
OCI-AML-2,135421197,1.0650932399576858
NB1,selumetinib-GDC-0941 (4-1 mol-mol),2.4185204185307527
SK-BR-3,4705,1.1013734177792738
NCI-H1155,9884685,-0.5170479452111597
SF268,4705,3.336245866912317
Lu-65,136227924,3.620246561182502
SK-LMS-1,10322450,5.260294901094195
PSN1,11152667,0.7920097543928998
OCI-AML-5,3854666,0.9845193843983524
RPMI-8226,54618771,0.103524211569064
BICR 22,9926054,1.8271931211135617
CAL-12T,9926054,1.6569209752811729
U-937,sirolimus-bortezomib (250-1 mol-mol),0.5850227728036819
IGROV-1,9884685,-0.088911709267569
BICR 18,2746,3.306459207135074
BT 444,4705,3.933248870863524
Hs 852.T,9915743,-0.5396545081507467
8505C,9868037,2.6963732773492572
ONS-76,selumetinib-GDC-0941 (4-1 mol-mol),-1.205136839893776
AGS,selumetinib-GDC-0941 (4-1 mol-mol),0.9665370398813388
HuP-T4,sirolimus-bortezomib (250-1 mol-mol),1.161558608864497
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
NCI-H2081,tanespimycin-bortezomib (250-1 mol-mol),0.018908734219335
HCC1588,tanespimycin-bortezomib (250-1 mol-mol),-0.9414361012739926
DoHH2,tanespimycin-bortezomib (250-1 mol-mol),-0.3609676807954009
ES-2,9935249,3.3722887493761857
CJM [Human melanoma],135659046,3.6050904853036703
BT-549,2746,3.8188337512891137
SEM,9911463,3.141152403249145
CAL-12T,9911463,4.058144807952839
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
Sq-1,9926054,2.1337916564135906
CAL-78,selumetinib-GDC-0941 (4-1 mol-mol),2.58322288214442
YD-38,136227924,2.6123275605059075
NCI-H1651,54618771,4.521553313874046
786-O,1566236,2.88270736752961
SNG-M,54618771,1.0542976852091588
BT 271,135421197,1.2817550115075582
LN-18,sirolimus-bortezomib (250-1 mol-mol),1.6485166407126024
SKM-1,100016,4.336407790429152
NCI-H2087,136227924,2.807670387816286
PSN1,100016,3.987578982943132
SNU-61,54618771,-0.470226071786205
ES-2,135398744,8.06870751291861
NCI-H1703,11152667,-3.4809417543540873
Lu-99,9868037,3.2143966099709655
SU-DHL-8,sirolimus-bortezomib (250-1 mol-mol),-6.359979517729665
GMS-10,9915743,1.3582856861071526
NCI-H2228,9926054,2.036678685605589
HEL 92.1.7,sirolimus-bortezomib (250-1 mol-mol),0.1862867514845364
HT-1080,sirolimus-bortezomib (250-1 mol-mol),0.4645124048276262
KE-39,9911463,3.415693188275342
MOLM-13,10322450,2.9930800125873045
NCI-H23,2746,2.7818216168279526
LOX-IMVI,54618771,-0.8031507578309087
CAL-51,1566236,2.769525954778687
BT 159,9868037,4.039671954943351
SK-N-BE(2),11494412,1.3144229317777725
SW1417,9884685,0.1615844377536893
ACHN,71751553,4.44708282710721
SNU-685,9915743,3.119233801889696
Malme-3M,3854666,2.9636380835575498
SCC-9,9884685,0.522968392230544
AGS,11152667,0.9910903722220584
SUP-T1,4705,3.362457199926275
BT 271,136227924,1.335352033885486
KATO III,9911463,4.145072857900557
NCI-H810,3854666,1.3321102661413062
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
OCI-Ly3,136227924,2.2750950031645885
Hs 934.T,9884685,-0.7666789770957926
Capan-1,11152667,-0.5862513866914233
HT-1080,11152667,-0.5358883400554086
DAN-G,9926054,1.747482520890968
F-36P,9911463,3.056113876518826
KMS-12-BM,100016,3.5545657198194873
BT-16,11152667,-1.4424120868288224
P3HR-1,9868037,3.788082301181329
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
COLO 678,1566236,2.5936141595100173
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
OCI-AML-3,135984461,4.624808466912499
L-428,135659046,3.7649753981582137
WSU-DLCL2,11152667,-1.6182237488430529
TALL-1 [Human adult T-ALL],sirolimus-bortezomib (250-1 mol-mol),0.4525392365030144
Namalwa,9935249,0.8927496794896076
NCI-H647,4705,2.403903221755703
NOMO-1,9915743,0.4758643096003905
TUHR10TKB,9884685,2.5502093698496004
SNU-1,11152667,-1.0568577120834788
HCC1500,9935249,2.2800833668468266
COV644,11494412,1.744559483625179
JHUEM-3,135421197,1.4304571308518408
BEN,135421197,5.032233949916212
AML-193,sirolimus-bortezomib (250-1 mol-mol),0.7759141374550513
A2058,3854666,0.7864755506685932
TALL-1 [Human adult T-ALL],49836020,4.412561834618748
LXF 289,54618771,-0.5375230222620658
T24,9915743,2.484963977138841
HEL,135421197,2.810551353794614
HT-55,tanespimycin-bortezomib (250-1 mol-mol),-1.2155769519281892
RPMI-6666,selumetinib-GDC-0941 (4-1 mol-mol),0.4507229369642581
BT 440,54618771,0.7745514333639397
PE/CA-PJ15,1566236,2.6409505588349353
MEC-1,1566236,1.1632689835014047
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
SU-DHL-1,136227924,2.1802521862386395
BT 245,11494412,1.2412391063444357
Hs 944.T,2746,3.0349004525827583
SUP-M2,3465537,1.2171909076225451
SNU-423,11494412,1.245479972676825
OVCAR-4,sirolimus-bortezomib (250-1 mol-mol),0.1609764343460656
OC 314,selumetinib-GDC-0941 (4-1 mol-mol),0.5636308108859065
NCI-H1694,9915743,-0.097259817128113
NCI-H2170,24779724,5.385987309009065
NB4,9926054,1.6278742802322663
SK-N-DZ,9884685,-0.9050200773000474
BT 328,54618771,1.300712581347958
C2BBe1,136227924,2.0906474270390656
EB1,24779724,4.283325009913098
Hs 934.T,135659046,4.578054187652552
BT 444,9884685,1.6676673594353697
SK-MEL-31,9915743,2.191298837926563
Mino,71751553,3.961570534496015
KNS-60,1566236,1.8846845687083928
NUGC-4,2742550,4.776949321673274
CL-11,4705,3.0893529529673347
TT2609-C02,sirolimus-bortezomib (250-1 mol-mol),1.6449110161663607
SNU-719,selumetinib-GDC-0941 (4-1 mol-mol),-0.9974612802611444
EFO-21,9935249,3.4290046574242843
UM-UC-1,9884685,0.3158725560360218
BICR 18,6918638,-0.187981376082111
HeLa,9915743,4.03760238390019
AsPC-1,135421197,1.8824248695595285
OCI-AML-5,54618771,0.4264677614075425
SK-HEP-1,11494412,3.332434654266433
PLC/PRF/5,4705,2.7931521546735243
Hs 944.T,135421197,1.7444427011785306
KNS-62,54618771,0.989715202363148
VMRC-RCZ,54618771,3.963095950994299
Ishikawa (Heraklio) 02 ER-,9868037,3.205963776347529
U-BLC1,49836020,5.6845894274854585
BT 416,136227924,3.4255307271180726
MeWo,6918638,-0.7125250805485809
Karpas-299,9911463,3.0084205212852724
NCI-H460,selumetinib-GDC-0941 (4-1 mol-mol),3.0919607246847076
COLO 699,73707386,3.740137690108706
NCI-H446,2742550,3.416612314830542
A2780,135659046,3.385733838662662
CAL-33,11494412,0.5999793453593346
KYSE-30,24779724,4.458734114330223
KMS-12-BM,54618771,-0.8802136937205215
HCC1500,11494412,1.8019649514762912
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
PK-59,11152667,-0.441675469971464
MSTO-211H,4705,2.457156821386339
Reh,selumetinib-GDC-0941 (4-1 mol-mol),2.2162895945823093
Kuramochi,136227924,3.2782581577037964
SH-4,2746,3.3582559523336024
A101D,54618771,1.2420685416826056
HEY A8,9935249,3.4696021143903333
UO-31,11152667,-0.0094884527945568
IMR-32,selumetinib-GDC-0941 (4-1 mol-mol),2.0130210869415515
TUHR14TKB,selumetinib-GDC-0941 (4-1 mol-mol),2.1009270469043897
BT 224,135398744,6.495060752655371
WM88,4705,3.410375599390418
OUMS-23,135421197,2.711287517534292
UM-UC-3,3465537,2.695798094049334
SJSA-1,2746,5.233978868985217
BICR 16,3854666,1.3467812594658026
MDA-MB-415,71751553,5.417271361950941
Panc 03.27,9926054,1.7808185952102251
LAMA-84,3465537,3.920493576455389
TUHR10TKB,135984461,5.527226516832142
G-402,10322450,4.125946909240017
IM95,sirolimus-bortezomib (250-1 mol-mol),0.6284965219885708
BICR 22,9915743,0.3047863731286212
BT 340,sirolimus-bortezomib (250-1 mol-mol),1.036760644305087
SCC-9,3854666,1.6335835525169635
NCI-H460,135421197,3.2510260026522233
MDA-MB-157,9884685,1.398372779004129
G-402,sirolimus-bortezomib (250-1 mol-mol),0.1655413434951251
L-363,49836020,4.471751893617592
BHY,54618771,-0.7807984758131394
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
HSC-4,65628,3.12205826618997
Hs 839.T,9926054,1.9387188117771836
PaTu 8902,54639665,4.483683562011812
HLF,136227924,2.390310427445978
MOLT-3,54618771,-0.579298933394039
HuP-T3,2746,4.662800576379415
H-STS,6918638,-0.6396360846494638
CL-11,9926054,1.919128241871703
SW1271,9911463,3.695583497273472
SH-4,9915743,0.7789394097193199
CA46,54618771,1.203400154931592
HuP-T4,9915743,-1.7741648598156543
Hs 888.Lu,54618771,0.7485520203089981
MOLM-13,135421197,0.945680487717708
JeKo-1,54618771,0.9651230591785864
JJN-3,6918638,-0.7413603432623325
UACC-257,2742550,4.012288915291852
YH-13,9926054,1.834128888426512
KYSE-30,9926054,2.699990284064641
JHOC-5,tanespimycin-bortezomib (250-1 mol-mol),0.5504047070747966
TTC-709,9868037,3.9116830012775816
OV-90,9926054,2.051582159797273
LS123,9935249,2.027322446683245
CHP-126,2746,1.549661784493303
WM88,9884685,-1.1119542466113133
KMS-34,selumetinib-GDC-0941 (4-1 mol-mol),0.0635053645557878
BT 147,54618771,0.8857496125783197
Hs 294T,2742550,3.9124130314345456
KE-37,selumetinib-GDC-0941 (4-1 mol-mol),2.002060120469268
U-CH1,11494412,5.678083341070562
SUP-HD1,9935249,0.0380094941240227
Hs 729.T,11494412,2.5231914609190667
IGR-37,9868037,4.196529232004268
SNU-878,11152667,-1.7105164771196346
BT 164,2746,3.0448887101441793
LXF 289,sirolimus-bortezomib (250-1 mol-mol),0.6089213560806236
NCI-H1339,sirolimus-bortezomib (250-1 mol-mol),1.1828252918019528
Becker,1566236,1.7807841622280378
VMRC-LCD,6918638,-0.8957275762534151
SK-N-BE(2),9926054,2.2939851330117413
SH-4,1566236,1.7518917759818655
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
Lu-65,selumetinib-GDC-0941 (4-1 mol-mol),-1.6504739583037105
NCI-H292,11152667,0.5464898224488388
TF-1,2746,2.294459830990238
HCC1143,9911463,3.749174224015704
U-CH1,1566236,1.8876808469756592
NCI-H2081,6918638,-1.1409095287475362
SNU-1066,selumetinib-GDC-0941 (4-1 mol-mol),1.622393970628324
KCL-22,135421197,1.194260119901322
MFE-296,2746,4.362260792624359
OCI-Ly3,10322450,2.4111759735163316
KE-39,3854666,4.449857131704124
PE/CA-PJ15,3854666,0.5733431717297748
PaTu 8988s,9911463,3.6809927178566855
SF126,135398744,7.810596319596066
SU-DHL-8,3854666,2.010086978430689
BT 330,tanespimycin-bortezomib (250-1 mol-mol),-1.5657589280340811
SNU-503,54618771,1.215393479173298
Lu-65,6918638,0.8216407628444748
KNS-42,sirolimus-bortezomib (250-1 mol-mol),0.2435231832120803
Lu-99,selumetinib-GDC-0941 (4-1 mol-mol),1.1181366334842004
Mono-Mac-1,9935249,2.3948099372524965
Panc 08.13,9868037,4.03637116886627
Yamato-SS,2746,2.81924703396879
PE/CA-PJ34 (clone C12),tanespimycin-bortezomib (250-1 mol-mol),-1.982258316980141
RS4;11,54618771,-1.3838955198533192
HL-60,tanespimycin-bortezomib (250-1 mol-mol),0.1959762790136793
HDLM-2,11152667,-0.0982473466118714
A-673,9935249,0.595201632659186
KMH-2,sirolimus-bortezomib (250-1 mol-mol),-3.0653636595991203
Hs 944.T,sirolimus-bortezomib (250-1 mol-mol),1.3396818337224137
Mono-Mac-1,1566236,1.6378087380099338
SHP-77,tanespimycin-bortezomib (250-1 mol-mol),-0.364724393269764
GI-1,9926054,1.7357819318992778
SNU-1033,11494412,3.797369316086489
PK-1,tanespimycin-bortezomib (250-1 mol-mol),-1.3417753505365824
A-673,9926054,1.7717409858597033
SW1783,10322450,4.230470764848986
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334
SNU-C2A,100016,6.499335908465164
A101D,9915743,1.230916500554605
HEC-59,9935249,3.547828303095583
KMRC-2,selumetinib-GDC-0941 (4-1 mol-mol),1.6802426748833608
KP-N-YN,9911463,4.355119869591486
Capan-2,9935249,3.196012622928356
HEC-251,11152667,0.8582943172462689
MOR/CPR,9926054,1.7872025764961004
SNU-1196,136227924,2.95634276982207
AML-193,10322450,2.9754304486857
SNU-16,4705,2.028758835255635
HEC-1-B,3854666,3.528509684945124
Kelly,9935249,2.7785496119201807
WM115,100016,7.477930972064711
HuCC-T1,9911463,3.575644452957985
GCT,136227924,3.024645180957839
ALL-SIL,135421197,0.8278001934093618
U-251MG,54618771,1.0937916825211575
NCI-H1092,tanespimycin-bortezomib (250-1 mol-mol),0.328880127360426
KMS-34,9935249,1.539915970001855
Mel Ho,11152667,0.8252449561031235
KMS-26,11152667,-2.145052290186052
SNU-C2A,10322450,3.700200592981039
NCI-H1623,3854666,1.505587442259218
PaTu 8902,4705,3.6244040622068256
MHH-CALL-3,10322450,4.0007371010331045
HCC1438,3854666,0.7940091935117004
SU-DHL-1,11152667,-1.9410189761528236
COR-L51,tanespimycin-bortezomib (250-1 mol-mol),-1.1077118907846166
SNG-M,9915743,0.6282873859108726
MeWo,11494412,0.7893375124921355
SW48,65628,3.988389614478155
TUHR10TKB,135421197,3.595491301203154
A-253,4705,3.938906906816397
KMS-27,135421197,2.249002810195298
SW48,9884685,-1.5395746259931604
BT 231,135421197,1.0763175924586934
SNU-620,136227924,2.4539673197881444
NCI-H196,11152667,-0.3084820466732423
8-MG-BA,9926054,2.058364924251872
PaTu 8988t,11152667,-0.7220641758089987
AU565,49836020,5.742264990221176
A-549,54618771,0.0374822867627876
2004,11152667,-2.5450594943975986
MCF-7,135421197,1.272552449753212
Ci-1,135659046,3.670902573768625
T-47D,100016,6.980531714745858
NCI-H1105,2746,0.8615179559982858
HT-1197,136227924,5.329383648142769
Reh,9911463,2.887324979980584
KE-97,3854666,-0.4981384374359918
LAMA-84,9868037,1.3276253526445787
2004,71751553,3.819859094471768
A-375,135398744,6.486116496095493
NOMO-1,4705,2.5023829157060926
VMRC-LCD,3854666,0.6115412380814026
MOTN-1,2746,1.1076991402099114
EM-2,9911463,2.8916487141843974
T24,135421197,1.5767187843599464
TTC-709,54618771,0.1325833030612315
NCI-H1568,9915743,-0.8427224057935273
MPP 89,2742550,3.993555422023738
HT-55,11152667,0.1150286371338621
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
KYM-1,11152667,-1.7906769013264132
SK-OV-3,11152667,-0.6824217491873509
Panc 05.04,73707386,3.515667776304821
HOP-62,9915743,2.3333223593469947
NCI-H747,9915743,-0.7315863736844913
TC-71,135659046,3.771711324789507
YKG-1,11494412,2.049778246411874
MOLT-13,9935249,1.2940380714229205
NCI-H1299,54618771,0.5506920644788533
YD-10B,100016,5.941622042216757
SF268,3854666,1.8198409399657236
Hs 766T,136227924,2.630952750368734
UACC-62,135659046,3.5566231675799123
DoHH2,73707386,-1.3802336356597755
SR,135421197,1.9567356952392363
OVISE,135984461,1.6429740508824469
NCI-H322,24779724,4.441371574711967
NCI-H446,sirolimus-bortezomib (250-1 mol-mol),0.5863083212438859
MKN7,135984461,4.326296832547204
COR-L88,selumetinib-GDC-0941 (4-1 mol-mol),4.210918027029114
MKN1,selumetinib-GDC-0941 (4-1 mol-mol),2.452796078251995
SNU-878,selumetinib-GDC-0941 (4-1 mol-mol),0.5330473997899833
NU-DHL-1,1566236,-0.7944323454419335
SK-ES-1,135984461,2.1821823459422
Ri-1,1566236,0.746437074488416
Hs 611.T,11152667,-4.000300813330283
DB,11152667,-0.1181623714214869
GI-1,4705,3.0771619650951214
Sq-1,2742550,3.759213633183168
KP-N-YN,3854666,3.696443980357986
MOLM-6,9926054,1.5702726782081282
MHH-CALL-3,135984461,3.2485861141409975
OV7,9935249,0.7087225870012266
Granta-519,4705,3.4024179319436483
SW1783,3854666,3.296513769962362
SNU-410,135984461,4.232022058920155
Panc 03.27,9935249,4.091964927593618
KYO-1,1566236,1.52682449500088
BICR 16,9884685,0.7876467739980545
SYO-1,9911463,4.053570521016679
Caov-3,9926054,2.84814467099178
MeWo,9935249,3.0187575448972854
EHEB,9868037,2.9297052804513934
WSU-DLCL2,54618771,1.0658572900197
OS-RC-2,9935249,5.541714857295115
SH-4,3854666,5.025906872043464
8305C,selumetinib-GDC-0941 (4-1 mol-mol),-0.5953379888353332
SNU-C4,selumetinib-GDC-0941 (4-1 mol-mol),1.401600163987786
RL,6918638,-0.8458065739236997
JHH-1,9926054,1.7588254192067414
Lu-65,135421197,2.266142941564523
Aska-SS,54618771,0.6758112733038071
BT 271,2742550,3.149966758396329
T98G,6918638,1.4380012949673455
Lu-99,100016,4.341210602126273
A3/Kawakami,6918638,-1.1948916865846906
HD-MY-Z,9935249,2.519302012591236
BT 216,sirolimus-bortezomib (250-1 mol-mol),0.2946031494778452
SET-2,6918638,-1.854101300935
EHEB,54618771,1.2042140049426533
BICR 31,54618771,0.3365869204450262
SaOS-2,9911463,4.168030006572111
NALM-6,73707386,2.2984921556780704
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351
HCC78,135421197,2.5201678114483683
OCI-AML-3,9915743,0.4173420308342337
NCI-H460,135421197,3.2510260026522233
TCC-Pan2,2746,3.0854386111148333
NCI-H716,71751553,4.800404342202104
COR-L51,sirolimus-bortezomib (250-1 mol-mol),0.5050478913341053
P31/FUJ,3854666,0.6136756098719494
Panc 03.27,9915743,1.9150966993651488
ZR-75-1,sirolimus-bortezomib (250-1 mol-mol),-0.944196489916664
NCI-H1703,selumetinib-GDC-0941 (4-1 mol-mol),1.0120925414359212
A3/Kawakami,9911463,3.9596615304001745
Lu-99,136227924,2.52697800854745
NCI-H1755,selumetinib-GDC-0941 (4-1 mol-mol),0.8235666459967586
KM12,2746,3.7112872132085686
SNG-M,2742550,4.721521036243505
MOTN-1,10322450,3.6897160275286343
Pfeiffer,selumetinib-GDC-0941 (4-1 mol-mol),-0.3312571594037772
H-STS,tanespimycin-bortezomib (250-1 mol-mol),0.0434064671940078
GI-1,2746,3.841206202688264
Li-7,54618771,0.3416557888944573
TE 441.T,3465537,1.109247742302779
PSN1,135421197,2.7573404072547327
SW579,9915743,0.8612316643696222
HCC1954,135421197,1.006556252272656
SW948,11494412,0.3616963479580831
NCI-H747,100016,6.898929440027426
U-BLC1,selumetinib-GDC-0941 (4-1 mol-mol),-2.579214218567442
A-549,3854666,3.2699518455850964
LS513,9868037,2.665917193045876
T3M-10,9915743,3.0037354208599996
KMS-28BM,54618771,-1.095324315742339
PK-45H,11152667,0.2417737455305368
SIG-M5,selumetinib-GDC-0941 (4-1 mol-mol),-3.523170450051492
NCI-H1581,100016,6.5572943300427795
TF-1,65628,4.208115912164116
RD,9915743,0.9845356275865762
L-363,73707386,2.44874868394157
BT 159,11152667,0.5411121048326067
DU4475,100016,3.3182611876021157
P3HR-1,11152667,-1.7804635987572712
IGR-1,9911463,4.350306132693756
HEY A8,100016,6.30003295297675
DB,3854666,-0.3666218398057528
COR-L95,3465537,1.5360689669151406
NCI-H889,11152667,2.2627288939831214
Caki-2,9935249,3.2046131890205243
SK-N-AS,9935249,1.6086220249478496
KYSE-30,6918638,1.557418868446986
BT 504,tanespimycin-bortezomib (250-1 mol-mol),-4.273282009198175
SNU-840,11152667,0.6546651786480734
MOTN-1,9935249,2.4236669844767755
SU-DHL-10,9915743,0.9308124359278332
BT 498,tanespimycin-bortezomib (250-1 mol-mol),2.266327980943949
KNS-62,selumetinib-GDC-0941 (4-1 mol-mol),0.6177155702395645
NCI-H1869,54618771,2.934235316942264
WM88,135659046,3.481693995509175
MDA-MB-157,9926054,2.0716850398098368
T84,65628,6.475428256450229
NCI-H23,71751553,4.365548247441621
NCI-H2141,9915743,0.5832119024567368
SK-MES-1,49836020,5.814503877703118
DAN-G,9935249,3.199039509516943
COLO 829,1566236,3.7680524824386135
SH-4,tanespimycin-bortezomib (250-1 mol-mol),0.1503763926907838
LOU-NH91,9911463,4.226439837654448
NCI-H810,9935249,2.010109308551092
MKN74,11152667,-0.1995571526819112
YD-10B,9926054,1.7388994338775816
A-375,9915743,2.060034252561476
NCI-H838,9884685,2.0145389854866345
TE 617.T,selumetinib-GDC-0941 (4-1 mol-mol),0.2172055936678418
MDA-MB-468,65628,4.048602457586348
CAL-51,9926054,2.2227862000004577
OVK18,54618771,0.5319615878172647
SaOS-2,3465537,1.5281169625539155
Daudi,3854666,0.3283534306514684
Pfeiffer,135984461,1.4360263209874906
YD-38,54618771,0.1066197400708346
Hs 839.T,selumetinib-GDC-0941 (4-1 mol-mol),3.521332428924413
KYSE-520,11152667,-0.2788738018769383
BV-173,9926054,1.6102872074476016
769-P,135984461,1.7373161428714323
RPMI-6666,9884685,-0.1073884108825948
Ci-1,54618771,0.8239917117342518
VMRC-RCW,9915743,1.0689932165793572
SUIT-2,135421197,1.9421505415119584
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
SaOS-2,135659046,3.828911922642458
BFTC-905,135421197,2.6921264103177
KMS-11,3854666,0.0996052694394281
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
GMS-10,tanespimycin-bortezomib (250-1 mol-mol),0.0800415609138278
HCC2935,selumetinib-GDC-0941 (4-1 mol-mol),0.0464684942355828
CHP-212,54618771,1.2694957147058317
Hs 895.T,1566236,3.875495749699162
HEC-151,9884685,0.5854860158758856
NCI-H2405,54618771,0.0947860267625534
A-172,2746,3.137938137682863
FaDu,54618771,1.2079595597502673
NCI-H1793,selumetinib-GDC-0941 (4-1 mol-mol),1.778228229757508
Capan-1,9911463,4.415677524412553
NCI-H747,1566236,1.766438037166322
TE-4,sirolimus-bortezomib (250-1 mol-mol),1.0624472113387091
NCI-H292,136227924,3.1886204590132654
HCC1419,10322450,4.752947220118952
REC-1,9868037,0.961521370423606
SNU-1,2746,3.00506247553621
GB-1,54618771,2.0040836599793077
NCI-H1341,11494412,-0.562249331475485
NH-6,650361,3.794392223759619
EBC-1,3854666,0.7076213009699341
NCI-H2110,3854666,1.2202267080403588
SET-2,2746,0.8916395455775363
KMS-20,9868037,2.1280335543005293
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482
F-36P,1566236,1.4994309826223562
CAS-1,9915743,1.3093689847422858
Caki-1,tanespimycin-bortezomib (250-1 mol-mol),2.360215695891997
A2780,11152667,-1.0749204847082217
SK-BR-3,6918638,-0.1564610837276475
SNU-1105,11152667,0.3397625589018838
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
MKN74,sirolimus-bortezomib (250-1 mol-mol),2.5374597800168446
SW579,135421197,1.841394745286318
TE 441.T,135659046,3.3291028889346066
M-07e,54618771,0.3587170705521248
NCI-H1563,9935249,3.0845372381099923
SF295,sirolimus-bortezomib (250-1 mol-mol),1.039702746506238
OCI-AML-5,9884685,0.3245592636969091
HCC1419,1566236,3.0079823710753923
YD-10B,sirolimus-bortezomib (250-1 mol-mol),0.8194985120964778
U-BLC1,65628,6.23836675001552
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
HEC-6,135421197,3.631820052963688
BT 248,54618771,0.8718785044821341
SNU-489,9926054,2.706160270050288
SNU-449,135421197,1.7191553190938056
SNU-601,71751553,5.5964452561972955
TC-71,2746,3.085188483378043
Reh,9935249,1.2522485980978375
Hs 944.T,9911463,3.7196895176851608
SW1710,11152667,-0.6686415545105019
KE-97,54618771,-0.8035636826323382
NU-DUL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.4841470415007147
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
SW948,2742550,2.6149964231270166
TM-31,6918638,1.2377309655221411
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
KO52,3465537,1.4492421646178062
SNU-1,71751553,4.430518042504184
COLO 699,sirolimus-bortezomib (250-1 mol-mol),-0.458397325764597
NCI-H1355,9884685,0.765717776543527
VCaP,1566236,2.9014070046824143
SW1990,selumetinib-GDC-0941 (4-1 mol-mol),1.2183464614228592
CAL-29,3854666,2.71198320496625
JHH-6,6918638,2.94778128430583
RKN,11152667,0.0617927102225113
Aska-SS,6918638,1.1582390446838242
NCI-H1869,9915743,-0.6149308552384661
SNU-738,9884685,3.081994636813429
SNU-869,65628,5.2914896740347785
KALS-1,2746,4.252891034132703
LOX-IMVI,sirolimus-bortezomib (250-1 mol-mol),0.6922186847217285
BC-3C,71751553,4.284434035767574
COLO 320,71751553,4.409375162477877
BT 248,9911463,2.7908107916357436
HOP-92,54618771,0.6588876018328178
PK-59,1566236,1.7362298213190046
MKN45,sirolimus-bortezomib (250-1 mol-mol),2.222344728894145
HCC44,9935249,3.223427936251387
KYM-1,65628,2.1252254904247656
SK-UT-1,9926054,1.807396230777958
GI-1,54618771,0.7325470873707357
IGR-1,2742550,3.6164330021426503
KNS-62,9911463,4.346358947523489
HDQ-P1,tanespimycin-bortezomib (250-1 mol-mol),3.130731084653335
KM12,tanespimycin-bortezomib (250-1 mol-mol),-0.2034233372604618
HeLa,11152667,-1.1066196767080478
A-204,100016,6.602223097366851
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845
Daoy,54618771,2.692188489844714
MDA-MB-453,9915743,0.2126089191242519
OV-90,100016,6.511633470460193
LCLC-103H,9911463,4.367340887441101
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054
BT 330,2742550,3.720607437110895
HLF,6918638,1.351490313619424
T98G,3854666,3.005982982811289
EN,1566236,4.189994188152843
VCaP,135421197,0.8808099569732696
KYSE-30,1566236,3.7632160201104186
Kelly,2746,1.4763853988158775
SK-OV-3,9926054,2.1800400954819716
NCI-H647,65628,4.301198610868103
SW1990,9935249,3.469784483732877
SK-BR-3,11152667,-3.133407190107384
JVM-3,sirolimus-bortezomib (250-1 mol-mol),-5.712232327729444
RL95-2,54618771,0.9471315050617304
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
NCI-H28,65628,4.1820759324242776
CAL-51,9915743,1.1260994347217144
HEY A8,54618771,0.8975201265586629
BT-549,136227924,3.266068806496957
CAL-27,3854666,0.635835630985428
HEC-6,11152667,-1.444625055884375
NCI-H1155,3854666,0.3602876365703957
DU145,54618771,3.337458824494602
23132/87,65628,4.231237876491767
VM-CUB-1,11152667,-1.0333830736737548
NCI-H1581,9926054,1.914442948452832
KYSE-450,11152667,0.9209824146572594
A-253,65628,4.217567213450775
BT 271,4705,1.1408708850439713
Hs 944.T,135659046,3.5243934331701268
SK-UT-1,sirolimus-bortezomib (250-1 mol-mol),0.646773190163625
HH [Human lymphoma],54618771,0.4732630552220457
SNU-182,54618771,-1.075104843594332
A-204,54618771,0.0789139316749608
Aska-SS,24779724,-1.025302849370559
NCI-H841,135984461,4.323824309438455
OCI-Ly19,6918638,-1.0527387975754474
BT 504,11152667,1.2887357418273375
HCC1395,3854666,1.6089767843252074
LS1034,9915743,2.2707321419893094
ESS-1,54618771,1.2318880484657342
Peer,9915743,-0.353266525071404
MKN1,10322450,5.563545254073129
PF-382,65628,3.430221294092043
OV7,9915743,1.7839177837721256
OVK18,100016,6.632788488948234
NCI-H2452,9868037,3.199558399493599
RERF-LC-Ad2,135984461,4.955680046889378
T98G,selumetinib-GDC-0941 (4-1 mol-mol),2.822030636893018
NCI-H2444,54618771,3.319337103675071
NCI-H810,11152667,-1.104847529984581
PE/CA-PJ34 (clone C12),9926054,1.748247929323894
DMS 53,71751553,3.942952237428104
NCI-H2087,9884685,1.9812992127779516
JeKo-1,11494412,0.2725686605120115
NCI-H2228,2746,2.5336872635274226
KMRC-3,136227924,3.033903598858876
NCI-H841,4705,3.1864652961877917
Panc 10.05,9884685,0.9993318997912782
Lu-65,135659046,2.9879940161565206
CCK-81,sirolimus-bortezomib (250-1 mol-mol),0.9757763076184672
HCC1395,135984461,4.308264403922993
JM-1,6918638,-1.945896791217812
SK-MEL-5,2742550,3.3094903780657368
NCI-H23,9926054,1.8354921761885392
Panc 10.05,selumetinib-GDC-0941 (4-1 mol-mol),-0.0838909853180393
COV644,9915743,2.089583867030486
NCI-H1693,1566236,1.8540342250412096
SEM,49836020,0.2207243584754971
EC-GI-10,135421197,2.6554260651885944
HEC-1-B,11152667,-1.21106376639031
A-253,9935249,3.057139117762592
RPMI-8226,54639665,6.381219990706471
COLO 699,54618771,0.7648431477044199
P3HR-1,135421197,1.4692220072432751
JHUEM-1,9915743,0.9861539346224674
HCC-56,9935249,3.344973391088982
WM115,11152667,0.9737214532192616
OV56,9926054,1.8437049272321575
NCI-H1693,9911463,3.5933449659927477
IA-LM,1566236,2.064855820915055
OCI-AML-5,9935249,3.1801154078434584
DLD-1,9935249,3.699749001194777
SK-OV-3,54618771,2.5849230632376923
NH-6,9935249,2.624855508560777
A-204,10322450,3.769962101678964
JVM-3,3854666,0.3289813551665968
SK-MEL-3,135421197,1.515093492040075
Ki-JK,100016,3.514869011895543
HDQ-P1,9915743,0.2716921146551485
BV-173,sirolimus-bortezomib (250-1 mol-mol),-2.492930235496017
SF539,135421197,1.037431947377599
Becker,3854666,0.4017122764286526
A-253,49836020,4.493346426084629
BT 328,tanespimycin-bortezomib (250-1 mol-mol),-1.4953584261079875
Panc 03.27,11494412,0.9108991016924464
C2BBe1,sirolimus-bortezomib (250-1 mol-mol),0.281617007338844
CFPAC-1,135421197,3.4833112622431357
BT 428,3465537,1.041948856740563
DBTRG-05MG,3854666,3.12566617937735
TE 617.T,6918638,0.5415631808582457
NCI-H522,9915743,1.083108246388964
BT 248,135659046,3.5168747963796636
HCC1419,2742550,4.650611377955487
SUP-T11,sirolimus-bortezomib (250-1 mol-mol),0.9294161353730758
G-361,9915743,0.2147475804393018
A-549,2746,4.106748757541722
KYSE-510,9868037,3.781080992935668
SNU-407,tanespimycin-bortezomib (250-1 mol-mol),0.2441686883353643
KYSE-450,1566236,2.943712788473633
Fu97,2746,1.9781372466422251
NCI-H1651,136227924,3.2782738852919966
23132/87,135421197,1.295481545457509
THP-1,10322450,3.145062676752804
KMBC-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2152983894179389
LS1034,9935249,3.2731145220005753
LC-1/sq-SF,2746,4.189437324423252
NU-DHL-1,9915743,0.5782531397120328
A-375,54618771,0.2489032260565352
Kasumi-2,135421197,0.8154486687594628
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
DU145,1566236,3.495730163617442
SNU-719,135421197,0.9792842920964928
Ishikawa (Heraklio) 02 ER-,11152667,-0.2897968836684769
SNU-61,9911463,3.407728451470452
REC-1,136227924,3.1866861789415855
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
BT 482,135421197,2.625315115733885
NCI-H1184,54618771,1.2504018594222124
DK-MG,4705,2.3650435397254492
SK-N-AS,135421197,2.9463042299637645
22Rv1,65628,3.6974933806561214
LK-2,1566236,3.949906628051727
NCI-H2029,3854666,1.065457939049436
NMC-G1,9911463,4.44969477965095
BxPC-3,11152667,-1.4400195695513092
HCC2279,9868037,3.3429801008899833
SK-N-MC,9926054,1.7404893912673354
COLO 668,selumetinib-GDC-0941 (4-1 mol-mol),1.3136339769423369
TE 617.T,2746,2.7076097617545276
WM88,71751553,5.868796186292424
SUIT-2,136227924,3.4861054974924133
SK-MEL-31,2746,3.1579151966275343
SNU-1041,9911463,4.300045729883578
A3/Kawakami,2746,0.9859280265710952
MDA-MB-361,6918638,0.2584524690871702
BDCM,135421197,0.954440132345953
TOV-21G,selumetinib-GDC-0941 (4-1 mol-mol),3.592857274356158
Panc 08.13,11494412,2.7627448463572177
NCI-H1869,71751553,5.160002179984854
BT 359,2746,3.6241977126009206
NCI-H2110,4705,2.9559067422385494
CML-T1,136227924,1.8923919385229255
MIA PaCa-2,9926054,1.823118001934022
COLO 668,2742550,3.5349511926835255
KO52,2742550,3.525067743551677
AN3-CA,11494412,0.238688631284878
23132/87,136227924,2.929197271565677
WM115,9884685,-1.925323313513864
TF-1,9935249,1.174824623802912
BICR 22,4705,3.4365696424802477
DND-41,9926054,1.3861019613196697
U-BLC1,71751553,4.056877782229039
M059K,135421197,3.1464794228942488
G-361,11152667,-0.4231393311970948
MDA-MB-468,11152667,-0.5073124090955701
CAL-27,2746,3.342989034660484
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
JM-1,9911463,2.675259516581914
Hep-G2,2746,2.5421699123058383
DV-90,11152667,-1.263843057681376
23132/87,9884685,0.434965052776624
8305C,sirolimus-bortezomib (250-1 mol-mol),0.6983572372591207
IM95,6918638,0.7344376580151405
Ci-1,9926054,1.7408061846273166
MPP 89,9915743,2.161327298254378
GSS,11152667,-1.6427216501784565
LXF 289,135984461,4.539632657840611
ST486,9935249,0.774563781013363
CAS-1,9935249,3.6183368085181553
THP-1,3854666,-0.2277266329399054
OVCAR-8,100016,5.760214455598188
IGR-37,4705,3.0869599188409658
RVH-421,135421197,2.7493093312166534
UO-31,2746,3.591448305166117
CAL-29,44487872,4.282164596032457
NCI-H69,11152667,0.8165842886713589
CCK-81,100016,4.4296308435579554
DU145,9915743,3.139044524773344
CAL-85-1,54618771,1.8439388085147956
A2780,9915743,1.3754925129164983
HT-1197,sirolimus-bortezomib (250-1 mol-mol),0.4279936775188873
CAL-12T,136227924,2.605918242540546
OE19,2746,3.0430549573559036
NCI-H650,9911463,4.297971078148598
SNU-423,9915743,2.488155909988838
Namalwa,135659046,3.012855120581617
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172
BT 239,3854666,0.6020621099838442
DEL,9884685,0.9674911622434976
MCAS,3854666,1.0662273712961947
MOLM-13,24779724,4.7751629548446894
T98G,71751553,5.013882600728961
SW1990,9911463,4.278474352365717
YD-8,9868037,3.0733964994503244
Hs 578Bst,71751553,5.4091919490870435
Aska-SS,136227924,2.71481465035111
TCCSUP,100016,6.5110410318476575
A-549,3465537,3.857188765779011
HCC827,9911463,4.568230901721179
COV644,136227924,2.3380958896938147
SK-MEL-30,9911463,3.9366573262978473
IST-Mes1,9935249,3.876611894197404
EoL-1,9884685,-2.267367014131727
SNU-16,2742550,1.6766119862774724
IGR-37,6918638,0.9669989882697694
HH [Human lymphoma],11494412,0.1412103893601752
NCI-H526,54618771,1.0633322876543316
HEL 92.1.7,71751553,4.617723136603169
Daudi,9915743,0.3665260221427978
SNU-C1,9935249,3.148720594073001
HCC1588,11152667,-0.4007938807614604
KP-2,11494412,2.702664786817325
D283 Med,11494412,-0.6782080211757803
COLO 800,1566236,1.997001649617786
SNU-1,3854666,2.125271252141142
HEC-1-A,3854666,1.770805804146439
HT-1197,tanespimycin-bortezomib (250-1 mol-mol),-0.7318651528628731
TOV-112D,65628,4.105671540915195
SW1783,24779724,3.9128595943603544
NCI-H226,tanespimycin-bortezomib (250-1 mol-mol),2.419002105970759
COLO 829,sirolimus-bortezomib (250-1 mol-mol),0.4169423726863133
BEN,selumetinib-GDC-0941 (4-1 mol-mol),4.689872875355836
LNCaP clone FGC,selumetinib-GDC-0941 (4-1 mol-mol),1.7020146925511015
JHH-6,1566236,4.1223255495253115
HCC1143,9926054,1.808099247882512
LUDLU-1,11494412,1.2447977541494917
HGC-27,10322450,3.112046430554876
EFE-184,3465537,3.1407639622077395
GCT,4705,3.1348509657034036
COLO 668,11152667,-0.8544795692513644
MOTN-1,54618771,0.6090768126034483
NCI-H727,11152667,-1.354343634557878
SNU-C4,9911463,4.273087904874907
SK-CO-1,54618771,-0.118181134306818
U266B1,9915743,0.5964925492166065
HCC1195,100016,5.060252338886612
HEL,136227924,2.725456875957553
ME-1 [Human leukemia],44487872,4.314288172726458
NCI-H889,sirolimus-bortezomib (250-1 mol-mol),0.2656480378384786
GaMG,sirolimus-bortezomib (250-1 mol-mol),1.2428919572047608
Hs 611.T,135421197,0.2639365806220374
SEM,tanespimycin-bortezomib (250-1 mol-mol),-2.121594680168012
Panc 02.03,136227924,3.0839082623333387
OCI-AML-2,100016,4.069849166636085
COLO 320,2746,2.553177448203693
CAL-27,9926054,1.784787570446616
OC 314,10322450,5.7270020231574446
ACHN,11494412,3.503130086985654
COV644,selumetinib-GDC-0941 (4-1 mol-mol),0.580143851486064
NCI-H1341,1566236,1.499019730270858
KMS-21-BM,3854666,0.4771292097987486
LCLC-97TM1,2742550,3.525188493197443
OV7,135421197,2.579158372442756
SK-LMS-1,2746,4.054624823156548
WM88,100016,6.2407728308576
ACHN,3854666,3.401003067580889
Mono-Mac-1,9884685,-0.2142901784268321
CGTH-W-1,9911463,4.280692853658182
COLO 678,9911463,3.776615868788405
KNS-81,9926054,3.3411524859237196
WM983B,9935249,3.2390804243426876
SNU-216,sirolimus-bortezomib (250-1 mol-mol),0.3912590686829094
BT 216,9935249,2.905393144849144
BT 239,9926054,3.266360841464617
Ri-1,73707386,2.473234427573793
BT 239,9935249,0.5202539451214898
OE33,71751553,4.3154384433130355
TE-8,9915743,1.7914899736385264
YD-38,tanespimycin-bortezomib (250-1 mol-mol),-0.8254079071300491
DU145,9911463,4.064467262158392
Hs 578T,71751553,3.352664213062509
KE-37,3854666,0.6473006828434584
HEY A8,9915743,1.8632242051136063
TE-1,73707386,3.78694357461448
NCI-H508,selumetinib-GDC-0941 (4-1 mol-mol),1.363383946626654
NCI-H1395,4705,3.4784735381586183
SU-DHL-8,135421197,1.0706680615676138
BICR 18,selumetinib-GDC-0941 (4-1 mol-mol),2.10893562893339
Karpas-422,71751553,4.158262906049952
Panc 05.04,3854666,4.206759252182565
2004,9935249,1.9457637987820169
NCI-H292,sirolimus-bortezomib (250-1 mol-mol),1.4329016074897702
Hep-G2,4705,3.661377424610174
MDA-MB-453,71751553,4.5545018888168185
Calu-6,44487872,4.552226004376926
SNU-61,9935249,2.942554259952632
DEL,100016,3.851368536137221
SW1990,9884685,1.028509429358882
U-BLC1,136227924,2.288895160726179
SR,9911463,3.2455364597382075
NCI-H1944,54618771,0.5378192056232364
L-540,2746,2.2201981774781383
LMSU,11494412,2.9419044574604554
NCI-H1693,9926054,2.0729608249560436
SH-10-TC,11494412,1.409264522589107
HH [Human lymphoma],2746,1.0745261144361813
DMS 454,9911463,3.0407786288723475
LXF 289,2746,3.190299829163617
COV434,9915743,-0.2434354150711091
SW1710,54618771,1.2075824947863512
SK-LMS-1,9926054,2.9005897081408833
COV434,9884685,-0.9978800737002462
DU145,tanespimycin-bortezomib (250-1 mol-mol),-0.7432626565730119
KMS-12-BM,9926054,1.301975129823355
SNU-1033,71751553,4.333449645170772
HCC-56,54618771,1.0985960691001735
NCI-H508,2746,2.9093324415745094
MG-63,sirolimus-bortezomib (250-1 mol-mol),0.1277203686177557
JL-1,54618771,3.703254873905745
BICR 18,3854666,1.5659435461984097
MFE-319,11494412,1.4507368814002106
OCI-Ly3,135421197,2.144739759882478
P31/FUJ,9868037,1.2869642230829814
SNU-387,6918638,0.7332887261776959
HEC-6,100016,5.931518422248653
Rh41,9884685,-2.3204125045611264
Yamato-SS,tanespimycin-bortezomib (250-1 mol-mol),-1.0267358122656502
Daudi,6918638,-1.8107043721369585
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
EFO-27,6918638,-0.5643283195590469
SK-MEL-24,71751553,5.203403695597485
Hs 852.T,selumetinib-GDC-0941 (4-1 mol-mol),1.139310291685008
TE-11,9911463,3.3577728460138414
SK-MEL-5,2746,2.5702716912932337
LS411N,9915743,2.8294092926119028
Ri-1,2746,1.8815592761229076
BICR 22,71751553,4.276876209585518
Calu-1,6918638,2.4930739459862936
GP2d,9926054,2.6461987815751096
KNS-62,3854666,3.1302523533571014
LN-229,135984461,0.9798021343059176
KYO-1,136227924,2.5889716651569614
SEM,135984461,1.5883939694151252
MDA-MB-231,9915743,4.40604807158467
BHY,2742550,3.1680059679217476
SK-MEL-2,6918638,1.2677051834629418
NCI-H2029,11152667,0.9806383957372796
Hep-G2,selumetinib-GDC-0941 (4-1 mol-mol),-0.4461378228189951
CAL-33,24779724,5.532658892433513
SNU-685,1566236,1.7579222323884358
L-363,sirolimus-bortezomib (250-1 mol-mol),-5.312309266116436
KMS-27,73707386,3.821733041812712
KYSE-140,11152667,-1.9920193440846787
SW1271,9926054,1.9992649208496855
HPB-ALL,9935249,1.7527438967861384
U-87MG ATCC,sirolimus-bortezomib (250-1 mol-mol),1.5742671980534302
Rh30,9935249,3.355243286720757
HCC4006,1566236,2.9393966315563076
LNCaP clone FGC,9926054,1.750086860049474
SW1088,4705,3.635040472252734
Hs 888.Lu,2742550,4.401570476814638
KNS-62,136227924,3.1878911405001236
M059K,6918638,0.417143769995747
NCI-H1734,11152667,-1.987198033015952
Kasumi-1,65628,4.818728513509837
KMS-11,selumetinib-GDC-0941 (4-1 mol-mol),1.0292581351367205
BT-16,9911463,3.6213577746189514
Hs 746.T,1566236,1.9781542235751777
MHH-ES-1,9915743,1.9071670198037491
Hs 888.T,135421197,-0.1341748338568028
TTC-709,6918638,1.4201492579902153
A-375,3854666,2.66860299543091
A4/Fukuda,65628,3.8428022223998366
MES-SA,2746,3.3783826340616243
SNU-216,1566236,1.785015766563616
L3.3,65628,4.284850303510067
SNU-626,11152667,0.4022575570601642
JMSU-1,9935249,2.904229608980848
NCI-H1299,9935249,3.5547957097116143
GI-1,11152667,-1.419511602006618
BICR 22,3854666,0.9977305103930704
TE 441.T,11494412,0.8893803866671172
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021
TE 441.T,2746,2.0767838467856654
Hs 940.T,selumetinib-GDC-0941 (4-1 mol-mol),2.512556445742238
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
SUP-M2,9926054,1.703022301763295
Hs 611.T,9915743,-0.4075331774048215
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
BT 112,100016,6.504213631006025
KMS-18,2742550,3.49349515314962
HCC2935,3465537,2.564859835808272
LK-2,sirolimus-bortezomib (250-1 mol-mol),0.5771573831788563
NCI-H1755,9926054,2.18101646942672
T3M-10,9911463,3.745237338298436
U266B1,sirolimus-bortezomib (250-1 mol-mol),0.0143822479563884
REC-1,54639665,4.455967355102018
PE/CA-PJ15,9926054,1.7631963091393454
SET-2,135421197,1.735218850040683
EFO-27,sirolimus-bortezomib (250-1 mol-mol),2.1280256093524264
HEC-1-A,9911463,3.802015322835987
KP-3,136227924,3.03068470875373
COV362,4705,3.5601253805360975
HT,11152667,-2.196108970099486
HOP-62,100016,6.313498249886369
OAW28,1566236,3.486252592676433
CAL-33,9868037,3.732658877947959
KLE,73707386,3.2783445744557307
Hs 688(A).T,9911463,4.549351986100886
DU145,65628,4.2291081704038325
DLD-1,tanespimycin-bortezomib (250-1 mol-mol),0.5980844777691691
EPLC-272H,3465537,1.4196473327996324
Mel JuSo,11152667,-1.5047268130647675
LoVo,sirolimus-bortezomib (250-1 mol-mol),0.1095810263563626
SCC-4,9884685,0.8808701095997418
KMS-21-BM,9868037,1.4447274996214214
Panc 02.03,100016,6.582809568040202
Hs 888.T,54618771,0.4236563431262232
KYO-1,11152667,-1.6457051301162502
SJSA-1,9926054,1.739207886020936
NCI-H226,9926054,2.2620908490117526
SIG-M5,9915743,0.6121664403334032
Hs 895.T,tanespimycin-bortezomib (250-1 mol-mol),2.1359790138247674
SK-MEL-24,9935249,2.8085259534778246
Hs 578Bst,9884685,1.886380711190355
YAPC,135398744,6.484368053683043
A2058,9911463,4.395992822531059
BICR 56,71751553,4.474191091785433
ST486,100016,6.384120256869386
LP-1,4705,3.1959395550133247
HH [Human lymphoma],9926054,1.7922289040675246
BT 482,1566236,2.665611750333292
DMS 273,135421197,2.3407622077730035
NCI-H1155,100016,6.5684025185087505
5637,9915743,-2.6589939523871347
GCT,2746,3.501463189612396
NCI-H1693,9915743,0.8308025375292787
SK-MEL-3,71751553,5.266797753387062
Calu-1,1566236,3.658841194975484
KMBC-2,11152667,1.3012621029988305
F-36P,24779724,4.9138855829975565
A-172,9884685,3.4220600168976008
Ki-JK,49836020,-3.31096865556518
NCI-H2405,9935249,3.7987191129461673
CAL-85-1,135984461,4.357321132215755
BT 248,6918638,2.3802175448525844
CW-2,tanespimycin-bortezomib (250-1 mol-mol),2.6313334952159844
SK-N-SH,54618771,1.3194145394853296
YKG-1,9935249,4.562558251006297
NOMO-1,54618771,-0.7336388686704796
U-CH1,11152667,0.6955238528116828
KMS-12-BM,4705,2.431122737655679
CML-T1,3854666,0.73725489161191
NU-DUL-1,65628,2.8411028717904734
KYSE-510,9935249,3.150721090572469
HCC-56,9911463,4.275331241701339
LMSU,71751553,4.583903358050372
BT 416,2746,4.178903855653317
HuH-1,selumetinib-GDC-0941 (4-1 mol-mol),1.7373904451201925
NCI-H2291,136227924,3.7471032532575457
HL-60,sirolimus-bortezomib (250-1 mol-mol),-0.1037456225306153
SNU-407,100016,6.489561303898527
A-375,135398744,6.486116496095493
YAPC,selumetinib-GDC-0941 (4-1 mol-mol),2.7150403374869856
SNU-C5,selumetinib-GDC-0941 (4-1 mol-mol),1.7590235463431136
EBC-1,54618771,0.4501558342724816
SW1088,11152667,-1.4774805215910087
RVH-421,selumetinib-GDC-0941 (4-1 mol-mol),0.2332916793846582
T84,11494412,-0.7217837675976604
Hs 895.T,11494412,4.004820419756853
HMC-1-8,9926054,1.7153047636867798
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
DMS 454,135421197,0.7906856651766786
NCI-H1184,2746,1.0703875331333406
RCH-ACV,49836020,-2.2684832321475774
REC-1,1566236,3.018034053127421
YD-15,tanespimycin-bortezomib (250-1 mol-mol),-1.46921905291906
NCI-H1355,9915743,1.7324952444054351
TUHR10TKB,2742550,3.0161349099279033
BT 286,65628,3.2626686935167544
NCI-H716,11494412,1.1252717992801926
HT,54618771,1.085769963879092
SET-2,9926054,1.6776501813643687
Hs 578Bst,9926054,3.786469361001098
ALL-SIL,9884685,1.523019065964201
DMS 114,2742550,4.758631670542552
SK-BR-3,9911463,3.827340075959426
UACC-257,135659046,3.626518059791559
HCC1419,11494412,3.802636442485394
NCI-H889,4705,2.395490274803622
GSU,135421197,3.362120533278017
HSC-4,tanespimycin-bortezomib (250-1 mol-mol),0.4907221930959023
IGR-37,11494412,1.023778204341386
Hs 294T,71751553,5.047281655304285
HEC-151,11152667,0.2545196919023241
BC-3C,1566236,3.5939971161988367
NCI-H1703,71751553,4.134415829550765
COLO 792,11494412,2.516630089039559
NCI-H1944,135659046,3.626487516875678
NCI-H460,tanespimycin-bortezomib (250-1 mol-mol),-0.1308052603631569
WM793,sirolimus-bortezomib (250-1 mol-mol),1.012836657947069
KYSE-180,2742550,4.361413861886047
UACC-62,11152667,2.4715685672767465
OE33,2746,2.7393344543249443
NU-DHL-1,9911463,3.294428726772871
NCI-H1650,4705,4.261347716805476
NCI-H2228,11152667,-1.3256620017520957
Ri-1,9911463,2.719411575193649
NCI-H810,2746,1.0986608343124125
BT 187,9926054,3.0457893099703197
COLO 699,3854666,0.677728842403528
TE-5,9935249,1.6516778855408267
Hs 839.T,4705,4.001099763666499
JM-1,11494412,0.2153546786296628
NCI-H1694,11152667,-1.6159587435744196
L-1236,11152667,0.9711871425868174
RERF-LC-Ad2,9911463,4.319203395941844
KYSE-520,tanespimycin-bortezomib (250-1 mol-mol),-1.1109729915268285
EoL-1,2746,-0.0046206936254649
SNU-C1,2746,1.4154378520046618
A-253,selumetinib-GDC-0941 (4-1 mol-mol),2.2204781544732284
253J-BV,tanespimycin-bortezomib (250-1 mol-mol),1.5580913101671798
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
SK-LU-1,54618771,0.3237862890103595
KE-37,tanespimycin-bortezomib (250-1 mol-mol),-0.6256036553504546
GOS-3,49836020,5.837697611269413
CAS-1,sirolimus-bortezomib (250-1 mol-mol),2.076174664589587
SJSA-1,65628,4.421860734175966
HEC-6,54618771,0.3851736338204913
IGROV-1,3854666,2.3355254440561137
TC-71,6918638,-0.2365825415632411
NCI-H1355,2746,3.638121411384877
SNU-503,1566236,3.964267180277688
BT 286,4705,3.0604993750879834
D283 Med,100016,3.728925578699804
NUGC-3,9926054,1.9670154065403471
T98G,135421197,2.3831918060045663
NCI-H322,10322450,4.379144140600869
SK-N-AS,9915743,0.9630784924267336
LOX-IMVI,65628,4.323385700869822
Calu-6,9911463,3.814763109547714
NCI-H2029,selumetinib-GDC-0941 (4-1 mol-mol),3.389084232117775
SNU-1033,9915743,1.252454153580825
DOV13,136227924,2.864785745195549
OCI-M1,6918638,-0.7125786973139969
BT-474,54618771,0.7682511511531626
KMS-20,2746,0.7437630311682376
NCI-H2141,135421197,1.2037655567537868
EJM,9915743,0.880814312418276
ACC-MESO-1,selumetinib-GDC-0941 (4-1 mol-mol),2.151335937805361
Fu97,54618771,-4.808914794700833
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
SH-4,11152667,0.2445827338007607
BT 187,10322450,6.076847615310279
NCI-H1395,2742550,4.633125791317317
SEM,135421197,0.5141119166667375
NCI-H647,135421197,2.605948730624533
EJM,49836020,4.362565190709962
M-07e,6918638,-1.343658816703153
KMRC-2,2742550,3.727908257312414
TALL-1 [Human adult T-ALL],10322450,3.187962745096946
HuH-6,3465537,0.6799951481772273
M-07e,2746,0.8814107880911471
DK-MG,9915743,1.7937332394851484
RPMI-8402,9915743,0.1468401173271679
BT 228,136227924,3.2498510190278314
DMS 114,1566236,2.6045957348634956
NCI-H446,9911463,3.3081231442060304
IGR-37,9935249,3.174032242283855
Panc 03.27,9884685,1.4792691761795522
IMR-32,11494412,-1.4286694328738665
Hs 766T,2746,3.89842644202364
A-375,135421197,1.9818816716343688
L-540,135984461,3.746123506346987
A-673,65628,3.827084992759042
Mono-Mac-1,65628,3.8711624211456215
HT115,sirolimus-bortezomib (250-1 mol-mol),0.8189257476447475
LP-1,44487872,5.2384234330551385
Hs 294T,9884685,0.4800605925029185
NCI-H1568,11494412,0.631822071405162
A2780,9935249,1.4583070792637778
HCC44,sirolimus-bortezomib (250-1 mol-mol),1.406227075762608
VCaP,2742550,4.205604430030452
KMS-11,10322450,3.512225559181566
DB,135659046,3.355027747328138
SNU-16,9915743,0.7177446910868589
NCI-H2081,9915743,0.926591953046768
HCC78,11152667,-0.3255847419940918
TT2609-C02,tanespimycin-bortezomib (250-1 mol-mol),-2.374986906427309
G-401,135659046,3.5574575455214608
Hs 940.T,49836020,0.3433567165193816
SK-MM-2,9911463,2.140550040440612
MDA-MB-453,9868037,1.568237926564538
BICR 16,sirolimus-bortezomib (250-1 mol-mol),-4.146745756723436
CJM [Human melanoma],3854666,0.9164819663884698
PLC/PRF/5,11152667,1.7058073401634024
OAW28,54618771,1.1011370240470315
U-CH1,3854666,3.825404484943735
Hs 729.T,2742550,3.942286133248854
HEL 92.1.7,54618771,1.044267286847691
PK-45H,9911463,4.054004002243204
HOP-62,9911463,3.8769302944036266
NCI-H2196,135984461,4.343785074544861
NCI-H1651,11494412,1.3542824137592235
MDA-MB-468,100016,5.725845417349072
COR-L88,tanespimycin-bortezomib (250-1 mol-mol),-0.4696067896304535
A3/Kawakami,sirolimus-bortezomib (250-1 mol-mol),-6.300755370161075
HT-144,9884685,0.7310557135267524
Hs 888.T,3465537,2.708625352273053
SK-N-SH,9884685,0.674262884402922
FU-OV-1,9926054,2.079351745951841
NU-DHL-1,3854666,0.0415857497138207
SYO-1,9868037,3.815139234423316
LoVo,9926054,1.9069881185353632
SK-MM-2,10322450,5.033500984762851
NCI-H2291,3854666,3.6740826337304022
Panc 10.05,10322450,4.07148015639342
Hs 578T,9915743,0.6778530093725601
KE-39,135984461,4.3782777468955745
TE-9,135984461,4.389815989870175
NCI-H1838,tanespimycin-bortezomib (250-1 mol-mol),0.7534040164239657
CAL-54,54618771,-0.0146618789918735
KMS-34,3854666,-0.3155498127279236
MG-63,11152667,0.9825777114082088
Hs 839.T,136227924,4.248389123686858
ChaGo-K-1,6918638,0.8510727110172542
Hep 3B2.1-7,11152667,0.7681962822393275
CCK-81,135984461,3.9266881520309247
SK-ES-1,9868037,1.8051819394038728
BHY,tanespimycin-bortezomib (250-1 mol-mol),-0.455078005089977
NCI-H660,9911463,3.200978092874424
SK-MEL-5,4705,2.45435106083484
SK-MEL-3,135984461,4.369065349705821
NCI-H1792,11152667,1.4250094925446752
THP-1,9884685,-1.0718495276637905
SNU-601,136227924,3.114119824082727
Hs 940.T,9911463,3.592326868154122
TE-8,selumetinib-GDC-0941 (4-1 mol-mol),2.5154311677987575
22Rv1,3854666,1.9155449359846033
SUP-B15,135421197,1.049763554342806
KYM-1,6918638,-0.4482897804277287
M-07e,11152667,-2.997128010914285
Peer,136227924,2.1160969435978303
NCI-H841,11152667,-0.143998376497437
SK-MEL-28,9911463,4.538912500786334
HMCB,2746,4.319833835287885
CCF-STTG1,1566236,4.223986774063583
NCI-H1703,100016,6.215140096774371
SU-DHL-8,9884685,0.5394241302496563
VCaP,54618771,1.0243470535164156
Reh,sirolimus-bortezomib (250-1 mol-mol),0.0012430835565731
SNU-1066,135984461,4.396874081929567
BxPC-3,100016,6.453363473458683
EPLC-272H,tanespimycin-bortezomib (250-1 mol-mol),-0.4152033872226455
BT 145,11494412,0.0535331415657337
HCT 116,tanespimycin-bortezomib (250-1 mol-mol),0.9696018979872172
42-MG-BA,9911463,3.88998551993186
Tm87-16,136227924,1.7990989939748585
HCC1833,136227924,3.0159379881399895
TE-5,9911463,3.65954938557894
RERF-LC-A1,3854666,0.6720221481756725
MKN1,136227924,3.2741698595271025
OAW28,9911463,4.007690751229585
JHOM-1,11494412,-1.2826925438789665
KMS-11,2742550,3.0552231561161447
GA-10,136227924,1.4612725021832749
2004,9868037,3.4947449671991735
Panc 08.13,11152667,-0.3273337674105917
MM1.S,2746,1.322857724988492
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
TE-9,3854666,0.8638769923044404
NCI-H1299,9926054,1.7323284970245385
GB-1,9911463,4.167195991638194
NCI-H322,11152667,-0.4802050567162326
RCC10RGB,6918638,2.235907203261483
Rh41,9935249,2.1844071013981377
SNU-719,65628,4.730492639805566
NCI-H647,135659046,3.6743271693589854
YAPC,9911463,3.901904463732921
KMS-20,9911463,2.8485967740948284
IGR-1,11494412,0.7039835706972326
U266B1,10322450,4.335564928351158
HD-MY-Z,135984461,4.3982026911884455
SNU-1076,9884685,-1.5611558865711956
HCT 116,3854666,3.4772433391395827
NCI-H889,10322450,4.7831613013187
JIMT-1,selumetinib-GDC-0941 (4-1 mol-mol),2.201344491734076
HCC1419,3854666,2.9721540619689972
Calu-6,73707386,3.776758288702592
DB,135984461,3.626527837681527
NCI-H1355,3465537,1.4614911488650857
LN-18,9911463,3.9395482508876714
HSC-2,100016,6.282703144403752
NCI-H2170,54618771,1.1991545038550235
OCI-Ly19,9926054,1.6873576988098775
LP-1,10322450,2.4863509324995827
RPMI-8226,9911463,3.1535934695934538
Hs 294T,9911463,4.3958964450734594
VMRC-RCW,11152667,-0.2135397069324333
VMRC-RCZ,2746,3.717022138974909
MDA-MB-435S,100016,6.42664314163943
JIMT-1,11152667,0.2510787979057463
DMS 53,135984461,4.182249903339298
HuP-T4,4705,0.794216535307181
NCI-H2029,136227924,2.308767464525173
SET-2,11152667,-2.526707061700353
L-428,2742550,2.838625484982941
YKG-1,2742550,5.856053185506653
DND-41,1566236,0.8938432244307261
KMS-20,100016,6.235059528000449
UACC-62,3465537,3.3991522699600023
SK-MES-1,100016,6.467052003541006
Mono-Mac-1,136227924,2.2269797620359864
MV4-11,9915743,-1.3857936300638058
COLO 684,4705,3.605341252393416
NCI-H146,6918638,-1.4860665745363582
BICR 22,9935249,5.2884064452137585
Mono-Mac-1,selumetinib-GDC-0941 (4-1 mol-mol),1.552083741866212
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
TUHR10TKB,9935249,3.5999871902501357
COLO 684,135659046,3.00478194293248
LS1034,135421197,0.962643417558857
MOTN-1,11494412,0.1932398209475109
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
647V,9915743,0.3723955679086398
CAL-51,10322450,3.881825194853649
JMSU-1,tanespimycin-bortezomib (250-1 mol-mol),-2.9678894652146584
EPLC-272H,1566236,2.3537284633634763
SNU-869,1566236,3.315368037807328
T-47D,9935249,3.0203001978251236
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
Hs 888.T,9935249,3.2466052266925822
FaDu,2746,3.60931245556166
RPMI-8402,9868037,1.5465007663482742
SNU-869,136227924,3.0372027283613505
SNU-16,1566236,1.6760978918576763
Hs 940.T,71751553,4.30632511382116
5637,9911463,3.863072039147436
HCC2218,9868037,3.0911136075501253
Kelly,9884685,-0.5846979087196816
DMS 454,4705,3.5434056229110498
LN-229,9926054,2.0012507920531206
BT 147,selumetinib-GDC-0941 (4-1 mol-mol),1.4700877243858868
NCI-H460,1566236,4.3513012021592505
TCC-Pan2,73707386,4.107129131333133
ME-1 [Human leukemia],135398744,6.466274911980868
NCI-H2030,135421197,3.075513669205883
ChaGo-K-1,71751553,4.486695284730435
NCI-H522,2742550,2.7952007563166203
HCC1428,4705,3.7350108144218983
BICR 6,9926054,1.8719413430769756
SW1990,9915743,2.956888864284862
NCI-H322,3854666,1.2832764839171569
TE-11,11152667,-0.8173606825709024
BL-70,135421197,0.854508793534898
BICR 6,49836020,4.408429630205201
A2058,9935249,3.321967887008341
UACC-257,sirolimus-bortezomib (250-1 mol-mol),1.215285215662541
Hs 888.T,9915743,0.1139967508569927
NCI-H810,10322450,2.3502016572001696
42-MG-BA,11152667,-0.8745465289807025
RD,44487872,5.83185828502989
G-402,6918638,0.7835735464626096
CW-2,9915743,-2.027282933968592
HCT 15,9884685,1.036755619748056
NCI-H2342,1566236,3.0828221386653314
NB4,selumetinib-GDC-0941 (4-1 mol-mol),-0.8849476640562556
WM793,9926054,1.9861694749243135
BICR 18,4705,4.076520014659249
SNU-840,sirolimus-bortezomib (250-1 mol-mol),-1.042474975863496
G-292 clone A141B1,71751553,4.310232300400396
RL95-2,sirolimus-bortezomib (250-1 mol-mol),1.4009445421830615
BT 239,2746,2.5478715326116252
SK-ES-1,9926054,1.5618900800676432
MOLP-8,9911463,4.2009596294807245
Rh41,73707386,2.6001924678488684
AM-38,54639665,-6.281262655351625
SNU-C4,sirolimus-bortezomib (250-1 mol-mol),0.5711150121168962
NCI-H2110,100016,6.079052375839209
KHM-1B,9911463,3.1729521589558125
GSS,135984461,1.9439618887139551
WM266-4,3854666,2.447764610666349
BT 145,6918638,0.0582257419032156
NCI-H2029,9915743,1.4952182425439322
WM88,136227924,2.639448330236639
JK-1,3854666,1.8994532314964685
MDA-MB-468,9911463,3.8192810544536058
CJM [Human melanoma],9926054,2.54173081148122
OCI-M1,1566236,1.1491839821612235
BT 416,9915743,-0.2022944112216887
ChaGo-K-1,4705,3.918553629962962
L3.3,11152667,-1.6552573738209355
KMS-20,11494412,0.3854055603119042
HEC-108,135421197,3.884784600125324
DND-41,9911463,3.037480492878027
BT 145,71751553,4.949668908284117
OCI-AML-5,11152667,-1.4309616874651
NCI-H510A,1566236,1.6103804489942135
BT 330,selumetinib-GDC-0941 (4-1 mol-mol),1.903493951226084
LAMA-84,2742550,4.382990016000107
KE-37,73707386,2.4219901291478214
NCI-H211,9915743,0.3286661494354852
NCI-H1373,9911463,3.627616196356772
JHH-5,1566236,3.0867040268076793
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
ONS-76,10322450,3.321198163736043
697,54618771,-1.411266128730911
SNU-1076,9915743,-3.1891763584227775
LN-18,135984461,4.397956692211827
SUP-B15,100016,6.907261874504965
NCI-H446,24779724,5.6591005956111475
TE-5,3854666,2.975196514311936
Mel Ho,9868037,3.9124116875783654
HCC1395,9915743,2.6383057789400746
SNU-1077,3854666,3.1308724985393255
LoVo,1566236,1.5203890875485482
CAL-51,54618771,0.0049145289548569
RPMI-6666,136227924,2.5880592922669097
Calu-3,selumetinib-GDC-0941 (4-1 mol-mol),0.8119052170432226
HCC1806,11152667,-1.845858422637801
MFE-296,4705,3.3548297681801387
P31/FUJ,135398744,5.7727848933678
OV-90,49836020,4.456425733691278
SF295,selumetinib-GDC-0941 (4-1 mol-mol),3.1244208578209736
LOX-IMVI,9911463,3.8715849180913633
TE 441.T,tanespimycin-bortezomib (250-1 mol-mol),-0.9090621811033658
COR-L88,2746,1.355169672755057
CAL-51,9935249,3.84795648434564
MHH-NB-11,65628,2.292899242166229
RL,sirolimus-bortezomib (250-1 mol-mol),-0.1936565509728958
OV7,71751553,5.024310013233452
Hs 611.T,71751553,2.589968262099222
BT 216,1566236,2.9702648671976757
SR,100016,4.130694890660373
BT 172,9926054,1.8062475080252252
JVM-2,9915743,-2.5513470723309095
SNU-1,selumetinib-GDC-0941 (4-1 mol-mol),0.1369641916187444
PE/CA-PJ15,3465537,1.6564118127840195
22Rv1,10322450,3.5094460128480987
NCI-H1563,1566236,3.3573548741774224
Kasumi-1,sirolimus-bortezomib (250-1 mol-mol),0.3681691235754297
BICR 22,49836020,2.6142262300183305
JHUEM-7,11152667,-1.617539087588013
BT 504,2746,4.403785985788142
NUGC-3,135984461,5.20039455882723
GOS-3,135421197,1.697146176044067
BT 112,1566236,1.551499234243426
SEM,9915743,-2.2587042117517284
SW1271,24779724,6.290779023739936
CL-11,9911463,4.035953193106903
QGP-1,135421197,1.134586890713183
KMRC-1,2746,4.901784458568857
NCI-H23,9884685,-0.0842435854190503
RS4;11,65628,2.763130092940229
PF-382,136227924,2.0859082008018084
KMRC-3,sirolimus-bortezomib (250-1 mol-mol),0.4876779746525405
SNU-C5,tanespimycin-bortezomib (250-1 mol-mol),0.6015716530365237
JeKo-1,2746,1.6598198436915612
Daoy,3854666,0.752712785298123
MOLT-13,9926054,1.5657094756283445
SET-2,71751553,3.975724095102093
KMS-11,11152667,-1.7623955377212943
BT-12,11152667,2.0016495749496137
KYSE-150,11494412,2.89214249755195
NCI-H2196,136227924,2.7386742576768643
Calu-3,11152667,-0.8542233160115779
DAN-G,tanespimycin-bortezomib (250-1 mol-mol),-0.938511355699207
LOU-NH91,9935249,4.429052878520747
COV644,3854666,1.1187746024873992
SW1417,11152667,-0.9008177066075654
RPMI-7951,135984461,1.8350083594586524
PaTu 8988s,9915743,-0.0886276947358788
MFE-319,selumetinib-GDC-0941 (4-1 mol-mol),2.3179582755717356
A-673,11494412,0.2373053627626316
TC-71,135421197,1.432077175902578
SW1271,49836020,-1.4027167140646708
SK-UT-1,11494412,1.7393092296584682
KP-3,9911463,3.5465517511972173
AM-38,10322450,-5.137257783739551
Fu97,1566236,3.693810032735882
LS513,49836020,4.383197758831643
TM-31,3854666,2.1009694082153105
BT 224,135421197,2.656676342588309
HLF,9926054,1.9113272674317217
G-402,9926054,1.7683002714551472
KMS-12-BM,65628,3.1283199596989624
BT 440,1566236,1.7318288618334623
NCI-H1563,6918638,2.248675960717125
BT 333,2746,4.493584993819337
SW1271,9915743,1.6128868969613257
T3M-10,10322450,3.511254114346124
OCUM-1,49836020,-0.6781383792077297
GSS,100016,3.718199006522657
P-STS,54639665,4.398592450418463
OVSAHO,135984461,5.613445307833131
NCI-H1339,1566236,2.281112121085828
KALS-1,135984461,4.764345529991705
NCI-H841,6918638,0.9604631046268464
SW1990,tanespimycin-bortezomib (250-1 mol-mol),-3.036947159692904
L-363,selumetinib-GDC-0941 (4-1 mol-mol),2.240470367275986
SK-HEP-1,71751553,4.559763777433237
EFM-192A,1566236,1.7365732775368694
SET-2,4705,3.0557910229077554
TE-14,9935249,3.117284410933106
SK-HEP-1,9915743,2.4580731883892293
MCF-7,54618771,-0.7262011969078179
Rh30,11152667,-1.7788269902081053
Namalwa,sirolimus-bortezomib (250-1 mol-mol),-0.1415528846199467
HCC366,54618771,1.7092661743346285
SW948,135421197,1.7477185084776832
NCI-H1703,11494412,-0.6929236113536564
NCI-H650,3854666,2.944937467815792
SNU-16,sirolimus-bortezomib (250-1 mol-mol),-0.2778167709338917
NCI-H1651,2746,3.195891738830615
BT 112,54618771,1.3381626551406447
HSC-2,3465537,3.4081587801176574
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084
D283 Med,9915743,1.368920834577302
F-36P,9935249,1.4854738782819463
MKN7,4705,2.6628082775423865
SYO-1,9915743,2.525873666544599
SK-N-FI,9884685,0.5794007214682347
U2OS,54618771,2.9736494040757924
FU-OV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4708101541145827
DEL,sirolimus-bortezomib (250-1 mol-mol),-0.5963284229759003
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272
A-375,65628,4.4466647793828855
HCC2218,100016,5.089450081937329
AML-193,6918638,-1.1768920136459526
SNU-668,9926054,1.9494933006011008
MHH-ES-1,11152667,-1.0440831311792091
T24,9884685,3.0703903022477643
DV-90,135984461,4.374368296493772
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
ST486,135659046,3.2413267660830316
SUP-B15,9926054,1.7233676505424833
PaTu 8988s,11494412,1.3671050203889736
AsPC-1,9915743,1.396378280260739
Mono-Mac-6,3854666,2.646035191331394
BICR 31,9884685,0.303781088019613
CHP-126,tanespimycin-bortezomib (250-1 mol-mol),1.029486462123943
BT-20,168313307,4.416530392456532
RL95-2,136227924,2.901366933043705
NCI-H211,11152667,-1.0917449852638887
NCI-H647,136227924,2.9483035397305164
A-375,9935249,3.760967262961611
OAW28,135421197,1.4901490212875883
CL-11,3854666,1.3042610376736252
BT-16,100016,4.275534033025709
IPC-298,9915743,1.3514375802174825
TE-9,11152667,-0.2283406603078907
ChaGo-K-1,9915743,2.151950733066917
DK-MG,54618771,1.0774373419981456
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
JHH-2,2746,3.041008676294123
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
NCI-H2081,9926054,1.7325996665522785
HT-1197,71751553,5.426785505505591
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982
HCC1833,9935249,3.7916141061990305
BT 482,135659046,5.385969156386867
Mono-Mac-6,tanespimycin-bortezomib (250-1 mol-mol),4.2631567174447556
PaTu 8902,2746,3.932313359375791
Namalwa,1566236,0.962108735319634
TALL-1 [Human adult T-ALL],9884685,0.4782618464268887
MOLP-2,9926054,1.6077834745045567
BT 131,9911463,3.3950142124992113
COLO 678,135421197,1.7545986410246563
JK-1,sirolimus-bortezomib (250-1 mol-mol),0.507486963529962
SCC-4,tanespimycin-bortezomib (250-1 mol-mol),-0.6950216335747628
P12-Ichikawa,3854666,0.4880959044456195
EJM,135984461,5.02990169097732
HOS,54618771,1.216646065025966
NCC-StC-K140,6918638,1.6255556223865495
SNU-478,3854666,1.0704157798123697
MOLT-13,136227924,1.9107910741830303
COV362,135421197,3.17227725861234
IGROV-1,11152667,-1.4116509977729443
BT 320,9926054,4.941319925063275
SF268,135659046,3.3969248782419608
ESS-1,135421197,2.603718676668537
FTC-133,11152667,-0.4786534736280033
MIA PaCa-2,49836020,4.16350045307359
COLO 829,11494412,4.564162529405607
KMRC-3,11152667,0.0454830194586134
BT 147,11152667,1.0893077431707785
AsPC-1,6918638,0.7071735542476161
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
NCI-H1395,9926054,1.836702615994444
NCI-H1395,100016,6.569605836811141
A-549,135421197,2.4799819746704075
SNU-216,4705,1.5383436923122542
EoL-1,135421197,0.8401357676850814
SEM,2746,-0.0565030951113346
IGR-1,11152667,0.1543834410514462
WM793,135984461,3.5730556754970175
SW1271,11152667,-1.5987482479879582
JK-1,9911463,2.3192555000733197
IMR-32,11152667,-1.250307023414486
RS4;11,11152667,-1.893444270216278
JeKo-1,4705,3.398339905986335
LoVo,3854666,1.417426416420887
HEL 92.1.7,6918638,-1.1828451874252928
SK-MEL-3,54618771,0.906293998556286
TT2609-C02,2742550,4.340338597954281
GDM-1,9915743,-0.2522404028033351
JHH-1,2746,1.382928885813351
Mel JuSo,9926054,2.008818568190823
NCI-H460,9926054,2.081701465030928
COR-L51,54618771,1.1553419440915085
KP-N-SI9s,4705,2.458330533365605
SK-MEL-1,49836020,3.8417397632517143
OCI-AML-2,9915743,0.8292990074766823
SNU-407,9884685,0.5059737152516742
EM-2,9935249,2.516925866453196
SNU-61,100016,6.106397388471953
OE33,65628,4.337074317818266
CMK,9915743,0.8633678445268913
SW1088,9911463,3.760639555360148
HEC-59,3854666,1.7819501596078249
LOX-IMVI,2746,2.55877549764083
U-BLC1,11152667,-2.158849665870786
HL-60,6918638,-0.8041494190093976
2004,3854666,0.9594440338227248
LCLC-103H,9926054,2.81223402195442
DMS 53,1566236,1.4544984078076502
HCC1195,sirolimus-bortezomib (250-1 mol-mol),1.8421532111980472
KP-N-SI9s,sirolimus-bortezomib (250-1 mol-mol),0.5710762504018412
BHY,9911463,3.455291934456847
HSC-4,24779724,5.454925638847944
BT 172,11152667,0.6586522998064477
GMS-10,9911463,4.363409531102835
SCaBER,selumetinib-GDC-0941 (4-1 mol-mol),-0.4937512054243923
TUHR10TKB,73707386,3.2234831136980464
NU-DHL-1,2742550,3.0949121408680886
UACC-257,2746,2.6143707562443135
NCI-H2029,100016,6.638892611020326
EKVX,4705,1.6368061530799292
HuP-T3,9926054,1.9266750805140576
RPMI-6666,100016,5.822007631719843
KYM-1,selumetinib-GDC-0941 (4-1 mol-mol),1.885650004060589
LS411N,11152667,-0.1489697958567156
PK-45H,71751553,4.624328155960912
Rh30,9911463,3.4097101365925786
L-363,3465537,1.4710509677174886
CAL-148,100016,6.461133409351435
WM115,10322450,3.651827454662003
GP2d,6918638,-1.154935446775354
SNU-840,135421197,1.1283252272940862
KE-39,54618771,0.8543301924142261
A3/Kawakami,100016,3.999978023882096
MES-SA,9935249,3.0678180432463873
HCC2935,9935249,3.0627293798034563
JVM-3,9915743,-1.1278742890902858
MOLT-16,tanespimycin-bortezomib (250-1 mol-mol),0.076704677105394
G-401,10322450,4.220475308231234
Ku812,135421197,1.6654017400601815
769-P,selumetinib-GDC-0941 (4-1 mol-mol),2.2458256114397788
ACC-MESO-1,9926054,4.037988480167424
IGR-39,136227924,2.6355333557661167
MOLM-6,54618771,-1.125250361131471
BT 444,24779724,4.4459296914982565
NCI-H661,9911463,3.595935737335879
A101D,49836020,-1.073011415975237
CADO-ES1,9911463,2.9400550809567454
Caki-2,6918638,1.5363275788764994
DV-90,9935249,1.6068796550141815
CAL-78,24779724,4.391845429611093
NCI-H1299,tanespimycin-bortezomib (250-1 mol-mol),0.405614896929535
Hs 944.T,9884685,2.467648358367301
KMS-12-BM,136227924,1.841540408480291
SJSA-1,tanespimycin-bortezomib (250-1 mol-mol),0.871032127395642
SNU-423,6918638,0.4106402962761268
SW579,9935249,2.1247219818786776
SR,9884685,0.4372930980383124
KYSE-150,71751553,4.3455313830128635
KNS-60,11152667,-1.945489843618092
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
BT 231,9915743,1.2683297871302317
BT 320,71751553,4.331550413851084
BDCM,24779724,4.545897019972193
U-937,100016,4.26159584690163
NCI-H2452,9915743,1.4140850498548845
Capan-2,54618771,-0.253287331081348
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
Kelly,135984461,4.326005791878528
NCI-H1650,9915743,2.357354883780035
IGROV-1,135421197,1.96820638017286
MeWo,71751553,4.508451230000785
NCI-H1793,135659046,3.4932365475314837
OAW28,9926054,1.976123345191561
SNU-449,135984461,4.468051833024593
HL-60,65628,4.481571906059771
TOV-112D,135659046,3.4067984131913938
MOTN-1,135421197,1.3703744240022513
697,10322450,2.5214685909488037
NCI-H2009,9911463,4.220122302208283
SW1417,54618771,0.6384319893864374
Panc 03.27,54618771,0.0634128871766815
BT 428,1566236,1.6245492383600229
SK-N-DZ,135421197,1.275457172430967
Hs 888.T,2742550,3.10434655175039
CHP-212,2742550,3.525103629838529
SBC-5,2742550,4.323082293816951
OV56,135398744,6.336681474599488
DND-41,3854666,0.757997992407008
KE-37,9935249,1.5126551967808797
CHP-126,135984461,6.03528386391008
KMS-21-BM,11152667,-1.593157926365923
ACC-MESO-1,135421197,1.1131712845559925
KO52,11494412,-1.6308846276697513
VMRC-RCZ,1566236,3.0269814676241924
SUP-HD1,9915743,0.8948687265051912
OVISE,54618771,1.319775250733869
HCC1395,54618771,2.360286103240852
SNU-61,135421197,1.1046098427392648
HeLa,11152667,-1.1066196767080478
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
HCT 8,4705,3.304717107003546
CAL-78,9911463,4.373353120464338
SNB-75,4705,4.116486299784252
SK-MEL-3,9915743,2.9768628838576037
WM983B,9884685,2.1138858450656937
SCC-4,9935249,3.0407089317538167
FaDu,3465537,2.9926809640711456
HLF,11494412,1.078147161015815
U-118MG,54618771,1.5788983669789174
HuH-28,sirolimus-bortezomib (250-1 mol-mol),0.2799415361995808
NCI-H747,6918638,-0.0618345557686977
HuH-1,9915743,2.131122478495969
YAPC,9935249,3.6850704434892823
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
HCC2218,3854666,2.216625580917516
BT 245,3465537,3.867182511877691
MES-SA,135421197,2.6547553279335543
GB-1,136227924,3.951727784027331
OV-90,11152667,1.1297317130055462
JHUEM-1,4705,3.281034175975557
CAL-12T,11152667,-2.142354911883577
P31/FUJ,9915743,-0.8907797257006451
HEC-265,135421197,3.07473850340402
SNU-423,2742550,3.778188563180187
Tm87-16,tanespimycin-bortezomib (250-1 mol-mol),-2.1995475163951217
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
LUDLU-1,135421197,2.9427726224498274
Hs 578Bst,6918638,3.629464164319933
NCI-H1915,9911463,4.383927524299923
BT 164,135421197,1.9530013508190165
BT 422,6918638,3.528900316043955
LOU-NH91,4705,2.8449970854381945
MHH-CALL-3,73707386,1.7975631964986447
NCI-H1385,9868037,2.914000161841284
SNU-C4,9926054,1.7359691760271532
SW620,11152667,-0.0002133218220567
BT-20,9935249,3.213936920036377
PK-1,6918638,1.0537426259825138
HCC95,3854666,3.6849865416308303
NCI-H2286,135421197,1.3585015224229091
SNU-182,10322450,3.100358710746125
SW1088,selumetinib-GDC-0941 (4-1 mol-mol),3.0866822201862374
697,135659046,2.7406453886964837
SUP-M2,65628,1.971543612334658
MDA-MB-361,9935249,3.141937087605061
ST486,1566236,0.5405681794856062
SIG-M5,135659046,3.608194247499591
A4/Fukuda,9926054,1.7963505717751411
HOP-62,4705,3.552280933872326
L-363,136227924,2.122664399399679
Hs 822.T,9926054,3.800948674297046
HEC-151,sirolimus-bortezomib (250-1 mol-mol),0.8769904812641561
BICR 56,4705,0.1068986630843261
NCI-H1869,11494412,4.466275600700225
Hs 729.T,135984461,4.562955987712422
COLO 668,100016,7.809114037996309
WM115,3854666,2.6196721416111024
Daoy,selumetinib-GDC-0941 (4-1 mol-mol),2.0496212726424914
BL-70,100016,3.880189960258483
NCI-H2110,10322450,4.394668434370401
NCI-H1155,135421197,0.9372585927098024
LOX-IMVI,3854666,2.4185877249013368
HEL 92.1.7,11494412,0.9504313755002392
SCC-4,71751553,4.298955474315719
Panc 02.03,71751553,4.925944110140211
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
SIG-M5,65628,3.9627714833655383
SCC-25,100016,6.900174579464034
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
NCI-H358,54618771,2.9972263013300955
CAL-54,sirolimus-bortezomib (250-1 mol-mol),0.5891301092659956
NCI-H647,24779724,4.284354116768243
PE/CA-PJ49,11152667,-0.7755260151132314
CAL-29,3465537,1.8717239313692025
NCI-H146,9926054,1.7480459470636802
LUDLU-1,9884685,1.2694311551040651
OCI-AML-3,3465537,1.1544662524916731
HEL,9935249,3.1121102066484827
Hs 611.T,65628,3.4812835817833183
TUHR4TKB,135421197,2.8220761476999665
NUGC-3,1566236,1.9302798040984224
GB-1,BRD-K16130065,4.42493590422296
BT 428,4705,1.6502431761366996
BT 172,9911463,2.9844378000407543
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
MOLM-6,4705,2.310096856528744
BL-70,10322450,2.4597869877226004
TC-71,54618771,1.220599365734416
TC-71,9884685,0.722756540979205
SaOS-2,24779724,4.377738848523283
A-673,10322450,2.1969870036583323
NCI-H322,11494412,1.1348066706862836
SNU-61,2742550,3.576212598776706
KMM-1,3854666,4.082078961009132
HOP-92,100016,6.879559613863246
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693
COV362,9926054,1.902525685415388
NCI-N87,100016,7.118039999797619
HL-60,136227924,2.3594265520512447
MHH-CALL-3,tanespimycin-bortezomib (250-1 mol-mol),0.530639980340651
MIA PaCa-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.2888147143095668
HT-1376,9915743,2.2155128053194777
OCI-Ly19,9935249,-0.0089677509466631
L-540,136227924,2.3931383545900524
OCI-Ly19,49836020,4.441664761754026
U-937,4705,3.455929812371293
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
ECC10,65628,3.692288785501721
TTC-709,sirolimus-bortezomib (250-1 mol-mol),0.2718728202081833
NCI-H1105,9926054,1.86457745322678
Peer,10322450,2.772201791811034
SK-MEL-24,10322450,6.176718296792277
LP-1,9926054,1.657631549896095
TE 441.T,49836020,3.964912597269393
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
SNU-738,54639665,4.332725290413926
NCI-H2009,sirolimus-bortezomib (250-1 mol-mol),2.102899194038225
CML-T1,135984461,1.8956927240773784
COLO 320,135398744,6.463011253269961
GCT,9915743,0.92699998919311
SK-UT-1,71751553,5.981983562576585
WM88,54618771,1.141068520778182
KMH-2,135421197,1.1476668863331456
UACC-62,tanespimycin-bortezomib (250-1 mol-mol),1.2383620234994217
HEC-1-B,selumetinib-GDC-0941 (4-1 mol-mol),1.120792302253412
HEC-265,9926054,2.077081644507314
BT 482,4705,3.30831403068686
WM983B,135659046,3.887851853089627
SNU-16,11494412,-1.5668452585582169
HT-55,135984461,4.061265813784957
OCI-AML-3,9926054,1.7279388216590237
Yamato-SS,136227924,3.1022512927874444
KMS-21-BM,65628,3.740044409654922
HCC1419,71751553,5.3223316013448985
A-375,54618771,0.2489032260565352
BT-549,71751553,4.2471267374516435
EFM-192A,6918638,-0.4995491162684927
SNU-119,9911463,2.8532899111041385
NCI-H508,135421197,1.875184072500521
TALL-1 [Human adult T-ALL],9926054,2.0252828062199257
BT 231,11152667,1.8482025461380396
BT 187,9915743,2.9672609424813
BCP-1,9935249,-1.7748725818635605
P-STS,selumetinib-GDC-0941 (4-1 mol-mol),4.834100084681968
NCI-H1092,11494412,2.17753949415027
Hs 852.T,2746,1.815262794144644
SK-MEL-1,9926054,2.8910201246716403
U-251MG,11494412,3.5194531484174822
SK-N-MC,168313307,4.3685059701661215
L-428,11152667,-0.972054324518145
NCI-H1581,73707386,3.3103978289770692
MHH-ES-1,65628,3.443367883229779
MDA-MB-415,selumetinib-GDC-0941 (4-1 mol-mol),-0.0962287719038293
KE-97,10322450,3.096998499841668
BEN,9911463,4.573978563534662
HL-60,9926054,1.793392077078212
ONS-76,100016,6.019166856387977
SF268,650361,5.434454407952264
OC 314,136227924,3.246361398875885
YD-38,selumetinib-GDC-0941 (4-1 mol-mol),-0.5949225463432135
BT 440,selumetinib-GDC-0941 (4-1 mol-mol),0.7235694327018775
BT 231,9884685,-1.167030956523576
BT 498,11494412,3.6640895055137017
NCI-H650,9915743,1.7401502562987152
TE 617.T,9884685,-0.3777668305269445
Sq-1,9911463,3.467859950121971
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758
RPMI-6666,tanespimycin-bortezomib (250-1 mol-mol),-0.2887832089561175
KYSE-30,65628,6.48911885956441
HCC1395,9911463,3.7308184139789855
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
Lu-65,9915743,2.050551276197927
HuH-6,9884685,0.3084855166914031
KMRC-1,9911463,4.4126092990485395
JHUEM-7,136227924,2.4332957155572688
JMSU-1,9911463,3.337278506693628
DAN-G,3854666,2.9021314616259435
DMS 53,24779724,4.53912068548046
MDA-MB-415,tanespimycin-bortezomib (250-1 mol-mol),-3.006075352171784
SK-MEL-1,9868037,2.6521511264174493
Ki-JK,135984461,3.4417965783615414
H-STS,54618771,0.7523066402016166
TYK-nu,tanespimycin-bortezomib (250-1 mol-mol),-0.3612776377127862
BT 112,selumetinib-GDC-0941 (4-1 mol-mol),3.393388864496841
LCLC-97TM1,10322450,3.85878970197106
NCI-H1703,9935249,1.5289979919056798
MHH-CALL-3,135398744,6.205129646453742
BT 498,136227924,4.389685115045935
DU4475,54618771,1.1300821286191531
Hs 822.T,6918638,4.296934000106513
Rh41,11152667,-1.370946283647722
WSU-DLCL2,9884685,-2.0768912685811056
IST-Mes1,2746,3.2096433183027604
HOS,sirolimus-bortezomib (250-1 mol-mol),0.4034549730700768
CAL-54,11152667,-1.096063440720087
OPM-2,136227924,1.7425170628423947
NCI-H747,11152667,-0.5062893189459198
HCT 15,135421197,1.319827384864071
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
NCI-H23,4705,3.013128646573162
DMS 114,10322450,4.614293219898761
TE 441.T,4705,3.429293976923017
DAN-G,11152667,-0.8681633456195671
SCC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.2085595072680022
NCI-H2170,135659046,3.716321979563838
Kelly,135398744,7.079466503802849
SCC-25,4705,0.8659317696448142
UACC-812,11152667,2.562952126743398
SNU-601,2742550,3.064615106373439
GA-10,9911463,2.3483289589885135
OAW42,135659046,3.5713429692189447
22Rv1,sirolimus-bortezomib (250-1 mol-mol),-5.664247196474798
MOTN-1,3854666,0.5699425367736352
Hep 3B2.1-7,3854666,3.158608075491721
NALM-6,sirolimus-bortezomib (250-1 mol-mol),0.084215684734826
COLO 800,135398744,6.478150217692287
SNU-119,9935249,3.2348685245924726
NCI-H2444,9926054,0.9505376631945008
OE33,9915743,2.242004758711727
SHP-77,135421197,1.1078063098339157
WSU-DLCL2,9935249,2.5426806019846864
SNU-407,135421197,1.3307309137808745
BT 428,9935249,1.746513548919668
SNU-1,4705,2.948044298069726
MM1.S,3854666,1.277087835200556
MDA-MB-453,tanespimycin-bortezomib (250-1 mol-mol),-3.425148302168821
IGR-39,49836020,4.439074954514643
FaDu,sirolimus-bortezomib (250-1 mol-mol),0.8335893601460954
42-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),0.6620658581773345
SNU-201,136227924,3.0451171975506903
BT-16,136227924,2.1772162484418924
SK-N-AS,100016,6.379811774246359
NCI-H1341,54618771,1.0375359960566886
HuG1-N,9926054,1.9171272639265269
CMK,selumetinib-GDC-0941 (4-1 mol-mol),2.84334284857712
NCI-H2023,9926054,1.8656368845898197
NCI-H2110,1566236,3.9517659227404263
ChaGo-K-1,10322450,2.8130717345361336
NCI-H1435,2746,2.5897217485668222
FaDu,9911463,4.044046112259449
BT 139,1566236,2.5894214641501345
NCI-H1693,135421197,1.2995160865472135
HMC-1-8,9911463,4.100955658112126
NCI-H1693,11494412,1.8422349416207413
Kuramochi,tanespimycin-bortezomib (250-1 mol-mol),2.338671099156103
JHOC-5,136227924,3.178485175637893
CA46,2742550,3.5037926309603944
EB1,11152667,-2.271733256733806
MKN7,1566236,1.7135584287859864
KMS-21-BM,9915743,0.1101239094873029
Ku812,9911463,3.2535027234043428
SHP-77,3854666,0.6540211692983887
OE21,100016,6.577886119924336
HeLa,11494412,0.2354090887840819
A3/Kawakami,4705,2.957663936707348
BT 444,selumetinib-GDC-0941 (4-1 mol-mol),1.0784151115799612
TE-8,3854666,0.6254057025947416
Kelly,3854666,0.4283162780328328
MeWo,1566236,1.7978340466809355
Hs 578Bst,11152667,3.6587285726164183
BT 248,2742550,4.585670765822412
TE-11,selumetinib-GDC-0941 (4-1 mol-mol),0.8389295990054343
DAN-G,54618771,0.722967916386815
EPLC-272H,9915743,-3.018922536526067
UM-UC-1,11494412,0.969963404603011
JURL-MK1,54618771,0.584482701420473
Hs 746.T,54618771,0.5763857654673513
NCI-H716,136227924,3.096712149885638
KMS-34,54618771,-0.7533215739464646
L-540,selumetinib-GDC-0941 (4-1 mol-mol),4.246283194196457
EFE-184,selumetinib-GDC-0941 (4-1 mol-mol),4.957759622991816
Panc 08.13,135984461,4.38718124814828
BT 159,sirolimus-bortezomib (250-1 mol-mol),0.8786451932311966
SF539,24779724,4.8810531030455415
YD-10B,136227924,2.2440881554064105
NCI-H196,selumetinib-GDC-0941 (4-1 mol-mol),1.8347621596974035
LN-18,135421197,2.222908154028884
JJN-3,sirolimus-bortezomib (250-1 mol-mol),0.0133563437119215
OVSAHO,3854666,3.3934113413340663
GDM-1,100016,5.649529454604957
A4/Fukuda,6918638,-1.9449982869755031
MEC-1,9911463,2.4578054116593555
SYO-1,sirolimus-bortezomib (250-1 mol-mol),0.8994859794760022
RERF-LC-A1,11152667,1.3803453308335734
EFE-184,1566236,1.7539601989723244
LC-1/sq-SF,sirolimus-bortezomib (250-1 mol-mol),0.7549261124626822
G-401,2746,2.560873344661061
A-375,3854666,2.66860299543091
HSC-2,54618771,1.8867567266847771
HT115,65628,4.396008028218786
Becker,71751553,4.672382658610356
HEC-1-A,11152667,-0.468005866747532
NCI-H810,49836020,4.546134729481912
OC 314,tanespimycin-bortezomib (250-1 mol-mol),-1.1782334155710066
HCC-56,135421197,2.032560895215065
LCLC-97TM1,9915743,-0.0836077976930932
SNU-761,135659046,3.552687853164843
EBC-1,9935249,3.3043470601843885
HCC1500,6918638,0.5709126385335386
NCI-H1184,49836020,5.907287846852096
NCI-H1838,9868037,3.6730401154480767
COLO 201,sirolimus-bortezomib (250-1 mol-mol),2.3709690887392516
BFTC-905,2742550,3.4288613566145356
NCI-H2122,1566236,4.547369215315693
SK-LMS-1,135421197,1.8226321341170344
COLO 741,49836020,-1.8257608892409716
Karpas-299,135421197,1.2662606482255232
L3.3,9926054,1.9335911906728165
NCI-H727,selumetinib-GDC-0941 (4-1 mol-mol),-1.3460907005826803
OCI-Ly10,11494412,1.3336698369044977
BICR 6,4705,4.392083823551742
ALL-SIL,3854666,-1.067048731148745
NUGC-3,135421197,1.602671962705462
OE19,100016,6.21408400033578
L-1236,73707386,1.6833815514075816
Capan-2,4705,4.948104259721338
CL-11,9915743,1.17704113749316
P3HR-1,2746,2.544135667971718
SNU-C1,1566236,1.8241631606910471
YAPC,54618771,0.5686030675412354
HuH-6,9915743,1.4192862158653652
T-47D,9868037,4.066424821107803
TYK-nu,54618771,0.511557548457066
Mel Ho,135984461,4.333479355055791
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
Lu-99,11152667,-1.4137916127487686
JHUEM-1,11152667,-1.2363443703261163
KE-97,sirolimus-bortezomib (250-1 mol-mol),0.1118131766190663
BxPC-3,136227924,2.62858882862477
A101D,11152667,0.6218248204283258
BT 286,9884685,0.8858351843955082
PE/CA-PJ49,3854666,0.40608223824848
TE-5,11494412,1.6145960929630034
LMSU,11152667,0.2226803323304874
WSU-DLCL2,tanespimycin-bortezomib (250-1 mol-mol),-0.4826072076602557
HMCB,6918638,0.939566819440244
Calu-6,135398744,6.4194279820254465
Ki-JK,tanespimycin-bortezomib (250-1 mol-mol),-1.1406777464208224
NCI-H660,71751553,3.85779920922312
LS1034,9926054,1.864667676562072
ST486,3854666,0.1902738125367225
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
A3/Kawakami,9915743,1.8122427094959257
JHH-1,tanespimycin-bortezomib (250-1 mol-mol),1.1160802698150678
Kelly,54618771,0.9246671147478912
SNU-216,11152667,-0.1857708456890594
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
SNU-1033,11152667,-1.2864641909035752
OV56,9935249,3.246105804019043
SU-DHL-1,73707386,2.8817783064824773
ACC-MESO-1,136227924,3.807440016829928
SUP-B15,9884685,2.0642771767960726
HCC1569,3854666,2.945082470894372
SET-2,10322450,3.4472789227229925
SNU-489,54618771,1.3505446494743896
COR-L51,4705,3.639553791730093
KMS-21-BM,100016,3.297202365361246
Hs 746.T,11494412,3.539724142394036
OS-RC-2,sirolimus-bortezomib (250-1 mol-mol),1.663291645677193
HCC1588,9935249,3.204556215826443
BT-20,9926054,1.9620105743223175
HCT 116,sirolimus-bortezomib (250-1 mol-mol),1.7104818148268468
KYSE-410,4705,2.1516675380518953
BT 139,2742550,2.665128125190364
DEL,3854666,-0.1483525975905523
OVCAR-5,135659046,3.4462487776762303
HPAC,9911463,2.695255349587433
DBTRG-05MG,135398744,6.409074750923468
SNU-1033,4705,2.6216736811916044
NCI-H929,11152667,-0.508669926836867
AU565,9868037,3.1053436778875843
NCI-H1581,65628,4.285371471418109
OVCAR-8,3854666,2.8229286254274624
NCI-H2029,9926054,1.852947583651784
FTC-133,selumetinib-GDC-0941 (4-1 mol-mol),4.492269110406249
TT2609-C02,135659046,5.602741752641771
MDA-MB-361,135421197,1.0665899538152213
8305C,136227924,2.5381850582467913
Panc 08.13,9911463,3.6396018844852662
Caov-3,54618771,0.7751702842643667
CAL-120,3854666,3.5869013773786573
NCI-H810,135421197,1.5773346723196464
KMS-20,3854666,0.6836854926820529
JHUEM-1,135659046,3.513270809180088
VMRC-RCW,9935249,3.8871203544868935
SNU-878,sirolimus-bortezomib (250-1 mol-mol),1.804977895321967
OCI-Ly3,1566236,1.0416509518508918
JHOM-1,54618771,2.421101396642466
JHH-5,11494412,0.4405846778714341
BICR 56,9915743,-1.8480051060237024
OCI-M1,136227924,3.580987744477365
PSN1,1566236,1.7739634802573778
HSC-2,2742550,4.322545974924492
KNS-60,4705,3.2659251845873425
A2780,2746,1.939184711313242
SNU-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1167274542532347
JVM-2,sirolimus-bortezomib (250-1 mol-mol),-7.352032858936448
B-CPAP,54618771,-0.888157328254987
BT 428,135421197,1.0281432833092603
WM793,65628,5.352978394453619
LOX-IMVI,11152667,-0.6802335307199879
HLF,selumetinib-GDC-0941 (4-1 mol-mol),3.676368121214341
CAL-120,135984461,5.818041384121715
MOLP-2,65628,-0.7445574295939409
DMS 273,9915743,1.912374780622189
Malme-3M,4705,3.370041144877098
LXF 289,9915743,1.5678711489122208
Caki-1,135421197,2.421962136106705
NCI-H2342,11152667,1.6588542110928108
COLO 205,100016,5.963233409359241
DMS 53,9884685,0.3261238173015792
Namalwa,10322450,3.877307531453308
RKN,135984461,0.6080422026652917
MIA PaCa-2,9935249,2.549119041340402
2004,9911463,3.209931377747237
NH-6,6918638,-1.4454078829022647
Hs 766T,selumetinib-GDC-0941 (4-1 mol-mol),-2.707404573640349
MOLT-16,2742550,2.806612523905755
LN-18,9935249,3.1873954770146486
RCC10RGB,71751553,5.18764953581067
CMK,tanespimycin-bortezomib (250-1 mol-mol),0.1761627875965655
697,9926054,1.6701290934346382
KLE,9915743,0.4681181116614699
SCC-9,11152667,-0.1233430086603879
PK-1,11152667,1.060142887302552
HT-144,49836020,4.351286347642034
Hs 944.T,54618771,2.424765430874906
DoHH2,65628,2.6605879457823627
LOU-NH91,1566236,3.241690914019502
NCI-H1869,2746,3.565752906078767
RPMI-6666,54618771,0.781806189170932
BT-20,135659046,3.529178166961368
TTC-709,65628,4.616344803397528
NCI-H1666,2742550,2.8978231696200547
PF-382,9868037,2.2881920680680756
A4/Fukuda,136227924,1.9204852137512072
KMBC-2,9884685,1.520589448798377
TE-15,10322450,3.2140192626835313
GA-10,6918638,-2.7044389235712187
COLO 792,2742550,3.342402133589489
BT 172,9884685,1.398754184455955
OCUM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2423134599079573
CAL-51,3854666,1.1494535123186709
Tm87-16,135421197,2.3570280625350057
PE/CA-PJ34 (clone C12),2742550,3.898499868649933
SNU-1066,65628,4.413733003264305
HDQ-P1,9884685,3.380052821161662
8505C,136227924,3.0385484032115215
NCI-H2228,2742550,6.139111772417892
HCC1806,3854666,3.691005549955363
A-673,1566236,1.6605846703776754
ChaGo-K-1,3465537,1.3270593672392677
JJN-3,136227924,1.2624051766932831
CAL-51,9868037,3.5441777448678615
SK-MEL-2,2742550,4.157489560725976
RL95-2,9911463,3.5456378999337077
YD-10B,9935249,3.5260896085305773
Lu-65,1566236,3.455735123137807
KNS-62,2746,3.88205889014037
Hs 729.T,6918638,2.1064288612965205
HT-1376,135421197,1.3113029615588312
OVCAR-5,sirolimus-bortezomib (250-1 mol-mol),0.9753915222823988
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
PE/CA-PJ34 (clone C12),71751553,4.188621560003168
TE-11,9884685,1.1318911845628066
NALM-6,9884685,-1.9004731956493823
CML-T1,9935249,2.5956918222650507
G-292 clone A141B1,65628,4.8871250703785805
KMS-20,135421197,1.5361253797366796
CJM [Human melanoma],6918638,1.423162618874033
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
CA46,135421197,1.13174100448049
SH-4,6918638,2.256041037231368
SU-DHL-10,9935249,2.725812831825159
NCI-H446,1566236,1.4112475546908474
NCI-H1435,3854666,3.178817498087244
HuH-1,135421197,1.8778683670700504
MG-63,9884685,0.4591360322389684
LS123,3854666,4.134120711084662
EB1,6918638,-0.9960989613224034
KMRC-1,3854666,2.659759078644905
BT-12,11494412,1.7743294145971482
BT 231,11494412,-1.440888792525865
COR-L95,100016,6.620829555802918
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555
VCaP,6918638,-1.0588034112716072
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014
SF539,100016,5.965471494853995
NU-DHL-1,11152667,-2.1433741052472493
U-937,2746,2.8216172923240825
MDA-MB-468,sirolimus-bortezomib (250-1 mol-mol),0.2787318869708576
SNU-1041,136227924,4.256354114890169
Rh41,selumetinib-GDC-0941 (4-1 mol-mol),-0.3258971504305004
SH-10-TC,71751553,4.325355534508399
Capan-2,sirolimus-bortezomib (250-1 mol-mol),0.8521756904723038
BT 286,135421197,2.331823163871174
JHUEM-7,135421197,2.2083604774336973
NCI-H1105,9915743,0.8862915101567481
DB,100016,4.066938426663746
NCI-H1373,3854666,3.2037739453809233
2004,54618771,0.1677615799091476
CAS-1,9868037,3.4810587934023363
HSC-2,tanespimycin-bortezomib (250-1 mol-mol),-0.2988768157355406
P12-Ichikawa,65628,3.061584325032845
HuH-6,11152667,-2.162019568572356
CGTH-W-1,9935249,4.1803974090658
KP-N-SI9s,54618771,1.0229229118908414
KNS-42,tanespimycin-bortezomib (250-1 mol-mol),0.1852378636050138
RPMI-7951,sirolimus-bortezomib (250-1 mol-mol),1.5520674857207382
KMS-27,9926054,0.4648817543416692
Kelly,73707386,3.676841116050576
HT,9868037,1.9905523234994904
TE-10,11152667,-1.9561905553634344
BT-20,10322450,4.517270992352955
HPAC,135421197,1.2085727097221448
NCI-H2452,2742550,5.209305166760603
Ri-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.0578389272938329
OS-RC-2,3854666,3.742004616856006
HT-55,3854666,3.4559567246974305
TTC-709,2746,3.375818132682937
NCI-H28,9868037,2.6779673338971826
NH-6,9926054,1.9034563361062868
A-204,135659046,3.450205324523238
NCI-H810,tanespimycin-bortezomib (250-1 mol-mol),0.3768886958286864
SW1353,135421197,2.4746920364366813
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
NCI-H1573,9926054,1.726764013189345
ONS-76,9926054,2.5108803232151304
KMRC-1,9915743,1.4003501061845525
KYSE-410,9926054,2.1669765108653483
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
KMS-26,selumetinib-GDC-0941 (4-1 mol-mol),-0.996356335755467
FTC-238,136227924,2.431059366258334
A3/Kawakami,9926054,1.6582602288279693
M-07e,9935249,0.4541689416973374
EJM,650361,3.796410138993618
SK-HEP-1,11152667,2.375581084403437
BT 172,sirolimus-bortezomib (250-1 mol-mol),0.9880201722030184
Sq-1,selumetinib-GDC-0941 (4-1 mol-mol),2.237150148829387
U2OS,sirolimus-bortezomib (250-1 mol-mol),1.3880787640011472
MOLT-13,9911463,3.0690071291401626
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
JHH-2,2742550,4.034353519220002
EKVX,135659046,3.5210765242905304
SK-BR-3,54618771,0.9510207607432342
SNU-1077,11152667,0.5302678511241536
KYSE-410,135984461,4.6292418393207235
Karpas-422,9926054,1.7787061620357676
MOLT-13,selumetinib-GDC-0941 (4-1 mol-mol),0.648080768379065
JHOS-2,71751553,4.578795631337799
LS123,9911463,4.230374012673379
SNU-1196,selumetinib-GDC-0941 (4-1 mol-mol),2.312847943895299
UO-31,135659046,3.3569813740472267
DEL,3465537,0.475159864785855
C2BBe1,2742550,3.0977711517053153
SCC-9,4705,2.492131143046821
MOLT-3,49836020,4.359982480668932
HSC-3,9926054,2.205728912393848
HEC-265,54639665,4.667688857990006
NCI-H1793,54618771,0.9383287956329432
NCI-H1703,sirolimus-bortezomib (250-1 mol-mol),-0.4256415561025075
M-07e,135421197,0.940164437961766
SCC-9,71751553,4.89059631642312
TALL-1 [Human adult T-ALL],136227924,2.458144705929413
LS1034,1566236,1.869812205803379
COLO 201,100016,6.515418099212221
KMBC-2,2746,3.623005517857566
VM-CUB-1,9935249,3.9687808377617855
SNU-8,3854666,0.7475509647190202
HMCB,9911463,4.262652850494811
EFO-27,9884685,1.4230112837032636
NCI-H2023,sirolimus-bortezomib (250-1 mol-mol),2.707809534730406
SNU-216,tanespimycin-bortezomib (250-1 mol-mol),0.2069315895115227
HT-144,100016,6.638904024373049
SK-N-DZ,11152667,-1.5791240084386322
KMS-27,49836020,5.305149991763679
KMRC-2,9935249,5.014843219573403
WM983B,tanespimycin-bortezomib (250-1 mol-mol),0.7695231376052774
HCC2935,1566236,1.7440828651971758
NCI-H522,135984461,5.248212763135773
T-47D,sirolimus-bortezomib (250-1 mol-mol),1.0675161294174855
CA46,65628,4.372814936384242
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
NU-DHL-1,9926054,1.5745053582273782
SYO-1,9935249,3.6195972707875255
NCI-H2052,54639665,-0.9573654652535992
COR-L95,135659046,3.614564650544248
AML-193,4705,3.164558666224438
EKVX,136227924,3.396888883126824
DOV13,selumetinib-GDC-0941 (4-1 mol-mol),3.389057426499923
SIG-M5,136227924,2.112174988724855
HCC366,tanespimycin-bortezomib (250-1 mol-mol),0.9918173547189246
COLO 792,selumetinib-GDC-0941 (4-1 mol-mol),-1.2874205422493403
HCC1438,9926054,1.860816529304143
OE21,2742550,3.7946471320286568
SNU-423,65628,4.328235834084208
SUP-B15,44487872,6.366307642327811
MeWo,135421197,1.5459550604441452
HEC-151,3465537,1.222208329394757
BT 159,10322450,4.663429189765849
NCI-H1568,4705,2.022283964907955
JHUEM-3,135659046,3.4797526976334003
KMH-2,54618771,-0.6611868525273566
EJM,9926054,1.7534790705740089
TC-71,11494412,0.2670168299570634
MOTN-1,135398744,7.842138367791958
SU-DHL-4,11152667,-3.818519597612646
NU-DHL-1,3465537,0.9340526955418934
DV-90,136227924,1.3959750608222408
DB,10322450,2.48234404234163
NCI-H520,tanespimycin-bortezomib (250-1 mol-mol),0.1006968831130432
Detroit 562,3854666,0.8163843049251128
P12-Ichikawa,10322450,3.1626592716679376
BT 333,71751553,4.321215757704447
JMSU-1,9884685,0.9431200811659592
SCaBER,4705,0.4436742600385659
Hs 746.T,9926054,1.836274642391939
NCI-H292,9868037,4.01216306257403
LXF 289,11152667,-0.4789950074309144
ESS-1,9915743,1.8900363437156489
JHH-2,54618771,-0.1274840314711515
Namalwa,9884685,-0.9006349124358586
SNU-886,9911463,3.862708319776098
OCI-AML-2,10322450,2.967388898319709
HCC1438,6918638,1.5215576875890318
KMRC-1,11152667,-0.0604913513883814
SK-MEL-1,sirolimus-bortezomib (250-1 mol-mol),1.7691939182804728
IM95,9926054,1.717853214717972
KHM-1B,9926054,1.3720275885206477
HPB-ALL,73707386,2.26309628791615
YKG-1,11152667,0.85211892000732
NCI-H1355,selumetinib-GDC-0941 (4-1 mol-mol),2.7709082983519564
MDA-MB-361,54618771,0.6906132618662956
JHOM-1,100016,6.419236010839144
LXF 289,9926054,2.043368643335034
SF268,9935249,2.638287761328334
G-402,4705,2.98367942972675
NCI-H1944,6918638,0.6118472454485641
KMS-18,9884685,-0.1468040785790071
NCI-H1581,selumetinib-GDC-0941 (4-1 mol-mol),1.7228993365162983
OVCAR-5,3465537,1.473355824395234
NCI-H1792,3854666,0.9694263265646962
GSU,100016,6.3262103117900805
NCI-H460,54618771,1.6853262233131374
PE/CA-PJ49,3465537,2.6771043941056254
42-MG-BA,2746,3.593124420605687
SNU-C5,24779724,4.378944664444423
TUHR10TKB,9868037,2.493221827195661
Hs 888.Lu,11152667,-0.35178931009223
MOLT-13,100016,6.122983577816604
SU-DHL-10,100016,5.73425222116556
Rh30,2746,3.242991400457772
OAW42,6918638,1.325262653338047
639V,9911463,4.4419540135561
BT 333,54618771,1.0971803659169013
Namalwa,11494412,-0.23219160030294
HCC827,selumetinib-GDC-0941 (4-1 mol-mol),0.5704009597174646
KMH-2,9911463,2.975818602931934
DU145,2746,3.3697589984535528
CCF-STTG1,6918638,2.2635117256438835
SNU-449,sirolimus-bortezomib (250-1 mol-mol),1.1578809609780345
LNCaP clone FGC,49836020,4.788899602776088
BT-16,6918638,2.124835074302428
DMS 273,10322450,3.6367733537116167
LAMA-84,selumetinib-GDC-0941 (4-1 mol-mol),-0.0298835136014615
SK-UT-1,135421197,2.4956722116312813
HCC4006,4705,-0.7694526877641281
HEC-1-A,6918638,0.4637384706031703
BT 147,9868037,4.310170196853697
IGROV-1,9911463,4.195269991960018
SK-MES-1,10322450,4.30384017318748
NCI-H2141,2746,2.383841945459931
HDQ-P1,650361,3.658442619133936
LC-1/sq-SF,9911463,4.2961748372048465
NCI-H2228,sirolimus-bortezomib (250-1 mol-mol),2.3578690583328887
SW1573,10322450,3.835483834832597
NUGC-3,2746,2.5957810637319625
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
SK-MEL-24,3854666,5.129098369298213
Panc 03.27,4705,3.85101081283364
Pfeiffer,9915743,-1.0333729924514143
G-361,9926054,2.5235638278884687
T-47D,135421197,1.1997772280694294
MHH-CALL-4,135421197,1.0493029833886585
ECC10,9868037,1.7411053203163678
DND-41,9915743,1.2658570457354406
HuH-28,selumetinib-GDC-0941 (4-1 mol-mol),1.7329089617670326
JHUEM-1,65628,4.833015195333772
SF126,9868037,3.6473603445619
HCC1569,10322450,3.661738408949136
BICR 6,135984461,4.397394430442058
LOU-NH91,3854666,2.9087049696787544
SU.86.86,4705,2.6337462408918846
697,9935249,-1.5234929638841532
NCI-H1703,168313307,4.427466714189447
SNU-1033,9868037,4.1632978097237014
NCI-H2009,9926054,2.181635437582939
SK-MES-1,54618771,-0.0773843626642112
YH-13,9911463,4.412003433189975
MSTO-211H,135421197,0.8053711662366769
LCLC-103H,135421197,1.2256317024766628
COV362,2746,5.138153782003929
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
CCK-81,11152667,-1.7483684618349902
GA-10,9884685,-2.5713880970623397
HSC-2,11494412,0.0401305850858842
NCI-H838,3854666,0.8537044590791573
RERF-LC-A1,100016,6.9126876628990885
Hs 294T,2746,2.985563453462856
KLE,54618771,1.0287660425791825
KMBC-2,3854666,3.5091352093149455
NCI-H1693,100016,7.64063251702684
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
GA-10,135659046,2.94673518989487
G-361,9935249,2.9804954875301024
KMS-34,100016,4.459610626448404
SK-MES-1,135659046,3.5561232881246805
HCC1806,2742550,4.245484328514533
COR-L95,136227924,2.879022500990784
Granta-519,2746,3.996696473436098
UO-31,9935249,0.1849232731406093
NCI-H441,3854666,5.865964482686562
YD-10B,tanespimycin-bortezomib (250-1 mol-mol),-2.1326183945103807
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
SNU-899,9911463,4.136676393958991
C2BBe1,10322450,3.982412687303459
SK-N-AS,54618771,1.0154959522530718
RS4;11,1566236,0.9422336167179756
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
Karpas-422,2746,1.689970111701259
BT 228,9935249,2.295715399425516
Reh,135421197,0.7565283422785475
SU.86.86,11152667,-1.681749243998976
GI-1,11494412,0.5016309927416697
HEL 92.1.7,65628,4.01135306171132
PC-3,135421197,2.1784840639419154
PL-21,9926054,1.453737550570679
SUP-B15,11152667,-1.17456524958868
SU-DHL-8,9911463,2.7396964773709764
HLF,3854666,1.0114410413454975
SNU-869,4705,4.285651078954769
Li-7,9911463,2.7835624344387924
CAL-33,4705,1.086643830288211
SNU-213,tanespimycin-bortezomib (250-1 mol-mol),-0.03636038337738
HCT 15,54618771,1.4400117592771968
BHY,9884685,0.3882857047327643
UM-UC-1,4705,3.153349109118703
Capan-1,9935249,3.692856081858843
A-549,100016,7.181380121169662
HCC38,6918638,0.6464158254242791
BT 112,136227924,2.645928432247734
MHH-CALL-3,100016,3.61949081353442
NCI-H2141,9911463,2.830365569007881
SCaBER,9911463,4.265148583814743
L-428,tanespimycin-bortezomib (250-1 mol-mol),0.8418435976707451
K029AX,54618771,0.9903222324801182
U-BLC1,tanespimycin-bortezomib (250-1 mol-mol),-2.071210678838922
HCC1500,71751553,4.671922723370954
TALL-1 [Human adult T-ALL],2746,0.9231868013667444
PaTu 8988s,4705,3.38811272412219
HSC-2,9926054,1.7452128350759892
NCI-H1339,9935249,3.107250994389658
DND-41,65628,2.868103877059646
UM-UC-3,9884685,3.162644039126796
CGTH-W-1,54618771,1.2189927241974945
DOV13,2742550,3.93484873738036
J82,65628,4.2082293918109706
TC-71,1566236,1.8045860018031188
IPC-298,54639665,4.406895640456026
Rh41,3854666,0.4955024650837225
NCI-H841,selumetinib-GDC-0941 (4-1 mol-mol),1.7546401329299928
Mel Ho,54618771,0.7088013166832736
LXF 289,135398744,6.087135496005038
Kasumi-2,136227924,1.9658135956042504
BV-173,9884685,-0.0886667703066502
Daudi,1566236,1.0534301581716357
SU-DHL-10,3854666,1.8889758804883152
IGR-1,sirolimus-bortezomib (250-1 mol-mol),1.4068933313589211
SYO-1,11152667,-1.8766382672810296
Karpas-422,9915743,0.8862360651040179
YD-38,9935249,3.800527323611882
COV362,54618771,1.3077362978490088
JHH-2,6918638,0.332827130243307
Kelly,100016,6.527674974645037
CA46,9926054,1.6892727173627182
JeKo-1,54639665,4.459417646835938
Hs 683,6918638,0.9726484186750864
NCI-H2122,9935249,3.63066345559963
EFE-184,tanespimycin-bortezomib (250-1 mol-mol),1.3257452416243327
NCC-StC-K140,100016,6.431860837963816
FTC-238,11152667,-1.371306432474619
YD-8,2742550,3.780440690417096
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
RL,9935249,1.1595020386945936
HOP-62,11494412,2.9227878689679105
A-549,3854666,3.2699518455850964
M-07e,136227924,2.437184343955499
NCI-H838,9911463,3.605104029249328
COLO 320,9926054,1.5350415050718291
NCI-H1666,135659046,3.3700367762048877
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
RT-112,selumetinib-GDC-0941 (4-1 mol-mol),2.1504291571764287
CAL-27,11494412,-0.2612711655416662
NCI-H1944,136227924,3.273500409836235
BICR 18,9926054,1.7755527669372533
COLO 800,54618771,0.8952139014407665
KATO III,2746,3.141354246007229
EFO-21,tanespimycin-bortezomib (250-1 mol-mol),0.1444768142311704
PE/CA-PJ15,54618771,-1.2856394778285385
NCI-H2405,sirolimus-bortezomib (250-1 mol-mol),-0.6741915043369825
NCI-H1092,9884685,5.208907292159036
NCI-H2009,100016,6.24887408197215
U266B1,11152667,-1.464396016979744
KP-3,11152667,-0.1171632623198148
BC-3C,3465537,3.2940431181911447
FU-OV-1,11152667,-0.9879051128837576
SNU-601,1566236,3.2761403052312534
SK-UT-1,100016,6.311695779547894
SUP-B15,54618771,-0.7938935218437335
Hs 936.T,9926054,1.615791858991988
KU-19-19,54618771,0.4920305765445359
BICR 16,9911463,4.5254282277171045
DMS 53,10322450,3.0772263685237062
CJM [Human melanoma],100016,5.681499096329984
SCC-25,9935249,3.4774309357547413
GA-10,2742550,2.2253737438129564
MHH-NB-11,9868037,2.6095173563675065
K029AX,11494412,2.307806821374703
RCH-ACV,9935249,2.7024850725527165
JHUEM-3,135984461,1.6896934055741442
NCI-H2170,selumetinib-GDC-0941 (4-1 mol-mol),2.2424418004959654
QGP-1,54618771,1.891890541476157
MEC-1,135421197,0.4740815920241465
NCI-H1734,136227924,2.5893506458509634
SCaBER,136227924,3.000538162090115
OUMS-23,54618771,-0.8110473327008938
UACC-62,4705,3.53935768937283
NCI-H520,2746,2.5300013032729556
ZR-75-30,3854666,2.361916002626113
YD-15,54639665,4.469393901086846
SW1271,9868037,2.9396003878324857
Peer,9911463,2.710753746966499
JHH-6,tanespimycin-bortezomib (250-1 mol-mol),2.875959809379233
ZR-75-1,9926054,2.043336248210882
DEL,54618771,0.826392883586264
CJM [Human melanoma],4705,3.52697616396543
GMS-10,135421197,1.564647859858216
COV362,136227924,2.2847413829349947
BT 440,11152667,0.0173379430865997
SW579,1566236,3.6379170014502393
SNU-685,135421197,3.6677204832747976
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
SNU-738,11152667,-1.159018364842496
KMS-12-BM,9915743,-0.3780298011492129
HT-144,6918638,0.3712139680778337
SNU-C1,71751553,3.9915077218774506
LMSU,54618771,1.0017714306772694
EKVX,11494412,2.903225819111975
NCI-H1355,24779724,5.688705326978688
HCC1419,11152667,2.886444938310032
RT-4,54618771,0.6660630053371256
BHT-101,9868037,3.7978715471358218
KMS-26,9935249,-0.1717529790774238
NCI-H2009,9935249,4.414461781647313
MDST8,54618771,1.2096098448968695
Hs 683,11152667,-1.390521313969312
COV644,6918638,0.0395517386882894
HT-1197,11494412,3.79217525742206
RKO,9926054,1.883626680074333
CW-2,9935249,2.613016499199886
NCI-H322,1566236,4.003179609874178
NCI-H929,73707386,0.8452841513210776
HH [Human lymphoma],9915743,0.3869476104558722
COLO 792,9915743,1.202162575993562
LS1034,49836020,4.406866434657065
YH-13,9915743,2.529803461221303
NCI-H1651,9926054,1.9046490097522224
OCI-M1,10322450,4.213723369205614
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
JHH-1,71751553,4.253382088977832
MSTO-211H,136227924,2.717505566177341
LoVo,135398744,6.330186357549225
HuT 78,selumetinib-GDC-0941 (4-1 mol-mol),-3.8107077874530657
HPAC,9926054,1.8309217170446392
TUHR14TKB,9915743,0.9798821424990548
HCT 8,9935249,3.19275811412893
SW1710,9911463,3.971766424444902
OCI-AML-3,6918638,-1.4001290252615282
P31/FUJ,136227924,2.3905530687579497
NCI-H2342,9926054,1.8673615783954545
NCI-H322,sirolimus-bortezomib (250-1 mol-mol),2.3812461676498144
NCI-H810,2742550,2.3856132718749197
EoL-1,4705,0.6699610598370959
HuH-1,1566236,4.12950114237624
OV-90,selumetinib-GDC-0941 (4-1 mol-mol),0.0279948147357564
BT 359,1566236,3.822998836032952
NCI-H146,24779724,4.32606530761132
JVM-3,135421197,0.8439957558117435
OVCAR-4,11152667,-1.393586523711413
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
KYSE-450,135421197,2.3081928088852774
CL-34,3854666,0.1027491710141273
TE 617.T,9926054,1.7506239081922086
ES-2,3854666,3.173981203722866
SNU-738,9935249,3.575205918033142
LS513,10322450,3.234062312565812
BL-70,54618771,0.7229646502566096
BT 416,135984461,1.873658392465374
BT 187,4705,4.226067351518777
OV56,sirolimus-bortezomib (250-1 mol-mol),0.4454120384496641
NCI-H1666,9884685,0.2740886740036458
HT-1080,4705,3.343447730900498
PE/CA-PJ49,2742550,3.734489746257058
PaTu 8988t,11494412,2.1257430484232525
786-O,54618771,1.0235126095922562
NCI-N87,65628,4.009039012864223
MeWo,9884685,0.7659797455120133
NCI-H1944,3465537,3.2781251694419677
HEC-251,54618771,0.8830858807964597
NCI-N87,135421197,1.227136310912881
COLO 320,135421197,0.8671243277775497
BT 428,10322450,4.171296655818114
HCC1500,65628,4.452955395596753
KYO-1,2742550,3.984579842487294
SK-LMS-1,4705,3.2417588485362554
TE-10,3854666,1.0043229420232422
Calu-3,135421197,0.9816420613117603
TE-1,65628,4.452520498092532
TE-8,2746,1.7722164747559497
HD-MY-Z,10322450,2.950696163732152
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567
COLO 668,tanespimycin-bortezomib (250-1 mol-mol),-0.9107908194631724
HuG1-N,11494412,1.1145937703232094
RERF-LC-MS,136227924,4.560045704487339
NCI-H2110,49836020,-1.7351781152481929
42-MG-BA,9868037,4.648919905548912
BICR 56,54618771,-1.9015282957289323
OC 314,9915743,0.9289282136331763
HCC4006,11494412,-0.4064620911690372
BT 232,11152667,1.540463264489362
NUGC-3,9935249,3.7836037686670543
BT-16,3854666,1.5084254792866438
HCC1143,54618771,1.714955024233068
MDA-MB-468,6918638,1.4750739327280944
SNU-503,4705,4.54925442873891
KMRC-2,11494412,6.4606307205450015
KMH-2,65628,3.890017095144683
ACHN,sirolimus-bortezomib (250-1 mol-mol),2.4619171301455736
PaTu 8988s,2742550,4.064177152940504
DB,9926054,1.795775748692003
TUHR14TKB,11152667,0.3855019531264219
OE19,9915743,-1.6834349992839135
HEY A8,sirolimus-bortezomib (250-1 mol-mol),1.5777182717045015
NCI-H1793,135421197,3.9424142241593145
MHH-ES-1,135421197,0.9821303635644922
BT 245,4705,2.436380122563236
JK-1,135984461,2.6256690501392717
SNU-387,9935249,4.473593036706646
CAL-33,136227924,2.366373998099427
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
LCLC-97TM1,11152667,-1.9849905525936635
TE 441.T,135984461,4.21306533466607
MM1.S,54639665,4.38877596087519
COR-L88,100016,6.409850176158066
DU145,sirolimus-bortezomib (250-1 mol-mol),0.8074859592711968
NCI-H1651,selumetinib-GDC-0941 (4-1 mol-mol),2.159962931758626
SNU-601,2746,3.467999192841188
HOS,9935249,3.318859677592704
REC-1,54618771,4.304155025574206
DU145,136227924,5.593457102459236
RS4;11,9868037,1.846875847822728
SUP-T11,54618771,1.250827086156436
NCI-H446,136227924,3.5012378178100487
NCI-H441,11152667,0.8838707075861002
HCC366,selumetinib-GDC-0941 (4-1 mol-mol),2.581638032416284
CAL-62,3854666,0.7777912107790768
BxPC-3,tanespimycin-bortezomib (250-1 mol-mol),-1.7059064780517903
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225
U-937,10322450,3.569133925539397
NCI-H2141,2742550,3.0407478548544544
Hs 895.T,135984461,4.899016961012941
A-498,9935249,3.347418171794467
EB1,71751553,2.2286483741209593
BT 159,6918638,2.114216253864974
HCC38,9915743,2.4807170857977865
A-673,3465537,3.0102553460613626
CFPAC-1,136227924,3.3404294087361883
H-STS,135421197,1.21674084203813
AMO1,11152667,-1.6304517231581788
SK-HEP-1,54618771,0.9570801540222316
NCI-H2052,135421197,2.7850999570051003
HMCB,11494412,1.1725416400884527
CW-2,135421197,1.1852786816312322
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
SF268,11494412,0.8419965889075506
Hs 611.T,135984461,2.1518456912790507
TOV-112D,9935249,3.1679986881841384
U-251MG,2742550,4.085614396741507
PE/CA-PJ41 (clone D2),9926054,1.8762765503479524
OAW42,11152667,-1.0580201050498812
RL95-2,100016,4.898266673475204
647V,selumetinib-GDC-0941 (4-1 mol-mol),1.2881187017164255
MHH-ES-1,100016,6.165620846351705
HPAF-II,2742550,5.057683204128017
Hs 578T,1566236,1.5797547304061297
Lu-65,9911463,3.1807959522129905
TE-1,49836020,4.425156685624386
Hs 839.T,9911463,4.51823555869199
Daoy,sirolimus-bortezomib (250-1 mol-mol),0.3965851996199208
RVH-421,6918638,1.0964005679710755
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
OCI-Ly3,11494412,0.0579198080364928
EBC-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.174699743525061
AN3-CA,9911463,3.862780684019093
TUHR14TKB,11494412,4.3199141466237805
TM-31,11494412,2.439889324117589
J82,100016,6.509431143115434
IPC-298,3854666,3.3185631134579667
GDM-1,135984461,4.082680160500648
JURL-MK1,tanespimycin-bortezomib (250-1 mol-mol),-1.9568027387357825
SW620,100016,5.873144490676751
SNU-1214,11152667,-0.0787501334473708
COR-L51,11494412,-0.9719928446177656
COV434,9926054,1.0674163383843658
MKN1,9935249,3.838267685606268
SNU-668,tanespimycin-bortezomib (250-1 mol-mol),-0.1123433935372655
NCI-H2029,4705,3.1961427877566173
T-47D,71751553,4.80525405007375
NCI-H661,sirolimus-bortezomib (250-1 mol-mol),0.684217370363433
SU-DHL-8,65628,2.7455564974118283
SW1088,9935249,3.794327561663299
Kelly,9911463,2.836372345977174
IGR-1,9926054,1.7421331192656782
HCC1428,sirolimus-bortezomib (250-1 mol-mol),2.58650359596758
SNU-478,sirolimus-bortezomib (250-1 mol-mol),0.1595579698583019
RL,9911463,3.2834076821465525
LS411N,9935249,3.5378716054356927
EFO-27,11494412,4.723849828867172
JJN-3,135421197,1.2672654970884558
A-172,sirolimus-bortezomib (250-1 mol-mol),0.3443286616456003
SK-N-BE(2),135398744,6.372852995200929
Li-7,10322450,3.813696147876763
DB,6918638,-1.1770450338568663
NCI-H2141,54618771,0.6862443380441183
GCT,9926054,1.6553855879894792
SNU-1079,135984461,-0.6651362104222878
A-204,44487872,4.615233082071892
Hs 895.T,sirolimus-bortezomib (250-1 mol-mol),2.0562146171637723
COLO 320,10322450,3.382399386681384
Hs 746.T,2742550,4.150215272270972
TF-1,3854666,0.2073598853175925
PL-21,9911463,3.159423653145491
PE/CA-PJ34 (clone C12),3854666,0.7943523247128464
UACC-62,135421197,3.0810150127011773
SNU-8,73707386,4.786793714978147
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
EFO-21,4705,3.5117788930279037
HCC202,9926054,2.1190704993467917
CAL-85-1,11152667,-0.0969922195386295
IGR-1,tanespimycin-bortezomib (250-1 mol-mol),1.1267581666470343
OC 314,6918638,1.2645256695778866
BT 239,9911463,2.823437133731174
Rh18,54618771,1.0178435523811953
NCI-H716,2746,2.8210994981095556
PE/CA-PJ41 (clone D2),sirolimus-bortezomib (250-1 mol-mol),1.841699935420702
MDA-MB-468,9915743,-0.4692748619853074
Lu-65,tanespimycin-bortezomib (250-1 mol-mol),-1.7851341397947351
HCC-56,11152667,-0.9440233104098088
MEC-1,9935249,1.043041648413363
BT 359,selumetinib-GDC-0941 (4-1 mol-mol),2.125695165959512
BHT-101,tanespimycin-bortezomib (250-1 mol-mol),1.2601290483730383
T84,24779724,4.300698841519802
IGROV-1,9935249,3.330117761231163
RERF-LC-Ad2,135398744,6.529632870190649
TE-1,2746,2.3035924875170997
EJM,65628,4.064740748344536
SHP-77,selumetinib-GDC-0941 (4-1 mol-mol),3.697439866327475
HEL 92.1.7,135421197,1.9345150408297491
MDA-MB-361,1566236,2.7545211526059643
SNU-119,136227924,3.0573258202750253
L-363,9935249,3.3152136583481893
ONS-76,11152667,-0.1692604119623072
Hs 578T,9926054,1.6885826482167057
KATO III,tanespimycin-bortezomib (250-1 mol-mol),0.4150623185921985
NCI-H1734,9926054,1.950289426848977
NCI-H522,54618771,1.252244709003548
TE 441.T,9926054,1.7722508105545176
NCI-H1734,3854666,0.8618341531909581
KM12,selumetinib-GDC-0941 (4-1 mol-mol),1.4045070472454428
Rh41,49836020,4.456584836146854
DMS 79,9935249,2.9784415958919848
SNU-216,9926054,1.7628487898715297
SK-LU-1,3854666,3.216847376167724
TE-8,54618771,2.0990725036496123
BT 498,9935249,2.416260478208693
TM-31,11152667,-0.2010667394462257
HEC-1-A,sirolimus-bortezomib (250-1 mol-mol),1.0212510715684435
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
SNU-1076,54618771,0.3413327758331145
OVCAR-8,tanespimycin-bortezomib (250-1 mol-mol),0.6249256155417496
NCI-H2170,9911463,3.949150680542003
JIMT-1,9884685,2.6126732364530487
LK-2,6918638,-0.400750886877545
M-07e,9884685,-1.2688501325272783
MOLT-16,selumetinib-GDC-0941 (4-1 mol-mol),2.290963052000247
Ri-1,54639665,5.943871116773062
BT 333,9884685,4.2715186714197815
SNB-75,9926054,1.9842991929062104
CAL-148,9911463,3.7959797988422226
MOR/CPR,sirolimus-bortezomib (250-1 mol-mol),1.9515018462114049
KE-97,2742550,4.218678752457228
SF539,71751553,4.845342915681748
HH [Human lymphoma],3854666,0.2843191725884716
KM12,44487872,4.22383894781136
SK-N-AS,11152667,-2.6826642832146126
HCC1500,4705,3.1720127097688073
DMS 79,65628,2.0742410834649316
MES-SA,54639665,-0.0179563616855297
BT 172,2742550,3.366341904499679
CAL-85-1,100016,6.683113656599713
KMBC-2,9911463,3.851747430991294
KNS-42,3465537,5.419781734929303
5637,11152667,-0.8505052650270252
NCI-H2052,9911463,3.999991108260545
NCI-H2110,11152667,-0.5579192362236717
TUHR10TKB,9911463,3.273764915717201
SNU-886,9926054,2.2284003182480774
BT 422,54618771,0.9695029183446764
SK-MEL-31,1566236,2.849502480165651
BT 187,100016,7.76208292164505
NCI-H1869,136227924,3.4575085361719955
BT-16,135421197,1.2495545603041716
KHM-1B,2742550,3.1994406451662045
NUGC-3,3854666,1.9021354568285025
DU4475,1566236,1.1054290653888534
KO52,100016,6.24417827042609
BT 504,9868037,3.967723190943412
CHP-212,65628,3.7734320584498744
HT-29,136227924,3.5079295938152706
BT 330,54618771,1.126600316617638
GSS,10322450,2.8723971217143824
BT 159,135421197,3.0775929354078926
MOLT-3,11152667,-1.3348646255930374
HPAC,3854666,3.57580848834068
BFTC-905,9926054,1.624797844745876
VMRC-RCW,2746,4.068142110971067
COR-L88,135421197,1.3679822518227
OV-90,71751553,4.590877608444182
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727
Hs 944.T,11152667,-3.1279512985211264
BT 159,tanespimycin-bortezomib (250-1 mol-mol),-0.0268795114387354
SW982,135421197,2.997806489210206
RERF-LC-MS,1566236,3.687566928717542
Peer,54618771,-0.6256151799638473
NCI-H1435,11152667,-0.3527509280063574
SUP-M2,100016,3.7473632933772394
HT-144,2746,3.166634323430978
HuG1-N,1566236,2.07821046362843
NCI-H1373,9935249,3.3287555686276504
JHH-2,9935249,4.674458161367072
HT-144,11494412,2.967267605483665
NCI-H460,136227924,3.925006850615035
MOLP-8,10322450,4.082153801594249
8505C,135398744,7.128245503588914
GCT,selumetinib-GDC-0941 (4-1 mol-mol),2.439679750854635
SUP-HD1,136227924,3.4836971225000735
SF126,tanespimycin-bortezomib (250-1 mol-mol),0.701676185557571
BT 131,1566236,1.8547694675327384
NCI-H1373,54618771,1.0971026728505908
SK-MEL-2,9926054,1.8796163413954976
KYSE-30,3854666,4.258040109077401
SNU-8,11152667,-0.943436801192986
BT-20,54618771,4.093139907883374
WM88,3854666,1.7326705708463876
BxPC-3,3854666,3.4835595653471167
COLO 320,135659046,3.560187032006994
MDA-MB-157,9868037,3.2071579521245823
K-562,100016,4.034095210213227
GCT,49836020,-4.509787849566978
DU4475,4705,3.033607783661443
YD-10B,135421197,0.9932980294986136
RERF-LC-Ad2,71751553,4.725836068423468
SNU-449,tanespimycin-bortezomib (250-1 mol-mol),1.8616843727931585
Ci-1,10322450,2.8273692765810643
RL,10322450,3.279088357497389
MDA-MB-468,selumetinib-GDC-0941 (4-1 mol-mol),2.2484170521033437
SUP-HD1,6918638,-1.2091323464126156
SU.86.86,selumetinib-GDC-0941 (4-1 mol-mol),2.756391846899265
SW1990,11494412,3.8548639457314184
HMCB,100016,6.123582467992384
MOLM-13,9926054,0.378361077880871
NCI-H1944,9926054,1.887577830316648
TT,9926054,1.79906613528668
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
PE/CA-PJ49,9911463,4.148173895384107
HEC-151,2742550,3.8773994743488966
Hs 746.T,4705,3.427191561764603
U-251MG,3854666,2.7881952029693657
SR,4705,3.533585643751883
CAL-29,54618771,1.1722146209139084
EFE-184,9911463,4.31832221914332
HLF,11152667,-0.0932620413517799
NOMO-1,135398744,6.340708200805823
DU145,2746,3.3697589984535528
Rh18,49836020,4.886485383707075
COR-L105,135421197,1.9442341701951136
LMSU,100016,7.332455698517509
NCI-H1373,11152667,0.0475707209909377
BT 187,selumetinib-GDC-0941 (4-1 mol-mol),2.194213096235158
TF-1,135984461,1.7189308198167896
SUP-T1,9868037,1.5835878510828882
KLE,11152667,-1.6090314572433455
PE/CA-PJ15,135421197,1.0415253026449975
CAL-85-1,2746,3.013278075815884
KMBC-2,6918638,1.17976161020614
NCI-N87,54618771,0.8863121899707505
SK-N-MC,6918638,-1.6031189268800108
OCI-Ly19,3854666,0.5741249589427668
HDQ-P1,9911463,4.421902621869527
BT 112,9926054,1.759668872476805
NCI-H1341,9926054,1.7553356281022332
JHOC-5,54618771,0.913993677886488
OV7,6918638,1.9769978883441133
DV-90,9915743,0.0761455851411662
IST-Mes1,9915743,1.0557522455188102
CAL-85-1,1566236,1.6913877607653736
BT 328,9935249,3.0923830009934843
PE/CA-PJ15,71751553,4.310591125974167
HuNS1,6918638,-1.0677458393848085
DU145,11152667,0.2266180408489874
HPB-ALL,136227924,2.35435467065409
VMRC-RCW,3854666,3.082282497439221
AML-193,135984461,4.549999355322756
A-253,6918638,0.9016181172742443
SK-UT-1,136227924,4.460190875137593
SNB-75,9935249,3.3000208836374245
Karpas-299,49836020,-1.2149928929897504
769-P,9911463,4.323897233798415
HCC4006,9911463,4.4581598628848385
Panc 03.27,11152667,-1.218178075757916
MSTO-211H,9868037,1.9157833543052896
EFE-184,9926054,2.5194211419802723
OE33,1566236,1.7756816603120642
A-204,9926054,1.5825801354867326
Reh,100016,6.483959173055827
GI-1,sirolimus-bortezomib (250-1 mol-mol),0.2030703478127671
COLO 678,selumetinib-GDC-0941 (4-1 mol-mol),0.6470701140991139
G-401,sirolimus-bortezomib (250-1 mol-mol),0.0501690880033574
CJM [Human melanoma],65628,3.795572451400352
TUHR4TKB,2742550,6.429098286465402
HDQ-P1,11152667,-0.6891382364348575
JURL-MK1,135421197,2.4135031491286285
SNU-1079,135421197,1.0783376836912564
OCI-Ly19,9911463,4.156908261510834
MOLM-6,1566236,0.8087277514740788
L-540,9884685,0.8390068676478399
L-540,54618771,-0.836764308956379
NCI-H2023,9935249,3.058599334588111
ChaGo-K-1,11152667,-0.0716632534971208
NCI-H2286,11152667,-1.5906920747470763
DND-41,selumetinib-GDC-0941 (4-1 mol-mol),0.5695513725916952
OCI-Ly19,136227924,2.004549918496879
SU-DHL-1,135421197,1.1384736779813156
T24,11152667,0.7065000488555848
ES-2,136227924,4.099714373678264
KMS-34,9884685,-1.7176410454877906
BL-70,135984461,4.106594232964942
SBC-5,9926054,3.0567796435466628
NCI-H1755,1566236,3.4537013601829525
NCI-H2170,9926054,1.935868452223027
NCI-H2029,6918638,-0.2360985045568938
MV4-11,9868037,1.3692321377880616
G-292 clone A141B1,3854666,1.01270133207083
BT 147,tanespimycin-bortezomib (250-1 mol-mol),-3.7345384366794665
NCI-H23,6918638,-0.9097469315005928
NCI-H1869,9935249,4.228137987840005
CAL-148,11152667,-0.6834238334432461
NCI-H526,9915743,2.0217278226524606
Ci-1,9915743,3.2992367606729496
SNU-81,selumetinib-GDC-0941 (4-1 mol-mol),-2.7364127388649937
SNU-1033,135984461,1.7836640453843908
RVH-421,71751553,4.673213631952434
GCT,135659046,3.4332962928318893
BC-3C,2742550,3.812502027917897
SW982,136227924,1.7454954285641082
RD,2746,3.2035817097570334
NCI-H1105,3854666,0.1958522634475155
JJN-3,24779724,5.7356283726242
ESS-1,136227924,3.049003867547222
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189
SK-N-SH,11494412,-1.1686339817034832
NCI-H1092,2746,3.1114505923007583
NCI-H1341,9911463,2.510960457156186
HCT 8,9911463,3.550140199778626
IPC-298,2746,3.067568930900854
CHP-212,11152667,-1.2052121008957308
RPMI-6666,135421197,1.415232327318222
8-MG-BA,selumetinib-GDC-0941 (4-1 mol-mol),3.0365797378883843
MOLP-8,2746,0.9128995235322724
SNU-869,135421197,2.4475958723974944
NCI-H446,9915743,1.175250953167702
MEC-1,3465537,1.2385420929167623
BT 422,11494412,3.3460147450919338
SK-MES-1,2746,3.092337082097677
Kasumi-2,100016,5.973936097539331
CMK,3854666,0.1868583071129725
SUP-T11,11152667,-4.45703936760011
CAL-120,9935249,3.71206437331414
PE/CA-PJ15,11152667,-0.7034244137409247
Yamato-SS,9926054,1.8348633448645275
ESS-1,49836020,-4.193111027878734
697,65628,2.1818307162762154
JHUEM-7,6918638,0.5834631364682521
NCI-H1838,9884685,1.3772556691931654
LMSU,3854666,2.6863801842781863
OCI-Ly3,135659046,3.630790427153339
RERF-LC-MS,54618771,0.9955970244631366
HCC1195,9926054,3.439884423988142
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
G-292 clone A141B1,135984461,1.9916208334171763
LK-2,9911463,3.718268646522675
MDA-MB-157,10322450,5.067042624032479
NCI-H524,11152667,-1.4634752762077046
SNU-1077,100016,6.64200464659652
JHH-1,9935249,3.114168862925099
SK-N-AS,49836020,4.951261339623108
HCC15,54618771,1.6567762934530044
SK-N-MC,3854666,0.4857062806503081
SR,1566236,1.8681155468369743
SNU-466,3854666,1.364536343751292
SaOS-2,2742550,4.001711578380083
NCI-H1299,3854666,3.0957339105974766
HCC1954,9935249,3.6133875865094063
THP-1,sirolimus-bortezomib (250-1 mol-mol),0.3217250845673337
LP-1,1566236,1.2090017249909242
HDLM-2,135421197,3.3057353966925613
KU-19-19,3854666,3.1161318305167995
KMS-20,10322450,3.2597318465423353
Capan-1,selumetinib-GDC-0941 (4-1 mol-mol),1.801614812477531
KU-19-19,11152667,0.8748891502312
FaDu,2742550,3.976628077260584
HCC366,3854666,0.9176175755914344
SNU-308,11152667,0.4634525960285107
KMS-21-BM,tanespimycin-bortezomib (250-1 mol-mol),-3.1292569725831796
HOP-62,135421197,0.8812919220198131
BT 147,9884685,1.61150148213557
HCC78,9911463,4.271642559456931
Capan-2,6918638,1.8511012185183664
NCI-H2081,2742550,2.443856607923171
U-BLC1,135659046,3.900294549540867
HT-1080,3854666,0.7314496106684282
BT 245,135659046,4.182181998244751
SK-N-AS,sirolimus-bortezomib (250-1 mol-mol),0.1203472334672894
SNU-410,9868037,3.710526937668442
KP-3,tanespimycin-bortezomib (250-1 mol-mol),-0.1312023090499479
LOX-IMVI,100016,4.319089113839007
YD-15,9926054,1.8520578861045605
RKN,9926054,2.8101544562472056
NCI-H2087,10322450,3.569680650808545
COR-L51,9911463,3.8563370562199286
MOTN-1,9926054,1.7711575511093696
BT 216,135398744,6.476974321326381
SK-MEL-28,4705,3.074639735007158
NH-6,3854666,-0.2101261717672276
Peer,54639665,4.400120880800027
TYK-nu,9911463,3.540996784535568
AML-193,9915743,-1.3116324914766342
RS4;11,tanespimycin-bortezomib (250-1 mol-mol),-0.3918084072183652
MKN74,11152667,-0.1995571526819112
VCaP,135659046,3.61578581295777
MEC-1,65628,3.8656059442846664
BT 286,sirolimus-bortezomib (250-1 mol-mol),0.4309119586946818
KMRC-20,11152667,-0.0779110822248748
NCI-H69,54618771,1.222543289082317
SK-N-MC,100016,6.319948334432407
NCI-H526,135984461,1.6602336964556588
DU145,6918638,0.5820093502251232
COV434,selumetinib-GDC-0941 (4-1 mol-mol),1.0563079487833569
JHUEM-7,3854666,0.7941739350816123
OV7,9926054,1.9278544510999935
NCI-H838,11494412,1.0155710484012703
Li-7,3854666,1.2438113999786788
Namalwa,selumetinib-GDC-0941 (4-1 mol-mol),2.0079218875345015
Mel Ho,9926054,2.124486503190193
MDST8,9911463,4.372295154952754
T84,9868037,2.575833887310964
GP2d,65628,4.475000453671442
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
NCI-H1184,9926054,1.8119934997453773
KP-4,135421197,2.59268452027494
NCI-H1651,3854666,1.3633084002246365
ONS-76,136227924,2.542073211711186
Mono-Mac-6,9911463,2.1674354406749914
Kuramochi,9911463,3.7010026849827087
Calu-3,tanespimycin-bortezomib (250-1 mol-mol),0.4939757205414833
OCI-AML-3,10322450,2.261433742122515
HuCC-T1,11152667,0.3942846705957664
SNU-601,9915743,5.263014958216545
HD-MY-Z,9884685,1.0880914261328605
Caki-1,1566236,4.675917153008097
Mino,3854666,0.1564706607141011
MES-SA,3854666,1.035679794156088
A-549,tanespimycin-bortezomib (250-1 mol-mol),1.43915921498023
HuH-1,136227924,2.959438331398248
SJSA-1,selumetinib-GDC-0941 (4-1 mol-mol),2.9428552640575236
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073
OE33,100016,6.493432597771833
SNU-503,sirolimus-bortezomib (250-1 mol-mol),1.3381896958753263
TE-8,1566236,1.7989435705839352
NCI-H2106,73707386,2.2062547399893417
IST-Mes1,11494412,3.57589790392084
BT 286,136227924,1.3356746395497436
L-363,2746,2.0484035065398007
Hs 578Bst,9935249,3.016320926718586
MOLT-3,tanespimycin-bortezomib (250-1 mol-mol),0.0214957708571904
LCLC-103H,3854666,3.318934857088878
Hs 888.Lu,100016,7.863224005148367
RERF-LC-Ad1,selumetinib-GDC-0941 (4-1 mol-mol),2.261809192633126
BT 482,11152667,0.8832813821321016
AsPC-1,4705,5.582464580618905
COLO 800,2746,2.915316687123913
KYSE-180,selumetinib-GDC-0941 (4-1 mol-mol),2.772952616484782
K-562,9935249,0.8993678101188762
NCI-H2170,11494412,1.250336821961045
COLO 668,6918638,-0.3397215553853323
ME-1 [Human leukemia],selumetinib-GDC-0941 (4-1 mol-mol),0.4788349760990721
MOLT-13,3465537,3.8394867045029217
BICR 22,54618771,-1.5156377594303725
CA46,3854666,0.2733202158609283
Li-7,tanespimycin-bortezomib (250-1 mol-mol),-1.0040061775367006
OCI-AML-5,11494412,0.989113534938917
WT2-iPS,6918638,1.254016270163871
SF539,4705,3.4621418210440296
LCLC-103H,54618771,0.2983505798341654
COLO 792,71751553,4.132027532829227
COR-L279,6918638,-1.2783041826308352
ES-2,135984461,1.833276143203305
GCT,135398744,7.690422491741855
COR-L105,54618771,2.0419110046350135
PE/CA-PJ41 (clone D2),11152667,0.8748020996772465
BT 498,3465537,2.67100305933086
IGROV-1,135398744,6.402844237905131
NCI-H2106,44494148,4.415574771245799
K029AX,136227924,2.929460109593454
RCH-ACV,65628,2.7817124037332435
HCC4006,9915743,-2.0110769744346824
KMS-28BM,sirolimus-bortezomib (250-1 mol-mol),0.5815431662005854
OCI-Ly19,11152667,-2.422275512682942
CAL-51,11152667,-1.203722258692511
KHM-1B,54618771,-0.6219515555388266
SK-MEL-2,54618771,2.1400716929659045
HDQ-P1,136227924,3.063540067223108
SUP-HD1,11152667,-1.1328719651576526
JHH-4,11494412,-0.1349570760111059
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
2004,tanespimycin-bortezomib (250-1 mol-mol),0.7644529480942643
GSU,136227924,3.064976264970486
ESS-1,6918638,0.5362706870956574
BT 232,selumetinib-GDC-0941 (4-1 mol-mol),2.347635090849183
PC-14,selumetinib-GDC-0941 (4-1 mol-mol),1.0786711406515603
OCI-Ly3,100016,3.877117461004623
NCI-H1944,2742550,2.9262336519999903
BL-41,135421197,4.0056146501146195
786-O,71751553,5.395169035424641
SNU-81,sirolimus-bortezomib (250-1 mol-mol),1.681791395416448
SNU-C5,9935249,3.152183771231709
RERF-LC-MS,71751553,4.213964581210796
EJM,44487872,4.364141533871357
Pfeiffer,tanespimycin-bortezomib (250-1 mol-mol),-0.0267896609776724
KE-39,11152667,0.74958800909379
LMSU,selumetinib-GDC-0941 (4-1 mol-mol),1.8803724999664797
CAL-27,136227924,2.2169431722835324
HD-MY-Z,2746,3.1927944542914393
K029AX,100016,6.8355789955685395
SK-MM-2,9935249,3.5161188228318987
MDA-MB-435S,9926054,2.269822503715403
U266B1,9884685,0.3768710353905473
OCI-AML-3,49836020,4.587745933093821
Ci-1,135421197,1.276790754576014
YD-15,9935249,4.133669624082237
CHP-126,9911463,3.8708790519739593
OAW42,4705,4.623217521868117
DK-MG,selumetinib-GDC-0941 (4-1 mol-mol),2.430443160394254
MOLM-6,2746,1.449988915639522
ACC-MESO-1,11152667,1.137280520783936
SNU-175,selumetinib-GDC-0941 (4-1 mol-mol),0.0356628717912123
SW982,54618771,0.7299689874898085
Mino,6918638,-1.9893642721575304
JHH-2,135659046,3.3681644336140284
LK-2,tanespimycin-bortezomib (250-1 mol-mol),-0.1134545910607498
HEC-6,sirolimus-bortezomib (250-1 mol-mol),1.9105485577838577
SET-2,tanespimycin-bortezomib (250-1 mol-mol),0.2740236023779227
Ri-1,9935249,2.110817780838048
BICR 22,135421197,2.0438055763788556
ZR-75-1,selumetinib-GDC-0941 (4-1 mol-mol),1.5981380020167046
NCI-H647,135398744,6.542739498462596
NCI-H28,9915743,1.3436778069227204
COLO 800,135421197,2.3295817527143243
BT 145,tanespimycin-bortezomib (250-1 mol-mol),-2.391322475110553
OCI-AML-5,9926054,1.291118063021603
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
647V,135984461,4.277931256809204
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
Hs 895.T,54618771,2.243323536930484
KMH-2,9935249,3.3935783727628426
L-428,135421197,0.7073965487557408
NCI-H520,11494412,0.2940036385814875
Hs 294T,tanespimycin-bortezomib (250-1 mol-mol),0.0201287487075006
OPM-2,9935249,1.874633336412032
HT-144,9915743,2.253768741240734
SW579,3465537,3.040854051366811
NCI-H460,9926054,2.081701465030928
TE-4,tanespimycin-bortezomib (250-1 mol-mol),-0.9407472033022316
MOLM-13,100016,3.967621300341963
GA-10,10322450,2.465288440600798
JHUEM-2,65628,2.577248815747806
IGR-37,2742550,3.8549971974634465
ChaGo-K-1,1566236,2.038584840253616
OVK18,2746,3.0954313714228316
HT-1376,9926054,2.913590047827676
CCF-STTG1,11152667,0.6516582666822289
MOLM-6,136227924,2.6719988051227386
HuG1-N,selumetinib-GDC-0941 (4-1 mol-mol),-3.3555719378633375
HCC1806,54618771,-0.2864222176978986
BICR 22,6918638,0.0558003797401064
SCC-25,selumetinib-GDC-0941 (4-1 mol-mol),-0.1587136183503204
TE-14,4705,1.5857323028822543
RPMI-6666,6918638,-0.5773375343735736
HCC2218,2746,2.1275689170875847
OAW42,11494412,1.718292738866412
Kasumi-2,3465537,0.5812514796989715
BT 164,1566236,1.750997539979922
TE-6,selumetinib-GDC-0941 (4-1 mol-mol),3.56930262529698
SNU-738,3465537,3.666758159287323
NOMO-1,9935249,2.770043096032674
TUHR10TKB,2746,4.350875917891638
Hs 683,100016,6.526692615081327
NCI-H1563,11494412,4.208131510093767
JeKo-1,11152667,-3.245778632504348
OCI-M1,2742550,3.075796712533082
SCC-9,9926054,1.898935947612019
CGTH-W-1,sirolimus-bortezomib (250-1 mol-mol),1.647706898870075
Panc 03.27,9911463,4.350526382797422
Calu-1,11152667,1.3026694822022318
HPAF-II,11152667,0.3961380987480721
SUP-HD1,11494412,0.2707492633532761
ZR-75-30,2746,3.4802316913865563
LOX-IMVI,3854666,2.4185877249013368
SW1271,1566236,1.9677070098040983
NCI-H322,6918638,1.1027062108790242
KLE,65628,4.416189153864011
P-STS,135421197,0.9430476955578664
COR-L51,135659046,3.365467483108773
RT-4,9935249,3.446453833049965
IGROV-1,54618771,1.2456991772210466
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
PF-382,100016,3.957595275699552
HSC-2,sirolimus-bortezomib (250-1 mol-mol),0.058005047365845
RPMI-8402,135398744,6.9217830210823434
SW1116,9935249,3.7478471232466464
BT 444,tanespimycin-bortezomib (250-1 mol-mol),-3.2528888157944684
NCI-H1915,11494412,3.124487070451525
HPAF-II,136227924,3.1547615754637
OVTOKO,11152667,-0.2633474356550239
KMS-34,135984461,4.175936368885124
KP-4,sirolimus-bortezomib (250-1 mol-mol),1.5699611904925963
PLC/PRF/5,135421197,1.8500736721187756
NH-6,4705,3.0039103568475674
KP-N-SI9s,135984461,3.392026045664003
SNU-5,selumetinib-GDC-0941 (4-1 mol-mol),-0.1592396564326592
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791
HuP-T4,9935249,3.6458180171980223
IPC-298,135421197,1.9910993623388888
BT-20,4705,3.454921322809781
DMS 79,135421197,1.224509473614064
TE-15,1566236,3.006173949892504
DMS 454,10322450,3.6931379827732664
A2780,24779724,4.3340331177123765
CML-T1,tanespimycin-bortezomib (250-1 mol-mol),-0.4350289295501254
HSC-3,135421197,2.8710443540281756
SK-LU-1,3465537,3.809052717752696
HEC-251,100016,6.174926130166858
COR-L105,10322450,4.112392966182136
SUIT-2,9935249,5.647291906272881
RMG-I,9915743,0.3310978387400572
AsPC-1,135984461,3.722049898583642
NCI-H1395,6918638,1.485308761584704
RPMI-7951,2742550,3.350018850838408
KMS-20,49836020,5.970121389426133
HuG1-N,tanespimycin-bortezomib (250-1 mol-mol),-2.4884631877439207
MOLP-8,135984461,3.690365922940533
TCC-Pan2,135421197,1.46026769574307
BFTC-905,9935249,3.626324338446925
SUP-HD1,135984461,4.187192866644665
NCI-H1105,sirolimus-bortezomib (250-1 mol-mol),0.3147728445720161
Ku812,54618771,-0.0049031848150657
HuP-T3,4705,2.7233440783632608
TOV-21G,9935249,3.3191148876859824
KMS-20,9935249,1.026705986562312
HCC44,9926054,1.5614419320460398
Lu-99,54618771,-0.746886748911533
UACC-257,3465537,2.953755053311969
5637,9935249,3.304332904161991
Capan-2,11494412,4.291482697999069
Hs 852.T,9926054,1.891936574698373
IPC-298,1566236,1.913696221898385
NCI-H2126,9926054,2.0707718665056456
HT115,selumetinib-GDC-0941 (4-1 mol-mol),-0.4177192932655061
LoVo,54618771,0.7060685526757626
J82,tanespimycin-bortezomib (250-1 mol-mol),2.212384566230415
HCT 8,9884685,1.0209967056986369
LNCaP clone FGC,6918638,-0.3198952238594262
NCI-H520,3854666,-0.551991556599842
HEC-1-A,selumetinib-GDC-0941 (4-1 mol-mol),0.8454811422727944
SU-DHL-10,73707386,3.373609446995838
BL-70,1566236,1.7416130953011706
UM-UC-1,sirolimus-bortezomib (250-1 mol-mol),0.2883897871436763
COLO 829,tanespimycin-bortezomib (250-1 mol-mol),-0.6009535916354974
Calu-6,135984461,4.796785128617679
WM983B,3854666,2.4188126448912075
NCI-H2126,sirolimus-bortezomib (250-1 mol-mol),2.4996087284391493
OCI-AML-3,3854666,0.3450933416643372
BT 172,54618771,0.7743085294895093
MHH-CALL-4,3854666,1.9842302826736613
HOP-62,9868037,3.695700187533532
JHUEM-3,2746,2.584117066729092
DK-MG,11494412,1.0754842837417289
HPB-ALL,9911463,3.8574243217658215
NCI-H2009,3854666,0.912328636385412
CAL-51,3854666,1.1494535123186709
OVK18,9926054,1.8068809708246223
PE/CA-PJ34 (clone C12),10322450,3.5530253232214664
EoL-1,2742550,1.6225337364075894
A4/Fukuda,3854666,-0.0838776105349313
DK-MG,11152667,1.484854643077864
KMRC-1,9926054,1.768451409600443
HCC366,135984461,4.314156466102652
Karpas-422,tanespimycin-bortezomib (250-1 mol-mol),-0.3820258248934754
ME-1 [Human leukemia],54639665,4.516656391788249
HSC-2,9884685,0.5039874094801778
TM-31,tanespimycin-bortezomib (250-1 mol-mol),0.6359976993745172
SNU-1041,9926054,2.2828270152060623
LoVo,9915743,-0.8819018227786422
LS513,selumetinib-GDC-0941 (4-1 mol-mol),-1.1553983681711826
GSS,sirolimus-bortezomib (250-1 mol-mol),-2.7575012848094147
TCCSUP,65628,5.421928358435332
HCT 15,sirolimus-bortezomib (250-1 mol-mol),0.2078755227007766
NCI-H1915,3854666,3.460087345196579
NCI-H508,9911463,3.6080758528024055
SCC-25,135421197,1.688972609410465
PK-1,1566236,1.9563055032628711
NCI-H322,tanespimycin-bortezomib (250-1 mol-mol),-2.794682738050535
HEC-151,54618771,1.151174886462992
CCF-STTG1,9911463,4.668972921835481
MM1.S,100016,6.180279624553647
HCC1569,9911463,3.793678704328586
SNG-M,selumetinib-GDC-0941 (4-1 mol-mol),2.713078980516464
HCC44,54618771,-0.1525308444748626
TE 617.T,3465537,1.2174694198208424
TE-14,3854666,0.9160893400358509
Lu-99,9926054,1.653362823410905
Peer,135984461,1.6438359963470832
SK-N-AS,65628,4.296687684289776
SF268,2746,2.880766016506668
BICR 56,135421197,3.0441014153106893
SW1573,135421197,1.3915330004591782
C2BBe1,3854666,2.885406461282777
CHP-126,65628,2.6111837286845243
P3HR-1,9911463,4.040866432648006
OE33,sirolimus-bortezomib (250-1 mol-mol),0.234198569818553
KP-4,65628,4.537508539882641
Pfeiffer,44487872,4.230977727945689
LCLC-103H,11152667,0.8142627496272367
COLO 684,11494412,0.8693565994616046
HPAF-II,54618771,2.4967516753926216
WM88,2742550,4.1257519283830595
OCI-Ly19,tanespimycin-bortezomib (250-1 mol-mol),0.3425077317029711
KO52,135421197,1.227280721989531
LC-1/sq-SF,136227924,3.5583860131764835
TCC-Pan2,9935249,3.899374521003951
Fu97,3854666,1.01101706440742
HGC-27,65628,4.265310037500784
MDA-MB-415,9911463,3.632692855147505
BT 231,9926054,1.8669465776815437
AU565,71751553,3.982904849419344
HuT 78,71751553,4.273670469751914
SW620,tanespimycin-bortezomib (250-1 mol-mol),-2.1840810190060287
SIG-M5,3854666,0.6952699424052499
KYSE-520,136227924,3.1208401396418592
IM95,65628,5.771975961367952
U2OS,3854666,0.8117112929653146
NCI-H929,9935249,2.217272904882535
LCLC-97TM1,3854666,0.8191923722369518
MDST8,2746,2.514425635914287
SW948,54618771,1.4567685239775812
Peer,100016,3.808596484759728
BT 504,selumetinib-GDC-0941 (4-1 mol-mol),0.4660055972927751
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
HCC44,100016,5.500199899639815
KMS-27,11152667,-0.6309596217329284
COLO 800,9915743,1.5977279916979588
IST-Mes1,54618771,0.8929247318821524
MHH-CALL-3,136227924,2.519521666896543
SR,selumetinib-GDC-0941 (4-1 mol-mol),2.945554798995567
NCO2,73707386,2.320986142131463
BT 147,3465537,1.2508282611469033
NCI-H727,136227924,3.2179651731130585
UM-UC-3,135421197,1.7291544564806811
BT 444,6918638,3.2929194636283023
EoL-1,54618771,-1.3490437314976569
OC 314,135421197,2.0874935264790646
GA-10,9926054,1.7130115486469382
NCI-H2170,3465537,3.4509317418058383
BT 139,sirolimus-bortezomib (250-1 mol-mol),1.2497154154601016
KO52,3854666,-0.4105607896605044
MFE-296,9868037,3.862165464380283
Panc 03.27,135984461,6.251236630594111
HSC-3,9915743,0.268265478867946
Malme-3M,49836020,-0.4276181558524726
EBC-1,sirolimus-bortezomib (250-1 mol-mol),-3.1620626490759633
JHUEM-1,11494412,0.6922251980518859
OVSAHO,11152667,2.3243832570578236
MEC-1,10322450,2.616136352285943
OPM-2,9915743,0.7579871544404475
LNCaP clone FGC,3854666,0.694335956852511
BT 428,9884685,1.1692312726776757
BHY,11152667,-1.171892891477289
SNU-1,135421197,1.7958722609417297
Hs 578T,9884685,-0.940364062265686
COR-L95,11494412,1.7619372096243109
NOMO-1,9884685,0.4754269892492985
PK-45H,54639665,4.450076753179179
Hep 3B2.1-7,54618771,-0.219926675598239
Hs 683,11494412,0.4021600423895013
MOTN-1,135984461,3.8565361151501585
SR,2746,2.1071904113131392
IGR-1,9884685,1.9069100613698544
BT 179,selumetinib-GDC-0941 (4-1 mol-mol),2.518966795971957
HOP-92,71751553,4.539782001552626
KP-N-SI9s,9915743,0.2181439527436794
A-375,11152667,-0.6556318193430793
NH-6,9884685,0.8141539195615259
VMRC-RCZ,135984461,4.612343951091238
HEY A8,24779724,4.871747298777593
SH-10-TC,135421197,2.8631167309091556
JL-1,11152667,0.7661061138281205
RL,54618771,1.0204483724933282
PC-14,54618771,1.2873092129984136
RD,3854666,0.8250746000487614
HCC95,9911463,3.4166261837623098
EKVX,2742550,3.9948619425475607
PaTu 8988s,2746,3.571987596167747
U-118MG,4705,3.313386331825358
MES-SA,10322450,4.209540173303182
CCF-STTG1,1566236,4.223986774063583
SK-MEL-31,sirolimus-bortezomib (250-1 mol-mol),1.406107901853138
P12-Ichikawa,9911463,3.30531247754742
CAL-148,9915743,1.3006857721800915
KMBC-2,49836020,0.1766293750985906
MPP 89,sirolimus-bortezomib (250-1 mol-mol),1.5945655725799224
MIA PaCa-2,sirolimus-bortezomib (250-1 mol-mol),0.2138092716811536
YAPC,11152667,0.3482753398657929
KO52,9915743,1.1549502462375985
JHOS-2,136227924,2.6850771580880783
L3.3,135398744,6.452563021638662
KYSE-30,2742550,3.649677885996823
JeKo-1,10322450,3.378353270661745
KMS-21-BM,9911463,2.539829104515626
SNU-119,9884685,1.7075636021097025
SK-MEL-24,9884685,1.802642811189954
COLO 668,9911463,2.6985000382715567
HCC827,sirolimus-bortezomib (250-1 mol-mol),1.7939037148295924
COV644,4705,3.798670959115779
Kelly,136227924,2.280835674454857
Hs 746.T,3465537,2.483002821893036
DU4475,2742550,2.301558915295113
JHUEM-7,selumetinib-GDC-0941 (4-1 mol-mol),0.8303698152358163
Reh,11152667,-1.6622100649738478
8-MG-BA,65628,4.1211650686240615
Mono-Mac-1,sirolimus-bortezomib (250-1 mol-mol),-0.8446882860578903
SR,9935249,3.2977617807698127
SNU-626,sirolimus-bortezomib (250-1 mol-mol),0.2861431467696579
KMS-18,10322450,4.373704561545144
TE-5,9915743,-0.2115886110471379
AsPC-1,11494412,3.580103428724827
Mel JuSo,135421197,1.941691146031138
Hs 944.T,9868037,2.6864916829697703
HCC38,71751553,6.251019673223731
SK-N-BE(2),9915743,0.2330456921975308
UACC-257,9911463,4.265034719630062
SNU-449,100016,6.350050439021361
IGR-1,2746,1.8985150610888328
HCC1195,9911463,4.371247220655063
F-36P,136227924,2.476842028434826
Hs 888.Lu,selumetinib-GDC-0941 (4-1 mol-mol),2.177806274579951
GSS,54618771,-0.6166501734641827
RPMI-7951,54618771,0.8844591471525661
Kasumi-2,6918638,-1.1951505869280743
SK-BR-3,tanespimycin-bortezomib (250-1 mol-mol),-1.1582465529639416
NCI-H2052,9926054,2.624833706657142
SK-MEL-28,9926054,3.4888277398466765
Mel Ho,sirolimus-bortezomib (250-1 mol-mol),-0.1905502812400849
OE33,tanespimycin-bortezomib (250-1 mol-mol),-0.7700127207654934
CML-T1,65628,2.7154825762494057
Mino,11494412,-0.5549437780850603
BT 440,tanespimycin-bortezomib (250-1 mol-mol),-2.7167133192176394
ACC-MESO-1,sirolimus-bortezomib (250-1 mol-mol),1.905625687431691
MOLM-16,11152667,-1.9263651409287528
CAL-12T,135421197,3.5670485271085868
NCI-H2452,100016,6.6405878618594985
Ri-1,9926054,1.5974379061435915
DOV13,10322450,3.678402258814296
NCI-H1915,2746,2.498380618372834
SNU-1196,3854666,3.3332348606215376
MOLM-13,73707386,2.881964792667641
BV-173,24779724,4.291946466896556
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631
SIG-M5,2746,2.071797250841479
BEN,54618771,1.4690006980639003
OE33,135421197,1.9963159792783505
HOP-62,71751553,4.571888658933869
Hs 888.Lu,9911463,4.373380817731519
MDST8,135984461,4.124255066625015
HCT 8,sirolimus-bortezomib (250-1 mol-mol),1.4500182233315906
PaTu 8988t,136227924,2.49705731140334
RL,3854666,0.4036099146730044
H-STS,sirolimus-bortezomib (250-1 mol-mol),0.1241794019468204
G-401,24779724,6.361263224396382
SNU-1196,54618771,1.539198282600217
BT 159,selumetinib-GDC-0941 (4-1 mol-mol),1.265249520396083
CCF-STTG1,2746,3.7135967128071385
KYSE-70,135398744,6.338938630156892
UO-31,3854666,1.8037632230339509
TE-8,2742550,4.06449029872564
MDA-MB-468,49836020,3.927183487044253
HCC15,9911463,3.642862209488471
NU-DUL-1,3854666,-0.2985589643704558
UM-UC-1,11152667,-0.6873058456507053
MFE-296,3854666,1.1807177077248874
SNU-601,selumetinib-GDC-0941 (4-1 mol-mol),-0.2622654032095929
PSN1,135984461,4.283628399888077
NCI-H1793,9911463,3.76780025503232
Rh30,3854666,3.1387459352284752
LS123,9915743,1.0126339899264374
RCC10RGB,9935249,3.9754060705766943
Sq-1,4705,2.78304746157314
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179
SK-HEP-1,3854666,3.0622551399292264
BT 422,135421197,2.465319301073433
MOLM-6,3854666,0.1170601989372903
BT 428,2746,2.3155764073240177
NCI-H1568,54618771,0.8004506686595156
RPMI-8226,136227924,2.992898649350054
AML-193,71751553,5.520545246875898
Rh18,4705,2.954039930023468
8-MG-BA,sirolimus-bortezomib (250-1 mol-mol),0.8530432118926453
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
BT-20,2742550,3.667982838644888
SW579,11494412,0.7321590256226097
U-937,selumetinib-GDC-0941 (4-1 mol-mol),2.5351871004530713
DU4475,9884685,-0.0580970001953044
TE-15,9915743,-3.4156269103241605
SK-MM-2,tanespimycin-bortezomib (250-1 mol-mol),1.2255908255092252
HEC-1-A,9884685,0.2654955927517619
TALL-1 [Human adult T-ALL],73707386,2.325158531134017
LS180,9915743,2.834892961755663
Hs 294T,135421197,2.57319967501113
BICR 56,6918638,0.6328735578862519
HSC-2,3854666,1.2957927638907802
NCI-H2087,100016,6.366125554898137
Hs 746.T,100016,6.2249168538435
U2OS,9915743,-1.5669717520878548
786-O,2746,3.398389202890904
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062
TE-11,9915743,-1.3132877910831091
NCI-H1299,sirolimus-bortezomib (250-1 mol-mol),1.6380242614391785
PE/CA-PJ49,selumetinib-GDC-0941 (4-1 mol-mol),0.8657642866761842
Panc 04.03,2742550,4.347188786942969
Hs 688(A).T,9868037,5.465863970600614
TT,54618771,0.4529536382950971
HuP-T4,100016,6.7159168289197915
PF-382,9915743,0.1930622386086079
Panc 04.03,2746,3.3610494767062513
TUHR14TKB,54618771,1.495898324291793
SNU-478,9926054,1.8304489551937344
A4/Fukuda,4705,2.104501352907832
BT 286,71751553,4.3381123592050015
KMS-20,24779724,4.331285550613222
HT-1197,2742550,3.6280622418897743
COR-L105,9926054,1.7310748902984938
A-673,9884685,0.1604809562987641
Hs 611.T,2742550,3.744335328422511
NCI-H747,135984461,2.203794550549454
KMRC-1,sirolimus-bortezomib (250-1 mol-mol),0.3840144129269961
LNCaP clone FGC,2746,2.220031738697338
BT 179,9926054,2.969670240545962
HCC827,54618771,-0.2286942378672794
HuP-T4,9911463,3.108892921619022
TOV-112D,2746,3.3421101516838445
SNU-503,135421197,3.1341230661682125
RCH-ACV,2742550,3.694340545440027
DV-90,6918638,-0.7904486688735644
Hs 888.Lu,3854666,2.6256598468811903
Hs 766T,71751553,4.306792933444251
RS4;11,9915743,-0.3402304070794544
WT2-iPS,135659046,3.296193945470927
NCI-H2085,1566236,1.816648295053065
L-363,100016,4.553463106890726
BT 164,11494412,1.7024726353165465
CJM [Human melanoma],11494412,0.950200915557512
DMS 454,9915743,0.9542388658928032
SF268,9911463,3.2093311468755843
Panc 04.03,135659046,3.760242578723066
TE-14,selumetinib-GDC-0941 (4-1 mol-mol),1.037456532239161
MKN45,136227924,3.646033724215572
KMBC-2,9926054,2.0094384239747294
HCT 8,71751553,4.527245038842783
EBC-1,136227924,2.637152829802991
NCI-H889,1566236,1.5127666053152062
ALL-SIL,49836020,-3.56746653346715
CMK,65628,4.289383545384549
MEC-1,9915743,0.3780873784747607
KMS-21-BM,2742550,2.736475414851647
Mel Ho,3854666,0.8589361448710405
RERF-LC-A1,tanespimycin-bortezomib (250-1 mol-mol),-1.931734288189376
Mono-Mac-6,9915743,0.3878185063656593
JK-1,136227924,1.8733417156502243
H-STS,9911463,3.056276034663577
NCI-H2444,9868037,3.8466322726518256
NCI-H526,9911463,4.043981545768548
PE/CA-PJ34 (clone C12),135421197,2.056271924404355
MDA-MB-231,2746,3.4899061229386965
MKN74,selumetinib-GDC-0941 (4-1 mol-mol),2.4361199969634924
FTC-238,selumetinib-GDC-0941 (4-1 mol-mol),2.3347122521245396
SNU-1214,selumetinib-GDC-0941 (4-1 mol-mol),-0.7739258064747034
NCI-H1755,54618771,-0.2834105943747247
BT 248,9935249,2.246614582121965
TF-1,11494412,-0.2484952250511907
SW579,44487872,4.882887167101439
CAL-27,9884685,0.5318876769597282
EoL-1,tanespimycin-bortezomib (250-1 mol-mol),-1.822520413880902
JHUEM-1,10322450,3.3656679927658213
SK-MEL-3,2746,3.317338205228237
Karpas-422,9884685,-1.8579964706591168
BT 187,tanespimycin-bortezomib (250-1 mol-mol),-2.6862986394516453
MES-SA,4705,2.820968448326189
LXF 289,9935249,3.315625346230847
EoL-1,65628,1.668421818220866
BC-3C,6918638,1.5868731043226476
LS123,selumetinib-GDC-0941 (4-1 mol-mol),1.252033053606901
SUIT-2,136227924,3.4861054974924133
NCI-H69,sirolimus-bortezomib (250-1 mol-mol),0.0331466406346395
NCI-H1650,selumetinib-GDC-0941 (4-1 mol-mol),2.5973614834330965
L-540,9935249,3.0305830105986
F-36P,2742550,3.2568507775815525
AU565,11152667,-0.8659767610796402
BICR 56,1566236,3.6638637762846993
KMS-11,sirolimus-bortezomib (250-1 mol-mol),-4.474522876358157
U-937,135659046,3.9710319401622063
OVCAR-8,135398744,6.524120777237468
BHT-101,135421197,3.464281402199008
NCI-H322,9911463,4.3692718252233895
CAL-27,9935249,3.0508585770185817
COR-L105,135984461,4.336047626093702
A-549,11152667,0.4045052003861268
BxPC-3,selumetinib-GDC-0941 (4-1 mol-mol),-1.450319129285142
NCI-H1944,tanespimycin-bortezomib (250-1 mol-mol),-2.853694695712997
KMS-11,136227924,2.4847849493179406
NCI-H929,49836020,2.30560189930029
K-562,9915743,1.457381054045144
BT 145,1566236,1.6358239953164144
U-118MG,2746,3.48796975848492
NCI-H2081,sirolimus-bortezomib (250-1 mol-mol),-0.0413699313219798
NCI-H2023,100016,7.201065180404722
KMS-21-BM,135421197,0.9217420053482288
Karpas-299,sirolimus-bortezomib (250-1 mol-mol),-3.935889732903339
OV-90,65628,5.030482917460489
SNU-5,11152667,-1.9781629384593116
SNU-213,54618771,0.1807958320323681
P3HR-1,9911463,4.040866432648006
NCI-H358,sirolimus-bortezomib (250-1 mol-mol),1.7482633742638032
P12-Ichikawa,tanespimycin-bortezomib (250-1 mol-mol),0.3962036190597272
HD-MY-Z,135421197,1.63491304477545
NCI-H838,sirolimus-bortezomib (250-1 mol-mol),0.8112840650122598
PLC/PRF/5,selumetinib-GDC-0941 (4-1 mol-mol),2.3628622666013683
RS4;11,73707386,2.6897318309889577
G-401,9926054,1.744192331951833
NCI-H2085,9935249,3.511786264079395
EFO-27,135659046,3.7618075322397297
KE-39,3465537,4.350124533164427
J82,1566236,4.508340274654256
JHOC-5,100016,4.009706795291197
G-401,54618771,0.8582285882331511
PC-14,2746,2.459398202696394
Capan-2,71751553,4.720349798394505
Lu-65,71751553,4.665406208764287
MG-63,100016,6.791496028485962
SF539,11152667,-2.173581814614824
NCI-H526,100016,5.298819017471169
K029AX,9915743,0.8984841793104903
769-P,sirolimus-bortezomib (250-1 mol-mol),0.7451378442227841
GCT,100016,6.941224948418202
BT 416,71751553,3.5669452232202317
COV644,tanespimycin-bortezomib (250-1 mol-mol),2.484857024985863
MEC-1,6918638,-1.2393643982661684
M059K,11152667,0.916806350052847
NCI-H2081,3854666,0.2078847774714705
NCC-StC-K140,3854666,-0.5733064353695863
U-937,9915743,1.290945765650766
TALL-1 [Human adult T-ALL],4705,3.508136996580395
NCI-H292,9911463,4.207043029649759
Hep 3B2.1-7,sirolimus-bortezomib (250-1 mol-mol),1.2691143155253628
NCI-H1355,9935249,2.9372219822756658
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
SUIT-2,135421197,1.9421505415119584
SK-MM-2,2742550,4.185293113762589
SF539,54618771,0.9520052550930058
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
KP-N-YN,2746,2.243582059323954
SCC-4,650361,3.7059662115412
AU565,9884685,0.3686008824574254
T3M-10,71751553,4.991092560172867
U-937,tanespimycin-bortezomib (250-1 mol-mol),-0.8253884714136634
TALL-1 [Human adult T-ALL],2742550,2.976976720806849
HT-55,9935249,3.3600824224650836
SUP-T1,135984461,2.153486266323967
HT-1080,100016,6.676268064255503
KYSE-70,9935249,3.427959003246725
NCI-H2452,9926054,2.7849990975548726
5637,selumetinib-GDC-0941 (4-1 mol-mol),0.4079577317339777
Ci-1,3854666,0.556588581107643
Yamato-SS,71751553,4.380711104717213
JHH-6,10322450,6.3752081259808415
A-498,135421197,2.4500558267656873
HCT 15,100016,6.694419225032017
HCC1806,tanespimycin-bortezomib (250-1 mol-mol),-1.018724698872974
BT 271,3854666,0.015916515144646
KYM-1,11494412,0.4173722915158559
COLO 205,sirolimus-bortezomib (250-1 mol-mol),2.1268339041997457
NCI-H446,135984461,1.479932164265367
SK-BR-3,136227924,2.8779705448471975
TYK-nu,49836020,4.345378886251337
KATO III,selumetinib-GDC-0941 (4-1 mol-mol),2.4282234364089863
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
NCI-H1299,9935249,3.5547957097116143
FaDu,10322450,3.9560507258071422
A-375,9915743,2.060034252561476
KYM-1,71751553,4.9624941614458935
TUHR10TKB,tanespimycin-bortezomib (250-1 mol-mol),1.8838456132179628
HCC2108,9926054,2.5765466804926445
697,135984461,1.702307522694506
OPM-2,65628,4.597670741376445
SF268,9884685,0.6614241142301136
COR-L47,tanespimycin-bortezomib (250-1 mol-mol),1.2425942007865165
BCP-1,11152667,-1.2520018158393194
A-253,71751553,5.043913374031373
SNU-1033,9935249,2.812235160690358
SW620,3854666,2.758810632628281
BT 172,9868037,4.137588031447499
JHOC-5,9935249,3.6862671571619225
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
BT 228,135421197,1.0231801193279042
HOP-92,11152667,0.0194334457460503
EoL-1,44487872,4.166402657118513
MDA-MB-435S,9935249,3.4809324238867863
SUP-B15,135398744,6.752582090660733
HEL,9868037,2.50949616555346
C2BBe1,1566236,2.772139102612497
NCI-H520,sirolimus-bortezomib (250-1 mol-mol),-2.273461177298922
OE19,9911463,4.190839758314233
MES-SA,9926054,1.7710161106499946
OVK18,11152667,-0.6962973198109103
SNU-16,49836020,4.5096990404507125
HEC-251,sirolimus-bortezomib (250-1 mol-mol),1.5826018331734562
MOLT-3,10322450,4.054866374407206
Ishikawa (Heraklio) 02 ER-,3854666,1.1543280454894709
NOMO-1,sirolimus-bortezomib (250-1 mol-mol),-0.7938299836559928
HEC-251,3854666,0.8388050556715588
OAW42,9884685,1.2574804791084064
SNU-668,136227924,2.8591825047695925
Panc 02.03,9935249,3.920507280118285
SNU-61,136227924,2.341371828887226
MOTN-1,9884685,4.168868767853732
NCI-H1299,9911463,4.155040762407167
OE21,1566236,3.330797910783387
OVTOKO,selumetinib-GDC-0941 (4-1 mol-mol),2.323282098150216
TE-8,135984461,3.955481797487968
MOLM-6,73707386,1.8712602450547513
Karpas-620,4705,3.7367070326716982
NCI-H2009,11152667,-0.3244172236423036
TUHR4TKB,3854666,3.4631850286996717
DMS 273,54639665,4.46621146803559
LNCaP clone FGC,11494412,0.5135445267768279
NCI-H661,9915743,-0.8538809858854721
RPMI-7951,3465537,-0.2413225331247042
Caki-2,9911463,4.333503624350426
COR-L279,9911463,3.362678282511464
NCI-H1792,9911463,4.29249161845891
LS123,9926054,2.1967740903619934
NCI-H358,2742550,3.487810889438015
NCI-H446,65628,4.365743972833802
COR-L105,4705,0.5312031062005766
OV7,54618771,3.08705703189789
NCI-H508,11152667,-1.4790798242730578
JHUEM-2,54618771,-0.9670015993235072
Hs 895.T,6918638,1.92517171748629
HT115,3854666,1.4354847640217934
SK-BR-3,selumetinib-GDC-0941 (4-1 mol-mol),-0.2707280025522744
CGTH-W-1,9884685,1.4891158923193792
OCI-Ly10,135421197,1.9634913874205968
Namalwa,9915743,0.490557645352366
OVCAR-8,54618771,0.8925254662704427
A-549,135421197,2.4799819746704075
PLC/PRF/5,135659046,3.5172360380546084
SNU-869,selumetinib-GDC-0941 (4-1 mol-mol),1.3245686314727811
SNU-1033,49836020,1.7840304926095434
JVM-2,3465537,3.696111807069497
COR-L95,2746,2.78697970441755
MJ,2746,3.266657890633373
NCI-H727,9926054,2.0492739470784445
HuP-T4,24779724,6.099439934888711
VM-CUB-1,9884685,0.5597863495737894
SK-CO-1,9915743,2.0474134916136184
BT 112,135421197,2.023572470173789
MES-SA,9911463,4.310178106628171
MOLT-13,9868037,1.8039325171319247
MOLP-2,11152667,-1.802656645325623
COV362,135659046,4.956551237170632
SUIT-2,54618771,1.0369427055295135
HT,selumetinib-GDC-0941 (4-1 mol-mol),2.035866243674196
HPAF-II,tanespimycin-bortezomib (250-1 mol-mol),0.3261912422307886
TM-31,sirolimus-bortezomib (250-1 mol-mol),0.5260626662043751
HL-60,9911463,4.3879479306105535
SF539,9935249,2.423475425325452
SNU-8,100016,6.375529183181613
SK-N-AS,6918638,-0.3067046964839828
BT 330,9935249,0.442722317267438
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
MHH-CALL-4,2746,0.6611792988086074
SR,9926054,1.591402599592269
CAS-1,11152667,-0.3875255691229622
NCI-H2023,selumetinib-GDC-0941 (4-1 mol-mol),2.6884050561180253
NCI-H28,2742550,3.992303917650692
U-937,2742550,3.439530464441688
SW1353,54618771,0.8265365902772687
SIG-M5,tanespimycin-bortezomib (250-1 mol-mol),-0.3458205812117419
NCI-H520,9915743,1.4167224147327635
HGC-27,tanespimycin-bortezomib (250-1 mol-mol),-1.4262734798711498
BT 428,9915743,0.3842410251142636
OCI-Ly3,tanespimycin-bortezomib (250-1 mol-mol),-0.0739277067008881
BT 224,11152667,1.4221978666724842
UACC-257,9915743,3.2321822894615546
BT 440,71751553,6.044533690123534
SK-LU-1,1566236,3.629821638142186
NCI-H2081,136227924,2.7498424735477913
NCI-H1694,54618771,0.8096670876443307
HuP-T4,135421197,1.5998853236041033
BHY,3854666,2.882550341834236
BT 330,6918638,2.094290704712354
Panc 04.03,sirolimus-bortezomib (250-1 mol-mol),1.3597378595777716
OAW42,2746,4.654777781524689
EKVX,24779724,5.209041273813266
HCC1500,9915743,1.9340540182592263
HL-60,9935249,1.0070236847489953
SNU-1105,54618771,1.067302549999792
DU145,135421197,3.2080942542888056
SK-ES-1,9911463,3.761079792155382
OVCAR-8,2746,3.926071578453057
SUIT-2,54618771,1.0369427055295135
DMS 53,3854666,0.9054182301635644
UACC-62,9935249,3.01689471253563
SNG-M,11152667,-0.3247836343382136
HMCB,1566236,1.7394312384979265
SK-LMS-1,1566236,1.8712285641000048
EN,sirolimus-bortezomib (250-1 mol-mol),1.0494581662942
RL95-2,11152667,-0.8669097015904319
BFTC-909,54618771,2.8225313881877545
MEC-1,11494412,0.0986564081761275
Aska-SS,11494412,1.6723137258667875
NCI-H1339,9915743,3.628924415446368
SNU-601,11152667,-3.2024778673902254
HuH-1,9911463,4.24697261954459
AU565,9935249,2.085801217703038
Rh41,136227924,2.134040377876842
TE-5,10322450,3.7882454446327087
BT 330,4705,1.8638133419743137
MPP 89,3465537,1.30185737748147
KYSE-70,3854666,1.6457032232411275
HCC1954,sirolimus-bortezomib (250-1 mol-mol),-8.401031472525755
WT2-iPS,2742550,4.265208753416965
VCaP,3854666,0.8856034047599067
OPM-2,9884685,-0.7869928949425254
KMS-26,100016,3.884140356330727
Hs 888.T,71751553,4.666696298230253
SaOS-2,9926054,1.5065280757428428
KALS-1,9884685,0.3630123980894349
NCI-H1373,1566236,3.9226527359425702
TE-5,9926054,1.840497993611495
SK-N-SH,6918638,-0.7450895378891518
COLO 668,136227924,2.7222662640570356
ECC12,tanespimycin-bortezomib (250-1 mol-mol),-0.7458523006445992
G-401,selumetinib-GDC-0941 (4-1 mol-mol),0.5111362666668609
SH-10-TC,9911463,4.344994867688331
SH-10-TC,100016,6.555483038363527
SNU-C5,73707386,4.781379809316252
NALM-6,selumetinib-GDC-0941 (4-1 mol-mol),-0.5223211713783823
HCC1438,4705,3.126117336231009
HEL 92.1.7,100016,4.201358504841771
MM1.S,9935249,3.6617301245150498
A-375,65628,4.4466647793828855
TALL-1 [Human adult T-ALL],65628,2.43503143696304
HuG1-N,9915743,3.4035980439406432
CAL-62,9926054,1.583748031587333
Hs 729.T,9884685,0.8131307080900988
MCF-7,selumetinib-GDC-0941 (4-1 mol-mol),1.646510277694018
SK-ES-1,10322450,3.263279499807968
CW-2,3854666,2.8676785339047512
647V,11152667,-0.9997029322393228
NCI-H292,tanespimycin-bortezomib (250-1 mol-mol),-0.1673864119679393
A2058,selumetinib-GDC-0941 (4-1 mol-mol),0.6721412852797596
PE/CA-PJ34 (clone C12),54618771,0.3330928840466188
OV7,9911463,4.355611595134673
HEC-108,sirolimus-bortezomib (250-1 mol-mol),0.3537850835558722
NCI-H1694,135659046,3.770401283474136
KMRC-20,3854666,4.622266524166492
KMRC-2,4705,3.2105980144700004
SNU-869,2742550,3.985788589548601
BL-70,9926054,1.763509439822291
U266B1,4705,3.88133298077809
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
COLO 792,136227924,2.7402829929938908
KYSE-410,9935249,4.016740976439891
COR-L95,9935249,2.976260244275784
M059K,135984461,3.9567991778438247
M-07e,100016,5.065678373530031
SW1990,100016,6.759971253936254
SW48,9911463,3.374803590447597
SNU-899,65628,4.4224431430468645
IGR-1,135421197,2.0618404907412473
D283 Med,1566236,1.5114731538286772
P-STS,2746,1.4034499567898922
NOMO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.2771882035135704
NCI-H1339,11494412,1.0306883056063765
COLO 829,65628,4.575219924330789
WM115,1566236,3.8332358430398847
LXF 289,9911463,2.935801973679381
DND-41,24779724,6.0388973137341155
Namalwa,9911463,2.7572577056870022
ECC12,9911463,4.410460667736256
639V,135421197,3.226794865257896
SNU-8,136227924,2.992589463119238
BT 145,9926054,1.693307076625488
CAL-78,sirolimus-bortezomib (250-1 mol-mol),0.4097773819170223
RPMI-8402,9935249,1.248313969132739
HuG1-N,136227924,2.3836679865505332
COV434,10322450,3.177068710390827
NCI-H1155,9911463,3.422756009393138
LK-2,9884685,0.5793401438981376
Panc 03.27,135421197,1.6982326506072338
NCI-H1435,73707386,2.9005384628289517
Hs 936.T,9935249,4.288072369675604
SF126,9911463,4.3238091091620525
LS180,100016,6.005443229591697
KYSE-30,135421197,1.7734254693963984
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
NCI-H292,9884685,1.805947993429832
TE-5,selumetinib-GDC-0941 (4-1 mol-mol),0.92004648470689
HCC78,9926054,2.494370122209171
TF-1,9915743,0.9371893849348516
TYK-nu,9915743,1.635959733436141
TT,sirolimus-bortezomib (250-1 mol-mol),1.7489880165366345
KCL-22,selumetinib-GDC-0941 (4-1 mol-mol),1.6879768271667388
NCI-H1373,sirolimus-bortezomib (250-1 mol-mol),1.9040141833310924
A2780,9911463,2.7303797257759235
RS4;11,2746,2.038871596243954
NCI-H1341,71751553,3.937953220570689
A-549,1566236,4.271699172517002
SU-DHL-6,9868037,3.231553190440303
SNU-387,135421197,2.3985099297623815
BICR 22,135984461,4.376718251500639
HT-1376,11152667,-0.1959046835831934
IGR-37,10322450,5.040348991848962
NCI-H747,selumetinib-GDC-0941 (4-1 mol-mol),-3.828774406071909
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
DU145,136227924,5.593457102459236
697,selumetinib-GDC-0941 (4-1 mol-mol),0.5718014976116145
SUP-T11,2742550,3.0787021809680044
PaTu 8902,1566236,3.6887913704860535
NCI-H810,9926054,1.762118845212232
SK-N-DZ,136227924,0.9645463461515836
IGR-37,9926054,1.73801540894826
MOLP-8,3854666,0.8063321236158104
BV-173,9868037,2.047976501818227
Hs 683,selumetinib-GDC-0941 (4-1 mol-mol),2.318747786701251
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
Hs 944.T,9926054,2.091458056725466
CAL-54,9884685,-0.6877334329271488
TE-4,1566236,3.823533230768045
SW48,3854666,0.5343434371102147
A4/Fukuda,2746,1.0000278581130588
SK-MM-2,135984461,1.4318073157862956
OC 314,135659046,3.480860974794082
Capan-1,4705,2.4129084207631943
TUHR14TKB,135659046,6.015555099108438
Caov-3,3854666,1.2394462987142651
SW1417,2742550,4.242431031209741
SNU-216,9935249,2.9187421404972165
BL-70,65628,3.443552461432303
CAL-54,6918638,-0.089811229970637
BICR 6,11152667,-2.1819410522068083
ACC-MESO-1,100016,6.4652465436588775
OAW28,9926054,1.976123345191561
NCI-H2228,selumetinib-GDC-0941 (4-1 mol-mol),1.1807966887528696
M059K,tanespimycin-bortezomib (250-1 mol-mol),0.2006380895510879
JHH-2,1566236,1.6731430194844064
HDLM-2,65628,5.287608845235475
PE/CA-PJ15,650361,5.890408316913619
HuT 78,9935249,1.327110293574704
G-361,selumetinib-GDC-0941 (4-1 mol-mol),-0.129609857983409
SK-ES-1,11152667,-1.0313660438121697
SK-N-FI,selumetinib-GDC-0941 (4-1 mol-mol),0.5932957788770222
LCLC-97TM1,135421197,1.517750954289076
PK-59,2746,3.5698867833367585
MHH-NB-11,selumetinib-GDC-0941 (4-1 mol-mol),0.4891965075201672
Reh,3854666,0.867730782820825
DND-41,11494412,0.7707126282349229
NCI-H211,9884685,-0.7968734906992008
HEC-6,135984461,4.376035832446469
NCI-H522,sirolimus-bortezomib (250-1 mol-mol),0.2435604528916691
HuH-28,3854666,3.680446535502344
HCC1569,sirolimus-bortezomib (250-1 mol-mol),0.3856699137888855
DV-90,selumetinib-GDC-0941 (4-1 mol-mol),-0.7506307924929138
YKG-1,71751553,4.894394979371257
Hs 940.T,24779724,5.686708728443863
BT 145,100016,5.857999875396141
SW1990,65628,4.249281655519801
NCI-H747,135421197,1.1053174645352293
KMRC-1,135421197,2.781168744821282
JHUEM-1,9935249,3.046679227327208
Mino,2746,0.8044795617412364
TOV-112D,3854666,1.2404915095556075
SNU-620,9915743,2.3587879241072227
CCF-STTG1,54618771,4.049347271840678
SK-MEL-30,9926054,2.6578574468285434
647V,2746,2.8879721375680214
NCC-StC-K140,11494412,-0.839248093029438
HCT 8,135421197,1.352992198121239
RKO,3854666,1.2691133577357363
PSN1,11494412,1.2145566639626413
OCI-AML-3,1566236,1.4852754357905558
CAL-27,1566236,1.710103727952198
YD-8,3854666,3.395603852355968
VCaP,136227924,2.2790218879563255
TE-4,9911463,3.1897003979431093
EKVX,71751553,4.292154921521479
A101D,136227924,2.7929516463081123
NCI-H650,selumetinib-GDC-0941 (4-1 mol-mol),1.2489714260088474
A-375,135421197,1.9818816716343688
SNU-620,135421197,2.4250401955395984
NCI-H446,100016,4.920277084242614
5637,54618771,0.8259357118151949
EBC-1,11152667,-0.3627843771120927
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
MKN1,2742550,4.9827202282235685
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
MKN7,9935249,3.2048024238983825
TE-10,9926054,2.0362558072853827
NCI-H2029,65628,4.268303683940135
PK-59,136227924,3.43326158684526
JHUEM-3,11152667,-2.492971610615099
HCC2218,10322450,3.115665598848324
MDA-MB-157,54618771,3.1146330047846877
253J,136227924,2.473625062581448
SNU-16,71751553,1.7407385044241688
CA46,1566236,0.9666867201201066
JeKo-1,sirolimus-bortezomib (250-1 mol-mol),0.3610522952079053
VMRC-LCD,11152667,-1.4796067866772968
NCI-H1869,6918638,1.090174259453097
TT2609-C02,selumetinib-GDC-0941 (4-1 mol-mol),0.2335990554024833
BL-41,9911463,3.564176203754708
HGC-27,9926054,1.079439551544522
EHEB,sirolimus-bortezomib (250-1 mol-mol),-0.8631286071127797
BT 422,9911463,3.7605478097150704
LOX-IMVI,135421197,1.985626548385356
SKM-1,9868037,0.7505046314280106
Capan-2,9884685,1.4728915431544811
TE 617.T,71751553,3.9067894428896928
KYSE-450,11494412,3.783526385415406
OE19,selumetinib-GDC-0941 (4-1 mol-mol),2.914512652837311
Hs 578T,136227924,2.600789152961688
SNU-1,100016,5.685360721271126
A-253,9911463,3.7937497344775815
RCH-ACV,9915743,0.3296075403381741
CHP-126,9915743,1.430510462525058
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
SK-MEL-5,135421197,1.8346447693413537
RT-112,9911463,3.6857409910721337
MFE-296,11494412,0.9022675907017478
OAW28,135421197,1.4901490212875883
SNU-16,9884685,2.9055473229469015
EM-2,73707386,5.173636041104296
EN,11152667,-1.326887253790568
HeLa,sirolimus-bortezomib (250-1 mol-mol),2.2283701197426553
Hs 683,9915743,1.4986187440690526
Caki-2,135984461,3.6867665044524025
COV434,tanespimycin-bortezomib (250-1 mol-mol),-0.6221104075249205
HCC2108,sirolimus-bortezomib (250-1 mol-mol),3.017488658473148
EFM-192A,136227924,3.313769329286525
SNU-C2A,136227924,3.0438027551295352
TE-5,2742550,3.747517930078368
Karpas-299,135984461,4.585524824228754
LMSU,4705,3.840410851100799
DAN-G,selumetinib-GDC-0941 (4-1 mol-mol),0.9464172392973902
MeWo,sirolimus-bortezomib (250-1 mol-mol),0.5468033899342802
BxPC-3,9935249,3.9268263105803727
TTC-709,9935249,1.8024072456954583
2004,11494412,0.904379471293079
HH [Human lymphoma],selumetinib-GDC-0941 (4-1 mol-mol),-1.1427111457994747
TE-5,3465537,2.4658323956499526
JeKo-1,3854666,0.6806935772544002
TE 441.T,9884685,0.7848536864337075
SNU-C2A,9935249,3.886157846226495
OV56,2742550,6.393989194319079
NCI-H2196,11152667,0.1681584585599158
NCI-H2342,selumetinib-GDC-0941 (4-1 mol-mol),3.1490507666269307
MFE-296,6918638,1.6270992147424843
A-204,6918638,0.7578791197634218
NCI-H2030,tanespimycin-bortezomib (250-1 mol-mol),1.0255259856925616
BT 504,3854666,0.6653491549199024
CGTH-W-1,136227924,3.107802787848976
DU145,135659046,3.5568052359419604
TE-14,9915743,-2.4468727006504483
KO52,71751553,4.277873961450632
PC-3,9926054,2.02880432108919
HPB-ALL,100016,7.357554409535215
TOV-21G,54618771,2.0367745651121867
MHH-NB-11,135421197,1.028464988751559
COR-L51,9915743,1.408034977719198
NCI-H322,54618771,1.4640514819881318
G-401,3854666,0.6606077023561356
Hs 611.T,49836020,3.6507368971801983
KP-4,100016,6.84348879863886
NCI-H1339,9926054,1.7994324687191725
Yamato-SS,11152667,-1.320791776573827
SNB-75,sirolimus-bortezomib (250-1 mol-mol),1.678317962717081
BV-173,136227924,2.1412277594985816
Ishikawa (Heraklio) 02 ER-,9911463,4.4894975893783435
NCI-H1373,135984461,4.3853156416266
SNU-1066,tanespimycin-bortezomib (250-1 mol-mol),-0.148232507345562
NCI-H209,54618771,0.4504113944457773
MEC-1,2742550,3.1493999603639526
KATO III,9935249,3.1862227458693475
TF-1,1566236,1.641325483030065
HEC-6,9926054,1.6312694597986903
NCI-H1666,9915743,-2.9000343533744353
ALL-SIL,100016,4.099229681419155
SCC-25,9911463,3.418657228936731
8305C,135984461,1.979761055337833
NCI-H1299,65628,5.181040397435313
OVCAR-5,2746,2.6087959831645433
IGR-1,54618771,0.8622245008505476
BT-549,6918638,1.3825585614023566
NCI-H196,sirolimus-bortezomib (250-1 mol-mol),1.900922719750797
NMC-G1,11152667,1.2131729378595566
HuNS1,49836020,4.176817793282971
Calu-3,sirolimus-bortezomib (250-1 mol-mol),-0.667685459302334
NCI-H1651,11152667,-0.8885478586200989
TC-71,9935249,1.560837001432667
BT 416,9884685,0.6464924018321844
GA-10,135421197,0.1177808721156358
TE-14,54618771,0.7402705360744307
OVK18,9935249,3.263802932433917
Panc 10.05,6918638,1.3073335951613236
MPP 89,4705,3.4869840360057855
P3HR-1,selumetinib-GDC-0941 (4-1 mol-mol),3.428071377165287
Mono-Mac-1,9915743,-1.5760754079944657
ACHN,135984461,1.8041050140456245
SW579,9911463,4.038751545861884
SH-4,9911463,2.562813688525255
KLE,sirolimus-bortezomib (250-1 mol-mol),2.0698040575432572
RCH-ACV,1566236,1.4143282835015505
Becker,sirolimus-bortezomib (250-1 mol-mol),2.1834069144396393
TE 617.T,tanespimycin-bortezomib (250-1 mol-mol),-1.7403863885968738
HGC-27,136227924,2.541882907814414
Hs 683,71751553,4.288998179151866
NB1,9884685,-0.4292622986017718
LP-1,11494412,0.682179564781432
SCaBER,9926054,1.794532433131724
HT,tanespimycin-bortezomib (250-1 mol-mol),-0.5308149065627191
KMS-34,9926054,1.6315221733896668
Hs 822.T,9911463,4.380200456677196
Hs 294T,1566236,1.721437690472421
Hs 729.T,1566236,2.2356986776894736
SNU-1076,135421197,2.6867393428940107
TT,9911463,3.632649980547299
MHH-CALL-4,9915743,0.0855702351312573
RPMI-8402,sirolimus-bortezomib (250-1 mol-mol),0.331212001560029
COR-L105,136227924,2.729950058152846
RCH-ACV,4705,2.8616908433941495
TCC-Pan2,9911463,4.063376197709276
SNU-478,9884685,-1.5309712705157508
NCI-H1944,65628,5.0529725090595985
SET-2,9915743,0.156310507538352
HT-1197,10322450,2.509794666751626
KYSE-410,sirolimus-bortezomib (250-1 mol-mol),0.4997693160347982
KE-39,135421197,0.9510973278490732
NCI-H838,selumetinib-GDC-0941 (4-1 mol-mol),1.9940738428957552
KMS-21-BM,24779724,5.254342909571376
NUGC-4,73707386,4.27548765999553
HCC202,54618771,2.3790685785467964
CHP-126,selumetinib-GDC-0941 (4-1 mol-mol),3.8559663060343
HCC2279,54618771,-0.3569311345677481
A-204,135421197,1.5277781833550137
NCI-H810,sirolimus-bortezomib (250-1 mol-mol),0.258624131959815
UO-31,4705,2.423149562470716
MOLM-6,135421197,0.9867364446858986
GI-1,9935249,3.04250008924813
HEC-59,9911463,4.219022102468233
PE/CA-PJ49,9884685,0.5185977592735194
JHUEM-7,9884685,-1.60078111934439
HCT 15,2746,3.234164073098613
LP-1,3854666,0.8576356397095183
Caki-1,6918638,0.9504524779019108
MDA-MB-468,135421197,1.1227139239966792
NCI-H2196,49836020,4.894055204627393
KMS-26,10322450,3.1640442596906104
WM88,1566236,1.820047619843189
SU.86.86,54618771,0.7552640390383902
BT 359,sirolimus-bortezomib (250-1 mol-mol),0.4069320029327686
JHUEM-7,135984461,4.346774383555173
ECC12,54618771,2.554935234255265
NCI-H1975,tanespimycin-bortezomib (250-1 mol-mol),-1.468609028011694
ST486,135421197,0.3717374472748143
NCI-H2170,9915743,-4.0730094679521125
DMS 114,selumetinib-GDC-0941 (4-1 mol-mol),1.847196257351989
CAL-78,9926054,2.780134265811309
GSU,9926054,2.0753432463220065
Hs 852.T,65628,4.460884218370228
SU-DHL-1,54618771,0.3433661921186922
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681
TE-5,65628,4.1265200072069455
Calu-6,49836020,4.336137767537177
TE-10,73707386,-4.3328999275948314
HuT 78,1566236,0.8672075486868017
Calu-1,71751553,5.536345694277309
SK-UT-1,6918638,1.3984076220807655
SNU-478,selumetinib-GDC-0941 (4-1 mol-mol),-0.9905008638696244
THP-1,4705,2.9352513647716836
SCC-25,49836020,1.4878182873068626
NCI-H1793,100016,7.252403961124031
DEL,135421197,2.352546042439028
U266B1,135984461,4.925134147369508
HEC-1-A,2746,3.527816775331282
KATO III,sirolimus-bortezomib (250-1 mol-mol),0.9695085232942704
TE-4,2742550,3.8546929103430174
SUIT-2,sirolimus-bortezomib (250-1 mol-mol),2.2579269293301527
MIA PaCa-2,9915743,0.7812754347673511
Karpas-620,3854666,3.775426831161984
8-MG-BA,71751553,5.547191078335952
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
NCI-H1573,9935249,2.8036192050574336
HuG1-N,11152667,-1.176066330134098
BL-70,135659046,3.3949027184182707
A-204,4705,2.732319737517574
HOS,11152667,-0.1843365091194761
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405
SNU-16,3465537,1.2882089943863808
NUGC-4,100016,6.130178573368833
RPMI-6666,135659046,6.863233968439554
EFM-192A,11494412,1.6268317124247755
LUDLU-1,11152667,-1.2221544436007594
DMS 53,9911463,2.8139915060011766
HSC-4,selumetinib-GDC-0941 (4-1 mol-mol),1.9348378913345816
HT115,9926054,3.740593425047279
Sq-1,9935249,4.030130164184431
QGP-1,9911463,4.188188217183116
MDA-MB-157,selumetinib-GDC-0941 (4-1 mol-mol),2.2510493382113155
PF-382,11152667,-1.8592814828562831
B-CPAP,136227924,3.258845757188781
Panc 08.13,selumetinib-GDC-0941 (4-1 mol-mol),0.8396472898062124
EB1,2742550,2.859851248001829
SW982,49836020,1.3794416609441722
IM95,11494412,0.4524692193792306
TE-4,9926054,1.7320967547040995
NCI-H2228,49836020,2.091075397258879
HuH-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8646931377295993
ES-2,9911463,4.341533806603841
NCI-H1666,9926054,1.8501166706396857
DOV13,3854666,3.159620572325968
NCI-H1650,sirolimus-bortezomib (250-1 mol-mol),1.0715909350533408
U2OS,100016,5.485609538675787
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636
NCI-H2030,9926054,2.071654789099982
COLO 684,6918638,0.5443329565313224
KYO-1,9935249,3.63147495537084
BT 239,6918638,2.260003296695808
RD,6918638,0.5242831454740873
PSN1,65628,4.215557225147028
A2780,135421197,1.3895584306244824
SNU-626,135421197,2.600343807362106
HGC-27,3854666,0.4310237545100587
SIG-M5,9926054,1.755465184389032
HCC4006,tanespimycin-bortezomib (250-1 mol-mol),1.0336276508061957
PC-3,11152667,2.8272133206200087
BC-3C,3854666,3.3854560486679053
SW1990,6918638,1.2411625887645945
VMRC-RCZ,6918638,0.7764115752639781
SK-MM-2,3465537,0.5878825614670627
MKN7,9884685,1.546576208419255
UACC-257,54618771,0.929112305561946
NU-DHL-1,2746,0.9771874808438498
MOLT-3,71751553,4.490864363539756
AML-193,135421197,0.7876033807150744
OC 314,24779724,5.172782111531357
Pfeiffer,11152667,-5.003109172861117
BT 139,4705,1.2736947517063846
Hs 683,4705,2.6530339386806476
A4/Fukuda,10322450,2.3588003127389277
MDA-MB-415,54618771,1.363110492584667
BT 216,2746,3.994166924580774
SF539,9868037,3.16067122997076
RPMI-8226,9884685,-0.1879223006811967
RT-4,3854666,3.7100044962154506
WM1799,1566236,1.692158319345263
SNU-423,135421197,3.0122188559971725
SNU-685,136227924,3.487679457544809
TTC-709,tanespimycin-bortezomib (250-1 mol-mol),0.5220611379237968
NCI-H650,11152667,-0.0238050356920854
OE21,135659046,3.360946677017383
HT115,54618771,0.5275869701844733
Hs 888.Lu,49836020,4.832752015410737
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
TE 617.T,10322450,3.863383234066746
P31/FUJ,135421197,1.0144502005310674
CAL-85-1,9935249,3.1583698268143157
253J,54618771,1.0062396076481863
SCC-9,9911463,4.4493328300482995
KP-2,135984461,4.592059766741548
SEM,9868037,2.0923686689232137
T3M-10,tanespimycin-bortezomib (250-1 mol-mol),-3.2480319159922515
PK-45H,135421197,3.006684170238441
UM-UC-3,100016,5.625806405184742
BT 131,136227924,1.4796003986288269
SUP-T11,9935249,2.2122809051591417
SU.86.86,136227924,3.0459574781144014
COLO 792,9926054,1.6988024802785178
DK-MG,9926054,2.480223353364803
SNU-1077,136227924,3.612132735883527
Hs 940.T,6918638,1.7343854780687948
BT 139,9911463,2.810742843963801
PE/CA-PJ49,2746,2.1917494925150653
NCI-H1341,24779724,6.355175868035526
D283 Med,136227924,2.613464686393682
NCI-H1568,1566236,1.6523344134899465
COLO 201,9935249,3.74717966542248
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
CML-T1,9926054,1.696565612874625
HEC-151,136227924,2.850288220591168
OVCAR-8,135421197,1.5864277094483568
T3M-10,135659046,3.5498820327325875
WM88,9926054,1.794473369640358
TE-14,9884685,0.211407416382201
T-47D,9911463,4.083486296646728
MFE-319,2746,3.158531328998989
MG-63,4705,3.9801982101515825
BT 271,tanespimycin-bortezomib (250-1 mol-mol),-3.34346586365967
AsPC-1,9911463,3.4970941612274693
HuP-T3,1566236,2.433067651410228
NCI-H1563,10322450,4.527770702811014
JHH-5,9926054,1.852888607063122
COR-L105,9911463,4.222864246171191
OPM-2,1566236,0.7571858740606694
SW48,100016,6.031440310304127
BT 328,11152667,1.7027658226426858
YD-15,9915743,-2.405110430781952
HCT 15,135984461,4.216464874302124
EHEB,135421197,1.2947733633872678
KMS-11,tanespimycin-bortezomib (250-1 mol-mol),-4.691870791647551
KYM-1,10322450,3.05782537023932
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
KYSE-450,54618771,1.2705031609145587
SNU-C5,65628,5.533856982258314
JHOC-5,selumetinib-GDC-0941 (4-1 mol-mol),2.1101820766966832
BT 504,4705,3.101925484309532
KMS-21-BM,sirolimus-bortezomib (250-1 mol-mol),-4.769329635088173
SK-MEL-31,54618771,1.4879835427229802
BT 359,9926054,3.2726911092773223
253J-BV,11152667,0.0104193756827245
JM-1,135659046,3.550517545140938
SK-LMS-1,11152667,1.335730322583835
SF295,3854666,4.284983950639361
LOX-IMVI,9926054,1.7031980960413209
A3/Kawakami,71751553,4.362373152095837
L-363,tanespimycin-bortezomib (250-1 mol-mol),-2.487698550401284
SNU-1033,65628,4.326862310201289
OCI-AML-2,44487872,4.166036259077145
SNU-5,135421197,2.4308176065595672
BT 232,3854666,3.559831057180391
NUGC-4,135421197,0.9656923984345016
ME-1 [Human leukemia],100016,5.540349228215307
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
SF268,136227924,2.8034077121566967
SCC-25,9915743,-2.46733650734929
SK-MEL-30,sirolimus-bortezomib (250-1 mol-mol),1.4325338004264097
M059K,136227924,2.883059674155944
RL,4705,3.6746067243503857
Detroit 562,9926054,1.947776964101976
JHUEM-3,9911463,3.690046931710037
DOV13,9911463,3.6581619709101383
SK-N-DZ,49836020,4.282357500475809
Rh30,54618771,1.1038289315266856
CAL-51,9926054,2.2227862000004577
T24,tanespimycin-bortezomib (250-1 mol-mol),0.0189711730076056
GP2d,54618771,1.3284936518837778
DMS 114,71751553,4.87881133729169
OE19,tanespimycin-bortezomib (250-1 mol-mol),-3.057865430510972
KE-97,9926054,0.8495096752282992
HuP-T3,9911463,3.677427040789425
U-CH1,6918638,0.5704766963302896
TALL-1 [Human adult T-ALL],135984461,3.024733387854321
SNU-16,10322450,2.297245339388599
NCI-H1915,4705,3.3172772088085307
RCH-ACV,10322450,3.427971439759819
BFTC-909,3465537,1.8561429441463555
NCI-H660,135659046,3.42543751190604
BHT-101,9911463,4.450414123842211
TYK-nu,1566236,1.811771162812953
SCC-4,2746,2.994805038812276
BT-12,9926054,1.4917142795883798
HL-60,71751553,4.3254524029405275
SUP-HD1,9884685,0.1146842786809414
Hs 294T,9935249,3.17037121804739
Kasumi-1,11152667,-6.314892495387823
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
OE21,54618771,-0.7908986466721764
Daudi,54618771,-0.114332288085178
HT-1197,4705,3.093520040309316
A2780,9884685,-1.5939943621043984
HuNS1,136227924,1.7771734051898846
BICR 6,135421197,2.188693589086808
Hs 611.T,tanespimycin-bortezomib (250-1 mol-mol),0.1632190347218379
BICR 31,11152667,-0.7818812516610519
KMRC-3,6918638,1.2491038866653728
NCI-H1838,9915743,0.3872640032202238
GCT,6918638,0.9621268988100647
Kasumi-2,1566236,1.00471674851072
U-118MG,9935249,3.6479372422776266
A-172,11152667,0.1923956558568524
TE-10,selumetinib-GDC-0941 (4-1 mol-mol),2.2597459184044593
HCC2279,9926054,2.352300509177514
HOP-62,11152667,-0.1983015993822777
EN,2746,3.955257118996246
KE-39,9915743,-0.5446321163343049
SNU-213,100016,6.954868306659309
BT 328,9868037,5.326885818831123
IGROV-1,3854666,2.3355254440561137
SNU-1077,9926054,3.1436307505327123
HOP-92,9868037,3.341339504436607
NCI-H660,9935249,1.6293188334591442
IST-Mes1,1566236,1.9315527075511711
HEC-265,49836020,-5.012817345393805
TE-4,10322450,4.2386221838106835
BICR 16,9935249,3.515936718867687
HGC-27,135398744,6.47323705988127
JHOC-5,9915743,-0.591005693368505
NCI-H1755,sirolimus-bortezomib (250-1 mol-mol),0.7810995530072428
SK-MEL-31,65628,4.422520079013974
L-428,136227924,2.9759698761374795
TE 441.T,2742550,3.688066908856028
JHOS-2,11494412,3.6714396856764857
A-253,sirolimus-bortezomib (250-1 mol-mol),0.2141066423714133
KHM-1B,3854666,1.0178761505547558
DU4475,2746,1.2992930311917237
TT,2742550,5.320745361223404
ST486,10322450,2.677792904621428
COLO 201,54618771,0.4783318937698353
KNS-60,54618771,0.379873149864298
COR-L95,9884685,1.274087436172542
Ci-1,1566236,1.8797102720685392
COV644,9911463,4.1377396171756144
BT 248,24779724,5.957496049021181
CML-T1,73707386,2.9358077283853974
HGC-27,9915743,-0.5179385932122726
HCC1806,9915743,1.1947371643854778
HCT 15,11152667,0.0648633497352948
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
OAW28,54618771,1.1011370240470315
HEL 92.1.7,3854666,0.8338262840039316
NCI-H2452,24779724,6.409137734448782
MFE-296,9926054,1.7629319837489352
SNU-46,selumetinib-GDC-0941 (4-1 mol-mol),1.1203054933058916
NCI-H2106,tanespimycin-bortezomib (250-1 mol-mol),0.3731532829488707
SNU-1214,9915743,-3.00050567913294
UM-UC-1,71751553,4.283600193961869
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
CA46,71751553,4.222934016329145
HCC1937,11152667,0.4358352072628013
HEL 92.1.7,136227924,2.7818707499809188
SK-BR-3,135984461,4.752422329058812
EFE-184,2746,3.7272239224015697
NCI-H1568,136227924,3.032081072579533
Hs 940.T,1566236,4.326667730982519
SW1417,4705,3.4268309691018377
SK-UT-1,9911463,4.1504947350424315
8505C,3854666,1.9826671632672512
Karpas-620,selumetinib-GDC-0941 (4-1 mol-mol),4.598341067647778
A-549,9926054,1.8971220341716168
Raji,9911463,2.729188500459454
TUHR14TKB,135421197,2.206090635498825
BT 179,4705,3.3464119205412697
ESS-1,4705,3.449305158476875
NCI-H1568,9884685,-0.6579514975056241
BT 286,135659046,3.5488699738704432
SEM,11152667,-6.712483327053162
MHH-CALL-4,11152667,-1.953186727917395
SNU-407,selumetinib-GDC-0941 (4-1 mol-mol),0.3272948267945177
Peer,9935249,1.2377857726534496
DMS 53,9935249,2.2286580352978858
NCI-H2122,2746,3.68558209467045
Mel JuSo,54618771,-0.9101150768043303
8-MG-BA,6918638,1.6355353194414102
Ri-1,11152667,-3.7285428023246943
BT 444,9868037,4.354992099001343
Hs 683,9935249,2.3161488384728575
Hs 944.T,9935249,3.2171969585361846
SCC-4,1566236,1.7714297882501675
DMS 273,11494412,0.2734180035919979
HCC1195,4705,3.3009207230647952
RERF-LC-Ad2,11494412,5.090684169686155
LNCaP clone FGC,100016,6.505127339133147
P31/FUJ,135984461,4.1454221372139894
LK-2,54618771,0.9625218695691432
SK-N-DZ,11494412,-0.9568858878968056
CAL-54,2742550,3.412395936689071
RERF-LC-MS,6918638,0.4520678244574614
COR-L105,11494412,3.277457630260471
KYO-1,9911463,3.8919177559591542
Daudi,9884685,-1.7998414591903729
SH-4,54618771,-1.4714653388751002
NCI-H747,136227924,2.5739387589966265
BICR 16,tanespimycin-bortezomib (250-1 mol-mol),-2.3692511571094244
H-STS,11494412,-0.8730313423515421
GSS,49836020,4.0402801556040036
HT-144,1566236,1.744450606587017
KO52,2746,2.0900422497447906
HCT 15,9926054,1.8634175733293992
L-540,100016,3.9234848652304097
TE-1,135421197,1.2529610572902146
BT 504,6918638,2.3418262484979593
NCI-H522,4705,3.8595388748644375
DBTRG-05MG,54618771,1.322739647725507
Raji,135421197,1.3656726509446273
EHEB,selumetinib-GDC-0941 (4-1 mol-mol),0.6698070674262858
HSC-2,9915743,-1.4415795953156172
SNU-489,9884685,2.750537044283334
NCI-H292,9915743,-0.4817131806939655
NCI-H810,135984461,4.558480725303822
NCI-H2286,100016,5.552985583261177
CHP-212,100016,6.525746829388361
Kasumi-2,10322450,3.5434418993684114
NCI-H1869,100016,6.8338343579730285
RD,selumetinib-GDC-0941 (4-1 mol-mol),0.4291937329067764
SNU-119,54618771,1.6343524810724477
CJM [Human melanoma],2742550,3.845461183394304
HuH-28,136227924,3.512267666844948
PK-1,136227924,2.8943441164421633
KMS-12-BM,1566236,0.5726482736694104
KYO-1,10322450,3.690990391858763
Hs 839.T,44487872,4.36119514235804
BV-173,135421197,1.3396067648225152
OV-90,1566236,2.845542775636685
NCI-H2196,6918638,0.6945006285388182
Hs 940.T,4705,3.481010414742296
Karpas-620,135421197,3.2232508043122587
JHOM-1,9911463,3.982223760363972
Hs 822.T,11152667,2.6413007405228703
SR,sirolimus-bortezomib (250-1 mol-mol),-4.8079752577906625
UM-UC-3,3854666,2.11257703860495
CAL-148,sirolimus-bortezomib (250-1 mol-mol),-6.661160669337239
Hs 683,1566236,3.857796471842603
NCI-H1869,71751553,5.160002179984854
CJM [Human melanoma],tanespimycin-bortezomib (250-1 mol-mol),0.2668516284110745
OC 314,2746,3.4168775378472893
DV-90,tanespimycin-bortezomib (250-1 mol-mol),-3.2159049827612356
NCI-H1395,1566236,2.7287407900944056
KE-39,9868037,3.621529869698051
P31/FUJ,9935249,2.700947453739227
NUGC-4,9926054,2.05156938319837
IGR-1,3854666,0.8648150741140344
Fu97,54639665,-0.9928942554758008
LCLC-97TM1,2746,2.92478275020961
A3/Kawakami,9935249,1.5690106286668166
BC-3C,sirolimus-bortezomib (250-1 mol-mol),0.3697062841938496
8305C,9911463,3.96844449411402
KP-2,11152667,0.1770667572692464
NCI-H838,2746,3.438518103958065
MDA-MB-453,3465537,1.8912554302439897
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
NCI-H1395,135984461,4.376761136039875
NCI-H1341,tanespimycin-bortezomib (250-1 mol-mol),-2.8449301183923756
NCI-H1838,49836020,4.844484842212348
K-562,136227924,2.737847329779252
BT 416,1566236,1.637828038025737
Hs 578Bst,54618771,0.4145984361233129
A-375,sirolimus-bortezomib (250-1 mol-mol),2.0398206768525475
NCI-H1563,135659046,3.636669670188891
SNU-410,2746,4.749931599758568
A-253,2746,3.706033536924258
JIMT-1,3854666,1.22286835521865
WM1799,9915743,1.2587525193703504
HEC-265,9868037,1.4639639907135185
CMK,1566236,1.14506767841984
SCC-9,2742550,4.1692460597635135
SNU-5,136227924,2.8950932658181876
SNU-8,tanespimycin-bortezomib (250-1 mol-mol),1.1303799126997314
SK-N-BE(2),100016,5.117046374692038
SK-N-DZ,9915743,0.9921777316804312
KE-39,11152667,0.74958800909379
HCC15,9935249,4.091947122155354
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
MEC-1,2746,2.441084907474043
SU-DHL-10,2746,2.3013930855347877
ME-1 [Human leukemia],11152667,-1.6733344626685482
PLC/PRF/5,6918638,0.9074037907911854
SCC-9,135421197,2.7056920215811293
LoVo,135421197,2.0078610802467307
LCLC-97TM1,9884685,-0.6945268748645868
JURL-MK1,9926054,0.5883612269898851
SNB-75,11152667,0.9716304572958736
Mino,135984461,1.4657661855370687
JHUEM-3,136227924,3.0400208358424243
KYM-1,9868037,3.127577125862836
T3M-10,11494412,3.4512689265696936
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
HCT 15,11494412,0.4362890009933227
CCF-STTG1,selumetinib-GDC-0941 (4-1 mol-mol),4.2264106032323445
SNU-449,4705,3.898593282840832
KMS-27,10322450,3.3921429038631707
L-428,54618771,0.5974116891557107
CW-2,135984461,4.848993009779452
SNU-449,54618771,0.9697829427454708
SF295,9911463,4.265275017996558
DV-90,2746,1.1630599878188876
ES-2,9915743,3.6243790068274384
SK-MEL-2,sirolimus-bortezomib (250-1 mol-mol),0.4660061968632925
HT-55,4705,2.5986536735617833
PL-21,9884685,-0.9848433807049898
U-87MG ATCC,tanespimycin-bortezomib (250-1 mol-mol),0.7593284831518214
NCI-H1373,100016,4.430083600999957
Toledo,11494412,2.936313599866626
EFO-21,100016,8.032262329904976
HCT 15,9915743,0.5336080219876301
HCC44,9911463,3.3099390770105748
JM-1,sirolimus-bortezomib (250-1 mol-mol),-0.3513681100208012
TE-8,4705,2.806711792876773
HEC-265,54618771,0.9168316740799288
SNU-503,100016,6.601678520618542
CAL-85-1,tanespimycin-bortezomib (250-1 mol-mol),0.6735355915529317
DMS 53,selumetinib-GDC-0941 (4-1 mol-mol),1.3170486781657051
RCH-ACV,73707386,2.164720549147375
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
HPB-ALL,9868037,2.0330145425513044
DMS 454,11152667,1.0827498525791113
EoL-1,9926054,1.828019217783983
BT 482,2746,5.533000175403538
PE/CA-PJ49,65628,4.299223683644022
A3/Kawakami,tanespimycin-bortezomib (250-1 mol-mol),-0.2399210374743367
ALL-SIL,136227924,2.439460537978413
Granta-519,9915743,0.9460784198503543
KALS-1,1566236,2.244162575984816
Panc 10.05,9935249,2.6158504828973626
SNU-489,11152667,0.659808026568522
MOLT-3,65628,1.183850627818121
YKG-1,3465537,3.622087306802616
JJN-3,10322450,3.7003001259189903
MOLT-16,9926054,1.655760518642202
Sq-1,2746,3.2736389846426532
NCI-H889,135421197,1.0362826511717604
NCI-H2106,135421197,0.6471538236638695
NCI-H2106,65628,5.651858118902885
HCC2279,9935249,4.25110367005722
JVM-3,selumetinib-GDC-0941 (4-1 mol-mol),1.8327445847214063
SCC-25,135984461,2.1535341859506776
HEL 92.1.7,2746,1.730022792287867
A-253,3465537,3.175691347672769
NCI-H929,135984461,1.9075332391524664
G-361,135984461,4.251520371382919
HuP-T4,54618771,-0.0993332629416019
2004,9926054,1.8081714609693849
JHH-2,9926054,3.1999514592679508
KU-19-19,135421197,1.2163789616721166
SNG-M,4705,3.157780900696135
WM1799,9911463,3.918930617108345
TM-31,2746,3.629695868471985
SK-MES-1,3854666,1.8711540273812308
EJM,9935249,2.9209217117855903
2004,136227924,1.8982400348113204
U-CH1,sirolimus-bortezomib (250-1 mol-mol),-0.0071193636307831
DMS 273,selumetinib-GDC-0941 (4-1 mol-mol),1.852942012782467
VM-CUB-1,9915743,0.0251855246366983
A-172,6918638,1.3272545759191037
697,100016,3.656696343596264
TE-1,9926054,2.343374218225638
HCC202,2746,3.341807216301485
Rh41,2742550,2.9632635418115916
SNB-75,71751553,4.563743784479649
NCI-H2029,9911463,2.565034474609612
Panc 08.13,9915743,2.266213209948084
YD-38,65628,4.316413155478777
U-BLC1,11494412,1.2654808753679463
HuH-28,49836020,4.5831032591173635
HuG1-N,4705,3.1646359507228623
Karpas-299,4705,2.3837874770371816
HSC-4,9926054,2.0278633205902468
Panc 05.04,54618771,3.033977458741074
NCI-H2342,sirolimus-bortezomib (250-1 mol-mol),2.0659171352443204
5637,65628,4.2797556217083965
NCI-H1435,135421197,1.75045264737253
VM-CUB-1,sirolimus-bortezomib (250-1 mol-mol),1.5945782994961089
Hs 683,2746,3.210764654839646
OVK18,73707386,3.069858343080502
NCI-H1694,136227924,2.5297757130143887
BT 172,135421197,1.393069790953409
CAL-85-1,9884685,-0.6129731803090307
ST486,tanespimycin-bortezomib (250-1 mol-mol),-0.6822883440168558
TE-5,135659046,3.5312451731544887
NCI-H647,9915743,2.3861555081982035
NU-DUL-1,73707386,2.96968071129634
Ki-JK,54618771,0.0695093081370742
KP-N-YN,71751553,4.417015018221096
YD-10B,9915743,-4.675964091727352
TE-1,135984461,4.283297519816261
EBC-1,2746,2.5031802936730547
Rh41,135984461,3.8957403720163177
EJM,6918638,-1.326291213724497
SW1783,2742550,4.177993888768022
OE33,9884685,-1.0024057051138902
Caov-3,73707386,3.637986514762385
SNU-213,135421197,2.2792835673188687
VCaP,135984461,3.022939486158339
BICR 6,136227924,2.7894508880651485
253J,9911463,2.6444907494378476
IGROV-1,4705,3.3098412390054603
KP-N-SI9s,9926054,1.6199423536774489
Kasumi-1,6918638,-1.672437064714565
BC-3C,selumetinib-GDC-0941 (4-1 mol-mol),1.2071985367174134
Hs 578T,54618771,1.0464366040522988
Sq-1,49836020,-1.2584721229421645
UO-31,6918638,1.142003131035845
NCI-H520,65628,4.358434508292663
TOV-112D,tanespimycin-bortezomib (250-1 mol-mol),1.1427039773069572
SUP-T1,135421197,0.9840092633419462
MFE-296,11152667,-1.49874727462349
KO52,10322450,3.562187913985661
MG-63,71751553,6.373877555127259
TE 617.T,2742550,3.402468402026986
Calu-1,136227924,3.5665542391568774
NCI-H1793,9868037,4.171600355487511
CCF-STTG1,4705,3.7462462996550534
TUHR10TKB,135659046,3.511153588074704
Caki-1,9884685,4.271295455862672
HCC1438,11152667,0.8769169282292807
L-1236,3854666,3.4070343749706784
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662
BICR 6,9915743,0.967897294058306
Calu-3,9935249,3.4211545663410585
NCI-H647,11152667,-0.8858853545948763
HEC-50B,11152667,-1.6153760473992984
WM266-4,135421197,2.204314792506349
BT-16,selumetinib-GDC-0941 (4-1 mol-mol),1.0815618001864344
PaTu 8988s,9884685,3.7069578425529257
GA-10,4705,2.180825520695711
KMS-27,135984461,4.260058247162953
DLD-1,11152667,1.1045398350406073
AsPC-1,2742550,5.133078791264603
JHOM-1,135421197,1.641458342897405
SCaBER,11152667,0.3321813903171761
Karpas-299,54618771,-0.1406101617053584
ECC12,3854666,0.9162836881070394
MDST8,11152667,-1.6082048518025778
MKN74,11494412,3.198332306822972
Toledo,9926054,4.027631226191203
CAL-85-1,3465537,3.465433741890866
HPB-ALL,135984461,3.5745681488529693
Hs 294T,11152667,-0.3503938468733086
Hs 895.T,2742550,3.795003582218494
NCI-H520,2746,2.5300013032729556
CHP-212,135984461,1.9564066999314385
HCC1588,100016,6.591658390404969
LUDLU-1,6918638,0.1404084517596252
Hs 688(A).T,9935249,3.392605669419124
BT-474,10322450,2.780600319023071
Panc 04.03,6918638,0.956445062850862
HT115,135984461,1.7227419077735964
MHH-CALL-3,9935249,3.71823055651671
RL,136227924,2.481613482211788
NCI-H1184,9935249,3.235256645331142
HuH-1,54618771,1.0275459281807533
TT2609-C02,9935249,3.1187203148031566
BT 172,9935249,2.02669963846525
SNU-C5,135659046,3.5746931112208853
NCI-H1694,2746,1.1698970904386303
CCK-81,135421197,1.1239650919721589
KYSE-410,2746,3.332005025730893
EB1,tanespimycin-bortezomib (250-1 mol-mol),-0.3360954254075145
PK-1,3854666,3.537340048707808
OCI-AML-2,9926054,1.545607447345451
L-363,9926054,1.3998682481230786
NCI-H146,9915743,-0.2957101551438801
SNU-C1,136227924,2.406947195401098
NCI-H211,selumetinib-GDC-0941 (4-1 mol-mol),1.1345350253302544
SET-2,11494412,0.7084758030554381
HT-1376,49836020,5.287165459832521
RMG-I,135984461,4.206545511526054
SNU-1077,9911463,3.723863128468891
ONCO-DG-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1798955899961833
NUGC-4,136227924,2.1432448607030308
UM-UC-3,1566236,1.790793058046746
Hs 944.T,1566236,3.0882237799515297
NALM-6,10322450,2.9761732504638103
HCC1438,1566236,3.420942312784018
BT 359,11152667,1.623883380648874
CML-T1,selumetinib-GDC-0941 (4-1 mol-mol),2.3571897890829323
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343
MOR/CPR,136227924,3.350851412370925
NCI-H2170,2746,3.369366607476525
SNU-886,11152667,-0.5084903707284607
ECC10,73707386,2.488909979454374
SW1783,9911463,3.515685844560525
D283 Med,65628,4.590969471061447
DMS 454,sirolimus-bortezomib (250-1 mol-mol),0.5194696170938634
GB-1,selumetinib-GDC-0941 (4-1 mol-mol),1.0997063493321384
OV56,54618771,2.692220458386417
BT 172,1566236,1.9782936054266065
HT115,100016,5.804685245268015
PC-3,10322450,4.846357152814794
CJM [Human melanoma],135421197,2.95523092671823
TE-4,9915743,-1.938588144911124
KG-1-C,sirolimus-bortezomib (250-1 mol-mol),1.4643068357470623
JHH-6,11152667,1.750975958865048
Kasumi-1,71751553,3.614972495109249
NCI-H146,2746,0.8652413173737366
GaMG,9926054,2.873858460522757
HCC38,11494412,0.4416317556150596
Ci-1,sirolimus-bortezomib (250-1 mol-mol),0.4066762870237297
BT 428,11152667,-0.1216773247617757
AsPC-1,2742550,5.133078791264603
IST-Mes1,136227924,2.313131576565863
NCI-H23,9915743,1.0695073587250767
COR-L88,9911463,3.307213706947891
P31/FUJ,9911463,3.6551866379259743
U266B1,2746,1.1489280814220546
M059K,9926054,1.7795727491270252
MFE-319,tanespimycin-bortezomib (250-1 mol-mol),0.5813484013187771
OCI-AML-2,136227924,1.951984345015637
KMS-21-BM,54639665,5.788754853748425
Pfeiffer,sirolimus-bortezomib (250-1 mol-mol),-8.074968240863114
HCC1500,9911463,3.4774936591741703
HCC1195,1566236,1.8667850509646169
MKN74,2746,3.2220393473660973
IM95,2746,2.7432811533123247
CMK,9911463,3.4147490124520075
23132/87,tanespimycin-bortezomib (250-1 mol-mol),-3.0777539592464227
NCI-H2405,100016,6.531050125500204
BT 286,9935249,1.1744552926242438
JHUEM-1,136227924,2.224041693066133
CL-11,73707386,2.162351861308678
MKN7,10322450,4.432955441296817
KMS-34,2742550,2.8353380812727416
SF539,65628,3.9792533711127582
MJ,sirolimus-bortezomib (250-1 mol-mol),-0.1253732166157266
CFPAC-1,100016,6.545938487461667
SNU-119,24779724,4.340610631668066
A3/Kawakami,135421197,1.197973904783629
THP-1,9935249,2.0469656741900955
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
SHP-77,sirolimus-bortezomib (250-1 mol-mol),1.6844110283136058
GDM-1,54618771,1.3683939355818997
KNS-60,650361,2.902836062071098
NCI-H522,9935249,3.002706281912375
JHOC-5,135421197,3.377612264303829
SK-MES-1,4705,1.78363684998227
CAL-51,selumetinib-GDC-0941 (4-1 mol-mol),1.9069951643813725
BT 428,9911463,3.0361887786890693
BT 245,3854666,0.2943168101858666
MG-63,6918638,1.818394000557256
NCI-H841,2746,3.2973731643311193
CCK-81,3854666,1.9040688936241612
GaMG,selumetinib-GDC-0941 (4-1 mol-mol),2.5044066808337644
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
HeLa,2746,3.522514487554161
KNS-81,11152667,0.7126411736718126
MV4-11,65628,2.0068612845632137
CAS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.9599714674157864
REC-1,9926054,3.5400616992055847
RERF-LC-Ad1,9911463,4.614184078770455
Peer,11152667,-2.098459258101671
BT 216,100016,6.740671439747835
GaMG,54618771,-0.7184169257406299
KALS-1,selumetinib-GDC-0941 (4-1 mol-mol),1.963503577041432
RERF-LC-MS,11494412,1.0302757077826894
NCI-H1838,9926054,1.7507639405240023
SNU-C5,9915743,1.1022150159535518
OCI-M1,3854666,0.1062277305509749
IGROV-1,2746,2.8413672686351212
GSS,tanespimycin-bortezomib (250-1 mol-mol),-1.8015851395784044
BT 320,9911463,3.706038906545982
SNU-601,6918638,1.0757828818218795
HuG1-N,10322450,2.6791795001351355
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
SNU-685,9926054,1.8961816645578051
EFE-184,9915743,2.640815176926095
HSC-3,sirolimus-bortezomib (250-1 mol-mol),1.8734787499367431
GP2d,9915743,-1.6456174019811347
T98G,9884685,2.6740995473938467
OPM-2,9911463,3.091122447781221
SF295,11152667,-1.2215974796941085
BT 232,136227924,3.5495643934514223
NCI-H520,2742550,4.31238635720589
JHOM-1,11152667,0.3930850023562942
SYO-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8383808288745799
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
BT 286,3854666,0.3675459578647432
NCI-H1155,65628,3.3222312629678776
EC-GI-10,selumetinib-GDC-0941 (4-1 mol-mol),2.251648827392905
MeWo,3465537,2.2989787553206806
22Rv1,2742550,3.8751655229026674
Granta-519,11494412,-1.422706675432074
SK-MES-1,9926054,1.7676300515090215
ME-1 [Human leukemia],136227924,3.8385097232305103
YAPC,9926054,1.8358643335634888
Panc 04.03,1566236,3.6247050899799698
SK-ES-1,3465537,3.500986365111438
NCI-H2081,9884685,-0.1678318744759171
TTC-709,135421197,1.6212603414567397
HSC-2,135659046,3.2324626300653465
KNS-62,11494412,3.2232509119756245
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
K029AX,selumetinib-GDC-0941 (4-1 mol-mol),-0.0187548496270864
BT 245,6918638,0.7917501577559235
HMC-1-8,sirolimus-bortezomib (250-1 mol-mol),1.238114753866591
ONCO-DG-1,3854666,0.637439715699951
JHUEM-1,135984461,4.231451308328731
LMSU,tanespimycin-bortezomib (250-1 mol-mol),0.1689419151943554
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
THP-1,1566236,1.6784142154407886
SK-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4310498502666769
NCI-H441,100016,5.015174861435744
NB1,2746,2.341012333124764
MHH-CALL-4,65628,1.9162335341820356
DEL,9915743,3.429632007483548
SNU-1196,9935249,3.6469845299154726
KNS-60,selumetinib-GDC-0941 (4-1 mol-mol),3.6071015552128873
SU-DHL-8,2746,1.0938758310486527
JHH-5,9884685,3.4124778347887106
PL-21,2746,1.912238920638634
COLO 684,9915743,1.4008131015785188
NCI-H1703,54618771,1.8200920979055903
AML-193,tanespimycin-bortezomib (250-1 mol-mol),-1.641441169090329
A-204,71751553,3.978264694616455
EKVX,9935249,2.6667854349625566
NU-DHL-1,136227924,1.2519389073848997
TE 617.T,65628,4.20520230930191
SNU-46,100016,6.6556000707540095
PF-382,3854666,0.8290647153929614
SW1353,3854666,1.0037118421292317
SNU-475,6918638,2.175803719234096
SNU-1,sirolimus-bortezomib (250-1 mol-mol),0.1110784277529242
KMS-27,sirolimus-bortezomib (250-1 mol-mol),0.0328786954835015
Hep 3B2.1-7,tanespimycin-bortezomib (250-1 mol-mol),-0.3332537957884871
ACC-MESO-1,135398744,5.83972457285084
KALS-1,9935249,3.898562329613611
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
SK-MEL-5,tanespimycin-bortezomib (250-1 mol-mol),1.5988116818939204
Hs 578Bst,11494412,4.466651990011993
SNU-601,4705,3.2115549185604757
OAW42,tanespimycin-bortezomib (250-1 mol-mol),2.1968698973757257
Mono-Mac-1,10322450,2.242206847932455
MKN1,sirolimus-bortezomib (250-1 mol-mol),0.957329263001516
BV-173,135398744,4.1083578998819945
HEY A8,selumetinib-GDC-0941 (4-1 mol-mol),1.3817126396854498
SIG-M5,sirolimus-bortezomib (250-1 mol-mol),0.1286056255448012
NCI-H1339,6918638,0.2750671891608724
DU4475,71751553,4.242765792802766
COV362,71751553,4.353596116077162
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
LS513,9935249,3.2653924263768643
TE-6,1566236,4.012567975048785
HEC-1-B,136227924,3.6469104939920154
T84,1566236,1.6536979341568203
Granta-519,6918638,-1.0102021398050984
BICR 6,1566236,1.9670842482993127
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
NCI-H1915,1566236,2.5492075643485532
Mel Ho,selumetinib-GDC-0941 (4-1 mol-mol),-1.3923525506877812
KYSE-30,9868037,3.995382741587693
LS123,sirolimus-bortezomib (250-1 mol-mol),1.3187092506497549
NALM-6,136227924,1.937403591420271
639V,54618771,0.9699506907820744
TC-71,9926054,1.5758673536433587
DV-90,11494412,-1.43146933490536
SW1353,9935249,5.005901458565512
KNS-42,11152667,1.7002195185356743
COV362,3465537,2.7023896432001733
MOLT-16,73707386,2.2080155946135007
SET-2,3854666,1.160822920042355
TCCSUP,9911463,4.056352676279941
BT 147,9926054,1.807277739033318
KMS-18,2746,2.154567509155723
NOMO-1,3854666,1.0231806307237967
NCI-H2087,54618771,-0.2190788311634532
OAW42,10322450,4.813249082593069
U-CH1,9915743,-0.5689803305661224
COV434,9935249,0.9840385733400504
IGR-1,1566236,1.9029402037211105
BT 216,65628,5.58909901665688
SK-ES-1,1566236,1.3455371740590636
SW1271,135659046,3.922158232881772
P3HR-1,1566236,2.3415442579386987
COLO 678,9926054,1.8882856749448629
SK-ES-1,9884685,-0.8929254514041229
A2780,sirolimus-bortezomib (250-1 mol-mol),-4.6812912688082555
LC-1/sq-SF,6918638,0.3702997456121862
NCC-StC-K140,2746,2.399339405510586
KYSE-180,9911463,4.116935332494812
T24,4705,3.5984863118556065
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
KYSE-30,9935249,3.1154683324094368
LUDLU-1,9935249,3.4988429310109264
BT 216,11152667,1.8521130172934532
K-562,2742550,1.8061055262772656
DK-MG,3854666,0.8707231532991512
5637,135421197,1.1694761088255747
EB1,10322450,2.387875240843174
NCI-H1339,9911463,4.3916675652750925
NCI-H2228,3465537,5.100002381629012
OE21,9935249,1.7053577449970625
NCI-H2452,136227924,3.4253193575490695
BT 224,71751553,4.407976562424278
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448
KYM-1,sirolimus-bortezomib (250-1 mol-mol),0.1122184014552232
NCI-H2052,sirolimus-bortezomib (250-1 mol-mol),3.0581569825638417
SUP-T1,100016,6.229647258472745
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
SNU-685,2746,3.0176644885418056
SNU-886,135398744,6.3424886084429435
BHT-101,sirolimus-bortezomib (250-1 mol-mol),1.6700358071481498
UACC-257,135421197,1.9290983247334992
HCC1954,54618771,-0.9668163478355224
SU-DHL-1,65628,3.0805404655500843
SNU-C2A,135421197,5.231431749442163
SNU-719,3854666,4.073079265106613
Sq-1,11152667,-1.3140921047356755
NCI-H196,9868037,4.869553170308075
Mono-Mac-1,9868037,1.9108517803242744
MHH-ES-1,49836020,5.438630069429388
RCC10RGB,135421197,4.393109316582631
BT 440,2742550,3.3908982659384668
LCLC-103H,sirolimus-bortezomib (250-1 mol-mol),2.0296751829948683
NCI-H1651,9911463,4.060056657134865
A-375,100016,6.005492870785018
NCI-H2029,2746,2.486824956560061
LS1034,11152667,0.8780645856082363
A3/Kawakami,3854666,0.4749804241070199
SNU-685,sirolimus-bortezomib (250-1 mol-mol),0.4201840468382607
HEC-151,135659046,3.7740160846468
NCI-H23,11494412,-0.4680789273941572
NCI-H211,3465537,0.5035689428238851
MDA-MB-361,100016,6.5281042722822145
G-292 clone A141B1,135398744,6.65861915049708
LS180,135984461,4.839780886141452
Rh41,9868037,1.7289800807892195
NCI-H526,9926054,1.8580444014969677
AN3-CA,3854666,0.7881289812333258
GA-10,9935249,-0.4353694549259401
KMBC-2,135421197,1.90199423292403
BT 145,3854666,0.0488390868227151
AsPC-1,tanespimycin-bortezomib (250-1 mol-mol),-2.405972862542407
JHH-2,11494412,1.3748169332763898
SCaBER,54618771,2.268737587506627
HOP-92,136227924,3.2563886907656725
